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Heterocyclic alcohols were coupled with π-nucleophiles in the presence of 
trimethylsilyl trifluoromethanesulfonate to provide a variety of substituted β-heteroaryl 
propionates, including those with contiguous quaternary centers.  This reaction also 
provided -heteroaryl propionates which were previously inaccessible by known methods 
by exploiting non-traditional Friedel Crafts reactivity. Good diastereoselectivity was also 
achieved when a chiral auxiliary was incorporated into the -nucleophile. 
Progress towards the synthesis of acutumine, an alkaloid possessing a densely 
functionalized aza-propellane core, two quaternary centers, and a neopentylic chlorine 
atom, was pursued.  A variety of routes were employed, with some of the key steps 
explored including a Moore cyclization between dimethyl squarate and protected butyn-
3-ols, a SmI2 mediated ring opening of a densely functionalized dihydroisoquinoline ring, 
and a Stille reaction to install an key allyl functional handle.   
 The thermodynamics behind the binding affinity of various ligands to the Src 
SH2 domain was also investigated.  A series of four ligands were designed and 
 vii 
enantioselectively synthesized in order to compare how differences in the conformations 
of the ligands affect the thermodynamics of binding.  Namely, cyclopropanes were 
introduced into tetrapeptides to restrict the ligands to their binding conformations.  The 
constricted ligands will then be compared to their appropriate flexible controls via the use 
of isothermal titration calorimetry (ITC) to determine the thermodynamics differences of 
binding between the two.   
 viii 
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CHAPTER  1: FORMATION OF -HETEROARYL PROPIONATES 
VIA LEWIS ACID MEDIATED TRAPPING OF BENZYLIC 
CARBOCATIONS WITH -NUCLEOPHILES 
1.1 INTRODUCTION 
-Heteroaryl propionates 1.1, are important synthetic targets because they are 
found in a variety of biologically active compounds.  Some examples of such compounds 
are depicted in Figure 1.1, and in each case the -heteroaryl propionate moiety is 
highlighted.  The propionates include a large range of - and/or -substituents, and while 
only indole and furan are shown below, many other electron-rich heterocyclic 
propionates can be found in the literature. -Heteroaryl propionates also exhibit a wide 
range of biological activities.  Indolmycin (1.2) is an antibiotic that exhibits significant 
activity against bacterial Staphylococci aureus.
1
  Furylalanine (1.3) is a common 
fungicide, whereas thaxtomine A (1.5) acts as a phytotoxin to induce necrotic lesions on 
potato minitubers .
2,3
  Indolobutyric acid (1.4) is an anti-inflammatory agent that 
specifically targets the COX-2 enzyme and hemiasterlin (1.6) can disrupt the mitosis of 
cancer cells.
4,5
  Two other natural products that also contain -heteroaryl scaffold include 
welwistatin (1.8) and actinophyllic acid (1.7), which have both been recently synthesized 
by the Martin group using methodology that will be described later.
6
  Welwistatin (1.8) 
has been shown to reverse multiple drug resistance of human cancer cells in combination 
with several anticancer drugs, while actinophyllic acid (1.7) can inhibit fibrinolysis.
7,8
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Figure 1.1 
 
1.2 MAIN METHODS TO SYNTHESIZE -HETEROARYL PROPIONATES 
There exist two main paths to access -heteroaryl propionates.  The first, (EAS), 
involves the conjugate addition of heteroaromatic nucleophilesto--unsaturated 
carbonyl derivatives (Scheme 1.1). The second route to -heteroaryl propionates, (SN1), 
involves an SN1-type reaction in which the heteroaryl ring bears a benzylic-like leaving 
group, which ionizes in the presence of a suitable Lewis acid (Scheme 1.1).  The nascent 
  
 
3 
carbocation can then be captured by a suitable -nucleophile to produce the desired 
propionate. 
Scheme 1.1 
 
1.3 SYNTHESIS OF -HETEROARYL PROPIONATES BY EAS 
One of the most direct and widely utilized methods to prepare -heteroaryl 
propionates is the Michael addition of electron rich heterocycles to -acceptors.  These 
conjugate additions are usually catalyzed by either Lewis or Bronsted acids. High 
yielding examples of both achiral and chiral reactions of this type are well precedented in 
the literature, with high stereoselectivity present in many chiral cases.
9-28
 However, this 
type of reaction is limited to the site of the heteroaromatic ring favored by classical 
electrophilic aromatic substitution reactions, and polyalkylation can be a significant 
problem for heterocycles that bear more than one active nucleophilic site.  Moreover, 
substitution on the unsaturated moiety (Scheme 1.1, R1, R2 = alkyl) is limited,
10,29,30
 with 
,-disubstitution products (Scheme 1.1, R3, R4 = alkyl) seemingly completely 
inaccessible through this route.  Specific examples from this route will be found in the 
succeeding paragraphs. 
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1.3.1 CONJUGATE ADDITIONS OF ELECTRON RICH HETEROAROMATIC RINGS WITH - 
ACCEPTORS CATALYZED BY BRONSTED ACIDS 
Acidic clays are efficient promoters of the conjugate additions of various indole 
derivatives to -unsaturated ketones and esters (Schemes 1.2 and 1.3).9   The reactions 
are moderate to high yielding (70-90%) for 3-unsubstituted indoles using both types of 
electrophiles, with -unsaturated ketones providing the best results.  The yields of -
unsaturated esters can be improved with higher reaction temperatures and longer reaction 
times, but polyalkylation may then become problematic. It is interesting to note that 
Jackson and coworkers were able to effect the Michael reaction between a 3-substituted 
indole and methyl acrylate to provide 1.18, albeit in low (35%) yield (Scheme 1.2).
9
  
Cintas et al. showed that addition of furan to methyl vinyl ketone (1.14) could also be 
catalyzed by Montmorillonite clay, though in this case the major product was dialkylation 
1.16 (Scheme 1.3).
31
  While this method boasts fairly straightforward reaction conditions 
and an easy workup (filtration of the catalyst from the reaction mixture), the use of 
unsaturated esters as electrophiles requires harsher reaction conditions that may not be 
amenable to acid sensitive substrates.  Moreover, -substitution on the Michael 
acceptor has not been shown, which would make this route a poor method to access -
substituted heteroaryl propionates.   
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Scheme 1.2 
 
Scheme 1.3 
 
Amberlyst-15 has also been used as an efficient Bronsted acid-promoter of 
Michael additions of indoles to -unsaturated ketones (Scheme 1.4).32  The reaction 
conditions were less harsh than using Montmorillonite clay, and the catalyst loadings 
were also lower (10 mol % vs. 20 mol %).  The conjugate additions took place in 
moderate to excellent yields (60-95%), and a limited number of -substituents were 
tolerated on the Michael acceptor.  However, the substrate scope was limited to 2-
methylindole and a few different unsaturated ketones.  No examples of additions to 
unsaturated esters, which would provide the most direct access to -heteroaryl 
propionates, were reported. 
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Scheme 1.4 
 
Bhanage and coworkers successfully catalyzed heterocyclic conjugate additions 
using polyvinylsulfonic acid (PVSA), a Bronsted acidic polymer 1.28 (Scheme 1.5).
33
  A 
variety of indoles were allowed to react with chalcones to provide the desired -
substituted adducts in moderate to good yields (46-92%).  Electron-rich indoles paired 
with electron-poor chalcones gave the best results, but like previous examples, the scope 
of the reaction was limited to a single heterocycle and a select few unsaturated ketones.  
The reaction conditions were also somewhat harsh as they required heating at elevated 
temperatures for long periods of time. 
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Scheme 1.5 
 
Triflic acid (TfOH) has been shown to catalyze Michael additions of indoles and 
pyrroles to -unsaturated ketones in moderate to excellent yields (60-94%) (Schemes 
1.6 and 1.7).
16
  The reaction conditions are very mild and environmentally friendly as the 
solvent was water.  However, the scope of this reaction is also limited to unsaturated 
ketones, and dialkylated propionates were the major products of the reaction when the 
acid sensitive pyrrole was employed as the nucleophilic partner. 
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Scheme 1.6 
 
Scheme 1.7 
 
Acetic acid (AcOH) has also been used to catalyze Michael reactions with indoles 
and unsaturated ketones (Schemes 1.8 and 1.9).  In 1957, Szmuszkovicz and coworkers 
reacted indole with methyl vinyl ketone in acetic acid at elevated temperatures.
34
  The 
conditions were rather harsh, and the yields of the resulting adducts were poor to 
moderate at best (31-75%).  However, Szmuszkovicz was able to effect addition at the 2-
position of the indole when the 3-position was substituted, albeit in only 31% yield.  
Dinnell and co-workers expanded upon the methodology to catalyze the conjugate 
addition of indole 1.45 with acrylic acid (1.46) using acetic anhydride as an additive to 
provide the -heteroaryl propionic acid 1.44 in a single step in 46% yield.35  This method 
  
 
9 
still suffers from a narrow substrate scope that does not encompass -substitution on 
the electrophile.   
Scheme 1.8 
 
Scheme 1.9 
 
In 2007, 2-iodoxybenzoic acid (IBX) was used to catalyze a one-pot oxidative 
Michael reaction of Baylis-Hillman adducts with indoles to provide -keto propionates in 
good yields (70-80%) (Scheme 1.10).
36
  The reaction was applied to a variety of Baylis-
Hilman adducts with both electron rich and electron poor indoles, but the scope seems 
rather limited to forming -keto, -unsubstituted indole propionates.   
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Scheme 1.10 
 
 
A variety of acidic ionic liquids have also been shown to promote heterocyclic 
conjugate additions (Schemes 1.11 and 1.12).  For example, the pyridyl ionic liquid 1.56 
can be used in a very low catalyst loading (1 mol %) to promote the addition of electron-
rich and electron-poor indoles to chalcones in very high yields (> 90%), though the scope 
of the electrophile was limited to chalcones.
37
  Imidazolium salt 1.63 also promotes 
conjugate additions of indoles to chalcones in excellent yields (>88%).
38
  However, the 
most interesting example using catalyst 1.63 involved the addition of indole to a -
disubstituted unsaturated ketone to provide the -disubstituted propionate 1.71 in 48% 
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yield.  While both of these catalysts show promise, their efficacy in Michael additions 
with indole seem limited to chalcones as the acceptor.   
Scheme 1.11 
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Scheme 1.12 
 
 
A few examples of chiral Bronsted catalysis of heterocyclic conjugate additions 
to-unsaturated ketones are also known (Schemes 1.13 and 1.14).28,39  Two examples 
shown below both utilize a chiral phosphoric acid scaffold to enable the Michael 
reactions.  In the first example, catalyst 1.72 (5 mol %) was used to promote the 
intramolecular Michael addition of indoles to -unsaturated ketones attached at the 2-
position of the indole (Scheme 1.13).
39
  The reaction produced the bicyclic adducts in 
  
 
13 
excellent yield and enantioselectivity regardless of the electronic nature of any other 
substituents present on the indole.  However, the reactions were very narrow in scope, 
and it is unclear whether or not this enantiocontrol can be expanded to intermolecular 
reactions.   
Scheme 1.13 
 
The second example of using a chiral phosphoric acid catalyst 1.78 to promote the 
addition of indole to -unsaturated ketones is shown in Scheme 1.14.28  While the 
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catalyst loading was low (2 mol %) and the conditions were mild, the reactions between 
indole and the electrophiles were moderate yielding with poor enantioselectivity.  
Chalcone electrophiles gave the best results with ee’s of 50%, while cyclic ketones gave 
the worst results (29% ee).  As poor as these results are, they established important proof 
of principle that intermolecular Michael additions of indoles to -unsaturated 
electrophiles can be facilitated by chiral phosphoric acid catalysts.   
Scheme 1.14 
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Another example of a chiral Bronsted catalyst is shown in Scheme 1.15.  The 
imidazolium camphorsulfonic acid complex 1.86 was used to promote the addition of 
various indoles to chalcones in high yield (>85%), but very poor enantioselectivity (19-
58%).
18
  Although the enantioselectivies were poor and the substrate scope was narrow, 
this catalyst provided another example of the possibility of achieving -heterocyclic 
propionates via Bronsted acid catalysis.   
Scheme 1.15 
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1.3.2 CONJUGATE ADDITIONS OF ELECTRON RICH HETEROAROMATIC RINGS WITH - 
ACCEPTORS CATALYZED BY LEWIS ACIDS 
Like the Bronsted acid-catalyzed conjugate additions, there are many examples of 
Lewis acid-catalyzed Michael reactions between heterocycles and -acceptors.  
Highlights of some of the more useful and versatile processes will be discussed. 
Some of the earliest examples of Lewis acid-catalyzed heterocyclic, Michael reactions 
include the use of iodotrimethylsilane (TMSI) and boron trifluoride etherate (BF3·OEt2).  
In 1983, Kraus and coworkers showed that a variety of furans add to hindered cyclic 
enones in moderate to good yields (67-95%) in the presence of stoichiometric amounts of 
TMSI (Scheme 1.16).
40
  The scope of the reaction is fairly limited, both with regard to 
nucleophile and electrophile, but it is important to note that significant amounts of mono-
alkylated product were produced as the major product of the reactions.  In many of the 
previous examples, polyalkylation plagued the use of furans in acid catalyzed conjugate 
additions.   
Scheme 1.16 
 
Another early example utilized catalytic amounts of boron trifluoride etherate 
(BF3·OEt2) to promote the reaction between indoles, furans, and thiophenes with enones 
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(Scheme 1.17).
41
  The reaction yields varied wildly (32-95%) with heterocycles 
containing electron donating groups and electrophiles possessing minimal, if any, 
substitution providing the highest yields.  Some of the most interesting products include 
furan 1.103, which bears -disubstitution, and indole 1.106, which reacted at the 2-
position of the indole, albeit in low yield.  -Unsaturated esters were not examined in 
the reactions, and the low yields indicated a lot of room for improvement. 
Scheme 1.17 
 
One of the cheapest and easiest Lewis catalysts employed in heterocyclic Michael 
reactions is elemental iodine (I2).  Bench stable, cheap, and easy to handle, iodine is an 
attractive option for catalysis.  Iodine promotes the reactions between indoles and 
chalcones (Scheme 1.18),
42
 -unsaturated ketones (Scheme 1.18),42 nitroolefins 
(Scheme 1.19),
15
 and Baylis-Hilman products (Scheme 1.20).
43
  In all instances, the 
reactions proceeded under mild conditions to produce the addition products in moderate 
to high yield (60-90%).  Some of the best examples include adduct 1.115, which contains 
  
 
18 
-disubstitution and was obtained in relatively good yield (70%), and 3-substituted 
indole 1.120, which was obtained in excellent yield (99%) when reacted with nitroalkene 
1.117 at the 2-position.  Pyrrole was also effectively used as a nucleophile with -
nitrostyrene (1.117), producing 1.121 in 70% yield.  While the results of these studies are 
are impressive, the scope of the electrophile remain narrow.  None of these reactions 
produced -heteroaryl propionates in a single step, nor do they include -substitution 
on the propionate.   
Scheme 1.18 
 
Scheme 1.19 
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Scheme 1.20 
 
1.3.2.1 METAL HALIDES  
Metal halides are another class of Lewis acidic catalysts that are frequently used 
in Michael reactions between heterocycles and -acceptors.  In 2001, Yadav and 
coworkers found that InCl3 efficiently promoted the reaction between indoles and a 
variety of -unsaturated ketones in good yield (>85%) (Scheme 1.21).11  The 
conditions were mild and featured short reaction times as well as low catalyst loading (10 
mol %).  However, no -unsaturated esters were examined, nor were any - and/or - 
substituents present on the ketones.  In 2009, Blay et al. expanded the scope of the 
nucleophile to include pyrrole, and he expanded the scope of the electrophile to include 
(E)-1,4-diaryl-2-buten-1,4-diones 1.131 (Scheme 1.22).
44
 
Scheme 1.21 
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Scheme 1.22 
 
Bandini and coworkers showed that InBr3 exhibited similar reactivity towards 
promoting heterocyclic Michael additions as did InCl3 (Scheme 1.23).  A variety of 
indoles were allowed to react with cyclic -unsaturated ketones in good yields (68-
95%), with N-H and N-Me indoles exhibiting similar results.
12
  Bandini reported an 
example of a hindered 2-substituted indole reacting with a hindered -substituted enone 
to provide indole 1.143 in an impressive 90% yield.  However, no examples with 
unsaturated esters were presented, so extra steps must be implemented to reach -
heterocyclic propionates.   
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Scheme 1.23 
 
Some other common halide salts that have been successfully employed in 
heterocyclic conjugate additions include FeCl3, ZnCl2, ZrCl4 and TiCl4.  In 2008, Wang 
and coworkers used FeCl3 (20 mol %) to promote the addition of various indoles to 4-
aryl-4-oxobut-2-enoates (1.145) in good yields (73-92%) (Scheme 1.24).
45
  Both electron 
rich and electron poor groups were tolerated on the nucleophile and electrophile to give 
the corresponding -substituted indoles.  Zhou and coworkers also used FeCl3 in 
conjunction with Mg(ClO4)2 and HMPA to induce the reaction of indoles with chalcones 
in modest yields (Scheme 1.25).
46
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Scheme 1.24 
 
Scheme 1.25 
 
Yamauchi showed that when furan (1.154) was treated with 1-acetyl-1-
benzoylethylene (1.153) in the presence of stoichiometric ZnCl2, Michael adducts were 
formed in good yield (Scheme 1.18).
47
  Unfortunately, polyalkylation was a major side 
product of the reaction, thereby limiting its utility.  In fact, when the reaction time was 
increased the dialkylated adduct 1.156 became the sole product.   
Scheme 1.26 
 
Zirconium (IV) chloride (ZrCl4) was also used as a catalyst for heterocyclic 
conjugate additions.  In 2006, Kumar and coworkers accessed a variety of -heteroaryl 
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propionates by using -unsaturated esters and -unsaturated malonates in Michael 
additions with indole, pyrrole, and pyrazole.  Some of their best results are shown in 
Scheme 1.27.  All heterocycles produced -heteroaryl propionates in good yields (72-
86% yield), under mild conditions and low catalyst loading (2 mol %).
30
  The method 
also worked well with various cyclic and acyclic -unsaturated ketones as the 
electrophiles, often with better yields than the aforementioned esters and malonates, but 
those adducts did not provide direct access to -heteroaryl propionates.  The only ester 
examined was ethyl acrylate, which provided the desired propionates in moderate yields 
(85-86%).  The malonate alkylidene 1.158 (where R3 = OBn and R4 = CO2Bn) reacted 
with the heterocycles in good yield, even tolerating the bulky isopropyl group at the -
position of the propionate, as illustrated by formation of 1.162-1.164.  However, unless 
an ester was desired at the -position, saponification and decarboxylation would be 
required to obtain a -substituted heteroaryl propionate.  The only major drawback to this 
method is the lack of scope of -substituted esters.    
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Scheme 1.27 
 
The alkylidene malonate electrophile 1.158 (where R3 = OBn and R4 = CO2Bn) 
(Scheme 1.27) can also be generated in the presence of a heterocyclic nucleophile, such 
as indole (1.165) to provide the same -substituted heteroaryl propionates (Scheme 
1.28).  This one pot procedure may save a step by in situ generation of the electrophile, 
but it requires the use of stoichiometric TiCl4 as opposed to 2 mol of ZrCl4.
48
   
Scheme 1.28 
 
In addition to the more common metal halides discussed previously, more exotic 
and expensive metal halides have been investigated in the context of heterocyclic 
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conjugate additions.  For example, in 2003 Bartoli used a solid supported cerium (III) 
chloride hydrate in conjunction with NaI to promote the reaction of various indoles to 
cyclic and acyclic enones in good yields (79-89%) (Scheme 1.29).
13
  Electron rich and 
electron poor indoles were equally effective in the reaction, but when a 3-substituted 
indole was subjected to the reaction conditions, the desired adduct was formed in only 
9% yield.  No -unsaturated esters were investigated.   
Scheme 1.29 
 
In 2005, Zhan and coworkers showed that SmI3 (20 mol %) promoted Michael 
additions of indoles to various cyclic and acyclic enones, as well as nitroolefins in good 
yields (>85%) (Scheme 1.30).
49
  While the reactions proceeded in high yields (85-95%), 
no -esters were examined, and SmI3 is an expensive choice for a Lewis acid, 
especially when the reaction conditions require a somewhat high catalyst loading of 20 
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mol %.  A couple of years later Kundu et al. used antimony (III) chloride to affect the 
reaction between indoles and chalcones in excellent yields (Scheme 1.31).
50
  The reaction 
worked equally as well on electron-rich and electron-poor electrophiles, but again, the 
scope of the reaction was limited to chalcones, and the cost of SbCl3 makes it an 
unattractive choice for a catalyst.   
Scheme 1.30 
 
Scheme 1.31 
 
Gold (III) catalysts have also been widely explored in the context of promoting 
Michael reactions of heterocyclic nucleophiles.  In 2007, Ambrogio and coworkers 
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reported the use of tetrachloroaurate (III) dehydrate (NaAuCl4·2H2O) to promote 
conjugate additions between indoles and methyl vinyl ketone (Scheme 1.32).
51
 Although 
the catalyst loading was low (1 mol %) and the use of ionic salt 1.190 as a solvent 
rendered the reaction environmentally friendly, the reaction conditions called for 
prolonged stirring at elevated temperatures. The scope of the electrophile was also 
limited to methyl vinyl ketone. Arcadi and coworkers expanded the scope of the reaction 
to include conjugate additions between indoles and a variety -enones (Scheme 1.33).52  
Though the catalyst loading was slightly higher (5 mol %) than used by Ambrogio, the 
reactions could be run at ambient temperatures for shorter periods of time.  The Michael 
additions worked well with both cyclic and acyclic enones (83-92%), and many had -
substituents present on the enone.  Even 3-substituted indoles worked surprisingly well in 
the reaction, but the larger the substituent on the 3-position the lower the yield of the 
conjugate addition.  Arcadi also successfully employed nitroolefins as the electrophiles in 
the Michael reactions of heterocycles, expanding the scope of the catalyst even further.  
The scope of the reaction was further extended to include pyrroles as nucleophiles 
(Scheme 1.34).
53
  Various pyrroles were reacted with methyl vinyl ketone to provide 
mainly dialkylated product, unless there was already a substituent present at the 2-
position of the pyrrole.  The yields were also considerably lower than those of the indole 
examples.  While NaAuCl4·2H2O shows promise as a catalyst for these Michael 
reactions, the scope of the reactions are not sufficient to overcome the cost of the catalyst, 
especially when it has been shown that other, less expensive catalysts produce similar or 
even better results.   
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Scheme 1.32 
 
Scheme 1.33 
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Scheme 1.34 
 
1.3.2.2 METAL TRIFLATES  
In addition to metal halides, metal triflates also promote the conjugate additions 
between heterocycles and various -acceptors.  First the achiral catalysts will be 
presented, followed by examples of enantioselective heterocyclic Michael additions.   
In 1996, Harrington and Kerr demonstrated the use of ytterbium (III) triflate in conjugate 
reactions between indole and -unsaturated enones (Scheme 1.35).54 In general, the 
reactions involving unsubstituted or mono-substituted enones proceeded in moderate to 
excellent yields (73-95%), whereas the reactions involving bulky or di-substituted 
electrophiles proceeded in poor to modest yields (3-44%). N-Methyl indole appeared to 
work better than indole itself as a nucleophile. In 1998, Harrington and Kerr improved 
their method by subjecting the reactions involving the bulkiest enones to increased 
pressure to facilitate addition (Scheme 1.35).
10
  While the increased pressure did improve 
yields (11-72%), the yields of - or - substituted indoles were still relatively low.  
Examples involving a nitroolefin and a malonate were also shown to be compatible with 
the catalyst, although no reactions involving -unsaturated esters were performed.  The 
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scope of this reaction seems limited to fairly unsubstituted ketones, which will not 
provide a satisfactory general method to access -heteroaryl propionates.   
Scheme 1.35 
 
 Vanadyl triflate (VO(OTf)2)  has also been shown to catalyze the conjugate 
addition between indoles and -unsaturated ketones in comparable (or better) yields to 
those obtained using Yb(OTf)3 (Scheme 1.36).
55
  In addition, the scope of the 
heterocyclic nucleophile was expanded to encompass furan and thiophene, which both 
reacted with cyclic enones in good to excellent yields (85-98%).  The vanadyl triflate 
conditions also tolerated -substituents on the electrophiles to provide the corresponding 
adducts 1.218 in good yields (ca. 90%).  However, no -unsaturated esters were 
examined, so the scope of this promising reaction may also be limited.   
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Scheme 1.36 
 
  In 2003, Alam reported that bismuth (III) triflate was an efficient catalyst to 
promote the addition of indole (1.223) to methyl acrylate (1.224) (Scheme 1.37).
56
  While 
the yield was modest (62%) and there was no substitution present on the electrophile, this 
example is one of the only ones to show that -unsaturated esters can be used in Lewis 
acid-catalyzed Michael reactions with heterocycles.   
Scheme 1.37 
 
 Scandium (III) triflate (Sc(OTf)3) and copper (II) triflate (Cu(OTf)2) are two more 
triflates that effectively catalyze the addition of heterocycles to -unsaturated ketones 
(Schemes 1.38 and 1.39).  Sc(OTf) was used by Kawatsura to induce the reaction of 
electron rich and electron poor indoles to cyclic and acyclic enones (Scheme 1.38).
57
  The 
reactions proceed in moderate to good yields (62-90%) and tolerated -methyl 
substituents on the electrophile, but no -esters were examined.  Bulbule showed that 
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Cu(OTf)2 promotes the reaction of furan and thiophene derivatives to cyclic and acyclic 
-unsaturated ketones in moderate yields (55-63%) (Scheme 1.39).58  However, 
dialkylation was a major problem unless the 2-position of furan or thiophene was already 
substituted.  While the scope of the Sc(OTf)3 -Cu(OTf)2 promoted reactions are limited, 
they are particularly important Lewis acids to consider because they were eventually 
developed into chiral catalysts for the enablement of heterocyclic Michael additions.   
Scheme 1.38 
 
Scheme 1.39 
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1.3.2.3 CHIRAL LEWIS ACIDS 
Jørgensen and coworkers were the first to develop an enantioselective Lewis acid-
catalyzed heterocyclic Michael reaction in 2001 (Schemes 1.40 and 1.41).
59
  Using the 
copper bisoxazoline catalyst 1.239, they showed that indoles and 2-substituted furans 
reacted with -unsaturated -ketoesters 1.240 in good yields (69-99%) and good to 
excellent enantioselectivities (79-99.5%).  Electron rich indoles generally performed 
better then electron poor indoles and the enantioselectivities of reactions involving indole 
were significantly higher than those of furan, though both the reactions were high 
yielding.  While this work is impressive, it is unclear how the products might be 
elavorated to -heterocyclic propionates.  Due to the bidentate nature of the catalyst, 
the electrophilic partner of the conjugate addition must have at least two Lewis basic 
sites, so -unsaturated esters would be unsuitable partners in the reaction.  Another 
potential pitfall associated with this method is that dialkylation of heterocycles other than 
indole may be a problem that would substantially limit the scope of the method.  All 
examples involving furans were performed with 2-substituted furans, thereby obviating 
the possibility of dialkylation. 
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Scheme 1.40 
 
Scheme 1.41 
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A few months after their seminal publication, Jørgensen and coworkers published 
a second paper in which they utilized the same copper catalyst 1.239 in conjugate 
additions between indole, pyrrole, or furan and aryl substituted alkylidene malonates 
1.253 (Scheme 1.42).
60
  The yields of the reactions were comparable to those observed 
previously, but the enantionselectivities from the reactions involving alkylidene malonate 
as electrophiles were significantly lower.  Many of the same limitations from the previous 
examples apply to the malonate reactions, although the products of these reactions are 
-substituted heteroaryl propionates, albeit very specific ones.  A few years later, 
Reiser et al. used the aza(bisoxazoline) copper catalyst 1.260 at only 5 mol% to promote 
the reaction between indole and phenyl alkylidene malonate 1.262 in 97% yield and 99% 
ee; this represents a significant improvement over the initial work of Jørgensen (Scheme 
1.43).
61
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Scheme 1.42  
 
Scheme 1.43 
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 In 2005, Linden and coworkers further expanded on the scope of catalyst 1.239 by 
incorporating ’-hydroxy enones as electrophiles into Michael reactions with indole and 
pyrrole nucleophiles (Scheme 1.44).
62
  The yields of the reactions were moderate to good 
(44-86%), but the enantioselectivities were high (85-95%).  The reaction also tolerated 
bulky groups, such as isopropyl.  Owing, however, to the bidentate nature of the copper 
catalyst, -heteroaryl propionates cannot be directly accessed using this catalyst.  The 
authors did show that their ’-hydroxy products 1.266 could be transformed into the 
heteroaryl propionates by oxidative cleavage with periodic acid (HIO4) and subsequent 
esterification (Scheme 1.45). 
Scheme 1.44 
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Scheme 1.45 
 
 In 2007, a slightly different copper bisoxazolone catalyst 1.273 was developed by 
Chen and coworkers to synthesize chiral tryptophan derivatives.
20
  -Aryl substituted 
nitroacrylates were allowed to react with various indoles in the presence of 1.273 (10 mol 
%) to yield -nitro, -aryl substituted -heteroaryl propionates in good yields (70-85%) 
and modest diastereoselectivities (Scheme 1.46).  They then reduced the nitro group 
using zinc and acetic acid to provide the desired tryptophan analogues.  The nitro group 
could also be reduced to provide -aryl, -heteroaryl propionates in moderate yield, but 
this method would be incompatible with halogenated heterocycles (Scheme 1.47).   
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Scheme 1.46 
 
Scheme 1.47 
 
 Singh and coworkers found that copper pyridyl bisoxazoline catalyst 1.284 
promoted the Friedel-Crafts reaction between indoles and 2-enoylpyridine 1-oxides 1.286 
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in good to excellent yields (75-97%) (Scheme 1.48).
27
  When the -substituent on the 
electrophile was an aryl group, the enantioselectivities of the reactions were high (83-
99%), but if the aryl substituent was replaced with any other group, the 
enantioselectivities of the corresponding reactions plummeted 1.291 (5%).  In addition to 
the narrow scope of the electrophile for the reactions, the further elaboration of the 
pyridine oxides to the desired -aryl, -heteroaryl propionates required rather harsh and 
forcing conditions (Scheme 1.49).   
Scheme 1.48 
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Scheme 1.49 
 
 Copper bisoxazolone catalysts and their related derivatives have been a widely 
explored area of Michael reactions involving heterocyclic nucleophiles and the examples 
shown above are just some of the many methods available in the literature.  However, 
useful work in the field has also been accomplished with other metals, including 
scandium, aluminum, zirconium, and hafnium; all of which will be discussed below. 
 In 2003, Evans and coworkers developed the bis(oxazolinyl)pyridine scandium 
(III) triflate catalyst 1.294 to effect the reaction between indoles 1.295 and crotonyl acyl 
phosphonates 1.296 to provide -substituted, -heteroaryl propionates in a single step in 
the presence of DBU and MeOH (Scheme 1.50).
63
  The method provides a convenient 
and clever solution to accessing -heteroaryl propionates directly from Friedel-Crafts 
reactions using bidentate catalysts.  Recall that in the previous copper catalyzed reactions, 
all of the products obtained from the Michael reactions between the heterocycles and 
their corresponding electrophiles required at least one further elaboration to obtain the 
desired -heteroaryl propionates (cf. Schemes 1.45, 1.47, and 1.49).  This is because the 
electrophiles that were used, such as ’-hydroxy enones (1.265), -aryl substituted 
nitroacrylates (1.275), and 2-enoylpyridine 1-oxides (1.286), needed to possess at least 
two Lewis basic sites in order to accommodate the bidentate ligands to achieve some 
measure of enantiocontrol.  Evans avoided this problem because he hydrolyzed the 
intermediate -indolyl acyl phosphonates 1.297 in situ with a suitable base and alcohol as 
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part of a one pot procedure.  As shown in Scheme 1.50, the reaction produced the -
substituted, -heteroaryl propionates in good yields (75-94%) and high 
enantioselectivities (97-99%), with the exception of when the -substituent was the 
highly hindered TBDPS-protected alcohol 1.301.  Limitations to this method include the 
preparation of and lack of -substituents on the electrophile (Scheme 1.50).   
A few years later in 2007, Evans further developed his method by using catalyst 1.294 in 
reactions with dihydroindoles 1.302 to provide exclusively 2-substituted indole adducts 
after oxidation with p-benzoquinone (Scheme 1.51).
64
  When 1.302 was catalyzed with 
1.294 in the presence of electrophiles of the type 1.303, dihydroindole behaved as a 
pyrrole, and underwent electrophilic aromatic reactions at the 2-position of the 
dihydroindole ring.  Oxidation of the addition product then provided the 2-substituted 
indolyl propionates in 75-94% yield and 57-99% enantioselectivities.
64
  Evans and 
coworkers developed a very clever method towards chiral 2-substituted indolyl 
propionates 1.304, but the use of the dihydroindole is more of a work around than a true 
solution towards obtaining 2-substituted indolyl propionates in a general and direct 
fashion.   
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Scheme 1.50 
 
Scheme 1.51 
 
 Another catalyst successfully employed in Michael reactions of heterocyclic 
nucleophiles include the aluminum (III) salen complex 1.305 developed by Bandini and 
coworkers (Scheme 1.52).
65
  -Unsaturated ketones underwent addition with 2-
substituted indoles in the presence of catalyst 1.305 to provide -methyl, -heteroaryl 
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ketones 1.308 in moderate to good yields (48-96%) and modest enantioselectivities (77-
88%).  The more electron-withdrawing the aryl group attached to the ketone electrophile, 
the better the reaction appeared to work.  Although the enantioselectivies of these 
reactions are not as good as some previous work, this salen catalyst was an important 
contribution to the field because it was the first example of a catalyst requiring only a 
monodentate chelating Lewis basic site on the electrophile.  This suggests that -
heteroaryl propionates could be accessed in a single step if -unsaturated esters were 
capable of being employed as electrophiles.   
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Scheme 1.52 
 
 The last example of a chiral catalyst used in heteroaryl conjugate additions was 
developed by Blay and coworkers and employs a BINOL-derived scaffold (Scheme 
1.53).  In 2007, the authors treated indole (1.315) and pyrrole (1.316) with enone 1.314 in 
the presence of catalyst 1.313 and Zr(OtBu)4 to yield the corresponding -methyl, -
heteroaryl ketones in good yields and enantioselectivities; with indole providing slightly 
better results than pyrrole.
66
  If the scope of the electrophile were expanded to -
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unsaturated esters, then this method would provide direct access to -substituted, -
heteroaryl propionates.   
Scheme 1.53 
 
1.3.3 ORGANOCATALYSTS 
 The early work done on organocatalytic Micheal reactions of heterocycles to -
unsaturated aldehydes was published by MacMillan et al. in 2001 (Schemes 1.54 and 
1.55).
67
  The authors developed the imidazolidinone catalyst 1.320 to lower the LUMO of 
various enal electrophiles via reversible formation of intermediate chiral iminium ions 
such as 1.321.  In the presence of suitable nucleophiles, such as heterocycles, attack of 
the extended iminium ion would occur in a 1,4- vs. 1,2-fashion due to the steric hindrance 
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about the iminium ion, thus producing -substituted, -heteroaryl aldehydes 1.322 in 
good yield and excellent enantioselectivity.  One of the most impressive features about 
this method was that no polyalkylation was observed with respect to pyrroles, probably 
due to the steric nature of the active electrophile.  Recall that both for furan and pyrrole, 
dialkylation was a major problem with respect to Michael additions of heterocyclic 
nucleophiles catalyzed by both Bronsted and Lewis acids.  Another nice feature of the 
method is that catalyst 1.325 can be recovered and reused.  One of the limitations in 
scope, however, is that -substitution on the -heteroaryl aldehydes appears inaccessible 
due to the steric hindrance of the catalyst used to impart the desired enantioselectivity 
over the reaction. 
Scheme 1.54 
 
Scheme 1.55 
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 A year later, MacMillan and coworkers expanded the scope of their reaction to 
encompass indoles (Scheme 1.56).
4
  Imidazolidinone catalyst 1.332, which featured a 
slight structural deviation from 1.325, promoted the reaction between a variety of 
electron rich and electron poor indoles with -unsaturated enals.  Like the pyrrole 
examples, the -substituted, -indolyl aldehydes were obtained in good yields and 
excellent enantioselectivities, though no examples bore an -substituent.  The authors 
further showed that the -substituted, -heteroaryl aldehydes could be converted to the 
corresponding propionic acids via oxidation with silver (I) nitrate in the presence of 
sodium hydroxide in good yield and enantioselectivity.  In fact, indole 1.340 is a known 
COX-2 inhibitor developed by Merck (Scheme 1.57).
4
   
Scheme 1.56 
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Scheme 1.57 
 
 The scope of the reaction was further expanded in 2007.  MacMillan and 
coworkers found that heterocyclic tetrafluoroborate salts 1.341 underwent reaction with 
-substituted, -unsaturated enals 1.343 in good yields and excellent 
enantioselectivities in the presence of 1.342 (Scheme 1.58).
68
  At first glance this method 
may seem more cumbersome due to the additional step of creating tetrafluoroborate salts, 
but the addition of the salts to the nucleophiles enabled less reactive heterocycles to 
participate in the reaction.  For example, benzofuran, which has poor -nucleophilicity, 
and furfuryl aldehyde, which is electron deficient both produced the desired -
substituted, -heteroaryl propionaldehydes in excellent yields and enantioselectivities 
1.345-1.346.  The addition of the tetrafluoroborate salt to the nucleophile also allowed for 
more reactive heterocycles (ie indoles) to react at non-classical electrophilic aromatic 
substitution positions (the 2 vs 3-position of indole) as shown with indole 1.347.  While 
this is certainly a useful method, a route that would not require the special preparation of 
a borate salt would be preferable, as would a route that could prepare -substituted, -
heteroaryl propionaldehydes.   
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Scheme 1.58 
  
 The cinchinone catalyst 1.348 was developed by Chen et. al. in 2007 and was 
found to successfully catalyze the Friedel-Crafts reaction between indoles and -
unsaturated ketones (Scheme 1.59).
69
  The yields varied depending on the size of the -
substituent of the ketone, but they were generally good for most ketones examined (72-
90%).  The enantioselectivities also varied, with electron rich indoles generally 
performing better than electron poor indoles.  While there is room for improvement, the 
method was impressive because it was the first example of an enantioselective 
organocatalyzed Michael addition between a heterocycle and an -enone.   
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Scheme 1.59 
 
Just a few months after Chen’s work was published, Bartoli and coworkers 
published a second report of enantioselective organocatalytic heterocyclic reactions using 
a quinine-like catalyst (Scheme 1.60).
70
  In the method of Bartoli, a chiral cinchona 
amine was coupled with two equivalents of D-N-Boc phenylglycine to provide the 
bifunctional catalyst 1.356.  Bartoli’s catalyst performed better than Chen’s catalyst, 
providing -substituted,-heteroaryl ketones 1.359 in high yields (56-99%) and high 
enantioselectivities (70-96%).  Unfortunately the scope of the nucleophile was limited to 
indoles, and -substituted enones were still out of reach as electrophiles.   
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Scheme 1.60 
 
1.3.4 HETEROCYCLIC ORGANOMETALLICS 
 Another common way to obtain -heteroaryl propionates via the conjugate 
addition pathway is to utilize heterocyclic organometallics as nucleophiles in Michael 
reactions. In general, these reactions tend to have a broader nucleophile scope as the 
inherent -nucleophilicity of the heterocycles can be overcome. However, these reactions 
also tend to require more steps and to utilize more expensive metallic reagents.  A brief 
survey of both chiral and achiral examples will be presented. 
 In 1988 Lipshutz and coworkers showed that lithiated higher order cuprates 
derived from furans could react with cyclic -unsaturated ketones in the presence of 
boron trifluoroetherate to produce the desired Michael adducts in moderate yields (ca. 
65%) (Scheme 1.61).
71
  The conjugate additions proceeded with considerably hindered 
enones, but when the steric bulk became too large to overcome 1,2-addition of the furan 
to the carbonyl would become the predominant product 1.365.   
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Scheme 1.61 
 
Organozinc heterocycles were also developed for use in Michael reactions.  
Knochel et al. examined the use of (trimethylsilyl)-heteroarylzincs 1.367-1.372 in 
reactions with cyclic and acyclic -unsaturated enones (Schemes 1.62 and 1.63).72  
Furan, thiophene, pyrrole, benzofuran, benzothiophene, and indole were all lithiated and 
transformed to their corresponding trimethylsilyl zinc methyl derivatives 1.367-1.372 that 
were then treated with cyclic and acyclic enones to provide the corresponding adducts in 
moderate to good yield (Scheme 1.62).  Knoechel’s work provides some of the only 
examples of conjugate additions wherein the less reactive benzofuran and 
benzothiophene were utilized as nucleophiles.   
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Scheme 1.62 
 
Scheme 1.63 
 
 Since 2003, a number of research groups had begun to investigate the use of 
rhodium catalysis in Michael additions of heterocyclic organometallic reagents.  Hayashi 
first reported the enantioselective conjugate addition of 3-thiophene boronic acid (1.384) 
to -unsaturated lactone 1.385 in good yield (79%) and excellent enantioselectivity 
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(99%) using 3 mol % of a rhodium BINAP catalyst (Scheme 1.64).
73
 Interestingly, the 
conjugate addition took place at the 3-position of thiophene as opposed to the EAS 
preferred 2-position.  While this was an impressive example of an enantioselective 
heterocyclic Michael addition, this was the only example presented in the paper.  It is 
unclear whether the scope of both the nucleophile and electrophile can be expanded.  A 
similar thiophene boronic acid 1.388 was shown by Konno in 2008 (Scheme 1.65).
74
  
Scheme 1.64 
 
Scheme 1.65 
 
 In 2008, Frost and coworkers reported the enantioselective conjugate addition of 
furyl and thiophenyl zincs to the -unsaturated lactone 1.391 in good yields (57-94%) 
and excellent enantioselectivities (86-98%) using a rhodium DUPHOS catalyst (Scheme 
1.66).
75
  The use of heteroaryl zinc reagents was generally favorable as compared to the 
use of their corresponding heteroaryl boronic acids due to the propensity of the heteroaryl 
boronic acids to undergo protodeboronation side reactions.  Interestingly, most of the 
reactions involving thiophenyl zincs worked very well with the exception of the 3-
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thiophene zinc reagent 1.400, which underwent  reaction with Hayashi’s catalyst 
providing 1.386 in 99% enantioselectivity.   
Scheme 1.66 
 
 As previously mentioned, the use of heteroaryl boronic acids in conjugate 
addition reactions suffered from the major problem of protodeboronation.  The Martin 
group developed chemistry in order to avoid this problem when the Michael adduct 1.405 
was needed as an intermediate in an ongoing natural product synthesis. We discovered 
that 2-furyl titanium tetraisopropoxide underwent reaction with furan-2(5H)-one using a 
rhodium BIPHEP catalyst to provide 1.405 in 60% yield and 98% ee (Scheme 1.67).
76
  
The scope of the nucleophile was expanded when cyclopentenone underwent reactions 
with pyrrole, thiophene, and indole in moderate to good yields (43-60%) and excellent 
enantioselectivities (90-95%).  Benzothiophene and benzofuran were also examined, but 
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due to their low -nucleophilicity, it was necessary to use the more reactive 2-substituted 
zinc reagents to achieve satisfactory yields (47-64%) and excellent enantioselectivities 
(98%) (Scheme 1.68).   
Scheme 1.67 
 
Scheme 1.68 
 
1.4 SYNTHESIS OF -HETEROARYL PROPIONATES BY SN1 TYPE REACTIONS 
The second major route to -heteroaryl propionates, (SN1), involves an SN1-type 
reaction in which the heteroaryl ring bears a benzylic-like leaving group that ionizes in 
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the presence of a suitable Lewis acid (Scheme 1.69).  The nascent carbocation can then 
be captured by a suitable -nucleophile to produce the desired propionate.  Precedent 
exists for reactions involving cations derived from various heterocyclic carbinols, as well 
as thiophen-2-yl chloride,
77
 and furan-2-yl acetate,
78
 but the scope of this process appears 
to be limited to a few combinations of heteroaryls and -nucleophiles (Scheme 1.69).18,79-
88
     
Scheme 1.69 
 
1.4.1 GRAMINE 
 The first, and the most classic, example of generating heteroaromatic benzylic 
cations was developed with gramine (1.415).  Gramine is an indole bearing a 
dimethylamino methyl group at the 3-position.  While stable in its neutral form, when 
gramine is quaternized 1.416, usually with MeI, the dimethylamino group is transformed 
into a good leaving group.  When the amino group leaves, a stabilized carbocation is 
formed that can be represented by the two contributing resonance structures 1.417 and 
1.418.  The carbocation can then be captured by a number of nucleophiles.   
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Scheme 1.70 
 
 Snyder was one of the early pioneers of gramine chemistry in the 1940’s.  In 
1944, Snyder and coworkers showed that gramine could be alkylated by diethyl malonate 
to provide diester 1.421 in 85% yield, though the conditions were extremely harsh 
(Scheme 1.71).
89
  Diester 1.421 could further be elaborated to 3-indole propionic acid 
(1.422), which has been used as a plant growth regulator and also as a key starting 
material for the synthesis of lysergic acid.
90,91
 
Scheme 1.71 
 
 Snyder also showed that -amido malonate 1.423 could undergo addition with 
gramine in modest yield to provide tryptophan (1.425) after subsequent saponification 
and decarboxylation (Scheme 1.72).
92
  A few decades later Hoffmann and coworkers 
expanded the scope of the reaction to include a variety of different indoles (Scheme 
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1.73).
93
  The reaction worked well for both electron-poor and hindered indoles, though 
the conditions were still rather harsh.   
Scheme 1.72 
 
Scheme 1.73 
 
 Enamines have also been shown to be effective nucleophilic partners in reactions 
with gramine (Schemes 1.74 and 1.75).  In 1965, two papers were published which 
featured the reactions of cyclic enamines with gramine.
94,95
  In both cases, harsh reaction 
conditions were used, and the resulting adducts were formed in poor to moderate yields.   
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Scheme 1.74  
 
Scheme 1.75 
 
 Other examples of nucleophiles used with gramine are shown in Schemes 1.76-
1.78.  In 1974, Matsumoto found that gramine methiodide (1.416) underwent reaction 
with -isocyanopropionate (1.440) to provide -heteroaryl propionate 1.441 in 63% yield 
(Scheme 1.76).
96
  Propionate 1.441 was further elaborated to substituted tryptophan 
derivatives.  While the yields were moderate, the conditions were considerably less harsh 
than in earlier examples.  In 1985, Freidinger alkylated gramine methiodide (1.416) with 
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-carboxylactam 1.442 to give the complex -disubstituted -indolyl propionate 1.443, 
albeit in low yield (25%) (Scheme 1.77).
97
  Propionate 1.443 was used to investigate 
biologically active peptides.  In 1996, Mortier and coworkers alkylated gramine 
methosulfate (1.445) with the enolate of diketopiperazine to provide the corresponding 
product in 57% yield (Scheme 1.78).
98
   
Scheme 1.76 
 
Scheme 1.77 
 
Scheme 1.78 
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1.4.2 IONIZATION OF BENZYLIC HETEROAROMATIC HALIDES 
While the ionization of benzylic halides and their subsequent capture with 
appropriate nucleophiles is well known, only a few examples are known in which 
heteroaromatic benzylic halides are employed as the electrophilic partners.  In 2004, 
Mayr and coworkers showed that the ionization of thiophene benzyl chloride 1.447 
proceeded in the presence of a stoichiometric amount of ammonium bicarbonate 
(NH4HCO3) to generate a heteroaromatic cation that was subsequent captured by 2-
methyl furan (1.448) in 48% yield (Scheme 1.79).
77
   The scope of the ionization of 
heterocyclic benzyl halides is extremely narrow, and there are no examples using 
nucleophiles such as silyl ketene acetals, which would provide -heteroaryl propionates 
directly.  Benzylic heteroaromatic halides are also known to be unstable and are prone to 
polymerizations that further limit their utility.   
Scheme 1.79 
 
1.4.3 IONIZATION OF BENZYLIC HETEROAROMATIC ACETATES 
 Prior to our work in the area, there was only one known example of a -
nucleophile alkylating a benzylic cation derived from a heterocyclic benzylic acetate.  In 
1997, Grieco and coworkers showed that the -disubstituted silyl ketene acetal 1.451 
reacted with furan-2-ylmethyl acetate (1.450) in the presence of catalytic magnesium 
triflimide (Mg(NTf2)2) in 48% yield (Scheme 1.80).
78
  While the yield of the addition was 
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low, the reaction was one of the first to show that -disubstituted, -heteroaryl 
propionates could be accessed relatively easily.  This result was particularly important 
because -disubstituted -heteroaryl propionate scaffolds had been completely 
inaccessible via any of the EAS methods described earlier.   
Scheme 1.80 
 
After our work was completed, Ghosez reported the ionization of primary 
heteroaromatic acetates with triflimide to produce electron-rich biaryls (Scheme 1.81).
99
  
Primary 2-thiophenyl, 2-furanyl, and 2-pyrrolyl acetates reacted with anisole (1.454) to 
produce the corresponding biaryls (1.456-1.458) in 70-98% yield.  2-Thiophenyl acetate 
(1.453, X = S) was the best electrophile in the triflimide promoted coupling, while 2-
furanyl acetate (1.453, X = O) was the worst. The reaction of the 2-pyrrolyl acetate 
(1.453, X = NSO2Ph) with anisole (1.454) was particularly interesting because it showed 
that electron-withdrawing groups may be tolerated on heterocyclic electrophiles in SN1 
type reactions.   
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Scheme 1.81 
 
1.4.4 IONIZATION OF BENZYLIC HETEROAROMATIC ALCOHOLS 
 Although heteroaromatic benzylic halides and acetates have been shown to be 
successful electrophiles in the SN1 type pathway towards -heteroaryl propionate 
scaffolds, the use of heteroaromatic benzylic alcohols as electrophiles would be 
preferable, because they are typically intermediates en route to heteroaromatic halides 
and acetates.  
Comins and coworkers were the first to incorporate 3-indolyl carbinols into ionization 
reactions with -nucleophiles (Scheme 1.82).  Alcohol 1.459 was ionized in the presence 
of either SnCl4 or TMSOTf to produce a stabilized carbocation that was then captured by 
allyl trimethyl silane (1.460) or silyl enol ether 1.462 to provide the corresponding 
adducts in good yields (67-88%).  Both 1.461 and 1.463 could be further elaborated to the 
desired -substituted, -heteroaryl propionates when subjected to suitable oxidation 
conditions.   
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Scheme 1.82 
 
Natsume et al. expanded the scope of Comin’s work by ionizing 4-indolyl 
carbinols with SnCl4 in the presence of silyl enol ethers in their synthetic work directed 
toward the hapalindole alkaloids (Scheme 1.83).
83
  The reaction of indole 1.466 with both 
cyclic 1.465 and acyclic 1.467 enol ethers provided excellent yields of the corresponding 
-disubstituted, -heteroaryl ketones 1.464, 1.468, and 1.470, though when the 
nucleophile became too hindered, elimination of the alcohol to an alkene 1.471 became a 
significant side reaction.  These reactions are important because the site of ionization can 
take place at a variety of places on the heterocycle, depending on the site of the reacting 
benzylic alcohol. In addition to providing hindered -heteroaryl ketones in a single step, 
these reactions also demonstrated that high yields could be achieved with electron 
withdrawing groups present on the indole.  The only downsides to this reaction are that 
the scope of the reaction appears to be limited to 4-indolyl tertiary carbinols and silyl 
enol ethers, which would require additional steps to elaborate to the desired -heteroaryl 
propionates. 
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Scheme 1.83 
 
Shortly after we began our studies, Rawal and coworkers reported a similar 
process in their work toward the welwitindolinone alkaloids (Scheme 1.84).
82,100,101
  
Tosyl protected 3-indolyl carbinols 1.472 and 1.473 were allowed to react with 
cyclohexyl silyl enol ether 1.465 in the presence of both SnCl4 and TiCl4 to provide -
heteroaryl ketones 1.474 and 1.475 in good yields.  Although Rawal did not extensively 
expand the scope of the reaction, he did show that halogenated indoles may participate in 
the coupling reaction.  This is important as aromatic halogens can serve as important 
functional handles in natural product synthesis.   
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Scheme 1.84 
 
1.4.5 CHIRAL IONIZATIONS 
There were two examples of chiral SN1 type reactions to provide -heteroaryl 
carbonyl compounds contemporaneous with our investigations.  The first is from 
Melchiorre and coworkers (Scheme 1.85).
102
 Using proline 1.477 as an organocatalyst, 
Melchiorre ionized aryl sulfonyl indoles with KF and alumina in the presence of a variety 
of propionaldehydes 1.478 to yield -substituted -heteroaryl aldehydes 1.479.  The 
products were obtained in good to excellent yields (63-92%), good diastereoselectivities 
(5:1 to 8:1 in favor of the syn-adducts), and good enantioselectivity (86-92%). If the 2-
position of the indole is not substituted with a methyl group then the enantioselectivity 
and diastereoselectivity suffer.  The authors speculate the methyl group provides the 
necessary steric bulk with which to interact with the proline catalyst to induce 
diastereoselectivity during the addition.
102
   Also, the scope of both reactions is currently 
limited to aldehydes, the catalyst loading is high, and reaction times are long.  While the 
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results of both Cozzi and Melchiorre’s work were impressive, there remained room for 
improvement. 
Scheme 1.85 
 
The second chiral example of the SN1 type nucleophilic capture of a heterocyclic 
benzylic cation came from Cozzi and coworkers who utilized MacMillan imidazolinone 
catalyst 1.481 to promote ionizations of indoles of the type 1.480 in the presence of 
propionaldehyde (1.482) and other aldehydes (Scheme 1.86).
103
  The resulting -
substituted, -heteroaryl ketones were produced in moderate yield (48%) and 
diastereoselectivity (2.6:1) in favor of the anti-adduct 1.483, while both syn- and anti- 
adducts, 1.484 and 1.483 respectfully, were formed in good enantioselectivities (86-
92%).  Cozzi’s work was impressive as proof of principle, but the scope of the reaction is 
extremely limited.  If the indole is not-substituted at the 2-position the enantioselectivities 
of the products plummet.   
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Scheme 1.86 
 
1.5 SUMMARY OF PRIOR ART 
Scheme 1.87 
 
It is evident from the preceeding survey that there are two main paths to access -
heteroaryl propionates.  The first, which was designated as EAS, involves the conjugate 
addition of heteroaromatic nucleophiles to--unsaturated carbonyl derivatives 
according to classic Friedel-Crafts reactivity pathways (Scheme 1.87).   Both achiral and 
chiral examples of this process are well precedented, and yields and stereoselectivities 
can be high employing both Lewis and Bronsted acids
9-28
.  However, this type of reaction 
is limited because new bond construction on the heterocycle only occurs at the site of the 
heteroaromatic ring that is favored in classical electrophilic aromatic substitution 
reactions, and indoles and pyrroles comprise the bulk of the examples.  Another 
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limitation is that substitution on the unsaturated reaction partner 1.10 (Scheme 1.87, R1, 
R2 = alkyl) is limited,
10,29,30
 with ,-disubstitution products 1.1 (Scheme 1.87, R3, R4 = 
alkyl) seemingly inaccessible through this route.  Moreover, most successful examples of 
enantioselective processes of this type require either an electrophilic partner with two 
Lewis basic sites to accommodate the bidentate metallic catalysts or an aldehyde on the 
unsaturated reaction partner that can form chiral iminium ions.  
The second route to -heteroaryl propionates, which was designated as SN1, 
involves an SN1-type reaction in which the heteroaryl aromatic ring bears a benzylic-like 
leaving group that ionizes in the presence of a suitable Lewis acid (Scheme 1.87).  The 
incipient carbocation is then captured by a -nucleophile to produce the propionate 1.1.   
Precedent exists for reactions involving cations derived from various heterocyclic 
carbinols, as well as thiophen-2-yl chloride,
77
 and furan-2-yl acetate,
78
 but the scope of 
this process is limited to a few combinations of heteroaryls and -nucleophiles.  
Moreover, the two enantioselective examples in the literature demonstrate proof of 
principle more than synthetic utility.   
 While there are methods for preparing compounds such as 1.1, it is evident that 
limitations persist, and there is no direct precedent for a number of possible bond forming 
processes.  After considering the available options, we determined that the greatest 
opportunity for development resided with the SN1 pathway.  Our first goal was to develop 
a concise and facile method to access a variety of -heteroaryl propionates, with varying 
degrees of - and - substitution.   
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1.6 MARTIN GROUP APPROACH 
In the Martin group’s total synthesis of welwistatin6 (1.8) a potentially useful 
methodology arose from a key carbon-carbon (C1 and C2 of 1.489) bond formation 
between the tertiary hydroxy indole 1.485 and the -nucleophile 1.488 (Scheme 1.88).104  
After considering the available options towards accessing compounds of the type 1.489, 
we determined that the greatest opportunity for development lied with the SN1-type 
pathway (cf. Scheme 1.87) and we decided to investigate the reaction further in order to 
develop a concise and facile method to access a variety of -heteroaryl propionates with 
varying degrees of - and - substitution.   
Scheme 1.88 
  
Toward that end, Dr. Tsung-Hao (Bob) Fu, a former Martin group member, 
expanded the scope of the coupling between 1.490 and 1.491 by examining the reactivity 
of other 3-indolyl carbinols with various silyl ketene acetals in the Lewis acid-catalyzed 
reaction.  Tsung-Hao first examined the reaction of the alcohol 1.490 with the silyl ketene 
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acetal 1.491 under a variety of conditions to furnish ester 1.492, eventually finding that 
the reaction proceeded in an optimized yield of 92% using THF as the solvent, 0.9 
equivalents of trimethylsilyl trifluoromethanesulfonate (TMSOTf) as the Lewis acid, and 
a reaction temperature of -40 °C (Scheme 1.89, Method A).   Encouraged by this result, 
the same conditions were applied to reactions of other 3-indolyl carbinols and -
nucleophiles to explore the scope of the reaction (Scheme 1.90).  In general, the yields for 
primary, secondary, and tertiary hydroxy indoles were comparable, and the reactions 
involving N-methyl indoles were higher yielding than were their N-H analogues.  It is 
also important to note that Tsung-Hao was able to achieve the formation of two 
contiguous quaternary centers in one transformation 1.497, which was one of the major 
limitations of the EAS pathway in Scheme 1.
105
 
Scheme 1.89 
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Scheme 1.90 
 
Having established that the reaction worked well with various combinations of 
indol-3-yl carbinols and achiral nucleophiles, it was a natural extension of the 
methodology to see if a diastereoselective version of the reaction was feasible.  In order 
to achieve this goal, Tsung-Hao explored the use of a chiral oxazolidinone on a -
nucleophile.  This type of reaction had been precedented by Fuentes and co-workers, who 
reacted the chiral silyl ketene N,O-acetal 1.503 with the N-acyl iminium ion generated 
from -lactam 1.502, to provide 1.504 and 1.505 in moderate diastereoselectivity 
(Scheme 1.91).
106
  Tsung-Hao reacted alcohol 1.506 with chiral -nucleophile 1.507 to 
give a mixture of 1.508 and 1.509 (15.1:1) in 90% yield, of which 1.502 was isolated as 
the major product (Scheme 1.92).
105,107
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Scheme 1.91 
 
Scheme 1.92 
 
The efficient synthesis of 1.508 is noteworthy because it illustrates the versatility 
of the SN1 pathway (cf. Scheme 1.87) and its potential for the enantioselective 
preparation of -heteroaryl--hydroxy propionates, which like -heteroaryl propionates, 
are important structural subunits of many natural products and their precursors.
108,109
   
The utility of this method was further reinforced by the completion of a formal synthesis 
of N-methylwelwitindolinone C isothiocyanate (1.8) by Tsung Hao (Scheme 1.93).
6
  One 
of the key features of the synthesis was the TMSOTf mediated reaction between 
vinylogous silyl ketene acetal 1.510 and 3-indolyl carbinol 1.485 to provide the highly 
functionalized -disubstituted, -heteroaryl ketone 1.511 in 60% yield.  Ketone 1.511 
was further elaborated to welwistatin (1.8) through a series of steps including an enolate 
arylation, and allylic alkylation (Scheme 1.94).    
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Scheme 1.93 
 
Scheme 1.94 
 
 Commercially available 4-bromoindole (1.515) was first N-methylated and then 
acylated to provide 1.516 (Scheme 1.95).
6
  Ketone 1.517 was alkylated using methyl 
magnesium bromide (MeMgBr) to furnish tertiary alcohol 1.485, which was immediately 
subjected to a Lewis acid-mediated coupling reaction with 1.510 to furnish 1.514 in 60% 
yield over two steps.  A Pd (0) catalyzed intramolecular enolate arylation of aryl bromide 
1.514 was promoted by the PEPPSI-IPr catalyst in the presence of sodium tert-butoxide 
(NaOt-Bu) to provide tricycle 1.518.  Silyl protection of the enol, followed by oxidative 
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rearrangement of the furan ring with N-bromosuccinimide (NBS), and selective reduction 
of the resulting ketone with borane provided allyl alcohol 1.521.   
Scheme 1.95 
 
After protection of allyl alcohol 1.521, enol 1.513 was unmasked, and treated 
directly with Bu3SnOMe, Pd2dba3, and trifurylphosphine [P(2-furyl)3] to deliver a 
mixture (7.7:1:1.2)  of enones 1.523 and 1.524 and vinyl ketone 1.525 (Scheme 1.96).
6
  
When the mixture of 1.523-1.525 was deprotonated with NaHMDS, the thus dienolate 
generated was captured with MeI to provide tetracycle 1.526 as a single diastereomer.  A 
two step sequence involving the global reduction and oxidation of the carbonyl moieties 
of 1.526 then provided the intermediate aldehyde 1.528 over 14 steps from bromoindole 
1.515 in 6.4% yield. 
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Scheme 1.96 
 Contemporaneous to the efforts of the Martin group, Rawal and coworkers 
published a total synthesis of N-methylwelwitindolinone C isothiocyanate (1.8) featuring 
common intermediate 1.528 (Scheme 1.96).
101
  While our synthesis towards 1.528 was 
three steps shorter than Rawal’s, his route toward 1.528 was slightly higher yielding 
(7.2%).
100
  We independently tried to synthesize 1.8 from 1.526 and 1.528, but we were 
unsuccessful in our attempts to install the vinyl chloride moiety.  We then decided to 
exploit an opportunity to complete a formal synthesis of N-methylwelwitindolinone C 
isothiocyanate (1.8), using Rawal’s endgame strategy. 
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Scheme 1.97 
 
 Rawal first reduced aldehyde 1.528 to alcohol 1.529, and then hydrazone 
formation followed by chlorination using N-chlorosuccinimide provided vinyl chloride 
1.531 in 60% yield over two steps (Scheme 1.98).
101
  Oxidation of indole 1.531 with 
magnesium monoperoxyphthalate (MMPP) followed by treatment with Dess-Martin 
periodinane then furnished oxindole 1.532.  Condensation of 1.533 with hydroxylamine 
produced oxime 1.534 which then underwent a modified Kim oxime 
rearrangement
101,110,111
 to provide N-methylwelwitindolinone C isothiocyanate (1.8) in 
seven steps and 31.2% yield from 1.528.   
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Scheme 1.98 
 
1.7  SUMMARY OF PREVIOUS MARTIN GROUP WORK 
Tsung-Hao had developed a good route toward -indol-3-yl propionates, but we 
desired a more general method to obtain all types of -substituted heteroaryl 
propionates.   In order to expand this methodology beyond the use of indol-3-yl carbinols, 
a broader array of heterocycles, including indol-2-yl carbinols, were envisioned as 
potential substrates. If successful, the reactions of these carbinols would further illustrate 
the versatility of the SN1 pathway in Scheme 1.1, because it would enable C-C bond 
formation at site not accessible through the use of Friedel-Crafts chemistry.  Recall that 
there were no known examples of indol-2-yl propionates being prepared through SN1-
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type reactions (cf. Section 1.4), though Natsume did report some examples in which a 
indol-4-yl carbinols underwent reactions with silyl enol ethers to produce substituted 
indol-4-yl ketones (cf. Scheme 1.82).
83
  Examples of indol-2-yl propionates prepared 
using EAS-type reactions were special cases that required the use of 3-substituted 
indoles, heterocyclic organometallics, or in the case of Evans,
64
 dihydroindoles (cf. 
Scheme 1.51), as nucleophilic partners (Section 1.3).  Furthermore, the indol-2-yl 
propionates and ketones products obtained from the EAS pathway were limited in two 
major ways.  The first was that the the indol-2-yl adducts were more likely to be ketones, 
as opposed to esters, because ketones are more electrophilic, and hence, more reactive 
partners in Michael additions.  Thus, extra steps would be required if we wanted to obtain 
indol-2-yl propionates.  The second limitation was that -substitution on the electrophilic 
enones or acrylates was not well tolerated in the conjugate additions, with ,-
disubstituted indol-2-yl propionates seemingly inaccessible through this route.  We 
believed that our approach would be able to overcome many of these problems to provide 
highly substituted -substituted indol-2-yl propionates in a single transformation if 
Tsung-Hao’s originally reactions could be generalized.  Ideally, the conditions would 
also be used in SN1-type reactions with other heterocycles, such as furan, pyrrole, and 
thiophene.  
We also sought to elucidate the scope and limitations of the -nucleophile in our 
ionization reactions.  As already discussed, most of the EAS examples required the use of 
-unsaturated enones or enals as electrophilic coupling partners, which would provide 
-heteroaryl ketones and aldehydes as opposed to -heteroaryl propionates (cf. Section 
1.3).  Moreover, if an enantioselective reaction were desired, then the electrophilic 
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coupling partner is further limited to include either two Lewis basic sites to accommodate 
bidentate metallic catalysts or an enal that can form chiral iminium ions (cf. Sections 
1.3.2.3 and 1.3.3). The SN1 pathway is more amenable to the direct production of -
heteroaryl propionates; however, far less work has been done in the area, and the scope of 
this process appears to be limited to a few combinations of heteroaryls and -
nucleophiles (cf. Section 1.4).  The -nucleophiles also tended to be heterocycles 
themselves, rather than more versatile silyl enol ethers or silyl ketene acetals that could 
be used to provide access to a larger array of -heterocyclic scaffolds.  Tsung-Hao had 
undertaken an initial survey of -nucleophiles, including those with -substituents and 
those that were cyclic, acyclic, and vinylogous, but most of the nucleophiles were silyl 
ketene acetals, and he had only examined them on one indol-3-yl system (cf. Section 1.6). 
We desired to test Tsung-Hao’s original -nucleophiles, among others, with a variety of 
heterocyclic carbinols in the ionization reaction to see how the results compared to the 
indol-3-yl system.   
There were only two enantioselective examples of SN1-type ionizations in the 
literature and that they demonstrated proof of principle more than synthetic utility (cf. 
Section 1.4.5).  Both examples were undertaken with 2-methylindol-3-yl systems and the 
methyl substituent at the 2-position of the indoles was necessary for interaction with the 
catalyst to induce enantioselectivity during the reactions.
102,103
  Tsung-Hao was able to 
affect a diastereoselective coupling with his indol-3-yl system when a chiral 
oxazoldinone was appended to the attacking -nucleophile, but he had only examined a 
single example (cf. Scheme 1.92).  We sought to expand upon Tsung-Hao’s initial 
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diastereoselective work, and ideally, develop our own enantioselective catalyst for the 
ionization as it was evident that there was room for improvement within the field.   
1.8  EXPANDING THE MARTIN GROUP METHODOLOGY TO INCLUDE INDOL-2-YL 
CARBINOLS  
The first systems we examined in our SN1-type ionization reactions were 2-
substituted indole carbinols (cf. Section 1.7).  Very little work had been done on the 
indol-2-yl systems, and if successful, the reactions of these carbinols would further 
illustrate the versatility of the SN1 pathway outlined in Scheme 1.1, because it would 
enable C-C bond formation at site not accessible through the use of Friedel-Crafts 
chemistry.  Toward that end, we synthesized carbinol 1.538 (Scheme 1.99) and silyl 
ketene acetal 1.540 (Scheme 1.100) according to known literature procedures.
112-114
  
Indole (1.536) was N-methylated using NaH and MeI in DMF to give 1.537. 
Deprotonation of 1.537 at the 2-position by n-BuLi followed by subsequent addition of 
acetaldehyde, produced carbinol 1.538 in 60% yield.  Enolization of methyl isobutyrate 
(1.539) in the presence of TMSCl provided silyl ketene acetal 1.540. 
Scheme 1.99 
 
Scheme 1.100 
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We began our investigations by applying Tsung-Hao’s optimized conditions 
(Scheme 1.100, Method A) to alcohol 1.533, resulting in a 39% yield of propionate 
1.535.  While the result of the reaction was disappointing, it was not entirely unexpected.  
Alcohol 1.533 is in a more difficult position on the indole to ionize compared to the 
indol-3-yl carbinol (Scheme 1.101).
115
   
Scheme 1.101 
 
 It is a long standing and well established fact that the 3-position of indole (1.542) 
is more reactive towards electrophilic aromatic substitution than the 2-position (Scheme 
1.102).
115
  This increased reactivity can be explained by the larger amount of -electron 
density that is present on the C3 vs. C2 of indole, which has been proven from both 
empirical experimentation and molecular orbital calculations.
115,116
 The electrons of the 
weakly basic nitrogen atoms readily delocalize into the pi system to adopt resonance 
structure 1.544 that can readily react with electrophiles to promote alkylation at the C3 
position.
115
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Scheme 1.102 
 
                                                                                                  
Though our method uses heterocyclic carbinols as electrophiles, the extra density 
at the C3 carbon of indole helps to stabilize the cation formed upon ionization of the 
indol-3-yl carbinol 1.545 with TMSOTf (Scheme 1.103).  We can show this extra 
stabilization by depicting the heterobenzylic cation of 1.545 as the extended iminium ion 
1.546.
115
  However, an extended resonance form can also be drawn from the cation 
formed upon ionization of 2-indolyl carbinol 1.548, namely the extended iminium ion 
1.547.  When the structures of both extended iminium ions are compared, we can see why 
indol-3-yl carbinols are more easily ionized than indol-2-yl carbinols.  To achieve the 
cation stabilization of 1.546, the aromaticity of the benzene moiety of indole is left 
wholly intact, whereas to achieve the cation stabilization of 1.548 the aromaticity of the 
entire indole ring must be disrupted.
115
  Though both 1.546 and 1.548 can be stabilized 
through -interactions, formation of 1.546 is both thermodynamically and kinetically 
more favorable. Its formation causes less of an energetic penalty and which results in 
faster and more facile ionization of indol-3-yl carbinols vs.  indol-2-yl carbinols.
115
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Scheme 1.103 
 
Once ionization of 1.545 had occurred, we speculated that a suitable -
nucleophile, in this case silyl ketene acetal 1.540, underwent reaction in the presence of 
TMSOTF to provide adduct 1.550 and silanol (Scheme 1.104).  Upon loss of the TMS 
group, the desired -heteroaryl propionate 1.553 can be formed along with by-products 
TMS ether 1.552 and triflic acid (TfOH).             
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Scheme 1.104 
 
Realizing the problematic step in the reaction of silyl ketene acetal 1.540 with 2-
indolyl carbinol 1.538 was most likely the ionization event, we sought to increase the 
reactivity of the alcohol by increasing its leaving group ability.  Thus, acetate 1.554 was 
prepared according to a known literature procedure from carbinol 1.538 (Scheme 
1.105).
113
  
Scheme 1.105 
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When acetate 1.554 underwent reaction with 1.540 using Tsung-Hao’s reaction 
conditions, we were gratified to find that propionate 1.541 was formed in 61% yield 
(Scheme 1.106).  The addition of the acetyl group seemingly facilitated the ionization 
reaction; however, we still thought that there was room for improvement.   
Scheme 1.106 
 
We conducted the reaction between acetate 1.554 and/or alcohol 1.538 and silyl 
ketene acetal 1.540 using a series of different temperatures, solvents, stoichiometries, and 
Lewis acids (Scheme 1.107).   Of the five Lewis acids screened, TMSOTf and Yb(OTf)3 
were the only two that produced the desired propionates, though Yb(OTf)3 provided 
lower yields of 1.541 than TMSOTf, presumably due to its insolubility in many of the 
solvents screened.  The rest of the Lewis acids provided either returned starting material 
or decomposition product, so we decided to continue using TMSOTf as our ionization 
promoter.    
After extensive optimization of the reaction temperature, stoichiometry, and 
solvent we found that the reaction generally gave the best results at lower temperatures 
and in polar solvents when TMSOTf was used as a Lewis acid promoter (Scheme 1.107).  
Presumably the polar solvents facilitated formation of the intermediate cation, and 
TMSOTf was more stable when kept at lower temperatures.  When acetate 1.554 was 
treated with stoichiometric TMSOTf in acetonitrile at -40 °C in the presence of a slight 
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excess of silyl ketene acetal 1.540 (1.5 eq) (Method B), we were extremely gratified to 
find that propionate 1.541 was formed in 91% yield.  These optimized conditions were 
later applied to alcohol 1.538, resulting in 69% yield of 1.541, thereby underscoring the 
superiority of the acetate 1.554 as a substrate (Scheme 1.108). 
Scheme 1.107 
 
Scheme 1.108 
 
Secondary acetate 1.554 also underwent reactions with -nucleophiles 1.555 and 
1.556 when treated with stoichiometric TMSOTf (Scheme 1.109).  Reaction of acetate 
1.554 with -unsubstituted TBS protected silyl ketene acetal 1.555117 provided the -
substituted propionate 1.558 in 68% yield, whereas the reaction of 1.554 with vinylogous 
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-unsaturated silyl ketene acetal 1.556118,119 provided enoate 1.559 in 47% yield as 
a single regioisomer.  O-Silylated dienolates are known to undergo regioselective 
addition to carbonyl compounds, presumably due to steric bulk of the O-silyl group 
which creates significant hindrance near the -carbon of the nucleophile.120,121  The 
relative stereochemistry of the double bond of enoate 1.559 was not established 
unequivocally, but NOE studies supported structure 1.559 (as opposed to 1.560) (Figure 
1.2).  Namely, we observed an NOE interaction between the vinylic proton Ha and 
protons Hb of structure 1.559 but not between the vinylic proton Ha and the protons of the 
vinyl methyl group of 1.560.  
Scheme 1.109 
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Figure 1.2 
 
 Pleased with the results of our TMSOTf mediated ionizations of secondary indol-
2-yl acetate 5.554 in the presence of a variety of silyl ketene acetals, we sought to use 
primary and tertiary indol-2-yl carbinols and/or acetates as electrophilic partners in the 
ionization reactions.   Toward that end, primary and tertiary indol-2-yl carbinols 1.565-
1.568 were synthesized from commercially available 1H-indole-2-carboxylic acid (1.561) 
according to known literature procedures (Schemes 1.110 and 1.111).
122-126
  Depending 
on whether N-H or N-Me indoles were desired, N-H compound 1.562 could be 
methylated using NaH and MeI to provide 1.563 in 92% yield (Scheme 1.110).  Primary 
indol-2-yl carbinols 1.565 and 1.566 were prepared from treatment of indol-2-yl esters 
1.564 and 1.563 with lithium aluminum hydride (LiAlH4), while tertiary indol-2-yl 
carbinols 1.567 and 1.568 were prepared from indol-2-yl esters 1.564 and 1.563 through 
reaction with excess methyllithium (MeLi) (Scheme 1.111). 
Scheme 1.110 
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Scheme 1.111 
 
Unfortunately, the reactions of the primary alcohols 1.565 and 1.566 with silyl 
ketene acetal 1.540 produced no isolable quantities of desired propionates 1.569 or 1.570 
(Scheme 1.112).  Realizing that primary indol-2-yl systems were less capable of 
stabilizing a carbocation than secondary indol-2-yl systems, we sought to increase the 
leaving group ability of the primary carbinols as we had done previously with secondary 
indol-2-yl carbinol 1.538 (cf. Scheme 1.105).  Towards that end esters 1.571 and 1.572 
were synthesized.
127
 However, we were disappointed to find that neither 1.571 nor 1.572 
reacted with TMSOTf in the presence of -nucleophile 1.540 to produce propionate 
1.570 (Scheme 1.113).  While we were saddened at the failure of our reactions, we 
decided that our time was better spent investigating propionates that were seemingly 
inaccessible through the EAS pathway, namely -substituted heteroaryl 
propionates, than trying to optimize the reaction between primary indol-2-yl carbinols 
and -nucleophiles.  Thus, we turned our attention towards tertiary indol-2-yl carbinols.   
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Scheme 1.112  
 
Scheme 1.113 
 
 When treated with stoichiometric amounts of TMSOTf in the presence of silyl 
ketene acetal 1.540, tertiary indol-2-yl carbinols provided -tetrasubstituted 
propionates 1.575 and 1.574 in 77% and 93% yield, respectively (Scheme 1.114).  N-
Methyl Carbinol 1.568 was a superior electrophile in the reaction as compared to 1.557, 
presumably due to the extra electron density that the methyl group provided to stabilize 
the intermediate benzylic cation (cf. Schemes 1.102 and 1.103).  Indole 1.568 was also 
shown to couple successfully with cyclic TIPS furan acetal 1.573
128
 to provide butanoate 
1.576 in 88% yield, further underscoring the utility of our method.   
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Scheme 1.114 
 
Our work on indol-2-yl propionates enabled the Martin group to complete a novel 
total synthesis of actinophyllic acid (1.587) (Schemes 1.115 - 1.117).
129
  The synthesis 
featured a key TMSOTf mediated coupling between tertiary indol-2-yl acetate 1.578 and 
silyl enol ether 1.579, followed by an intramolecular addition to provide the complex 
tricyclic intermediate 1.580 in 92% yield in a single step (Scheme 1.115).   
Scheme 1.115 
 
 Tertiary indol-2-yl acetate 1.578 was obtained in 85% yield from indole (1.581) 
through a carboxylate directed lithiation/acylation sequence (Scheme 1.116) and 
dihydroazepinone 1.579 was accessed from known hydroazepinone 1.583 in 77% yield 
over two steps (Scheme 1.117).
129
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Scheme 1.116 
 
Scheme 1.117 
 
 After the key SN1-type ionization reaction between carbinol 1.578 and -
nucleophile 1.579, protection of the indole nitrogen and Pd (0) catalyzed removal of the 
Alloc group in the presence of N,N-dimethylbarbituric acid (NDMBA) provided 
tetracycle 1.584 (Scheme 1.117).
129
  The secondary amine of 1.584 was reductively 
alkylated with 2-chloroacetaldehyde (ClCH2CHO) and then enolate formation using t-
BuONa induced an intramolecular ring closing reaction to provide pyrrolidine 1.585.  
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The Boc and benzyl ether protecting groups of pentacycle 1.585 were removed, and the 
resulting diol spontaneously cyclized to provide lactol 1.586, the structure of which was 
confirmed by single crystal X-ray analysis.  Oxidation of lactol 1.586 provided the 
hydrochloride salt of actinophyllic acid (1.587) in 10.1% yield only ten steps. 
 
1.9  SN1-TYPE IONIZATION REACTIONS INVOLVING FURANYL CARBINOLS  
 The reaction between primary furanyl acetate 1.588 and silyl ketene acetal 1.540 
had been reported by Grieco prior to our investigations, but the yield of ester 1.589 was 
only 48% (Scheme 1.118).
78
  Obviously there was room for improvement, and we 
believed that our method might be able to improve upon his results. 
Scheme 1.118 
 
We explored the TMSOTf mediated ionization reaction between primary furan-2-
yl carbinol 1.590 and -nucleophile 1.540, but we did not see formation of the desired 
propionate 1.589 (Scheme 1.119).  Indeed, the reaction appeared to provide only 
decomposition products.  We then treated acetate 1.588, the same electrophile that Grieco 
used, with stoichiometric TMSOTf in the presence of silyl ketene acetal 1.540, and we 
found that propionate 1.589 was produced in 36% yield (Scheme 1.120).  After numerous 
attempts to optimize the reaction by changing the solvent, temperature, rate of addition, 
length, and stoichiometry of the reagents of the reaction, we were unable to improve the 
yield of propionate 1.589.  We suspected that either acetate 1.588 and/or propionate 
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1.589 were unstable to the reaction conditions.  Furans are known to be unstable in 
strongly acidic conditions, and if any adventitious water were present in the reaction then 
triflic acid was likely being generated as a byproduct.  Our hypothesis was seemingly 
confirmed when we independently subjected carbinol 1.588 and propionate 1.589 to the 
reaction conditions in the absence of a -nucleophile and found that in both cases 
significant decomposition had occurred.  Adding a proton sponge, such as 2,6-di-tert-
butylpyridine, to the reaction did not improve the yield.  We also tried the addition of 4 Å 
molecular sieves to remove any adventitious water that might be present, but they also 
failed to improve the yields of 1.589. 
Scheme 1.119 
 
Scheme 1.120 
 
Grieco utilized magnesium triflimide Mg(NTf2)2  as the Lewis acid for his 
coupling reaction, touting it as a safe alternative to magnesium perchlorate.
78
  However, 
Mg(NTf2)2 is not commercially available, so we prepared it
130
 and investigated its use a 
possible replacement for TMSOTf in the acid sensitive furanyl SN1-type ionization 
reactions.  While we were able to replicate Grieco’s original results, namely the reaction 
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between acetate 1.588 and -nucleophile 1.540, we could not improve upon his yield.  
We even investigated the use of hexafluoroisopropanol (HFIP) as both solvent and Lewis 
acid for the coupling, but -nucleophile 1.540  had only a half-life of minutes in HFIP so 
that approach was quickly abandoned.
131
  When we tried to promote indol-2-yl carbinols 
ionizations with Mg(NTf2)2, we did not observe any of our desired propionates (cf. 
Section 1.8).  Although the Mg(NTf2)2 mediated reaction between 1.588 and 1.540 
provided furan-2-yl propionate 1.589 in a 10% higher yield than did the reaction 
mediated by TMSOTf, it appeared that TMSOTf would be the more suitable Lewis acid 
for the development of a general method towards -heteroaryl propionates.   
We then synthesized the secondary and tertiary furan-2-yl carbinols 1.592
84
 and 
1.593 respectively, from commercially available 2-acetyl furan 1.591, via the addition of 
either NaBH4 or MeLi (Scheme 1.121).  Acetylation of 1.592 with acetic anhydride in the 
presence of pyridine then provided acetal 1.594.
132
  Attempted acetylation of the tertiary 
alcohol 1.593 under the same conditions resulted in sole formation of the elimination 
product 1.595.  
Scheme 1.121 
 
The reaction of secondary acetate 1.592 and silyl ketene acetal 1.540 worked the 
best of the furan series to give propionate 1.596 in 62% yield, while the reaction of 
secondary carbinol 1.592 and 1.540 resulted in decomposition (Scheme 1.122).  
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Treatment of tertiary furan-2-yl carbinol 1.593 with TMSOTf in the presence silyl ketene 
acetal 1.540 provided propionate 1.597 in 45% yield (Scheme 1.123).  In general, tertiary 
alcohols worked the best in the reaction of -nucleophiles with heterocyclic alcohols, but 
in this case the increased acid sensitivity of the furan may have led to the decreased yield.  
Carbinols would produce stoichiometric triflic acid in the reaction as compared to 
acetates, where triflic acid formation would be dependent on the presence of adventitious 
water (cf. Scheme 1.104).  With the more robust indole series, this was not a problem, but 
with the furans and pyrroles acid sensitivity became an issue. Ionizations reactions using 
secondary acetate 1.594 and tertiary carbinol 1.593 in the presence of 2,6-di-tert-
butylpyridine, 4 Å molecular sieves, and Mg(NTf2)2 were also examined, but the yields 
of propionates 1.596 and 1.597 remained unchanged. 
Scheme 1.122 
 
Scheme 1.123 
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1.10 SN1-TYPE IONIZATION REACTIONS INVOLVING PYRROLE CARBINOLS  
 We prepared tertiary pyrrole carbinol 1.602 and secondary pyrrole carbinols 1.600 
and 1.605 according to known literature procedures for use as substrates in our TMSOTf 
mediated coupling reactions (Schemes 1.124 – 1.126).133-136 Secondary carbinol 1.600 
was obtained from N-methyl pyrrole (1.598) via a Vilsmeier –Haack formylation 
followed by reaction with methyllithium (Scheme 1.124), while tertiary carbinol 1.602 
was obtained from the addition of methyllithium to 2-acetyl pyrrole 1.601 (Scheme 
1.125).  There were few examples of SN1-type reactions using heterocycles containing 
withdrawing groups, so we synthesized 1.605 in order to investigate whether the 
ionization would proceed (Scheme 1.126).
82,83,137
  N-Protection of 1.604 with 
phenylsulfonyl chloride (PhSO2Cl) followed by sodium borohydride (NaBH4) reduction 
provided secondary carbinol 1.605 (Scheme 1.126).   
Scheme 1.124 
 
Scheme 1.125 
 
Scheme 1.126  
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When stoichiometric TMSOTf was used to promote the reaction between 
secondary carbinol 1.600 and silyl ketene acetal 1.540, propionate 1.609 was formed in 
49% yield (Scheme 1.127).  We surmised that the instability of the starting alcohol, 
which is known to oligomerize at room temperature in as little as one hour, as well as the 
underlying acid sensitivity of  primary and secondary pyrrole carbinols and acetals, most 
likely contributed to the mediocre results.
133
  We varied many of the same reaction 
variables as we had in the furan series of experiments, but we were unable to increase the 
yield of 1.609.  The corresponding N-methyl secondary acetate was not examined in the 
reaction because of its known instability.
133
    
Scheme 1.127 
 
We also examined the reaction of secondary carbinol 1.605 with TMSOTf in the 
presence of silyl ketene acetal 1.540 to provide propionate 1.610 in 42% yield (Scheme 
1.127).  This result showed that the coupling reaction can proceed in reasonable yield 
with an electron withdrawing group present on the pyrrole nitrogen atom.  Although this 
type of reaction has been precedented to work with electron withdrawing groups on the 
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indole nitrogen atom,
82,83,137
 this is the first example of using an electron withdrawing 
group on a pyrrole nitrogen atom.  
Tertiary alcohol 1.602 underwent reaction with -nucleophile 1.540 in the 
presence of TMSOTf to provide 1.608 in 88% yield (Scheme 1.127). This result 
underscores the general superiority of tertiary heteroaromatic benzylic carbinols as 
electrophiles in SN1-type ionization reactions.   
1.11 SN1-TYPE IONIZATION REACTIONS INVOLVING THIOPHEN-2-YL CARBINOLS  
 Thiophene derived carbinols 1.612 and 1.613 were synthesized for use as 
substrates in our TMSOTf mediated ionization reaction (Scheme 1.128).  Secondary and 
tertiary alcohols, 1.612
84
 and 1.613, respectively, were synthesized in much the same 
manner as previous heterocyclic alcohols.  Namely, NaBH4 or MeLi was added to 2-
acetylthiophene (1.611) to produce the corresponding secondary 1.612 and tertiary 1.613 
alcohols.  Secondary alcohol 1.612 was then reacted with acetic anhydride in the 
presence of DMAP according to standard literature procedure to give acetate 1.614.
138
 
Scheme 1.128 
 
 Secondary thiophen-2-yl acetate 1.614 was ionized with a stoichiometric amount 
of TMSOTf in the presence of silyl ketene acetal 1.540 to provide ester 1.617 in 79% 
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yield (Scheme 1.129), whereas the same ionization reaction using tertiary thiophen-2-yl 
carbinol 1.613 provided propionate 1.618 in 84% yield.  Secondary thiophen-2-yl 
carbinol 1.612 was also investigated as an electrophile, but its reaction with 1.540 
provided propionate 1.617 in only 50% yield.   
Scheme 1.129 
 
  1.12 CONCLUSION 
In conclusion, we developed and expanded upon Tsung-Hao’s original SN1-type 
reaction between indol-3-yl carbinols and silyl ketene acetals to create a general method 
for forming -tetrasubstituted -heteroaryl propionates using a variety of different 
heterocycles.  Ten heterocycles, including indol-2-yl, furan-2-yl, pyrrol-2-yl, and 
thiophen-2-yl carbinols and/or acetates,  were found to couple with four different achiral 
-nucleophiles, 1.540, 1.573, 1.556, and 1.555, to provide highly substituted -heteroaryl 
propionates in a single step in moderate to excellent yields (42-93%) (Scheme 1.130 and 
Figures 1.3-1.6).  In general, secondary acetates and tertiary alcohols were better 
substrates than primary carbinols, which either did not work at all or provided poor yields 
of the desired propionates.  The more acid sensitive members of the furan and pyrrole 
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series (Figures 1.4 and 1.5) also provided lower yields of -heteroaryl propionates than 
the indole and thiophene series (Figures 1.3 and 1.6).   
Scheme 1.130 
 
Figure 1.3 
 
Figure 1.4 
 
Figure 1.5 
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Figure 1.6 
 
We were very pleased to find that the TMSOTf mediated reaction between 
tertiary heterocyclic carbinols and -disbstituted silyl ketene acetal 1.540 produced 
-tetramethyl -heteroaryl propionates in high yield, which was a major limitation 
of earlier EAS and SN1-type routes.  The ability to form contiguous quaternary centers in 
a single step is a powerful, and often difficult, synthetic transformation,
139
 and we were 
gratified that our method could provide those products with such ease.   In fact, the 
preparation of 1.574 was the first example of an extremely hindered -
tetrasubstituted-heteroaryl propionate being formed in a single step (Figure 1.3). 
We were also able to achieve high yields of -heteroaryl propionates from reactions 
using heterocyclic carbinols that did not follow classical Friedel-Crafts reactivity 
pathways, such as indoly-2-yl carbinols and acetates (Figure 1.3).  Prior to our work, 
there were very few examples of indol-2-yl propionates in the literature, and of those 
special cases there were no known examples of indol-2-yl propionates being prepared 
through SN1-type reactions (cf. Section 1.4).  Propionate 1.574 really highlights the best 
parts of the method, namely, the ability to form contiguous quaternary centers, as well as 
the ability to overcome traditional Friedel-Crafts reactivity pathways.   
While our work has made a valuable contribution to the field, there is still room 
for improvement. 
140,141
   We reported the formation of a single diastereoselective 
propionate from the reaction of indol-3-yl carbinol 1.506 and N,O-acetal 1.507 (Scheme 
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1.131), but extensions of this work would provide a wide variety of diastereoselective 
-substituted -heteroaryl propionates.  Future work would be focused toward the 
development of an asymmetric catalyst which we could use to obtain enantioselective -
heteroaryl propionates in a single step.  Also, while we showed that vinylogous, -
substituted and unsubstituted, cyclic and acyclic silyl ketene acetals were tolerated in the 
reaction, future work on the -nucleophile would be directed toward nucleophiles with -
substituents other than carbon to provide -hydroxy or -amino -heteroaryl propionates.   
Scheme 1.131 
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Chapter 2: Acutumine 
2.1 INTRODUCTION 
The alkaloid acutumine (2.1), first isolated from the rhizome of the Asian vine 
Menispermum dauricum in 1929,
142
 has long been used in traditional Chinese medicine 
as an analgesic and antipyretic (Figure 2.1).
143
  However, its unique tetracyclic, chlorine-
containing structure was not fully elucidated by X-ray crystallography until the late 
sixties.
144-147
  Since that time, acutumine has garnered much interest in the synthetic 
community because of its moderate, selective inhibition of human T-cell growth (IC50 = 
13.2 mM).
143
  This cytotoxicity could potentially be used as a therapy for T-cell related 
leukemia and lymphoma.
143
  Acutumine and its closely related analogue dauricumidine 
(2.2) have recently been shown to exhibit activity against the hepatitis B virus surface 
antigen secretion of the Hep G2.2.15 cell line, with IC50’s of 1.415 mM and 0.450 mM, 
respectively. 
148
  Acutumine has also been suggested to have anti-amnesiac properties in 
animal experimental models.
149
  
Figure 2.1 
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2.2 PROPOSED BIOSYNTHESES 
Sugimoto and coworkers (Scheme 2.1) have discovered, through carbon labeling 
experiments, that acutumine (2.1) is derived from two molecules of tyrosine (2.3).
150
  
Sugimoto et al. have also shown that the immediate biosynthetic precursors to acutumine 
(2.1) are dechloroacutumine (2.4) and its hydroxyl epimer dauricumine (2.5), which once 
chlorinated can epimerize to provide acutumine (2.1).
151-153
  Also of note, the pathway 
proceeding from dechlorodauricumine (2.6) to actumine (2.1) was also found to proceed 
more successfully as compared to the seemingly more efficient route from 
dechloroacutumine (2.4) to acutumine (2.1).  While the beginning and end stages of the 
biosynthesis of acutumine have been elucidated, only hypotheses exist as to the 
remaining intermediary steps of the process. 
Scheme 2.1 
 
 Barton proposed a biosynthesis of acutumine (2.1) based upon the biosynthesis of 
the related alkaloid sinomenine (2.7) in 1968 (Scheme 2.2).  He and his co-workers 
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showed that sinomenine is derived from reticuline (2.8) through an oxidative aromatic 
coupling via sinoacutine (2.9).
154
   
Scheme 2.2 
 
 Based on his observations of reticuline, Barton proposed a similar biosynthesis of 
acutumine (2.1).  An oxidative phenolic coupling of starting biaryl 2.10a would provide 
intermediate 2.10, which could then be further elaborated to acutumine by ring 
contraction and isomerization (Scheme 2.3).
155
  Barton also provided a possible 
mechanism for the ring contraction (Scheme 2.4), but this process was later cast into 
doubt by two independent studies (Schemes 2.5 and 2.6).
155-157
   
Scheme 2.3 
 
 Barton had originally proposed that dienone 2.10 would undergo bis-epoxidation 
to provide ring 2.12.
155
 He then envisioned that bis-epoxide 2.12 could undergo a 
Favorski-type rearrangement to provide 2.13, whereupon decarboxylation and oxidation 
  
 
110 
would provide cyclopentene ring 2.15.  Rearrangement of 2.16 followed by a hydride 
shift would then provide the secondary cation 2.18, which could be stereoselectively 
captured by a chloride ion to produce acutumine (2.1).  However, this proposal was 
highly speculative, and attempts to justify the route experimentally did not provide 
support for the overall transformation (Schemes 2.5 and 2.6).
155-157
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Scheme 2.4 
 
In two independent investigations, a bis-epoxidation of the cyclohexenone moiety 
of intermediate 2.10, namely compound 2.20, was carried out in an attempt to produce a 
bis-epoxide (Schemes 2.5 and 2.6).
155-157
  However, neither study obtained a bis-epoxide 
product, which was a key intermediate in Barton’s proposed acutumine biosynthesis.  In 
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the first study by Matoba et. al., it was proposed that lactone 2.23 was the product of two 
subsequent oxidations of compound 2.20 with epoxidizing agents (Scheme 2.5).
156
  
However, Wipf suggested that Bayer-Villiger products 2.25, rather than bis-epoxides, 
were obtained as products (Scheme 2.6).
157
   
Scheme 2.5 
 
Scheme 2.6 
 
Wipf et. al. also proposed an alternative biosynthetic pathway of acutumine 
(Scheme 2.7).  Acutumine could come from compound 2.26, which is very similar to the 
natural product acutudarin (2.27).   The mechanism by which this ring contraction may 
take place is shown in Scheme 2.8.  Oxidation of cyclohexenone 2.28 to the o-quinone 
like structure 2.29, followed by a rearrangement and decarboxylation could provide the 
cyclopentenone ring of acutumine 2.32.
157-161
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Scheme 2.7 
 
Scheme 2.8 
 
2.3 PREVIOUS SYNTHESES 
 While acutumine poses a great deal of interest within the synthetic community, 
thus far only four synthetic studies have been reported.
162-165
  Of those four, two are 
approaches to the propellane core of acutumine (2.1), while the other two are 
enantioselective routes to the desired compound.  All four will be discussed in detail in 
the forthcoming sections. 
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2.3.1 PARTIAL APPROACHES TOWARD THE SYNTHESIS OF ACUTUMINE 
The first published synthesis of the tricylic core of acutumine 2.33 was developed 
by Sorensen in 2007.
162
  The key step in the synthesis of 2.33 involved a cascade of 
carbonyl dependent reactions starting from pyrrolidine 2.34, which was synthesized from 
known pyrrolidinone 2.35 (Scheme 2.9). 
Scheme 2.9 
 
 Pyrrolidinone 2.35 was available in three steps from N-Boc protected 3-
aminopropanoic acid (2.36) in 93% yield (Scheme 2.10).
162,166
  Pyrrolidinone 2.35 was 
alkylated with propargyl bromide (2.41) to provide racemic 2.42, which was then 
subjected to a Grignard reaction with 2.43 to provide tertiary alcohol 2.44 in 91% yield.  
The terminal alkene of 2.44 was then epoxidized using standard conditions to provide 
2.45, which was a good substrate for the palladium (II)-catalyzed carbonylative 
cyclization reaction between the alcohol and alkyne moieties to provide vinylogous 
carbonate 2.46.  The epoxide was then transformed to ketone 2.34, the key intermediate 
of the synthesis, thereby setting the stage for the carbonyl cascade that would lead to the 
tricyclic core 2.33.
162
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Scheme 2.10  
 
 
 The first step of the cascade sequence involved the base catalyzed -elimination 
reaction of 2.34 to generate the intermediate enolate 2.48 that then underwent an 
intramolecular Michael addition to provide diester 2.49 (Scheme 2.11).  Upon enolate 
formation, 2.49 engaged in a Dieckmann-like condensation to provide 2.33.
162
  Despite 
this concise approach to the tricyclic core, Sorensen has yet to report a total synthesis of 
acutumine, and it is unclear whether his route will be amenable to an enantioselective 
synthesis of the molecule. 
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Scheme 2.11 
 
A second approach towards the acutumine propellane core was reported by 
Reisman et al. in 2012 (Scheme 2.12). The main features of the approach include a site 
selective [2+2] cycloaddition followed by a retro-aldol/aldol sequence to provide the 
tetracyclic core 2.50.
164
 
Scheme 2.12 
 
Reisman and coworkers used commercially available bromo-phenol 2.54 as their 
starting material and followed their previous route to convert it to dihydroindolone 2.61 
(Scheme 2.13).
167
  Phenol 2.54 was first converted to sulfinimine 2.56 over two steps in 
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74% yield, which then underwent Grignard addition with furanyl nucleophile 2.57 to 
provide the corresponding adduct 2.58 in 68% yield and >98:2 diastereoselectivity.  
Vinyl bromide 2.58 was subjected to a Stille reaction with vinyl stannane 2.59 to furnish 
enol ether 2.60 in 86% yield.  The sulfonyl group of 2.60 was cleaved by acid to provide 
an intermediary indolone that was immediately reduced to the dihydroindolone 2.61 by 
NaBH4.  However, further elaboration to the desired pentacyclic [2+2] product 2.62 was 
unsuccessful. 
 
Scheme 2.13 
 
It was later found that the reason for the unsuccessful [2+2] reaction was due to a 
photolytic oxa-di--methane rearrangement (Scheme 2.14).168  The rearrangement 
product 2.63 was hypothesized to fragment to the unstable spirocyclic iminium ion 2.64, 
which was captured by adventitious water from the reaction to provide pyrrolidine 2.65.  
The structure of pyrrolidine 2.65 was assigned based upon 
1
H NMR, 
13
C NMR, IR and 
HRMS analysis.   
  
 
118 
Scheme 2.14 
 
   
 In order to circumvent the undesired rearrangement, Reisman and coworkers 
amended the route by masking one of the alkenes of the dienone 2.61 as an epoxide 
(Scheme 2.15).  Dienone 2.61 was epoxidized exclusively at the least hindered olefin to 
provide 2.66 in 70% yield.  When enone 2.66 was subjected to the photolytic [2+2] 
conditions, the desired adduct 2.67 was obtained in 54% yield, thereby providing the 
quaternary centers of acutumine in a single step.  Dihydrofuran 2.67 was then elaborated 
to the corresponding bromohydrin 2.68 in 88% yield.  However, when 2.68 was subjected 
to either mildly acidic or basic conditions, decomposition predominated, and none of the 
desired tetracyclic 2.70 was detected. Reisman and coworkers hypothesized that the 
reason for this was the undesired reactivity of the epoxide in 2.68.   
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Scheme 2.15 
 
 
 As the epoxide had proven an ineffective protecting group for dienone 2.61, they 
removed the troublesome alkene via reduction (Scheme 2.16).  Dienone 2.61 underwent a 
site-selective copper-mediated conjugate reduction with polymethylhydrosiloxane 
(PMHS) to provide tetrahydroindolone 2.71 in 75% yield.  When 2.71 was irradiated, the 
desired pentacyclic product 2.72 was produced in 71% yield.  Dihydroxylation of 2.72 
with OsO4 and NMO provided lactol 2.73, which was further elaborated to hemiketal 
2.76 via the desired retro-aldol/aldol sequence in 60% yield.  Unfortunately, hemiketal 
2.76 was resistant to all additional efforts to elaborate it to acutumine (2.1).      
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Scheme 2.16 
 
  
In conclusion, Reisman and coworkers have enantioselectively prepared 
hemiketal 2.76 in 10 steps and 6.9% overall yield effectively using a [2+2] cycloaddition 
retro-aldol/adol sequence.  While Reisman was able to obtain the propellane core in a 
short sequence of steps and high yield, she admitted that hemiketal 2.76 was most likely 
not a viable precursor to acutumine.  The route also features a key Stille reaction, which 
is not desirable to perform on a large scale due to all the tin and triphenyl arsine 
byproducts produced.   
 
2.3.2 ENANTIOSELECTIVE TOTAL SYNTHESES OF ACUTUMINE 
There have been two total syntheses of acutumine to date.
163,165
  After publishing 
two different studies towards the core of acutumine,
169,170
 Castle et. al reported the first 
total synthesis of (-)-acutumine in 2009.
163
  Some key features of the synthesis include a 
regio- and stereo-selective, oxidative radical-polar crossover reaction to establish the 
spirocyclic acutumine core 2.80
169
 and an asymmetric Nakamura allylation
171
 followed 
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by an anionic oxy-Cope rearrangement to set up the formation of the final pyrrolidine 
ring 2.1 (Scheme 2.17).
163
    
 
Scheme 2.17 
 
 
 Castle first prepared cyclopentene 2.85, which was obtained from the enantiopure 
mono-protected diol 2.82 (Scheme 2.18).  Compound 2.82 is not commercially available, 
but may be readily accessed from the commercially available, albeit expensive 
(approximately $138/g), enantiopure acetate 2.86 via a pivalate protection/acetate 
deprotection sequence.
172
   With 2.82 in hand, Castle protected the free alcohol as its 
triethylsilyl (TES) ether and then removed the pivalate group to reveal alcohol 2.83.  This 
alcohol was then oxidized to the corresponding enone, which was iodinated to provide 
2.84.  The ketone was next reduced via the Luche procedure to provide the free alcohol 
that was subsequently protected as the tert-butyldimethylsilyl (TBS) ether to give 
cyclopentene ring 2.85.   
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Scheme 2.18 
 
 
 Castle’s key radical-polar crossover reaction required 2.94, which was prepared in 
six steps from 2,3-dimethoxyphenol (2.88) (Scheme 2.19).  Compound 2.88 was first 
subjected to a Reimer-Tiemann reaction to provide aldehyde 2.89, although in only 14% 
yield.  The phenol was next protected, and the ring was regioselectively nitrated to 
provide compound 2.91.  The nitro group was then transformed to aryl iodide 2.92 in 
41% yield under standard reaction conditions.  The aldehyde was subjected to a Wittig 
homologation to provide the new aldehyde 2.93, which was oxidized to a carboxylic acid 
that was converted into the Weinreb amide 2.94.
169
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Scheme 2.19 
 
 Fragments 2.85 and 2.94 were coupled via a Grignard reaction to provide 
intermediate 2.81 in 63% yield (Scheme 2.20).  Ketone 2.81 was stereoselectively 
reduced using the Corey-Bakshi-Shibata (CBS) catalyst (2.95) to provide alcohol 2.96, 
which was subsequently mesylated and displaced with chloride to provide 2.97.  The TES 
ether was cleaved using hydrofluoric acid and pyridine (HF·pyr), and the resulting 
alcohol was oxidized to the enone in the presence of pyridinium chlorochromate (PCC) to 
provide 2.98, thus setting the stage for the radical-polar crossover reaction.  When 
irradiated in the presence of hexabutylditin ( (Bu3Sn)2 ), iodide 2.98 presumably 
generated an aryl radical that combined with the double bond of the enone to form a 
spirocycle, repositioning the radical - to the ketone.  Triethylaluminum is then believed 
to have acted as a one-electron donor in order to generate an enolate that then trapped the 
oxaziridine 2.99 to provide -hydroxy ketone 2.80 in 62% overall yield.  This elegant 
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transformation proceeded with complete stereoselectivity to give the enantiomerically 
pure hydroxy-ketone 2.80 with small amounts of side products 2.100 and 2.101.
169
   
 
Scheme 2.20 
 
 The hydroxy-ketone 2.80 was then stereoselectively reduced to diol 2.102, the 
more sterically accessible alcohol of which was silylated to provide 2.103 (Scheme 2.21).  
The benzyl ether was removed by hydrogenation to selectively reveal phenol 2.104, and 
oxidation with phenyliodonium diacetate (PIDA) provided the masked ortho-
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benzoquinone 2.105.  After protection of the secondary alcohol of 2.105 with benzyl 
bromide (BnBr), a Nakamura asymmetric allylation
171
 was performed to provide 
homoallylic alcohol 2.78 in 79% yield and 93:7 diastereoselectivity.
163
 
 
Scheme 2.21 
 
 An anionic oxy-Cope rearrangement of homoallylic alcohol 2.78 provided 2.77 in 
92% yield with retention of stereochemistry (Scheme 2.22).  Next, the alkene moiety of 
2.77 was oxidatively cleaved to an aldehyde which underwent a reductive amination to 
provide secondary amine 2.107.  In the presence of boron trichloride (BCl3), the amine 
engaged in a Lewis-acid catalyzed cyclization to provide tetracyclic 2.108 in moderate 
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yield.  Following cleavage of the TBS ethers, the resultant alcohols were oxidized to their 
respective ketones 2.109, and removal of the benzyl groups furnished secondary alcohol 
2.110.  Treatment of 2.110 with titanium tetrachloride (TiCl4) and base in methanol 
(MeOH) provided acutumine (2.1) as a 3.7:1 separable mixture of acutumine (2.1) and its 
regioisomer 2.111.
163
   
 
Scheme 2.22 
 
 
 While Castle’s work is the first successful synthesis of acutumine, there is still 
ample room for improvement.  The total number of steps is not reported, but is most 
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likely to be in low thirties.  It is unclear how many steps it took the authors to prepare the 
two main starting materials 2.85 and 2.94.  Starting from 2,3-dimethoxyphenol, it is six 
steps to Weinreb amide 2.94,
169,173,174
 and from the expensive and not widely available 
(1R,4S)-4-hydroxycyclopent-2-enyl acetate (2.86), and five steps are required to prepare 
2.85.
169,172
   
 The most recent synthesis of acutumine was reported by Herzon and coworkers in 
2013.
165
   Some key features of their route include an early stage regioselective Diels-
Alder reaction that set the stereochemistry for all subsequent reactions as well as a retro 
Diels-Alder/Hosomi-Sakurai sequence to provide the tetracyclic core 2.113, and a late 
stage selective hydrogenation to furnish acutumine (2.1) (Scheme 2.23).  
 
Scheme 2.23 
 
 Herzon used mescaline derivative 2.116, which can be obtained from the 
commercially available acetal 2.117 in four steps, as his starting material (Scheme 
2.24).
175
  In the event, acetal 2.117 was reductively cleaved with 9-BBN, and then 
oxidized to provide alcohol 2.118 in 76% yield.
175
  Alcohol 2.118 was then converted to 
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azide 2.116 according to standard protocols, though the yield was not given.
175
  Azide 
2.116 was oxidized to p-quinone 2.119 in 48% yield.  Quinone 2.119 then underwent a 
regioselective Diels-Alder reaction with cyclopentadiene 2.120 in good yield and 
enantioselectivity to provide 2.121 exclusively as the endo adduct.
176
  Quinone 2.121 was 
then subjected to Staudinger reaction conditions to provide iminoquinone 2.115 in 
excellent yield.   
 
Scheme 2.24 
 
 The coupling partner for the iminoquinone 2.115 was synthesized from readily 
available D-ribose (2.122) (Scheme 2.25).  Ribose 2.122 was converted into acetal 2.123 
in five steps via known procedures.
177
  Palladium catalyzed disilylation followed by 
hydrolysis of the trimethylsilyl enol ether thus provided acetal 2.124 in 91% yield.
178
  
Acetal 2.124 was next transformed into enol triflate 2.125 using Comin’s reagent in 88% 
yield.  Vinyl triflate 2.125 underwent a Stille coupling with the propargyl tin reagent 
2.128 to provide alkyne 2.126 in 77% yield, which was then deprotonated with n-Buli to 
provide the lithiated anion 2.127. 
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Scheme 2.25 
 
  
Iminoquinone 2.115 was methylated under standard conditions to produce the 
iminium ion 2.129, which was captured by the alkynyl anion 2.127 to provide the 
addition product 2.116 as a single diastereomer (Scheme 2.26).  The somewhat 
counterintuitive stereoselectivity from the addition was attributed to the orientation of 
pyrrolidine ring in the iminium ion.  Adduct 2.114 was next heated to effect a retro Diels-
Alder reaction to provide the dienone 2.130 in 98% yield.  Alkyne 2.130 was reduced by 
hydrostannylation 
179
 to provide vinyl stannane 2.131, which in the presence of TBAF 
underwent a Hosomi-Sakurai reaction to provide the complete tetracyclic core 2.132, 
albeit in only 37% yield.  The regioselectivity of the hydrostannylation was believed to 
be due to the propensity of alkyne 2.130 to insert into a palladium hydride to form an 
intermediate with -allyl character, as well as the steric hindrance present at the carbon 
- to the cyclopentene ring.   
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Scheme 2.26 
  
Once 2.132 was obtained, two main challenges remained. These were the 
introduction of the chlorine atom and the oxidation of the spirocyclic cyclopentene ring 
to the desired vinylogous ester of the natural product.  Towards this end, vinyl stannane 
2.132 was transformed into the corresponding vinyl chloride in the presence of copper 
(II) chloride (CuCl2),
180
with subsequent acid catalyzed cleavage of the acetal to provide 
diol 2.113 in 79% yield over two steps (Scheme 2.27).  Diol 2.113 was then oxidized 
under Swern conditions to provide the intermediary dione 2.133, which was not isolated, 
but was instead immediately subjected to sequential reaction with sodium thiomethoxide 
and diazomethane to yield tetracycle 2.134 in 97% yield over two steps.  Treatment of 
2.134 with N-iodosuccimide (NIS) and formic acid (HCO2H), resulted in the elimination 
of the thioxide group to provide mixed ketal 2.135 as a mixture (3:1) of diastereomers).  
Mixed ketal 2.135 then underwent a rearrangenent in the presence of Hunig’s base 
(DIPEA) to provide enone 2.136.  Enone 2.136 was treated with ammonia in methanol to 
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cleave the formyl group, and the resulting lactol 2.137 was oxidized with Dess-Martin 
periodinane (DMP) and then reduced with sodium tetraborohydride (NaBH4) to provide 
2.112 in 28% yield over five steps.   
Scheme 2.27 
 
 All that remained in Herzon’s synthesis was the stereoselective reduction of vinyl 
chloride 2.112 to the correct diastereomeric alkyl chloride to provide acutumine (2.1).  
This was accomplished using homogeneous hydrogenation conditions
181-184
 to obtain 
acutumine (2.1), albeit in only 17% yield (Scheme 2.28).  Presumably the 
stereoselectivity of the reduction was directed by the hydroxyl group and tertiary amine 
of vinyl chloride 2.112.
181-184
  The majority of the material recovered was the 
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dechlorinated product dechloroacutumine (2.4), which was the exclusive product 
obtained using more standard catalytic hydrogenation conditions (H2, Pd/C).   
 
Scheme 2.28 
 
 In conclusion, Herzon et al. have developed an enantioselective synthesis of 
acutumine comprising 31 steps with an overall yield of 0.06%.  Some of the key features 
included an early stage regioselective Diels-Alder reaction which enabled substrate 
control of all subsequent reactions as well as a hydrostannylation/Hosomi-Sakurai 
sequence which provided expedient access to the tetracyclic core.  However, some 
challenges remained.  For example, the synthesis would have been more impressive had a 
cyclopentenone of the desired oxidation state could have participated in the Hosomi-
Sakurai reaction, eliminating the need for all the additional oxidative manipulations.  The 
authors did examine a variety of other conditions for closing the tetracycle with a variety 
of different cyclopentenones in the presence of Lewis acids and heat, yet none of the 
desired tetracyclic core was obtained.  Thus, the Hosomi-Sakurai reaction with the TMS 
group present on the cyclopentenone was the only option available to them.  Another 
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major drawback of the synthesis is the low yield of the final hydrogenation step.  While 
they can easily access the dechlorinated acutumine precursor 2.4, the authors did not 
disclose how they would elaborate that intermediate to the acutumine.   
 While the work of Sorensen, Reisman, Castle, and Herzon highlighted some 
interesting chemistry towards the formation of acutumine, there is still room for 
improvement.  Sorensen was able to furnish the propellane core of acutumine 2.33 in 
23% yield over 10 steps using elegant enolate chemistry, and Reisman was able to 
synthesize the complex pentacyclic core 2.76 in 6.8% yield over 10 steps using a clever 
regioselective [2+2] cycloaddition.  Yet as efficient and high yielding as these syntheses 
were, it was unclear whether 2.33 or 2.76 could be further elaborated to acutumine.  
Reisman even admitted that 2.76 was most likely not a viable precursor to acutumine 
while Sorensen’s work was completed over 10 years ago with no subsequent work having 
been published since that time. 
 Castle completed an enantioselective total synthesis of acutumine in 2007, 
furnishing the molecule in 0.004% yield over at least 30 steps.  Pioneering a novel 
radical-polar crossover reaction, he was able to stereoselectively furnish the spirocycle of 
acutumine in a single step. However, the synthesis was lengthy, and with the exception of 
the radical polar crossover reaction, lacked efficiency and to a certain degree, creativity.  
The synthesis disclosed a number of protecting group manipulations and most of the 
reactions in the sequence could be considered routine.  It seemed to us that a more 
streamlined approach to acutumine might be possible.  However, Castle’s efforts are not 
to be belittled as he was the first to accomplish the total synthesis of this incredibly 
complex molecule.     
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 Herzon also completed an enantioselective total synthesis of acutumine fairly 
recently.  The molecule was obtained in 0.06% yield over 31 steps.  His route featured a 
regioselective Diels-Alder reaction between an iminoquinone and a silyl cyclopentadiene, 
wherein the cyclopentadiene was cleverly used as a chiral auxiliary to guide a key 
acetylide addition.  The route also featured Hosomi-Sakurai reaction to close the 
spirocyclic ring of the acutumine core.  However, the route was not without its faults.  
The route was lengthy and though Herzon was able to furnish the tetracyclic core of 
acutumine quickly and uniquely, a large amount of his synthesis was spent 
functionalizing the -hydroxy vinylogous ester cyclopentene ring of the spirocycle.  The 
repeated functional group and oxidation manipulations of that particular moeity of 
acutumine were largely responsible for the high step count of the total synthesis.  Also, 
the last step of the synthesis, a selective hydrogenation of a vinyl chloride group, 
proceeded in only 14% yield.  Clearly there was still room for improvement within the 
field.   
 It is also important to note that we were pursuing our studies concurrent to those 
of Herzon and Reisman.  As will be shown in subsequent sections, we also favored a 
strategy in which an iminoquinone played an important role.  When we started our 
investigations, only the work of Sorensen and Castle had been known.  While their work 
was commendable, as discussed above, we believed that we could come up with a more 
streamlined and elegant approach to the acutumine.  We were interested in the 
biosynthesis of acutumine and wanted to develop a strategy towards that end.   
To quickly summarize section 2.2, what was known for sure about the 
biosynthesis of acutumine was that it was derived from two molecules of tyrosine and 
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that the last step of the biosynthesis involved the installation of a neopentylic chlorine 
atom.
150,152,153
  The route from tyrosine to dechloroacutumine was believed to consist of 
an oxidative coupling followed by benzylic acid type rearrangement, yet nothing has 
been proven.
154-157
  Neither Sorensen nor Castle pursued a strategy similar to the 
proposed biosynthesis, and we saw an opportunity to both explore new and interesting 
chemistry as well as test some of the hypotheses with regards to the biosynthesis of 
acutumine.
154-157
  Herzon and Reisman also appear to have found inspiration in the 
biosynthesis of acutumine, as our strategies show some similarities, though we did not, 
and could not, have known this at the start of our investigations.   
2.4 MARTIN GROUP BIOMIMETIC APPROACH 
 In our proposed synthesis towards acutumine, we envisioned the incorporation of 
two key biomimetic steps.  The first, was a novel latestage stereoselective radical 
chlorination that would exploit the existing stereochemistry of the spirocyclic hydroxyl 
group to direct the addition of the chlorine radical to the correct face of the molecule 
(Scheme 2.29).  The second key step we had envisioned was a diastereoselective 
oxidation cyclization/Micheal addition sequence that would set up the tetracyclic core of 
acutumine 2.138, preferably in a single one-pot reaction.  Both will be discussed in detail 
below. 
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Scheme 2.29 
 
 
 As Sugimoto and coworkers had discovered, the chlorine atom of acutumine was 
incorporated in the last stages of the biosynthesis.
152,153
   We were intrigued by this 
concept and believed that we could access acutumine (2.1) from tetracycle 2.137 via a 
novel radical chlorination in which an oxygen-centered radical at the secondary alcohol 
2.141 would generate a carbon centered radical that will regio- and stereoselectively 
deliver the chlorine atom to the propellane core (Scheme 2.30).  The oxygen radical could 
be generated by any number of standard techniques, including a possible Hofmann-
Loffler-Freytag radical initiation.
185-187
  Though directed radical functionalizations are 
known to proceed better in rigid substrates, which would certainly describe the tetracycle 
of 2.141, almost all of precedented directed radical functionalizations occur through 1,5-
hydrogen abstraction; our substrate would require a 1,4-hydrogen abstraction.
185-187
  
However, 2.141 has no accessible protons available for a 1,5-hydrogen abstraction, so the 
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directed functionalization may still occur as desired.  When a three-dimensional model 
was built, it looked as if the desired diastereotopic proton, Ha, would have been more 
accessible to the oxygen atom of the hydroxyl group than Hb, futher encouraging our 
pursuit of a late stage radical chlorination.  It was a scientific question that we were very 
interested in answering.  However, if our original plan proved to be too bold then we 
could also elaborate our free hydroxyl to a carbamate group, such as the  trifluoroethyl 
carbamates of Baran,
188
 which can proceed through oxygen or nitrogen centered radicals 
to provide more favorable 1,5 and 1,6-hydrogen abstractions while still providing our 
desired “1,4-hydrogen abstraction” product, 2.142. 
 
Scheme 2.30 
 
 We envisioned accessing 2.143 from cyclopentenedione 2.138 via an asymmetric 
sulfa-Michael addition /Pummerer sequence.  In order for this sequence to be successful, 
we required a way to desymmetrize the cyclopentenedione ring so that we would be able 
to selectively oxidize the C2 position as opposed to the C1 position (Scheme 2.31).    
Thiols have been shown add to 1,2-maleic acid esters and cyclic enones in the presence 
of chiral catalysts, both organocatalytic and transition metal based, to provide 
regioselective and/or diastereoselective Michael addition products.
189-191
  A thiol moiety 
at the C2 position of the cyclopentenedione ring would provide an excellent functional 
handle with which to elaborate 2.143 to acutumine.  Fortunately the complexity of 
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tetracycle 2.138 should help to reinforce a spatial bias between C1 and C2 to facilitate 
differentiation between the two.  Also, we will not need to worry about whether thiol 
addition occurs from the top or bottom face of the molecule, as the chiral center at will be 
destroyed to provide the vinylogous ester of 2.137.  
 
Scheme 2.31 
 
Once the two carbonyl groups are differentiated, subsequent oxidation of the thiol 
of 2.143 to its corresponding sulfoxide will enable the Pummerer rearrangement to take 
place.  Elimination of the thiol group would provide the trione 2.144, which should 
selectively enolize to 2.145 in the presence of acid and methanol.
192
   Stereoselective 
reduction of the ketone would then provide tetracycle 2.137 (cf. Scheme 2.29). 
Scheme 2.32 
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Our second biomimetic key step involves a diastereoselective oxidative 
cyclization/Michael addition sequence to provide tetracycle 2.138.  The sequence could 
be envisioned as a discrete two step process, or ideally, as a “one pot” reaction (Scheme 
2.33).  A proposed mechanism for the sequence is described below (Scheme 2.34). 
 
Scheme 2.33 
 
 We proposed that phenethyl amine 2.140 could be oxidized in the presence of a 
hypervalent iodine reagent, such as phenyliodonium diacetate (PIDA), to furnish the 
aromatic cation 2.146 (Scheme 2.34).
193-196
  Intramolecular capture of said cation with the 
appended chiral carbamate of 2.147 would provide the tetracycle 2.138.   We had hoped 
to control the stereoselectivity of the reaction with the chiral auxiliary appended to the 
attacking nitrogen atom.
197-199
  Though hypervalent iodine mediated intramolecular 
cyclizations are well-precedented for electron rich aromatic phenethyl amines and 
alcohols,
193-196
 we were curious to see if we could effect the cyclization at an extremely 
hindered site and in a stereoselective manner.  Oxidative cyclizations to create masked 
p,p-disubstituted quinones was known, but one or both of the p-substituents are usually a 
low molecular weight alcohol (ie methanol or ethanol) which carries considerably less 
steric bulk as compared to our system 2.140.
193-196
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Scheme 2.34 
 
 Another interesting scientific question we sought to answer with our oxidative 
cyclization was whether we could also effect an intramolecular Michael addition between 
the cyclopentenedione ring and newly formed quinone of 2.147.  The cyclopentenedione 
anion formed upon the addition of an appropriate non-nucleophilic base to the oxidative 
cyclization mixture should add regioselectively to the enone of 2.147 as opposed to the 
vinylogous ester, thus providing the tetracyclic core of acutumine, in most preferably, a 
single step. The diastereoselectivity of the Michael addition should not be of concern 
because the anion should add to the same face of the quinone as the ethyl substituent to 
which it is attached.   
  If both the oxidative cyclization and Michael addition were found to be 
successful, then we would have been the first to create an efficient and elegant 
biomimetic synthesis of acutumine’s core.  It is also important to point out that the 
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cyclopentene ring of the tetracyclic core we hoped to achieve, namely 2.138, would 
require minimal oxidation and protecting group manipulations to achieve the hydroxyl 
cyclopentenone found in the final product.  Recall that the synthesis of the said hydroxyl 
cyclopentenone had been a significant problem for both Castle and Herzon’s syntheses, 
requiring numerous steps.   
2.5 FIRST GENERATION MARTIN GROUP APPROACH 
 Though we were excited to test the viability of our biomimetic key steps, we had 
to devise a way to quickly and efficiently obtain intermediate 2.140.  Towards that end, 
we pursued a number of different strategies simultaneously, the first of which features a 
reaction called the Moore cyclization (Scheme 2.35).
200-203
   
Scheme 2.35 
 
 The Moore cyclization is a well-known process for making highly substituted 
quinones.  The cyclization features a 4-electrocyclic opening of a cyclobutene ring 
2.148 to deliver a reactive ketene intermediate 2.149 that cyclizes in a 6-exo-dig fashion 
to provide a diradical intermediate 2.150.  Intermediate 2.150 then abstracts a hydrogen 
atom to provide quinones of the type 2.151.
200-203
   The Moore cyclization was appealing 
to us because it could provide highly substituted quinones in a minimal amount of steps.  
We envisioned using this strategy to access our key intermediate 2.140 (Scheme 2.36).   
 Working backwards, we believed that phenethyl amine 2.140 could be obtained 
through a transition metal mediated coupling between aryl triflate 2.153
204
 and the known 
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cyclopropyl cyclopentenedione 2.152 (Scheme 2.36).
205
 Though we had seen precedent 
for the opening of a similar cyclopropyl ring with an aryl cuprate, we anticipated that the 
reaction might be difficult given that the aryl triflate was o,o-disubstituted.
204
  Triflate 
2.153 could be furnished from phenethyl mesylate 2.154 through a series of fairly routine 
functionalizations, including a selective mono triethylsilyl (TES) phenolic protection. We 
would obtain mesylate 2.154 from the lithium acetylide addition of 2.156 with 
dimethoxysquarate (2.155)
206
 to produce the requisite cyclobutene ring with which to 
carry out the Moore cyclization
207
 described above. 
Scheme 2.36 
 
 
The first challenge that we encountered in the forward synthesis was the 
preparation of a suitable alkyne with which to add to dimethoxysquarate 2.155 (Scheme 
2.37).  We were considering both but-3-yn-1-amines and but-3-yn-1-ols but ideally we 
wanted to introduce a nitrogen atom as early as possible in the synthesis to increase to 
minimize the step count.  Protected alkynols were known to be well tolerated in Moore 
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cyclizations, as were tertiary amines, though we did not know what to expect from 
primary or secondary amines as they were not mentioned in the literature.
208-210
  
Scheme 2.37 
 
Towards that end, the reaction between dimethoxysquarate (2.155) and Boc-
protected homopropargyl amine 2.160
211
 was investigated (Scheme 2.38).  The dianion of 
2.160 was prepared
212
 with n-BuLi and added to a solution of dimethoxysquarate (2.155) 
at -78 °C. The cyclobutene ring 2.161 was heated under reflux in toluene to provide 
quinone 2.162 in 18% yield over two steps.  Unfortunately, a major side product was 
formed upon the addition to squarate 2.155, and that that side product was carried 
through the following Moore cyclization.  The side product was isolated through column 
chromatography and was identified by 
1
H NMR and LRMS data to be squarate 2.163 
(Scheme 2.38).  While the acidic carbamate hydrogen was found to survive the Moore 
cyclization, the initial addition of the dianion of 2.160 to dimethoxysquarate (2.155) was 
unfortunately not selective under the aforementioned conditions.   
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Scheme 2.38 
 
 The reaction was carried out in the presence of a couple other common bases (ie 
CaH2 and LDA), both alone and in combination with one another, but side product 
formation continued to predominate.  Attempts were made to access other nitrogen 
acetylides, namely 2.164-2.166, however phthalimide 2.164 did not add to 
dimethoxysquarate (1.155), and the bis-siloxypyrrole 2.165 and azide 2.166 could not be 
obtained through known procedures (Figure 2.2).
213-215
 
Figure 2.2 
 
In light of our unsuccessful attempts to incorporate a nitrogen atom into the 
acetylide addition, we decided that the next most desirable alkyne for the synthesis would 
be but-3-yn-1-ol (2.167).  Its use would preclude the need for a protection/deprotection 
sequence, leaving our total step count unaffected.  In order for the reaction to proceed, it 
was necessary to use the dianion of alcohol 2.167 (Scheme 2.39).  After initial 
deprotonation experiments, it was found that two equivalents of lithium diisopropylamide 
(LDA) provided the best results, but the yield of quinone 2.168 never exceeded 10% and, 
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like carbamate 2.160, but-3-yn-1-ol (2.167) was abandoned in favor of an alkyne that 
would provide the desired quinone 2.159 in higher yield (cf. Scheme 2.37). 
Scheme 2.39 
 
 Thinking that a silyl group would impart the desired stability for the alkyne 
partner while still retaining the ability to be chemoselectively cleaved, 2.169 was 
synthesized in a single step from but-3-yn-ol (2.167) according to established literature 
procedures.
216
  Alkyne 2.169 was lithiated and added to dimethoxysquarate (2.155).  The 
subsequent cyclobutene ring underwent a Moore cyclization to provide quinone 2.170 in 
81% yield over two steps (Scheme 2.40).  We also briefly examined the tert-
butyldimethylsilyl (TBS) protected alkyne in the sequence, but found that it performed 
worse than the TES variant.   
Scheme 2.40 
 
 Reduction of quinone 2.170 to its corresponding hydroquinone 2.171 was 
accomplished in 67% yield via a catalytic hydrogenation in acetonitrile (MeCN) (Scheme 
2.40).  Ethyl acetate (EtOAc) and methanol (MeOH) were also screened as solvents, but 
use of ethyl acetate provided the hydroquinone 2.171 in lower yields, whereas use of 
methanol led to silyl group cleavage.    
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The next step in the synthesis was to differentiate between the two phenol 
functionalities in hydroquinone 2.171 by selectively protecting the less hindered of the 
two with a bulky protecting group.  The tert-butyldimethylsilyl (TBS) group was chosen 
due to its large size and ease of removal; however, all attempts to isolate the TBS-
protected hydroquinone were fruitless (Scheme 2.41).  The only products isolated from 
the reaction were starting material 2.171, quinone 2.170, and what was believed to be 
bicycle 2.172 based on 
1
H NMR and mass spectrometry evidence.  Namely we saw loss 
of the –TBS group and phenolic hydrogen in the 1H NMR spectrum. We also saw the loss 
of the –TBS group in the mass spectrograph.  Since it appeared that the TES group was 
not surviving the reaction conditions and that there might be selectivity issues with 
cleaving a TES vs. TBS group, we decided to pursue another starting alkyne partner for 
use in a Moore cyclization.  
Scheme 2.41 
 The TES-protected quinone 2.170 was used to test the feasibility of introducing a 
nitrogen functionality into the system immediately after the Moore cyclization (Scheme 
2.42).  First, the silyl group of 2.170 was cleaved with a solution of hydrofluoric acid 
(HF) and pyridine (Pyr) in MeCN to provide the free hydroxyl group, which was next 
mesylated to provide 2.173 in 80% yield (Scheme 2.42). Neither the reaction of the 
mesylate 2.173 with sodium azide (NaN3) followed by Staudinger reduction nor the 
reaction of 2.1173 with ammonia in methanol appeared to produce any of the desired 
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iminoquinone 2.174.
217,218
  Both reactions produced complex reaction mixtures, and no 
identifiable compounds were able to be separated and characterized from the mixtures.   
Scheme 2.42 
 
 
 We then focused upon finding alternative alkynes of type 2.157 (cf  Scheme 2.37, 
FG = OR) for which to try in the acetylide additions/Moore cyclization sequence.  We 
decided upon a p-methoxybenzyl (PMB) protected but-3-yn-1-ol 2.175, (Scheme 2.43) as 
the PMB group would be easily removed by mild oxidants and was robust enough to 
survive the quinone reduction.  Synthesized from but-3-yn-1-ol (2.167) by an established 
literature procedure,
219
 PMB-protected alkyne 2.175 was subjected to the acetylide 
addition/Moore cyclization sequence to provide quinone 2.176 in 41% yield.
208,209,220
 
Scheme 2.43 
 
 Reduction of 2.176 to hydroquinone 2.177 was problematic (Scheme 2.44).
221
  
While the TES-protected quinone 2.170 (cf. Scheme 2.40) underwent reduction to its 
corresponding hydroquinone 2.171 in the presence of Pd/C and hydrogen gas (H2), this 
method was not successful for the reduction of 2.176.  The product of the reaction was a 
complex mixture, from which no compound could be cleanly isolated.  Based on the 
1
H 
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NMR spectrum of the crude reaction mixture, we hypothesized that PMB cleavage was 
most likely a competing reaction.  A variety of other standard reduction conditions were 
examined, but all reactions provided either a complex mixture of productions or no 
reaction at all.  
Scheme 2.44 
 
 The next butynol protecting group selected for examination was methoxymethyl 
(MOM).    Alkyne 2.178, which was prepared in one step from the commercially 
available but-3-yn-1-ol (2.167) by an established literature procedure,
222
 was subjected to 
an acetylide addition/Moore cyclization sequence to provide quinone 2.179 in 89% yield 
(Scheme 2.45).  Reduction of quinone 2.179 by hydrogenation provided the desired 
hydroquinone 2.180 in 96% yield.   
Scheme 2.45 
 
It was again time to focus on selective silyl protection of the least hindered phenol 
in order to advance hydroquinone 2.180.  There was no literature precedent available for 
the selective protection of a less hindered phenol in the presence of a more hindered one 
but we again reasoned that a bulky silyl group such as TBS might preferentially silylate 
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the least hindered phenol (Scheme 2.46). However, attempts to incorporate TBS into 
hydroquinone 2.180 resulted solely in returned starting material.  Accordingly, we 
examined the less hindered TES protecting group.  After a brief survey of conditions, we 
found that the reaction of 2.180 with triethylsilyltriflate (TESOTf) in the presence of 2,6-
lutidine provided quinone 2.182 in 25% yield (Scheme 2.47).
223
  Two-dimensional 
1
H 
NMR and 
13
C NMR experiments were carried out on compound 2.182 to support its 
identity (Figure 2.3).  NOESY correlations were used to identify the orientation of the 
TES-group.   There were two main NOESY correlations that led to the assignment of 
compound 2.182 as the desired regioisomer (Figure 2.3).  There was a correlation 
between the phenolic OH peak and the two benzylic hydrogens atoms (Hb) of the MOM 
side chain and also a correlation between the hydrogen atoms of the TES-protecting 
group and the aryl hydrogen atom (Ha).   
Scheme 2.46 
 
 
 
Scheme 2.47 
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Figure 2.3:   
 
After a survey of different reaction conditions, we found that the optimal 
conditions involved a slow (syringe pump) addition of a solution of TESOTf  in DCM 
(1.1 eq., 0.7 M) to a solution of hydroquinone 2.180 and 2,6-lutidine (2.0 eq.) in DCM 
(0.014 M) at -78 °C to provide the desired mono-protected compound 2.182 in 56% yield 
(Scheme 2.48).  Two main problems had to be overcome.  The first was the formation of 
the bis-silylated side product 2.183 (Figure 2.4).  Adding the TESOTf in a solution of 
DCM over time and decreasing the overall concentration of the reaction mixture 
eliminated the bis-silylation problem.  However, the reaction still did not proceed to 
completion, so further optimization was required.  In some reactions, the bicycle 2.184 
appeared as a major side product (Figure 2.4).  The structure of 2.184 was supported by 
LCMS and 
1
H NMR experiments, which showed the loss of both the phenol proton and 
the -OMOM moiety. Operationally, the TESOTf solution had always been added to the 
hydroquinone solution before the 2,6-lutidine.  We reasoned that if the order of addition 
were reversed then the side product formation would be suppressed as the Lewis 
mediated cyclization could not take place in a sufficiently basic environment.  This was 
indeed the case and the formation of bis-silylated 2.183 and bicycle 2.184 were 
suppressed.   
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Scheme 2.48 
 
 
Figure 2.4 
 
  Phenol 2.182 was reacted with triflic anhydride (Tf2O) and triethylamine (Et3N) 
to provide aryl triflate 2.185 in 76% yield (Scheme 2.49).
224
  Recall that we desired to 
effect a metal mediated coupling between 2.185 and the known cyclopropylpentenedione 
2.152
225
 in order to obtain our key oxidative cyclization precursor 2.140 (cf. Scheme 
2.36).  However, after a thorough search of the literature, we found that there was no 
precedent for a metal mediated reaction between an o,o-disubstituted aryl triflate and a 
cyclopropane containing multiple electron withdrawing groups.  The most relevant prior 
art was a reaction between aryl cuprate 2.187 and cyclopropyl dicarboxylate 2.186 to 
produce 2.188 in 82% yield (Scheme 2.50).
204
 However, the precedent was far from ideal.  
Our reaction would require an electron rich aryl o,o-disubstituted cuprate be made from 
triflate 2.185 (Scheme 2.51), which is not at all similar to the precedented dichloro aryl 
cuprate 2.187.   Nonetheless, we set out to try the precedented conditions on our system.   
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Scheme 2.49 
 
 
Scheme 2.50 
 
Scheme 2.51 
 
In order to effect the desired copper mediated cyclopropane coupling, it was first 
necessary to convert aryl triflate 2.185 to an organocuprate.  Our precedent had shown 
that cuprate 2.187 was obtained from reaction between 1,2-dichloro-4-iodobenzene 
(2.190), t-BuLi, and copper (I) cyanide (Scheme 2.52),
204
 so we set out to obtain aryl 
iodide 2.191 (Scheme 2.53). Replacement of the triflate with iodide was attempted with 
sodium iodide,
226
 but our efforts failed to produce anything other than returned starting 
material (Scheme 2.53).  A likely hypothesis for the failure of this reaction is that our aryl 
ring was too electron rich for the triflate to be reactive towards nucleophilic aromatic 
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substitution.
227
 We desired to form an organocuprate directly from triflate 2.185,
228,229
 but 
we needed to bring through more material. 
Scheme 2.52 
 
Scheme 2.53 
 
Unfortunately, upon attempted scale up of the synthetic sequence, we were faced 
with three major problems.  The first was that we could not scale up the selective mono 
TES protection without a considerable loss in yield (Scheme 2.54).  When run on a scale 
of approximately 100 mg or smaller, the reactions proceeded reliably in about 56% yield, 
but when the silylation was attempted on a larger scale, the yields decreased to less than 
20%.  While this was a solvable problem, we did not want to expend considerable effort 
to solve it until we were sure that triflate 2.185 was a viable precursor to our desired 
intermediate 2.189 (cf. Scheme 2.51).  Towards that end, a series of smaller (ca. 100 mg 
or smaller) silylation reactions were run, and all of the phenol 2.182 obtained was 
combined and stored in a freezer under nitrogen.  Our second major problem was that 
phenol 2.182 was not amenable to being stored, even for short periods (three to five days) 
under nitrogen in a freezer. The material was found to decompose rapidly into a complex 
mixture, from which none of 2.182 was recovered.  While this could be solved by quickly 
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transforming phenol 2.182 to triflate 2.185, we again, needed to bring through more 
material from the beginning of the synthesis. 
 
Scheme 2.54 
 
The third major problem with the route was our starting material. 
Dimethoxysquarate (2.155) is a known irritant,
206
 and the slightest exposure caused an 
allergic-like reaction that would present itself in the form of hives and last from three to 
four weeks (Scheme 2.54).  While the risks associated with 2.155 did not automatically 
preclude its use as a starting material in our synthesis, this problem, in addition to the 
other two previously mentioned gave us pause to reconsider the route.  During this time, 
it is important to know that we were also pursuing a parallel route towards key 
intermediate 2.140, and that the route appeared to be the more promising of the two (cf. 
Scheme 2.36). With three considerable problems occurring within the first five steps of 
this route, and the viability of the use of o,o-disubstituted triflate 2.185 in a metal 
mediated coupling in question, we decided to abandon this route and devote our full 
resources to what we felt was the better synthesis.   
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2.6 SECOND GENERATION MARTIN GROUP APPROACH 
At the time the synthesis featuring the Moore cyclization was being investigated, 
another route towards intermediate 2.140 was also being developed (Scheme 2.55).  We 
envisioned that phenol 2.140 would come from aryl bromide 2.192 through a sequence 
including aryl bromide and enone olefin reductions, preferably undertaken in a single 
step, and an alkylation/elimination sequence at either of the -carbonyl carbons in 
cyclopentadione 2.192 to provide cyclopentenedione 2.140.   Aryl bromide 2.192 would 
be obtained from the alkylation of ethyl ester 2.193 with 1,3-cyclopentadione and 
subsequent elimination of the resulting tertiary alcohol.  Ester 2.193 would come from a 
SmI2 mediated cleavage
230
 of tetrahydroisoquinoline 2.194, which would be obtained 
from a regioselective Pictet-Spengler reaction between amine 2.195 and ethyl glyoxylate.  
The bromine atom of 2.195 serves the very important purpose of directing the Pictet-
Spengler reaction.  When we developed this route, we found no precedent for controlling 
the regioselectivity of a Pictet-Spengler reaction with a phenethylamine of type 2.197 
(Figure 2.5).
231
  Though the ether groups adjacent to Ha and Hb were different, Battersby 
had suggested that a benzyl ether would not serve a bulky enough group with which to 
significantly affect the regiochemistry of the Pictet-Spengler reaction.  Therefore, we 
came up with the unconventional solution to use a bromine atom as a blocking group, 
with which to direct the reaction.  We envisioned that the desired phenethylamine 2.195 
could be obtained from the readily available phenol 2.196.   
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Scheme 2.55 
 
 
Figure 2.5 
 
The route started with the bromination of commercially available vanillin (2.198) 
to provide 5-bromovanillin (2.199) according to a well-established procedure (Scheme 
2.56).
232
  Crude aryl bromide 2.199 was then subjected to a copper-catalyzed nucleophilic 
aromatic substitution reaction to provide diol 2.200, which is also commercially 
available, but much more expensive than vanillin (2.198), in 52% yield over two steps.
233
  
It is notable that this route was already an improvement over the Moore cyclization route 
as it worked well on multigram scales (ca. 50 g).   
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Scheme 2.56 
 
 The next step in the sequence was the known regioselective methylation
233
 of 
2.200 (Scheme 2.57) which proceeded in 78% yield.  As electron-rich phenolic anions are 
known to be easily oxidized in the presence of oxygen,
234
 an attempt was made to 
improve the yield of phenol 2.196 by removing oxygen from the solvent via the 
freeze/pump/thaw method; however, there was no improvement. 
Scheme 2.57 
 
  The regioselectivity of the methylation can be explained by the enhanced acidity 
of the phenol para- to the electron-withdrawing aldehyde moiety.  The structure of 2.196 
was also supported by the lack of symmetry present in the 
1
H NMR spectrum.  Phenol 
2.196 was then selectively brominated ortho- to the phenolic hydroxyl group using 
bromine (Br2) and acetic acid (HOAc) to provide aryl bromide 2.201 in 79% yield 
(Scheme 2.58).  The regioselectivity of the reaction was again supported by NOE data 
(Figure 2.6).  The bromine would serve as a blocking group to ensure the correct 
regioselectivity of the upcoming Pictet-Spengler reaction.  Phenol 2.201 was protected as 
its benzyl ether 2.202 in 91% yield.  It is important to note that as in the above 
methylation reaction (cf. Scheme 2.57), the electron rich phenolic anion of 2.201 
appeared to be susceptible to oxidation in the presence of oxygen.  When the reaction was 
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performed in DMF, the yield of 2.202 was 61%; however, when the reaction was 
performed in freeze/pump/thaw deoxygenated DMF the yield of 2.202 increased to a 
reproducible 91% yield (Scheme 2.58).   
Scheme 2.58 
 
Figure 2.6 
 
 Aldehyde 2.202 was then subjected to standard Henry reaction conditions with 
nitromethane to give nitroalkene 2.203 in 86% yield.  Nitroalkene 2.203 was reduced 
using lithium borohydride (LiBH4), chlorotrimethylsilane (TMSCl) and THF (forming 
BH3·THF in situ) to provide a mixture of amine and N-OH compounds 2.204 and 2.205 
according to LCMS and 
1
H NMR data (Scheme 2.59).
235
  Sodium borohydride (NaBH4) 
and lithium aluminum hydride (LAH) were also examined as reducing agents, but all 
resulted in debromination.  While the mixtures of amine and hydroxyl amine 2.204 and 
2.205 were inseparable by acid/base extraction and column chromatography, 2.205 was 
quantitatively converted to amine 2.204 upon further reduction by stirring with zinc (Zn) 
in acetic acid (AcOH) at room temperature for 14 h (Scheme 2.60).
236,237
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Scheme 2.59 
 
Scheme 2.60 
 
The crude amine 2.204 was next mixed with ethyl glyoxylate (2.206) in the 
presence of molecular sieves to generate an imine, and benzyl chloroformate (CbzCl) and 
trimethylsilyl trifluromethansulfonate (TMSOTf) were added to effect the Pictet-Spengler 
reaction (Scheme 2.61).
238
 Tetrahydroisoquinoline 2.207 was thus obtained in 30% yield 
(unoptimized) over two steps from nitroalkene 2.203 (cf. Scheme 2.59).      
Scheme 2.61 
 
The next step in the synthesis was to subject tetrahydroisoquinoline 2.207 to a 
reductive ring opening reaction (Scheme 2.62).  Although known for being a difficult 
reagent to work with,
239,240
 samarium diiodide (SmI2) had been shown to be an effective 
promoter of reductive ring opening reactions in systems similar to 2.207.
241,242
  Samarium 
diiodide is a powerful reductant, and in the presence of oxygen will readily, and for all 
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intent and purposes irreversibly, oxidize to SmI3 which would not promote the reductive 
ring opening reaction.
239
  There are a variety of ways to prepare SmI2,
239
 but the most 
simple and atom-economical method is to add iodine to a solution of samarium powder in 
deoxygenated THF (Equation 2.1).
243
   
Scheme 2.62 
 
 
Equation 2.1 
 
 
 When 2.207 was subjected to SmI2 in the presence of HMPA and a proton source, 
none of the desired ring opened product 2.209 was observed (Scheme 2.63).  After 
extensive optimization of such factors as stoichiometries, proton sources, and 
temperature, the only product observed other than returned starting material was 
debrominated tetrahydroisoquinoline 2.209.  The bromine, having served its purpose in 
the previous Pictet-Spengler reaction, was no longer needed, and its loss was of no great 
concern.  However, the possibility that the aryl anion generated by the loss of the 
bromine from 2.207 in the SmI2 reaction was interfering with the ring opening reaction 
did pose a concern.  Toward that end, the aryl bromide was removed from 2.207 prior to 
the ring opening reaction (Scheme 2.64).
244
  However, the SmI2 reaction with 2.209 
provided only returned starting material.   
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Scheme 2.63 
 
 
Scheme 2.64 
 
 We looked to the proposed mechanism of the SmI2 mediated ring-opening and a 
model of tetrahydroisoquinoline 2.209 for answers.  The mechanism for the ring opening 
reaction, as hypothesized by Honda,
230
 would begin with the addition of an electron to the 
carbonyl group of the ester moiety of 2.209 to create the radical anion 2.211 (Scheme 
2.65).  The hydroxyl anion could then be quenched in situ with an appropriate proton 
source to provide the radical 2.212.  At this point, Honda presumed that the mechanism 
may diverge into one of two distinct pathways (Path A and Path B), though he has shown 
no support for one over the other.  In Path A, a second molecule of SmI2 could donate a 
single electron to the radical species 2.212 to create anion 2.213, the carbon-nitrogen 
bond of which could ionically fragment to form the enol 2.214.  In path B, the radical 
species 2.212 could first undergo homolytic carbon-nitrogen bond cleavage to provide 
2.215, which upon contact with a single electron from a second molecule of SmI2, could 
form the enol 2.214.  Acidification and tautomerization of 2.214 would provide the 
desired phenethyl carbamate 2.210.  In either case, Path A or Path B, carbon-nitrogen 
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bond cleavage would preferred if there were an anti-periplanar orbital alignment between 
the ester p-orbital containing the radical or anion and the * orbital of the carbon-
nitrogen bond.   
Scheme 2.65 
 
We next looked for any structural features within dihydroquinoline 2.209 that 
might disrupt the orbital alignment necessary for carbon-nitrogen bond cleavage to occur.  
After building a model of 2.209, it was thought that the Cbz group on nitrogen might be 
forcing the ethyl ester to adopt an axial conformation on the cyclohexane ring (Scheme 
2.66  and Figure 2.7).
245,246
  We usually depict carbamates as drawn in compound 2.209; 
however, it is well- established that the nitrogen-carbon bond of a carbamate contains 
significant sp
2
 character, because of contributions from the resonance form 2.216 
(Scheme 2.66).  Such resonance contributions can have a significant effect the preferred 
conformation of a carbamate, especially for to 2- and/or 6-substituted N-carbamoyl 
piperidines, and heterocycles that include these rings, including tetrahydroisoquinolines 
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(Scheme 2.66).  The sp
2
 character of the nitrogen-carbon carbamoyl bond can create 
significant A1,3 strain between the carbamate and any 2- and/or 6-substituents on the ring 
(Scheme 2.66 2.218 and Figure 2.7 2.220).  In order to mitigate the unfavorable steric 
interaction, the 2- and/or 6-substituents will preferentially adopt an axial, spatial 
orientation on the piperidine ring if possible (Scheme 2.66, chair 2.219 as opposed to 
chair 2.217).
245
  We believed that as a result of the ester adopting an axial conformation, 
as shown in 2.219, the * orbital of the carbon-nitrogen bond would be aligned 
orthogonally to the p-orbitals of the carbonyl π-system, thereby preventing the orbital 
alignment necessary for the ring opening to occur according to the proposed radical 
mechanism (cf. Scheme 2.65 and Figure 2.7). However, we can see from the simplified 2-
ester substituted piperidine structures 2.220 and 2.221, where the ester is shown adopting 
a position under the ring, that the p-orbitals of the axially 2-substituted ester moiety of 
2.221 can align anti-periplanar to the *-antibonding orbital of the C-N bond.  It appears 
that the axial conformation of the ester should not prevent the SmI2 mediated ring 
opening from occurring. 
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Scheme 2.66 
 
 
Figure 2.7 
 
Our assumption was supported by Honda and coworkers, who successfully 
induced the SmI2 promoted ring openings of acyl protected piperidines with ester or 
ketone substituents at the 2-position of the ring, which presumably adopted the 
orientation of conformer 2.221 during reaction (Scheme 2.67).
242
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Scheme 2.67 
 
Honda has also promoted the ring opening of isoquinoline derivatives, such as 
2.226 and 2.228, with SmI2 (Scheme 2.68 and Scheme 2.69).
230
  The SmI2 ring opening 
reactions tended to be more successful when the 2-substituent of the piperidine ring was a 
ketone, as opposed to an ester, and also when tetrahydroisoquinolines were used as 
substrates.  In general, the more electron withdrawing the heterocyclic substrate, the 
better the ring opening reaction proceeded.  Though the piperidine ring of 
tetrahydroisoquinolines cannot adopt a true chair conformation, a conformational analysis 
of a physical model of N-H tetrahydroisoquinoline shows that whether the ester moiety of 
the ring is in a pseudoaxial (2.231) or pseudoequatorial (2.232) position, orbital 
alignment appears favorable for SmI2 mediated C-N bond cleavage (Figure 2.7). 
Scheme 2.68 
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Scheme 2.69 
 
 
Based on Honda’s precedent, we were optimistic that the SmI2 ring opening of 
2.209 would proceed without incident (Figure 2.9).  Our substrate contained an 
isoquinoline ring, an ester at the 2-position of the piperidine ring, and a carbamate on the 
isoquinoline nitrogen.  All three features had been shown to be tolerated using Honda’s 
conditions, yet tetrahydroisoquinoline 2.209 remained resistant to the ring opening.  
However, while Honda had disclosed that the ring opening reaction worked separately 
with N-acylated/carbamoylated piperidines (2.222 and 2.224) and 2-ester/acetyl 
substituted tetrahydroisoquinolines (2.226 and 2.228), he had not shown an example 
where both were combined, namely a compound of the type 2.233.  Our key intermediate 
2.209 was a 2-ester substituted N-carbamoylated tetrahydroisoquinoline  that remained 
resistant toward all attempts to cleave the C-N bond using SmI2 (Figure 2.9).  We 
concluded, based on our empirical experimental evidence, that Cbz-protected 
isoquinoline 2.209 was in some way forcing an unfavorable conformation of the ester to 
the carbamate, thereby preventing SmI2 promoted ring opening.  
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Figure 2.9 
 
 
Recall that the mechanism of the ring opening required alignment of an ester p-
orbital containing the radical or anion and the * orbital of the carbon-nitrogen bond in 
order to be successful (cf. Scheme 2.65).  At first we believed that the ester moiety of 
2.209 adopted an axial orientation in order to avoid A1,3 strain with the Cbz moiety.  With 
the success of N-acylated/carbamoylated, 2-acetyl/ester substituted piperidines 2.222 and 
2.224, we made two assumptions that made us rethink our original hypothesis.  The first 
was that the ester or ketone substituents of 2.222 and 2.224 were in an axial position, and 
the second was that the axial orientation of the acyl group appeared to facilitate the 
reaction rather than prevent it.  Honda had also shown the ring opening to be successful 
when tetrahydroisoquinolines were employed as substrates; therefore we concluded that 
the failure of 2.209 to undergo reaction with SmI2 was most likely due to the combination 
of the two features.  While we can only speculate as to the true cause, we hypothesized 
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that the rigidity imposed upon the piperidine moiety of 2.209 by the phenyl ring of the 
isoquinoline system in conjunction with the N-carbamate caused the piperidine ring to 
adopt a twisted chair conformation in which the ester ended up in neither an axial nor 
equatorial, yet wholly unproductive, position (Figure 2.10).  
When a physical model of a simplified N-carbamoylated, 2-ester substituted 
tetrahydroisoquinoline was built and studied three configurations of the molecule seemed 
possible (Figure 2.10).  Tetrahydroquinoline systems, similar to those of 2.209, have been 
shown to adopt boat conformations (2.234).
245-248
  While this analysis is highly 
speculative and no computational studies have been done, we surmised that the most 
favorable conformation for our desired intermediate 2.209 (cf. Figure 2.9) would not be 
2.234, though it did seem to have the orbital alignment required for SmI2 mediated C-N 
cleavage to occur.   In 2.234, it appears that the ester can adopt an axial orientation, 
which we had already surmised was favorable toward the SmI2 ring opening conditions.  
However, the boat structure would also be associated with unfavorable gauche and A1,3 
interactions that would decrease the likelihood of 2.209 adopting the conformation 
depicted in 2.234.
247,248
  
While we are unsure of the exact cause, it seems clear that the ester at the 2-
position of the tetrahydroisoquinoline ring will not be able to adapt either a pseudo axial 
nor pseudo equatorial conformation, resulting in poor orbital alignment between the -
orbital of the ester and the * orbital of the C-N bond.  The orbital alignment appears 
favorable in the boat conformer 2.234, but our empirical experimental results imply that 
is not the conformation that our intermediate 2.209 has adopted as all out attempts toward 
SmI2 mediated cleavage of the C-N bond have failed.  Admittedly this is a rather 
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simplistic way to look at the system, and computational and two-dimensional NMR 
studies would be needed to provide a more comprehensive picture of the system.   
Figure 2.10 
 
 
While we can only speculate as to the true cause of the failure of 2.209 to react 
with SmI2 ring opening conditions, we hypothesized that the rigidity imposed upon the 
piperidine moiety of 2.209 by the phenyl ring of the isoquinoline system in conjunction 
with the N-carbamate caused the piperidine ring to adopt a twisted chair conformation in 
which the ester ended up in neither an axial nor equatorial, yet wholly unproductive, 
position (Figure 2.10).  We decided to remove the carbamoyl group of 2.209 in the hope 
of alleviating whatever unfavorable strain was causing our desired ring opening to fail.  
Also, N-H and N-Me, 2-ester substituted tetrahydroisoquinolines had already been 
precedented to work well using Honda’s conditions.230 
Eager to test our hypothesis, we synthesized tetrahydroisoquinoline 2.237 using a 
Pictet-Spengler reaction (Scheme 2.70). Hydrochloride salt 2.236 was mixed with ethyl 
glyoxylate (2.206) and triethylamine (Et3N) in the presence of molecular sieves to 
produce the corresponding imine, which could be isolated and characterized.  The crude 
imine was then dissolved in a solution of toluene/TFA (1% by volume) and heated for 1.5 
h to provide the desired tetrahydroisoquinoline 2.237 in 94% yield.
249
  A lot of time was 
spent optimizing this reaction, and some key points to its eventual success include using 
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precisely one equivalent of ethyl glyoxylate, as well as running the imine formation 
reaction at room temperature in the presence of base as opposed to solely heating the salt.  
Without both of the aforementioned conditions in place, side products related to multiple 
incorporations of ethyl glyoxylate (2.206) appear in significant quantities as shown by 
1
H 
NMR and LCMS evidence.  
Scheme 2.70 
 
Tetrahydroisoquinoline 2.237 (Scheme 2.71) was then treated with SmI2 in the 
presence of HMPA and a proton source to provide a mixture (50:50) of compounds 2.238 
and 2.239 according to LCMS results.  Attempts to separate the mixture by 
chromatography or making amine salts failed to provide clean material for 
characterization, so the mixture was used directly in the next step.  Methylchloroformate 
was added to the mixture of 2.238 and 2.239 in the presence of triethylamine to provide a 
mixture of carbamates 2.240 and 2.241.  Carbamate 2.241 (R=Br), could be cleanly 
separated by chromatography and was used in subsequent steps.   
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Scheme 2.71 
 Carbamate 2.241 was reduced by hydrogen gas in the presence of a palladium 
catalyst to provide phenol 2.242 in 64% yield, removing the benzyl group and aryl 
bromide in a single step (Scheme 2.72).  Phenol 2.242 was next subjected to hypervalent 
iodine mediated oxidative cyclization conditions to provide either of dienones 2.243 or 
2.244 or a mixture of both in 41% yield.
250
  Hexafluoroisopropanol (HFIP) is commonly 
used as a solvent in oxidative cyclizations due to its high dielectric constant and low 
nucleophilicity. 
195,251
  Based on 
1
H NMR and 
13
C NMR spectral evidence, the product of 
the oxidative reaction was tentatively assigned as compound 2.244 (Figure 2.11).    
Scheme 2.72  
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Figure 2.11 
 
 
 Identification of the product from the oxidative cyclization was initially 
misleading due to its LCMS.  The desired product of the reaction, bicycle 2.245 (cf. 
Figure 2.11), has a molecular weight of 339 g/mol, corresponding to an LCMS mass of 
340 (M+1), which was the observed mass from the reaction mixture.  However, when the 
reaction was repeated on a larger scale, enough of the product was isolated so that 
reliable 
1
H NMR and 
13
C NMR spectra could be acquired and analyzed.  The presence of 
an acetate peak in the 
1
H NMR suggested that the product was likely 2.243 or 2.244 (cf. 
Scheme 2.72), which are known to be possible products in these oxidative conditions, 
especially in more nucleophilic solvents.
195,196
  Uncyclized products 2.243 and 2.244 
could also exhibit a mass of 340 in the LCMS, provided the –OAc group was easily 
ionized either by the mass spectrophotometer or the TFA present in the LCMS solvent.  
The 
1
H NMR and 
13
C NMR data of the product were more consistent with the ortho-
acetoxy substituted dienone 2.244 than the para-acetoxy substituted dienone 2.243.  For 
example, the 
1
H NMR spectrum showed two drastically different methoxy groups, with 
one group shifted approximately 0.5 ppm upfield, whereas the 
13
C NMR spectrum 
showed a carbon atom shifted to approximately 90 ppm.  While the desired product was 
not obtained from the oxidative cyclization reaction, there was cause for optimism 
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because there is precedent for obtaining ring closed products like 2.245 by treating ring- 
opened products like 2.243 and 2.244 with acid.
195,196
  
 Following the closest precedent available,
252
 ortho-substituted dienone 2.244 was 
treated with boron trifluoride dietherate (BF3·OEt2) in the presence of 4 Å molecular 
sieves at 0 °C for 45 min, resulting in complete consumption of starting material (Scheme 
2.73).  Unfortunately, either the starting material or product appears to have decomposed 
under the reaction conditions, as the product LCMS trace showed at least five peaks, 
none of them matching the mass of the desired product 2.245. The reaction was repeated 
at -78 ºC with the same results.  More experiments were planned to attain the desired 
bicycle 2.245, but as will be discussed below, the SmI2 ring opening reaction could not be 
repeated, resulting in the ultimate abandonment of this route, much to our chagrin.   
Scheme 2.73 
 
 We were excited and optimistic about our initial oxidative cyclization results and 
eager to continue our investigation, but we had run out of phenol 2.242 and needed to 
obtain more in order to proceed (cf. Schemes 2.71 and 2.72).  Towards that end, a large 
scale SmI2 ring opening reaction was carried out on 500 mg of tetrahydroisoquinoline 
2.237 to provide what was thought to be a mixture of products 2.238 and 2.239 by LCMS 
(Scheme 2.74 and cf. Scheme 2.71).  We could not purify the crude product mixture to 
verify the structures, but we felt our assumption was justified as we had experienced 
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debromination of the Cbz protected isoquinoline 2.209 with SmI2 (cf. Scheme 2.63).  The 
crude mixture was treated with methylchloroformate, and the resulting mixture was then 
partially separable by flash chromatography.  Brominated product 2.241 was the first 
product eluted from the column, but all other products eluted from the column as 
mixtures.  Therefore, the 
1
H NMR spectrum of the other major product was not 
definitive.  Hence, the best way to identify this product was from the LCMS, which 
suggested a mass of 432, corresponding to the same mass as 2.240.  A mixture of the 
fully characterized 2.241 and what was believed to be major side product 2.240 was then 
subjected to the hydrogenolysis reaction to give two products corresponding to LCMS 
masses of 342, the mass of the desired product 2.242, and 436. This result was 
unexpected as it was believed that 2.240 and 2.241 should have converged to the same 
product 2.242. Upon purification by chromatography, the desired product 2.242 was fully 
characterized. The other product having a mass of 436, appeared to be tricycle 2.246.  
The 
1
H NMR spectrum of 2.246 showed a doublet representing the protons alpha to the 
cyclic ether at approximately 4.5 ppm, broadened proton signals in the 1-2 ppm range 
corresponding to a cyclohexane ring, and the lack of a phenol or aromatic proton, all in 
support of structure 2.246.    
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Scheme 2.74 
 
 
Though unprecedented, we speculate that tricycle 2.246 most likely arose from 
the unsaturated tricycle 2.247, which could be formed under the SmI2 reaction conditions 
according to the proposed mechanism shown in Scheme 2.75.  SmI2 could react with the 
aryl bromide of 2.239 to form a radical, which could then react with the benzyl ether 
2.248 to produce a different aryl radical 2.249.  A second SmI2 molecule could then 
donate a second electron to the aryl radical, generating an intermediate carbanion 2.250, 
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which upon protonation with methanol would produce tricycle 2.247.  It is important to 
note that tricycle 2.247 has not been fully characterized and could be any number of 
double bond regioisomers; only one possibility is shown for the sake of simplicity. There 
is no precedent for this type of reaction with samarium diiodide. However, the LCMS and 
1
H NMR evidence shows that the product of the reaction does not have two fully 
aromatic benzene rings. Namely, the LCMS mass of 436 that led us to believe the 
benzene ring had not been cleanly removed and the 
1
H NMR spectrum had shown a 
series of complex broadened peaks between 1-2 ppm, characteristic of cyclohexane rings 
that integrated to 15 protons (including the ethyl group of the ester moiety) and a doublet 
representing the protons alpha to the cyclic ether at approximately 4.5 ppm.  Another 
convincing piece of evidence was the lack of aromatic protons in the 
1
H NMR spectrum.  
Scheme 2.75 
 
 
With the new tricycle 2.247 proposed as the other major product of the SmI2 ring 
opening reaction (cf. Scheme 2.74), a pathway for the production of 2.246 is shown 
below (Scheme 2.76).  Carbamate formation to give tricycle 2.251 would provide a 
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product with the same mass as observed by LCMS (432).  Diene 2.251 would then be 
reduced in the hydrogenation reaction to provide tricycle 2.246.   
Scheme 2.76 
 
 In order to combat the undesired side product formation, the next modification in 
the synthesis was to remove the aryl bromide prior to running the SmI2 mediated 
cleavage.  Using transfer hydrogenation conditions,
244
 we were able to reduce the aryl 
bromide in the presence of the benzyl ether to provide the desired 2.252 in 51% yield 
(Scheme 2.77).  With amine 2.252 in hand, the ring-opening reaction was once again 
investigated (Scheme 2.78).  Somewhat disappointingly, after 30 reactions the success 
rate of the reaction was approximately 50%, with the highest isolated yield of any 
reaction being 25%.  The yield, however, was promising in the fact that LCMS analysis 
of crude reaction mixtures showed that the only peaks present at the end of reaction were 
those that corresponded to HMPA and the desired product 2.238.   
Scheme 2.77 
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Scheme 2.78 
 
As nitrogen atoms were known to be a good ligands for Sm (III),
253,254
 it was 
suspected that the low yielding cleavage reactions might be attributed to the 
complexation of product 2.238 to the Sm (III) salts generated from the reaction.  A 
variety of work-up procedures were investigated in order to separate 2.238 from the Sm 
(III) salts (Scheme 2.79).  Samarium (III) salts can be solubilized in aqueous acidic 
solutions (Path A) or removed via filtration (Path B).  Both pathways produced 
approximately the same low yield (~10%) of amine 2.238.  In Path A, this may have be 
attributed to the water solubility of the primary amine product under acidic conditions, 
and in Path B, the amine may have formed an insoluble complex with the filtered 
samarium (III) salt.  A third option for work-up then, was to concentrate the crude 
reaction mixture and attempt to break the Sm (III) – amine chelate by functionalizing the 
amine in the presence of the Sm (III) salts (Paths C and D).  However, these routes also 
produced comparably low yields (~10%) of the carbomethoxy carbamate 2.240.  This 
was particularly disheartening as we were unable to advance the synthesis because we 
could not bring up more of the desired intermediate 2.242 (cf. Scheme 2.72). 
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Scheme 2.79 
 
Recall that we had started subjecting tetrahydroisoquinoline 2.252 to the SmI2 
reaction because of the problems we had previously encountered with the use of 
tetrahydroisoquinoline 2.237, namely significant side product formation (Figure 2.12 and 
cf. Scheme 2.74).  Also recall, that the purpose of the SmI2 mediated ring opening 
reaction with 2.237 and 2.252 was to provide more material with which to investigate a 
key oxidative coupling step within our synthesis (cf. Scheme 2.72).  By the time we were 
working with tetrahydroisoquinoline 2.252, we had already invested a significant amount 
of time and effort into improving the SmI2 ring opening reaction, though we had yet to 
figure out if our key oxidative cyclization reaction was viable.  In the interest of time, we 
decided to momentarily forego additional optimization of the SmI2 reaction in favor of 
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advancing material through the reaction between 2.237 and SmI2 in order to investigate 
our biomimetic key reaction.   
Figure 2.12 
 
Unfortunately, we were never able to further investigate our key oxidative 
cyclization.  Much to our surprise, we were unable to reproduce any of our previous 
success in reacting 2.237 with SmI2.   The trouble started when we had to switch our 
source of samarium metal for the preparation of SmI2.  While for a time we were able to 
reliably produce 0.1 M solutions of SmI2 in THF, when we ran out of the particular bottle 
of samarium that we had been using, we were unable to replicate any of our previous 
results.  We had been using a bottle of 40 mesh samarium powder obtained from Acros, 
and when that was consumed, we ordered more from the same vendor.  The new bottle 
we received had the same lot number as the previous bottle, yet the results were 
irreproducible.  The preparation of SmI2, and the many problems that plague it, will be 
discussed in detail below. 
2.6.1 SMI2 
 
 While a variety of methods to prepare SmI2 have been published, there are two 
main preparations that are the most frequently used (Figure 2.13).
239
  The first, which is 
based upon the original Kagan paper from 1980,
255
  generates SmI2 from samarium 40 
mesh powder and 1,2-diiodoethane in THF distilled from sodium benzophenone ketyl 
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under nitrogen at room temperature.  Kagan reported that if the solvent was very pure, 
then the induction period was instantaneous.  The presence of excess samarium in the 
mixture was observed to increase its stability.  The reaction is believed to proceed either 
directly to SmI2 via an oxidative insertion and -elimination pathway (Eq. 1) or through 
formation of a Sm (III) iodide, which then further disproportionates to SmI2 and ethylene 
in the presence of excess samarium metal (Eq. 2).
243,255
   
 The second way to prepare SmI2 involves the use of samarium 40 mesh powder 
and iodine, first reported by Imamoto in 1987.
243
  Imamoto was the first to propose that 
the formation of Sm (III) iodide and subsequent disproportionation into SmI2 and 
ethylene was a valid pathway for SmI2 formation (Eq. 2).  His hypothesis proved 
accurate, as he was able to use iodine, which is a less expensive and easier to handle than 
1,2-diiodoethane, as the iodide source for the reaction (Eq. 3).  The reaction requires 
heating under reflux and a longer reaction time (ca. 12 h) than Kagan’s method.    
Figure 2.13 
 
 
 In the course of this project, there have been 84 attempts to generate SmI2.  Iodine 
and 1,2-diiodoethane have been used as iodide sources;  THF was used from a solvent 
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system, in which it was passed through two columns of activated neutral alumina prior to 
use and toluene was passed through a column of activated neutral alumina as well as 
further deoxygenated by being passed through a column of activated Q5, as was THF 
freshly distilled over potassium benzophenone ketyl, either sparging or 
freeze/pump/thawing the former in order to deoxygenate it; and the reactions have been 
run at room temperature, under reflux, in the sonicator, and/or numerous combinations of 
each.  Samarium has always been used in excess (ranging from 1.2 to 2.0 eq.) and the 
reactions have even monitored the reactions under nitrogen vs. argon gas.   
In general, Imamoto’s procedure has been the most reliable.243  Iodine and samarium (40 
mesh powder or chips both work, although the chips take longer due to their lower 
surface area) were mixed together in deoxygenated THF (via freeze/pump/thaw) under 
either nitrogen or argon at room temperature, and the mixture was then heated under 
reflux.  In most instances, the characteristic “Prussian blue” color would appear after 20 
min., and on smaller scales the reaction was complete within an hour.  However, the 
reaction was sensitive to scale, and larger batches of SmI2 often required more time to 
come to completion.  In Imamoto’s orginal paper, he prepared a solution of SmI2 from 3 g 
of samarium metal via heating under reflux overnight; this is a good rule of thumb for 
SmI2 preparation on larger scales.  One can check the final concentration of SmI2 in THF 
by iodometric titration (Figure 2.14).
253
  Samarium diiodide reacts with iodine to provide 
samarium (III) iodide with a visible color change from blue to yellow.  It is important to 
note that the maximum concentration of SmI2 in THF is 0.13 M,
256
 even though 
references in the literature may claim to prepare and use 0.2 M solutions; solid SmI2 is 
extremely susceptible to oxidation.
253
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Figure 2.14 
 
   After trying numerous different methods and ideas based upon the literature, we 
were at a standstill.  The project could not move forward with our present route unless we 
could reliably produce SmI2 (cf. Scheme 2.71-2.72), so we decided to reach out to an 
author of a recent SmI2 book, Dr. Robert A. Flowers, II.
239,253
  Among the various 
suggestions that he and his graduate student shared with us, many of them echoing what 
we had stated in preceding paragraphs, he mentioned that samarium metal can form 
oxides when left to sit for long periods of time.  Apparently the only way to remove the 
samarium oxides was to crush the powder with a mortar and pestle in a glove box, 
thereby releasing more “fresh” surface area.  When we tested this theory on our “new” 
Acros bottle, the SmI2 reaction instantly starting working as it had before; we were able 
to reliably produce 0.1 M solutions of SmI2 in THF on a weekly basis.  The SmI2 
solutions can be stored for up to a week under argon and at room temperature as long as 
excess samarium metal is present in the solution.  Soon after finding the source of the 
problem, and excellent article was published by Procter et al. which investigated many 
factors in relation to the production of SmI2 and came to the same conclusion that we 
did.
240
  Namely, that the quality of the metal is the main factor in preparation and as long 
as it is activated either by crushing or stirring under an Argon atmosphere overnight, will 
produce SmI2 by any of the methods described above. 
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2.6.2 SUMMARY OF PICTET SPENGLER ROUTE 
 
Having solved the problem of generating solutions of SmI2, efforts to reproduce 
earlier successes were initiated (Scheme 2.80).  Much to our chagrin, we were still unable 
to repeat our previous work.  At this point in the project, work had been focused on the 
SmI2 mediated isoquinoline ring opening for over a year, and we needed to make a 
difficult decision.  The overall goal of the project was to synthesize acutumine and not to 
optimize reactions between SmI2 and tetrahydroisoquinolines so we decided to abandon 
our current route.  It was clear that we needed another strategy to reach our desired 
oxidative cyclization precursor.   
Scheme 2.80 
 
A summary of all the work that had been done with SmI2 and isoquinolines over 
the course of the project can be seen in Scheme 2.81.  Recall that we began our 
investigations with Cbz-protected tetrahydroisoquinoline 2.207.  We found that when 
SmI2 and 2.207 were allowed to react, the only products obtained were debrominated 
2.209 and returned 2.207.  Hypothesizing that the reduction of the bromine atom 
interrupted the radical process necessary for carbon-nitrogen bond cleavage to occur, we 
subjected 2.209 to the reaction conditions; however, the tetrahydroisoquinoline did not 
react.  After a mechanistic and structural analysis, we then came to the conclusion that 
the Cbz carbamate group might be forcing the piperidine ring into a twisted chair 
conformation, resulting in the misalignment of the p orbital of the ester group and the * 
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orbital of the breaking carbon-nitrogen bond.  We then synthesized the free amine 2.237 
and were gratified to find that it reacted with SmI2 to produce the desired ring opened 
product 2.239.  However, the reaction also produced significant quantities of the tricycle 
2.247.  In an effort to rid ourselves of the unproductive 2.247, we synthesized 2.252.  
Tetrahydroquinoline 2.252 was also found to produce the desired ring opened product 
2.238, however, we had difficulties isolating the free amine.   
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Scheme 2.81 
 
 
 
In general, the SmI2 mediated ring opening reaction worked best with the free 
amines 2.237 and 2.252, though both reactions resulted in poor yields and of the desired 
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products.  The reactions also proved to be notoriously unreliable, and in the end we 
decided that our efforts would be better spent on a different route than trying to optimize 
either reaction.   
 
2.7 THIRD GENERATION MARTIN GROUP APPROACH 
The most recent incarnation of the Martin group approach to acutumine is shown 
in Scheme 2.82.    The approach features much of the same chemistry that we had used in 
our second generation approach (cf. Scheme 2.55), though a key difference was the use of 
a chemoselective allylation/oxidation sequence (2.225 to 2.253) to install our 
cyclopentenedione precursor as opposed to the troublesome Pictet-Spengler/SmI2 
sequence.  We envisioned that phenol 2.140 would come from aldehyde 2.253 through a 
fairly standard alkylation/elimination/reduction sequence. Aldehyde 2.253 would be 
furnished from oxidation cleavage of the allyl group in 2.254, and 2.254 could be 
obtained from aryl bromide 2.195, a well-established intermediate from our second 
generation synthesis.   
 
 
 
 
 
 
 
 
 
  
 
188 
Scheme 2.82 
 
 
We had already developed a reliable and scalable route from phenol 2.196 to aryl 
bromide 2.195, so we used that to our advantage (cf. Section 6 and Scheme 2.83).  As a 
brief summary, commercially available aldehyde 2.196, which is also readily available 
from vanillin (2.198) in three steps,
257
 was first brominated ortho- to the phenol, and the 
resultant phenol 2.201 was immediately protected as its benzyl ether 2.202 in 91% yield 
(Scheme 2.83). Aldehyde 2.202 was then subjected to standard Henry reaction conditions 
with nitromethane to give nitroalkene 2.203 in 86% yield and 2.203 was reduced and 
acidified to provide the amine salt 2.236 in 76% yield.
235
  
 
 
 
 
 
 
 
 
 
 
  
 
189 
Scheme 2.83 
 
  
 We then sought to allylate compound 2.236; and similar to what we had done in 
our second generation sequence (cf. Scheme 2.61), we planned to use the bromine atom 
of 2.236 as a blocking group to direct the regioselectivity of the reaction. A search of the 
literature presented us with an attractive molybdenum mediated allylation, wherein 
electron-rich aromatics were allylated with allyl acetates and esters under relatively mild 
conditions, which we were eager to try (Scheme 2.84 and 2.85).
258,259
  Molybdenum 
hexacarbonyl (Mo(CO)6), or Mo (0), was known to promote the reaction between veratrol 
(2.255) and allyl methyl carbonate (2.256) to provide a mixture of mono-allylated 
regioisomers (2.257 and 2.258) in 67% yield (Scheme 2.84).
104
  Some disadvantages to 
the procedure included a high reaction temperature, a 24 h reaction time, and the 
requirement for a large excess of veratrol (2.255); however, as Malkov and coworkers 
have shown, a Mo (II) catalyst can also promote similar reactions under much milder 
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conditions (Scheme 2.85).
258,259
  They showed that the allylation reaction between 1,2-
dimethoxy-3-methylbenzene (2.259) and cinnamyl acetate (2.260) could be catalyzed by 
Mo(CO)4Br2
105
, a Mo (II) catalyst, to produce a mixture (77:23) of 2.261 and 2.262 in 
57% yield at rt over 6 h.  The more Lewis acidic Mo (II) catalysts presumably facilitate 
coordination of the catalyst to a Lewis basic site on the leaving group of the allyl group, 
thus promoting Mo -allyl formation.  The electron-rich aromatic nucleophile can then 
attack the Mo -allyl, thus completing the allylation.  The reaction works best between 
electron-rich aromatics (2.225 and 2.259) and allyl groups that can stabilize the positive 
charge created upon -allyl formation (2.260).258,259 
Scheme 2.84 
 
Scheme 2.85 
 
 Carbamate 2.277, which was synthesized in 57% yield from amine hydrochloride 
salt 2.236 (cf. Scheme 2.83), was subjected to molybdenum catalyzed allylation reactions 
under the conditions precented above (cf. Schemes 2.84 and 2.85), but no reaction was 
ever observed (Scheme 2.86).  These failures likely result from complexation of anilines 
  
 
191 
and amides derived from anilines with Lewis acidic, molybdenum catalysts, effectively 
shutting down the reaction.  Accordingly, we surmised that the carbamate 2.277 may 
have been too Lewis basic.
259
  The nitro-olefin 2.203 and aldehyde 2.202 were thus 
screened using a variety of molybdenum catalyzed allylation conditions, but to no avail 
(Scheme 2.81).   
Scheme 2.86 
 
  Because many of our synthetic intermediates were electron-rich aromatic rings 
(cf. Scheme 2.83, 2.202 and 2.236), we queried whether they might be good substrates in 
Friedel-Crafts allylations.
260-264
 Previously we had speculated that carbamate 2.277 was 
too Lewis basic for use with the Lewis acid molybdenum catalyst, (cf. Scheme 2.86) and 
as a nitrogen atom was ultimately needed at that position, nitrile 2.269 was prepared 
according to standard procedures (Scheme 2.87).  Aldehyde 2.202 was reduced, and the 
resulting primary alcohol was activated by thionyl chloride (SOCl2) and replaced with a 
chlorine atom.  The chloride was then treated with sodium cyanide (NaCN) to furnish 
2.269.  Nitrile 2.269 was screened in a variety of Lewis acid-mediated, Friedel-Crafts 
reactions, varying the electrophile, 2.270, time, temperature, solvent, and Lewis acid,
262
 
but none of the desired product 2.271 was ever observed.  Aldehyde 2.202 and nitro-
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olefin 2.203 (cf. Scheme 2.83) were also investigated as substrates in Friedel-Crafts 
reactions, yet none of the desired product was ever observed.   
  
Scheme 2.87 
 
We then investigated whether the allyl group could be introduced into an aromatic 
compound using anionic chemistry.   There was only one aryl proton on aldehyde 2.202, 
so we envisioned that it might be possible to deprotonate this proton with a strong enough 
base to generate an anion that could be alkylated with a suitable electrophile (Scheme 
2.88).  We examined the deprotonation of 2.202 with three different amide bases, LDA 
(2.274), lithium 2,2,6,6-tetramethylpiperidine (2.275), and a combination of lithiated 
N,N,N’-trimethylenediamine (2.276) and LDA (2.274).265-267  The reaction between 
2.202 and LDA (2.274) produced alcohol 2.273, while reaction between 2.202 and 
lithium 2,2,6,6-tetramethylpiperidine (2.275) produced returned starting material.   We 
then sought to try the combination of lithiated N,N,N’-trimethylenediamine (2.276) and 
LDA (2.274). Aldehyde 2.202 was reacted with lithiated N,N,N’-trimethylenediamine 
(2.276) in situ to protect the aldehyde against reduction as a hemiaminal, which then 
when LDA (2.274) was added, would direct the base to the proton ortho to the 
aldehyde.
266,267
 Although there was only one aryl proton in system 2.202 and 
regioselectivity was not an issue, it was believed that the coordination between the 
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methylenediamine and LDA would facililtate deprotonation; however, the only product 
obtained was alcohol 2.273. 
Scheme 2.88 
 
 The possibility of transition metal cross coupling reactions was then examined.  
We had a large stockpile of amine hydrochloride salt 2.236 which we thought we could 
elaborate to an acceptable cross-coupling precursor (Scheme 2.89).  The aryl bromide of 
2.277 would have served as a good functional handle for oxidative addition of a transition 
metal catalyst; however, the bromine atom was not at the site of the ring that we needed 
to allylate.  We needed to introduce a moiety at the desired allylation site which would 
preferentially undergo oxidative addition with a transition metal catalyst in the presence 
of the aryl bromide of 2.277.  Towards that end, we found a useful, albeit expensive, 
procedure to introduce iodine atoms into electron-rich aromatic groups involving the use 
of iodine and silver (I) trifluoroacetate. 
268,269
  The iodination proceeded in modest yield 
(55%) to provide aryl iodide 2.278 (Scheme 2.89).  The aryl iodide was then subjected to 
Stille conditions
270
 to provide the desired compound 2.280.  The first time the reaction 
was run, bis-allylation product 2.281 was also obtained, but when the reaction was run 
with a substoichiometric amount of allyl stannane, all bis-allylation was eliminated.  
Unfortunately, we could never obtain a good yield for the reaction as the product 
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remained contaminated with tin by-products, despite multiple column chromatography 
purifications.  
  
Scheme 2.89 
 
 
Though efforts will be ongoing to optimize the promising the promising Stille 
reaction between 2.278 and 2.279, allyl compound 2.280 was the furthest we were able to 
advance our total synthesis of acutumine in the time given (Scheme 2.89).   
2.8 SUMMARY 
Though we faced a number of difficulties throughout our efforts towards the total 
synthesis of acutumine, we were able to overcome many of the problems encountered and 
achieve some notable successes.  First we investigated a route toward key intermediate 
2.140 (Figure 2.15) which featured an acetylide addition/Moore cyclization sequence 
(Scheme 2.90 and cf. Section 2.5).  We developed conditions for the previously 
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unprecedented mono-TES silylation of  the least hindered phenol of diphenol 2.180 and 
were able to expand upon the scope and limitations of but-3-ynol derivatives, for example 
2.178, in acetylide addition/Moore cyclization sequences.   
Figure 2.15 
 
Scheme 2.90
 
We then explored a route which featured a Pictet-Spengler/SmI2 mediated ring 
opening sequence to provide 2.146 (Scheme 2.90 and cf. Sections 2.6 and 2.7).  We 
developed a regioselective Pictet-Spengler, in which we used the bromine atom of 2.236 
as a blocking group in a reaction with ethyl glyoxylate (2.206) to provide 
tetrahydroisoquinoline 2.237 in 94% yield.  We also discovered an important limitation 
of SmI2 mediated ring opening reactions (Schemes 2.91 and 2.92). Honda had shown that 
SmI2 had been previously shown to be an effective promoter carbon-nitrogen bond 
cleavage of both piperidine and isoquinoline systems,
230
 but we found that the reaction 
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did not work when a carbamoylated isoquinoline system, namely 2.227,  was employed 
as a substrate.  Proposing that the presence of a carbamate on the piperidine ring of a 
tetrahydroisoquinoline system disrupted the orbital alignment necessary for carbon-
nitrogen bond cleavage to occur, we were gratified to find that when the carbamoyl group 
was removed from 2.227 to provide tetrahydroisoquinoline 2.249, the reaction proceeded 
to provide phenethyl amine 2.251.  We were also able to conduct preliminary oxidative 
cyclization studies towards our key intermediate 2.146.  We were pleased to see that 
carbamate 2.253 was oxidized to mixed o-ketal 2.225 when treated with a hypervalent 
iodine reagent, thus providing support towards the viability of our key step (Scheme 
2.86).    
Scheme 2.91 
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Scheme 2.92 
 
 
2.9 FUTURE DIRECTIONS 
The most recent route towards acutumine featured an allylation reaction in order 
to access key intermediate 2.140.  Towards the end of my time on the project we found 
some promise using a Stille reaction to install an allyl group on aryl bromide 2.278 that 
we believed we could potentially functionalize to key intermediate 2.140 (Scheme 2.93).  
While the results are preliminary, we are optimistic that our efforts will provide us with a 
viable intermediate to reach acutumine. 
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Scheme 2.93 
 
 
 
Upon accessing aryl bromide 2.278, we realized that the synthesis could be 
shortened if 2.282 could be used as a starting material (Figure 2.16).  Fortunately, we 
were able to find precedent for preparing aryl bromide 2.289 (Scheme 2.94),
271
 which we 
envisioned we could then elaborate to the desired amine 2.282 using procedures we had 
successfully developed in our second generation approach (cf. Scheme 2.83).  Radix and 
co-workers were able to obtain aryl bromide 2.289 from the commercially available ester 
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2.283 (Scheme 2.94).
271
  The phenol groups of 2.283 were protected as their TBS ethers, 
and then the ester group of 2.284 was reduced to alcohol 2.285. The alcohol was oxidized 
to an aldehyde and the TBS groups were cleaved in HCl/THF to provide the diphenol 
2.286 in 67% yield over four steps.
271,272
  A mono-bromination of aldehyde 2.286 with 
NBS provided aryl bromide 2.287, which was then selectively methylated to provide 
phenol 2.288.  The main product of the reaction was RSM, with a little over-methylated 
material.
271
  Phenol 2.288 was then protected as its benzyl ether to provide 2.289 in 88% 
yield.  We envisioned that aldehyde 2.289 could undergo a Henry reaction to provide 
nitro-alkene 2.290, and that reduction with diborane could provide the desired amine 
2.282 (Scheme 2.95). 
Figure 2.16 
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Scheme 2.94 
 
 
 
Scheme 2.95 
 
 We could then explore a Stille allylation reaction with aryl bromide 2.282 
(Scheme 2.96 and cf. Scheme 2.89) to provide 2.291, which upon further oxidation, 
alkylation, and reduction could provide our key intermediate 2.140.     
Scheme 2.96   
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Chapter 3: Design and Synthesis of Ligands for the Thermodynamic 
Evaluation of Protein Ligand Interactions 
3.1  THE ROLE OF PROTEIN–LIGAND INTERACTIONS IN DRUG DESIGN 
 Small peptides have been shown to bind to a variety of therapeutically important 
receptors, so optimizing the protein binding affinity (Ka or IC50) of small peptide ligands 
is critical to the development of new drug candidates.
273-275
   Unfortunately, the 
complexities involved in molecular recognition phenomena in biological systems are not 
well understood, and it is often difficult to predict how ligands will bind to biological 
targets.
274-282
  When a ligand binds to a receptor, specifically a protein in the context of 
this discussion, in an aqueous media, a number of noncovalent interactions are initiated 
that can effect conformational changes to the entire macromolecule.
273-275
  These 
processes are complex and often comprise a number of competing associations, such as 
solvent reorganization.
274-282
  As a result of this complexity, it has been historically 
difficult to separate the processes into discreet components that can be 
quantified.
274,275,278
  Thus, a method to systematically examine the factors that influence 
protein-ligand interactions would enhance our ability to understand how modification of 
a ligand will correlate to changes in binding affinity. This method would be a particularly 
powerful tool for scientists working in the field of drug design.
273
   
 The rational design of small molecule and peptide drug leads usually begins with 
the modification of a compound that is known to bind to a receptor with a favorable 
affinity, meaning the compound is associated with either a high Ka or low IC50 value.
273-
276
  Ideally, structural data of the ligand in its biologically active conformation within the 
binding pocket of the protein would also be known.  Examples of structural data may 
include information regarding van der Waals (vdW) interactions, polar contacts, such as 
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hydrogen bonds and ionic interactions, or the orientation of water molecules at the 
protein-ligand interface.
274,275
  An analysis of these data can provide a good starting place 
with which to modify ligands in order to enhance binding affinity.  However, while 
structurally modifying a ligand may result in a change in binding affinity, the numerical 
Ka or IC50 value does not explain the cause of the change.  Knowing this information is 
equally as valuable as knowing the binding affinity as it would provide the first steps 
toward truly de novo ligand design in order to study molecular recognition phenomena in 
biological systems.  Currently there is no definitive method that can be used to predict 
ligand design, though some general guidelines do exist.
273-282
      
As previously mentioned when protein-ligand binding events are investigated, 
usually only the binding affinities as measured by either a Ka or an IC50 value are 
reported.
273-275
  A deeper understanding of protein-ligand binding might be achieved if 
more information were available. It is our belief that knowing how the thermodynamics 
for protein-ligand associations differ among various protein-ligand systems will provide 
valuable information about binding events.  Specifically, information relating to the 
changes in binding enthalpy (ΔHº) and binding entropy (ΔSº) are critical.  However, 
information relating to both ΔHº and ΔSº is not readily available from routine studies of 
binding events without the use of either a van’t Hoff analysis or isothermal titration 
calorimetry (ITC).
273-282
 A comprehensive investigation of both the structure and 
energetics of protein-ligand interactions would provide a much more detailed picture of 
molecular recognition phenomena in biological systems. 
While many principles are often invoked to explain differences in the activity 
resulting from molecular recognition phenomena, we will focus specifically on the effects 
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of conformational constraints.  Making predictions about how these complex biological 
systems will behave is formidable because of their dependence on solvent reorganization 
and protein dynamics, among others.  A “ligand-centric” approach, namely the analyzing 
the effects of conformational constraints onto the ligands, is an attractive option for study 
of molecular recognition phenomena.
274
 While the effects of other factors involved in the 
association processes are difficult to approximate, a ligand constraint provides something 
tangible that can be measured and analyzed, hence our interest.  In order to obtain 
meaningful thermodynamic data of protein-ligand interactions a systematic experimental 
approach should be followed.
274,275
  Ideally, the structure of a known small molecule 
should be incrementally changed, and the effects should be measured by a suitable 
analytical method to provide comparative thermodynamic data.  If the native peptide 
cannot be easily modified to incorporate a conformational constraint, then a suitable 
flexible peptide mimic should be synthesized for use as a control molecule.  The 
constrained peptide mimics should be as close in structure as possible to the native and/or 
control compound.  For example, control molecules should have the same number of 
heavy atoms, the same functional groups, and the same number of hydrogen bond donors 
and acceptors.  Most importantly, both flexible and constrained ligands, must bind in the 
same or similar matter to the target protein.
274,275
  In the context of conformational 
constraints, we will examine flexible vs. constrained ligands that follow these guidelines 
in order to elucidate the enthalpy (ΔHº), entropy (ΔSº), and free energy (ΔGº) of binding. 
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3.1.1 BINDING THERMODYNAMICS 
 Protein-ligand interactions may be most simply explained as an equilibrium 
between the free protein (P) and ligand (L) and the protein-ligand complex (PL) in water 
(eq. 3.1). The subscripts n, m, represent the number of water surrounding the native 
protein and free ligand, while the subscript x represents the number of water molecules 
surrounding the protein-ligand complex.  The other water molecules represent the bulk 
aqueous solution.  
Equation 3.1  
 
 
 
 A simple representation of the complexation event in water is shown in Figure 
3.1.  Water molecules surround the apo protein and free ligand, but upon association, 
some water molecules must be displaced into the bulk solution as interactions between 
the protein and ligand replace the interactions from the water molecules.  Then the 
remaining water molecules reorganize themselves around the new complex, creating a 
new system of hydrogen bonds.   
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Figure 3.1 The reorganization of water molecules upon protein-ligand binding 
 
 
The association constant (Ka), and dissociation constant (Kd), for the forward and reverse 
interactions in eq. 3.1 can be expressed by eq. 3.2, 
Equation 3.2 
 
 
which is a rearrangement of the Arrhenius equation.  Ka is related to the free energy 
(ΔGº), enthalpy (ΔHº), and entropy (ΔSº) of the protein-ligand interaction through the 
Gibbs’ free energy equation (eq. 3.3),  
Equation 3.3 
 
where R is the universal gas constant (1.985 cal K
-1
mol
-1
), and T is the temperature in 
Kelvin.  Equation 3.3 can also be rewritten as eq. 3.4, 
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Equation 3.4 
 
which relates ΔGº directly to ΔHº and ΔSº. 
The enthalpy of binding represents the heats of formation and/or breaking of all 
possible non-bonded interactions (ie dispersive van der Waals (vdW) and polar contacts) 
while the entropy of binding represents changes in the order of the system.
273
  As can be 
seen by equations 3.3 and 3.4, ΔGº, and subsequently Ka, is dependent upon the interplay 
between the enthalpy and entropy terms.  If one could optimize either ΔHº and ΔSº, or 
ideally both terms, then the binding Ka of the protein-ligand complex could be greatly 
enhanced.   
   The enthalpy of binding is often considered more difficult to optimize than the 
entropy of binding because the enthalpic term is reliant upon distance and angle 
dependent polar interactions, as well as non-dispersive vdW interactions, but some 
guidelines exist for how to carry out such investigations.
274,275,283-285
  Two common 
strategies toward optimizing the binding enthalpies of protein-ligand interactions include 
maximizing existing favorable interactions between protein and ligand and/or creating de 
novo favorable non-bonded contacts.
274,275
   These optimization studies are largely guided 
by structural information obtained from the bound native ligand/protein complex through 
x-ray crystallography.  However, some major disadvantages of this method include the 
static nature of crystallography, and the fact that bulk water molecules, or those that are 
displaced from the protein and ligand upon formation of the protein-ligand complex, are 
invisible using crystallography (cf. Figure 3.1).
274,275
   Crystallography can only capture a 
single snapshot in a dynamic complexation process, and while some hydrogen bond 
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interactions between water and the complex can be seen in the crystal structure, the 
interactions amongst the water molecules themselves are large contributors to the overall 
thermodynamics of molecular recognition phenomena in biological systems (ie 
solvation/desolvation processes).  Nondirectional vdW forces may also be optimized, but 
they are much weaker than the more specific polar contacts.
286
 
The entropy of binding is often considered the more desirable thermodynamic 
term to optimize because it is generally easier to restrict rotors of a ligand through 
conformational constraints than it is to induce precise orientation and angle dependent 
polar interactions between a ligand and protein.
274,275,287
  Introducing conformational 
constraints, usually rings, onto ligands restricts their flexibility, and their inclusion has 
been shown to increase the binding affinity of the association process.
274,275,287
  The 
increase in affinity is usually attributed to the entropy, rather than the enthalpy of 
binding.  The general belief is that the restriction of independent rotors in a ligand ideally 
preorganizes the ligand into its biologically active binding conformation, therefore 
lessening the entropic penalty paid upon binding.
274,275,287
  However, this is a hypothesis 
and little hard data exists to prove that the increase in affinity is due to entropic, and not 
enthalpic effects.
274,275
  
  Another common strategy that is used to increase binding affinity is to add 
nonpolar surface area to the ligand.
274,275
  There exists a phenomenon in molecular 
recognition of biological systems called the “hydrophobic effect”, and it is directly 
related to solvent reorganization upon binding.
288-292
  It is generally believed that the 
desolvation of non-polar surface area leads to favorable changes in entropy, but we have 
found that that is not always the case a little later.
274,275,280,293
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3.1.2 ISOTHERMAL TITRATION CALORIMETRY 
 As mentioned previously, when work is done in the field of protein-ligand 
interactions, the binding affinity is usually expressed as a Ka, an IC50, or a Ki (inhibition 
constant) value, though these are not direct measures of affinity.  While Ka is a direct 
measure of the binding energy (cf. eq. 3.3-3.4); Ki’s and IC50’s are calculated quantities 
that measure a biological effect and not an actual thermodynamic parameter.  However, 
they are still frequently reported as measures of ligand potency in the literature.  The 
Cheng-Prusoff equation
294
 (eq. 3.5) relates Ki to IC50,  
Equation 3.5 
 
where I50 represents the free concentration of inhibitor at 50% maximal activity, S is the 
free concentration of the substrate being measured at 50% maximal activity, and Km is the 
concentration of the substrate at 50% maximal activity.   
 When thermodynamic parameters such as ΔHº and ΔSº are desired, there are only 
a few methods available with which to determine them.
284,285,295,296
  One way is to 
conduct a van’t Hoff analysis (equation 3.6), 
Equation 3.6 
 
where R is the universal gas constant, and T is the temperature in Kelvin.  However, one 
of the largest problems with the van’t Hoff analysis is that Ka is not truly independent of 
temperature; moreover, if slope of the resulting graph is off by even a small amount then 
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ΔHº and ΔSº will yield inaccurate values.  Another major problem with van’t Hoff 
analyses is that the method requires a large number of experiments to be performed at 
different temperatures to generate a plot, which consequently requires large amounts of 
valuable protein and ligand that may not be readily available.  However, most of these 
problems can be avoided through the use of isothermal titration calorimetry (ITC).
296,297
  
ITC measures ΔHº and Ka directly with one experiment, and only ΔSº need be calculated.  
This method is generally easier and more accurate than the van’t Hoff analysis. 
 An experiment involving ITC is performed by incrementally adding small 
amounts of a solution of a ligand to a calorimeter held at a constant temperature, and 
filled with a solution of protein.  The energy required to hold the calorimeter at the 
constant temperature gives ΔHº, while the Ka for the interaction can be determined by 
integrating ΔHº against stoichiometry.296,297  Though ITC is a powerful tool, many 
researchers choose not to report values for ΔHº and ΔSº, choosing only to focus on Ka.  
While we know that Ka can provide a measure for how well a ligand binds, it does not 
explain the how or why of the protein-ligand interaction; for that we need to know more 
details about the reactions, namely ΔHº and ΔSº.  The Martin group has already made 
significant contributions to this area and those results will be discussed below.   
3.1.3 SOLVENT REORGANIZATION AND THE HYDROPHOBIC EFFECT 
Protein-ligand interactions involve reorganization of solvent water molecules 
about both the protein and ligand.  Bulk water molecules are generally disordered, but 
when a solute is introduced, a cavity forms.  The solute occupies the cavity, and then the 
water molecules re-arrange themselves around the solute molecule in order to maximize 
the available hydrogen bonds.
298
  This same principle applies to the introduction of 
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proteins and ligands into an aqueous solution.  The tendency of nonpolar molecules to 
aggregate with one another in an aqueous solution is called the “hydrophobic effect”.288-
292
  When nonpolar surface area is added to a ligand, its binding affinity usually 
increases, and the increase can be either entropically or enthalpically driven.
274,275
 When 
the hydrophobic effect is entropically driven, it is believed that the displacement of an 
ordered water molecule from the cage surrounding the cavity of the non-polar protein 
and/or native ligand into the bulk solution is favorable, as the newly freed water molecule 
gains more degrees of freedom (cf. Figure 3.1).
288,290,292
  However, other studies have 
shown that the displacement of a water molecule from an unbound protein or ligand is 
enthalpically driven, as sub-optimal hydrogen bonds are replaced with more favorable 
distance and orientation dependent contacts within the bulk solvent.
291
   
Desolvation effects on binding are generally determined by measuring changes in 
the heat capacity (ΔCp) of complex formation.
273,278,295
  Complexation heat capacity is 
dependent upon temperature and can be represented by Equation 3.7, 
Equation 3.7 
 
where T represents temperature in Kelvin and p represents that the change in enthalpy 
over time occurs under constant pressure.  The ΔCp for a given protein-ligand association 
may be determined from ITC experiments by performing the association at a variety of 
different temperatures and then plotting ΔHº against temperature.  If the hydrophobic 
effect is present in the protein-ligand system, then ΔCp will be negative, regardless of 
whether the effect is enthalpically or entropically driven.
273,278,295
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3.1.4 ENTHALPY-ENTROPY COMPENSATION   
It can be difficult to design experiments that would only affect either the enthalpy 
or entropy of a protein-ligand association.  For example, if the enthalpic term is enhanced 
to cause the protein and ligand to bind tighter, then the entropic term may become 
unfavorable due to the increased order in the system and offset some of the enthalpic 
gain.  Conversely, if the order of the system were to become more disordered then 
favorable non-covalent interactions may be broken which may adversely affect the 
enthalpic term this phenomenon is referred to as “enthalpy-entropy compensation”.273,299-
304
.  Although it is not well understood, it appears that solvent reorganization and protein 
dynamics upon binding play important roles.  Our group was most focused on using 
ligand-preorganization as a means to enhance binding affinity by lessening the entropic 
penalty paid upon the association event, and a more detailed discussion follows.   
3.1.5 LIGAND PREORGANIZATION 
 Binding affinity may be improved by constraining a peptide, traditionally in its 
biologically active or bound, conformation.
274,275,287
  This is also commonly called ligand 
preorganization.  When ligand preorganization is utilized and an increase in binding 
affinity is observed, the enhancement is usually attributed to a smaller entropic penalty 
upon binding because the ligand is already preorganized into the desired binding 
conformation.
284,285,295
  Figure 3.2 represents a simple illustration of the ligand 
preorganization concept.  The “constrained” ligand possesses fewer degrees of freedom 
(translational, rotational, and conformational, though conformational is the most 
predominant) than its “free” counterpart, which theoretically leads to an increase in 
binding affinity due to the lessening of the entropic penalty paid upon complexation of 
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the protein and ligand.   Preorganization also includes the benefit of a possible increase in 
selectivity of the ligand for the protein receptor.
305
   
Figure 3.2:  The entropic benefits of ligand preorganization. 
 
 
A number of options are available to introduce a constraint into a peptide ligand, 
and they fall into two main classes: non-covalent and covalent.
306
  Non-covalent 
constraints are also referred to as “local constraints” and comprise - and N-methyl 
amino acids and D-amino acids.  A local constraint is generally defined as a constraint 
that affects a single residue of a peptide.  Non-covalent constraints typically constrain the 
ligand through intramolecular H-bonds, which induce a secondary structure in the peptide 
(ie  -helices, -turns, etc.).306  Covalent constraints are generally comprised of cyclic 
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modifications to known peptide binders.  These cyclic modifications can either be 
incorporated into the side-chain or backbone of the peptide, or they can be a combination 
of both (Figure 3.2).  Examples of cyclic covalent constraints range from cyclopropane 
rings to large macrocycles. The work of the Martin group with cyclopropanes will be 
discussed in depth in succeeding sections. 
Figure 3.3:  Types of ligand preorganization. 
 
 
3.2 EARLY WORK IN LIGAND PREORGANIZATION 
 One of the seminal examples of associating ligand preorganization with enhanced 
binding affinities was accomplished by Bartlett and coworkers.
307-310
  Bartlett was 
interested in inhibitors of aspartic protease penicillopepsin, namely phosphorylated 
pseudopeptide 3.1 (Table 3.1).  Believing that native ligand bound with penicillopepsin in 
a bent (3.1b), as opposed to linear (3.1a) conformation, Bartlett first designed the 
macrocyclic peptide mimic 3.2, as well as the acyclic mimics 3.3 and 3.4, in order to 
investigate whether ligand preorganization would result in an enhanced binding affinity.  
They found that the most constrained mimic, macrocycle 3.2, was found to bind to the 
protease with the best affinity, as measured by Ki’s.  Though 3.2 did not bind nearly as 
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well as native ligand 3.1, this was still one of the first successful applications of a 
conformational constraint used to enhance binding affinity.
309
   
Table 3.1 
 
 
 
 
 
 
Ligand Ki (nM) penicillopepsin 
3.1 2.8 
3.2 800 
3.3 7600 
3.4 1 x 10
5
 
3.5 42 
3.6 0.10 
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Bartlett then synthesized acyclic mimic 3.5 and macrocycle 3.6, which were more 
accurate structural comparisons to the original pseudopeptide 3.1 (Table 3.1).
307,310
  Both 
3.5 and 3.6 were found to bind to aspartic protease penicillopepsin more favorably than 
mimics 3.2-3.4, with macrocycle 3.6 being a 420-fold more potent binder over that of 
flexible control 3.5. 
307-310
  When x-ray structures of 3.5 and 3.6 bound with the protein 
were obtained, both ligands were found to bind to the protein in the same manner, 
indicating that Barlett had successfully designed a flexible/constrained peptide mimic 
pair.  Though he did not collect thermodynamic data, Barlett speculated that the increased 
affinity was due to an entropic and not enthalpic benefit. 
 Another early success exhibiting enhanced binding affinity through ligand 
preorganization was accomplished by Tsantrizos and coworkers in their investigation of 
inhibitors of hepatitis C viral NS3 protease (Table 3.2).
311
  Based on known hexamer 3.7, 
macrocyclic mimic 3.8 and its flexible control 3.9 were synthesized and constrained 3.8 
was found to be a 36-fold more potent binder than flexible 3.9.  Again, no 
thermodynamic data were collected so the authors could not elucidate whether the 
enhanced affinity was due to a more favorable entropy or enthalpy of binding. 
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Table 3.2 
 
 
 
 
 One of the first ligand preorganization studies that collected thermodynamic data, 
in addition to binding affinity values, was done by Williams.  He investigated the 
thermodynamics of a series of glycopeptidic mimics of the antibiotic vancomycin (3.10) 
and found that glycopeptide 3.11 dimerized with itself with 21-fold more potency than 
did vancomycin (3.10) (Table 3.3).
279,292,312,313
  The increase affinity was attributed to 
both a more favorable enthalpy and entropy of dimerization.  Williams further went on to 
Ligand IC50 (M) NS3-NS4A 
3.8 0.011 
3.9 0.400 
  
 
217 
do extensive work towards understanding entropy-enthalpy compensation and non-
covalent interactions in aqueous biomolecular systems. 
21,39,40
   
Table 3.3 
 
Ligand Kdim 
ΔH°obs  
(kJ mol
-1
) 
TΔS°obs  
(kJ mol
-1
) 
3.10  700 -36 ± 2 -20 ± 5 
3.11 1.5  x 10
4
 -51 ± 3 -27 ± 3 
3.3 PREVIOUS WORK IN THE MARTIN GROUP 
Recall that our major goal was to examine flexible vs. constrained ligands in order 
to elucidate the enthalpy (ΔHº), entropy (ΔSº), and free energy (ΔGº) of binding of 
molecular recognition phenomena in biological systems.  Our strategy was to change the 
structure of a known small molecule incrementally and then measure the thermodynamics 
effects by ITC to provide comparative thermodynamic data.  Structural data of the ligand 
in the binding pocket was crucial, as that allows for interpretation of the thermodynamic 
results.  If the native peptide was not easily modified then a suitable flexible peptide 
mimic was synthesized as a control molecule to compare against constrained peptide 
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mimics.  The constrained peptides were as close in structure as possible to their flexible 
control compounds, meaning that control molecules had the same number of heavy 
atoms, the same functional groups, similar numbers of hydrogen atoms, and the same 
number of hydrogen bond donors and acceptors.  Most importantly, the flexible and 
constrained peptide mimics had to bind to the target protein in the same or similar 
manner. 
Four types of cyclopropane pseudopeptides were developed by our group in the 
nineties. 
274,275,314-323
 As shown in Figure 3.4, we were interested in side-chain to 
backbone constraints (cf. Figure 3.3) in order to simultaneously restrict the backbone and 
rigidify the side-chain to a single orientation.  Side chains are known to make important 
contributions to the binding affinity of certain molecules, but their spatial orientation is 
often overlooked in the field of ligand design and we had hoped to rectify this.
306
   
 A side chain may be constrained to the backbone of the peptide via the N- or C- 
linkage (Figure 3.4, path a and b, respectively).
274,275
  If we followed path a, then the 
amide nitrogen was replaced with a carbon atom in order to form the desired 
cyclopropane, while if we followed path b, we excised the carbonyl group to provide the 
desired cyclopropane.  By controlling the stereochemistry of the cyclopropane ring, we 
reinforced the backbone structure to either provide an extended (3.13 and 3.14) or turn 
inducing (3.15 and 3.16) local structure to the peptide, represented by the backbone angle 
.  The side chain orientation was also controlled to mimic either a gauche (-) (-60º), 
gauche  (+60º), or anti conformation with respect to the peptide backbone, as represented 
by angle χ.274,275,306  The gauche (-) conformation is illustrated by the position of R2 in 
peptide 3.13, whereas the anti conformation is illustrated by the position of substituent R2 
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in peptide 3.14.  The use of specific examples of pseudopeptides 3.13-3.16 will be 
discussed in detail in the following examples.   
Figure 3.4:  Types of ligand constraints. 
 
3.3.1 RENIN PROTEASE INHIBITORS 
The Martin group first investigated the use of trisubstituted cyclopropane 
constraints in binding studies with renin protease inhibitors.
274,275,316
  Renin protease 
inhibitor 3.17 (Table 3.4) was chosen because of its potency, as well as because it was 
thought to bind to the enzyme in an extended, -strand conformation.  As such, 
constrained peptides 3.18 and 3.19 were designed and synthesized by methods developed 
within our group to constrain both the side-chain and backbone of 3.17 at the P3 position.  
In both peptides 3.18 and 3.19, the trans stereochemistry of the cyclopropane constraint 
  
 
220 
had locked the backbones of the peptides into extended conformations, while the phenyl 
group orientations differed to represent both the gauche (-) and gauche (+) orientations, 
3.18 and 3.19, respectively, of linear peptide 3.17.  Peptide 3.17 was an appropriate 
control for compounds 3.18 and 3.19 because all three contained the same number of 
heavy atoms and hydrogen bond donors/acceptors, as well as the same functional groups.   
Table 3.4 
 
  
 
 
 
When the activities of the ligands were tested under standard assay conditions, it 
was found that flexible 3.17 bound with approximately the same affinity as the 
Ligand IC50, nM at pH 6.0 
3.17 0.36 
3.18 0.7 
3.19 200 
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constrained 3.18, while its cyclopropyl diastereomer 3.19, was found to be 300-fold less 
potent as an inhibitor.
274,275,316
 The data thus support the conclusion that the phenyl group 
side chain of 3.17 bound to aspartate protease renin preferentially in a gauche (-) 
conformation, though we did not observe any noticeable increase in binding affinity due 
to the preorganization of the ligand.  However, this study did prove that cyclopropane 
backbone/side-chain restraints were valid peptidomimics for ligand-receptor binding 
studies setting the stage for future experiments. 
3.3.2 MATRIX METALLOPROTEASE INHIBITORS 
We next turned our attention toward introducing cyclopropyl restraints into the 
known matrix metalloprotease (MMP) inhibitor 3.20 (Table 3.5).
274,275,324
  Peptides 3.25 
and 3.26 were synthesized to orient the backbone of the peptides in an extended 
orientation, due to the trans stereochemistry of the cyclopropanes, while also orienting 
the isopropyl group of P1’ in both the gauche (-) 3.25  and gauche (+) 3.26 
conformations.  When biological assays of 3.25 and 3.26 were run against four different 
varieties of MMP’s, the binding affinities of 3.25 and 3.26 were found to be significantly 
lower than that of the parent compound 3.20, suggesting that neither 3.25 nor 3.26 bound 
in a similar manner to MMP as 3.20.   
Crystallographic data were available for the bound complex MMP-1 and 3.20 and 
it indicated that the isopropyl group of P1’ and the phenyl group of P2’ were oriented anti 
to one another in the bound structure.
274,275,324
  As we had already shown the design and 
synthesis of cyclopropanes of the type 3.14 (cf. Figure 3.4), which are formed via the 
excision of a carbonyl group in the parent compound 3.12, we decided to incorporate 
cyclopropanes of type 3.3 into peptide 3.20.  Thus, compounds 3.23 and 3.24 were 
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synthesized, with the cyclopropyl group constraining the isopropyl group of P1’ in 3.23 
and the cyclopropyl group constraining the phenyl group of P2’ in 3.24.  Also notice that 
the amide functionality of 3.24 was transposed as opposed to 3.20.  However, now that 
we had excised a carbonyl group from 3.20, the peptide was no longer a suitable flexible 
control.  Peptides 3.21 and 3.22 were synthesized to act as flexible controls for 3.23 and 
3.24, respectively.  Both 3.21 and 3.22 contain the same number of heavy atoms and 
hydrogen bond donors/acceptors as the restricted peptides 3.23 and 3.24.  When the 
efficacies of peptides 3.21-3.24 were tested towards various MMP enzymes, it was found 
that they were two to four orders of magnitude less effective than the original inhibitor 
3.20.  Clearly the P2’ carbonyl group, which was excised in peptides 3.21 and 3.23, and 
the P3’ amide, which was transposed in peptides 3.22 and 3.24, were important to the 
bioactivity of inhibitor 3.20.  While the overall efficacy of peptides 3.21-3.24 went down, 
we did notice significant differences in bioactivity between the flexible (3.21 and 3.23) 
and constrained (3.23 and 3.24) peptides.  Constrained peptides 3.23 and 3.24 were found 
to be more potent than their flexible controls (3.21 and 3.22), indicating that ligand 
preorganization did provide a thermodynamic benefit to the complexation event, though 
we did not know if the increase in affinity was due to ΔHº, ΔSº or a combination thereof.  
We did not measure the discreet thermodynamic parameters because it was not available 
at the time.
274,275,324
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Table 3.5 
 
3.3.3 ENKEPHALINS 
 Enkephalins, a class peptides that bind to opioid receptors (- and -), were 
believed to bind to the receptors in a conformation that incorporated a -turn according to 
structural and computational studies.  The intramolecular hydrogen bond between the 
carbonyl group of Gly
2
 and the amide nitrogen atom of Leu
5
 in potent opioid binder Leu-
enkephalin methyl ester 3.27 (Table 3.6) was believed to reinforce the observed -turn in 
IC50 Values (M) for MMP inhibitors 
Ligand 
MMP-1 
HFC 
MMP-2 
gelatinase A 
MMP-3 
stromelysin-1 
MMP-7 
matrilysin 
3.20 0.0025 0.0007 0.016 0.0065 
3.21 26% @ 100 M 6.0 124 2.5% @ 100 M 
3.22 36% @10 M 6.15 Inactive @ 10 M 40% @ 10 M 
3.23 0.054 0.064 1.0 0.78 
3.24 1.9 0.26 6.9 6.7 
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the binding conformation.
274,275,325
 We had already developed a method with which to 
access constrained peptides that we believed would reinforce -turns through the use of 
cis oriented cyclopropanes (cf Figure 3.4, peptides 3.15 and 3.16), so we designed and 
synthesized ligands 3.28-3.30.  Extended peptide 3.31, which incorporated the use of a 
trans-cyclopropane as a constraint, was also synthesized in order to act as an extended 
control for peptide 3.28; if 3.27 actually did bind to the opioid receptors in a “turned” 
orientation (as opposed to an extended conformation), then we would expect 3.31 to 
perform worse than 3.28.  As a number of carbonyl group and amine nitrogens were 
excised from the original binder 3.27, we also synthesized flexible control ligand 3.32, 
which had the requisite number of heavy atoms and hydrogen bond donors/acceptors.  
 Ligands 3.28-3.32 were tested against - and - opioid receptors to provide mixed 
results.  Compounds 3.29 and 3.30, which both incorporated cis cyclopropanes into the 
Phe
4
 residue, did not exhibit any activity towards either the - or - opioid receptor.  It 
appears that the introduction of a -turn reinforcing constraint could not overcome the 
loss of the hydrogen bond between Gly
2
 and Leu
5
 in 3.27. Peptide 3.28, however, did 
show some affinity for the -receptor, as did its extended conformer 3.31 and flexible 
control 3.32.  Unfortunately, 3.28, 3.31, and 3.32 all bound with approximately the same 
affinity, which was overall approximately 100-500 fold less than the original ligand 3.27; 
and we were unable to make any significant contributions to the hypothesis that cis 
cyclopropanes can stabilize -turns in binding conformations.274,275,325   
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Table 3.6 
 
 
 
3.3.4 RAS FARNESYLTRANSFERASE INHIBITORS 
Ras farnesyltransferase inhibitors of the type 3.33 were first presumed to adopt a 
-turn conformation upon binding in early literature studies, but then later studies 
supported an extended binding conformation, though neither was definitively confirmed 
 Ki (nM) IC50 (nM) 
Ligand 
[
3
H]DAMGO 
() 
[
3
H]Cl-DPDPE 
() 
GPI() 
MVD () 
3.27 3.9 ± 1.1 10.6 ±3.0 167 ± 14 87 ± 15 
3.28 1355 ± 263 >10000 640 ± 241 4261 ± 921 
3.29 >10000 >10000 NA NA 
3.30 >10000 >10000 NA NA 
3.31 2159 ± 95 >10000 NA NA 
3.32 438 ± 230 >10000 NA NA 
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(Table 3.7).
274,275,326
  We decided to synthesize both cis and trans cyclopropyl constrained 
peptides 3.34, 3.36, and 3.37 as replacements for 3.33 to determine whether they could 
provide evidence for either a -turn or extended binding conformation between the 
ligands ras farnesyltransferase receptors.  As significant structural changes between 
compounds 3.34, 3.36, and 3.37 and original inhibitor 3.33 were present, the flexible 
peptide 3.35 was synthesized as a suitable control molecule.   
 Ligands 3.34-3.37 were all found to be less potent that the original inhibitor 3.33 
when subjected to standard biological assays with ras farnesyltransferase, with flexible 
control 3.35 exhibiting the best bioactivity.
275,326
  Constrained cis cyclopropyl ligand 3.36 
and its corresponding trans cyclopropyl extended conformer 3.34 bound with similar 
activity, though 3.36 was slightly more favored.  Peptide 3.37 was found to exhibit the 
worst activity, indicating that the phenyl group of residue A
2
, depicted in structure 3.33, 
most likely prefers the gauche (-) orientation exhibited in 3.36.  Additional 
crystallographic studies were performed on compound 3.36 itself, but no compelling 
evidence was found to indicate that 3.36 actually did induce a locally turned structure.  In 
fact, further modeling studies showed that both 3.36 and 3.37 were capable of adopting 
extended conformations in the binding pocket of ras farnesyltransferase.
275,326
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Table 3.7 
 
Inhibitor IC50 (nM) 
3.33 38 
3.34 1055 
3.35 320 
3.36 760 
3.37 7200 
 
3.3.5 HIV-1 PROTEASE INHIBITORS 
 HIV-1 protease inhibitors, 3.38, are known to bind in extended conformations to 
the corresponding receptor, specifically as -strands.274,275,320  Having previously had 
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luck with reinforcing extended structures with trans-cyclopropyl constraints (cf. Table 
3.6), we hypothesized that the introduction of trans-cyclopropyl constraints at the P2 and 
P2’ residues of 3.38 would further reinforce the -strand conformation which, in turn, 
would increase binding affinity.  Toward this end we designed and synthesized 
compounds 3.39-3.42.  When tested as inhibitors of HIV-1 protease, it was found that all 
the peptides 3.39-3.42 bound with comparable affinity to the original peptide 3.38, with 
compounds 3.40 and 3.42 providing a slightly more favorable binding affinity.
274,275,320
   
Table 3.8 
 
Inhibitor IC50 (nM) 
3.38 0.22 
3.39 0.31-0.35 
3.40 0.16-0.21 
3.41 0.47 
3.42 0.17 
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 After several investigations into cyclopropanes as constrained peptide mimics, it 
was becoming clear that we were not seeing any significant increase in binding affinity 
due to preorganization of the ligands (cf  Tables 3.3-3.7).
274,275
  In most of the previous 
examples, with the exception of Table 3.8, the constrained ligands were compared to 
appropriate control ligands with the same number and type of heavy atoms as well as the 
same number of hydrogen bond donors and acceptors, so we should have been able to 
observe any discrete differences in binding affinity that arose from preorganization of the 
ligands.  We needed more information in order to determine if our cyclopropyl 
constraints were actually restricting the ligands in the favorable binding conformation.  
Towards that end, an X-ray crystallographic study was conducted on the complex of 
HIV-1 protease and ligand 3.40.  The bound structure of compound 3.40 was found to 
resemble that of other known inhibitors.  The data from this study were then compared to 
a separate NMR study, which determined the preferred structure of ligand 3.38 in 
solution (Figure 3.5).
274,275,320
  This result was particularly exciting because for the first 
time we were able to compare the structure of a stabilized flexible bound protein-ligand 
conformation in solution to an X-ray crystal structure of the constrained complex.   
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Figure 3.5: A crystal structure of bound 3.40 overlaid with the NMR structure of unbound 
3.38.
a
  
 
 
a
 Adapted with permission from Martin, S. F.; Dorsey, G. O.; Gane, T.; Hillier, M. C.; Kessler, H.; Baur, 
M.; Mathae, B.; Erickson, J. W.; Bhat, T. N.; Munshi, S.; Gulnik, S. V.; Topol, I. A. "Cyclopropane-
Derived Peptidomimetics. Design, Synthesis, Evaluation, and Structure of Novel HIV-1 Protease 
Inhibitors" J. Med. Chem. 1998, 41, 1581-1597.  Copyright (1998) American Chemical Society. 
When the crystal structure of bound 3.40 was overlaid with the NMR structure of 
unbound 3.38 there was generally good agreement between the two.
274,275,320
  The most 
noticeable difference between the two structures was that the orientation of the benzyl 
groups at the P3 and P3’ residues were mismatched. However, it must be noted that the 
benzyl groups are freely rotating and that only one conformation was shown 
274,275,320
  
This study answered two main questions for our research project.  One, we knew that 
cyclopropyl constrained peptides bound to receptors in approximately the same 
conformation as known inhibitors; and two, we knew  that the bound conformation of the 
ligand was similar to the conformation of the unbound ligand in solution.   Our 
hypothesis that cyclopropyl constraints could act as viable peptide replacements was 
validated, but the question remained. Why did we not see any change in binding affinity 
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due to ligand preorganization?  We needed more data to better interpret our results, thus 
the time had come to investigate the discrete components of the binding free energy: the 
enthalpy and the entropy of binding.   
3.3.6 THE THERMODYNAMICS OF PSEUDOPEPTIDES BINDING TO THE SRC SH2 DOMAIN 
 The Src SH2 domain, a small protein domain which is involved in the regulation 
of signal transduction pathways, like the Grb2 SH2 domain, is known to bind to 
phosphotyrosine peptides.
327,328
  After our success obtaining crystal structure data for the 
HIV-protease bound complexes, we desired to study another system that was structurally 
well-defined, as was the case for the Src SH2 domain.
327-330
  Specifically, peptide 3.43, 
which is a tetrapeptide fragment, has been shown to bind to the Src SH2 domain in an 
extended conformation with high affinity (Table 3.9).
274,275,331,332
  Knowing that the 
phosphotyrosine residue was a key component to the bioactivity of 3.43, as it is for all 
SH2 domains, we designed and synthesized the cyclopropyl constrained ligand 3.44 in 
which the backbone of the peptide was locked in an extended conformation and the 
phosphotyrosine residue was restricted to its predicted gauche (-) binding 
orientation.
274,275,333
  While we excised an amide nitrogen atom from molecule 3.43 in 
order to make compound 3.44, the nitrogen atom was not predicted to participate in any 
key hydrogen bonding interactions in the binding pocket so we had hoped to avoid any 
significant enthalpic penalties.  The terminal amide group of 3.43 was also replaced by 
the transposed N-methyl amide of 3.44 in order to accommodate the cyclopropyl 
restraint, while retaining the vital C=O bond.  The structural changes resulting in the 
creation of 3.44 from 3.43, namely the addition of an extra carbon atom to introduce the 
cyclopropane ring and the transposed amide, were significant enough so as to require a 
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more appropriate control molecule, namely flexible ligand 3.45, which contains the same 
number of hydrogen bond donors and heavy atoms as 3.44. 
Table 3.9 
 
Ligand Ka 
ΔG°obs  
(kcal mol
-1
) 
ΔH°obs  
(kcal mol
-1
) 
ΔS°obs  
(cal mol
-1 
K
-1
) 
ΔCp,obs  
(cal mol
-1 
K
-1
) 
3.43  4.1 (± 0.1) x 10
6
 -9.01 ± 0.01 -6.06 ± 0.05 9.9 ± 0.2 - 
3.44 1.0 (± 0.1) x 10
7
 -9.55 ± 0.07 -5.91 ± 0.04 17 ± 1.0 -225 (± 9) 
3.45 1.7 (± 0.6) x 10
7
 -9.80 ± 0.20 -7.33 ± 0.03 8.3 ± 0.5 -213 (± 17) 
 
 When ITC experiments were carried out for complexes of 3.44 and 3.45 with the 
Src SH2 domain, it was found that 3.44 and 3.45 were approximately equipotent binders, 
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showing slightly better affinity than native ligand 3.43.
274,275,333
  Whereas in our previous 
ligand-protein binding endeavors we had not found a definitive correlation between 
ligand constraints leading to greater entropic benefits, we were gratified to see that the 
ITC data from this set of experiments showed that the constrained peptide 3.44 had a 
considerably more favorable entropy of binding than its flexible control 3.45 (by a 
margin of approximately 9 eu/mol).
274,275,333
  We were finally able to obtain data which 
lent support towards the general hypothesis that constraining ligands in their bioactive 
conformations would lead to a lesser entropic penalty on binding; however, we had also 
hypothesized that the lessening of the entropic penalty should have also lead to an 
increase in binding affinity, yet it did not.  Still, we were extremely gratified to find that 
our group had provided the first evidence that ligand preorganization can result in 
entropic benefits during binding.   
 Recall that the constrained and flexible ligands, 3.44 and 3.45 respectively, were 
found to bind to the Src SH2 domain with comparable affinities even though 3.44 bound 
with a more favorable entropy.
274,275,333
  As discussed previously, the phenomenon of 
enthalpy-entropy compensation is notoriously hard to predict and complicates our 
understanding of molecular recognition in biological systems.
274,275
  Changing either the 
enthalpy or entropy of the association does not guarantee a favorable increase in binding 
affinity because it is difficult to predict how a change in one thermodynamic parameter 
will affect the other, nor is the compensation effect required to balance out.  What is 
known is that solvent reorganization and protein dynamics play an important role in the 
process.
274,275
 As the entropy of binding became more favorable for ligand 3.44, the 
added advantage was most likely offset by unfavorable enthalpic interactions throughout 
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the bound complex, resulting in equipotent binding affinity of the constrained and 
flexible ligands of constrained 3.44 and flexible 3.45. 
 In an effort to determine the specific causes of the enthalpic penalty, a series of 
ITC, X-ray crystallography, and computational studies were undertaken in order to 
elucidate the structure of the bound ligand-protein complex.  We utilized ITC in order to 
obtain the observed changes in heat capacity (ΔCp,obs) of the complexes by graphing the 
enthalpy of binding of the complexes at different temperatures (cf. Equation 3.7).
274,275,333
  
Our experiments showed that no such significant interactions seemed to account for the 
enthalpic differences between 3.44 and 3.45 as the heat capacity values were found to be 
identical within experimental error.
274,275,333
   
 Next a crystal structure of the bound complex of 3.44 with Src was investigated 
by X-ray crystallography.
274,275,333
  Unfortunately, a crystal of the flexible ligand-protein 
complex (3.45) was not available for comparison at the time of the original investigation, 
so the original crystal data from Waksman, using native peptide 3.43, was used instead.  
While not an ideal structural comparison, the binding affinities of 3.43-3.45 were all 
within experimental error of one another so the comparison should still have been able to 
yield some useful insights.   
 In Figure 3.6, three bound structures of the native peptide 3.43 were overlaid with 
two bound conformations of 3.44.
274,275,333
  As predicted from our experimental binding 
affinities, the bound conformations of 3.43 and 3.44 were very similar to one another.  
The only significant structural differences appeared to arise in the orientations of the +1 
and +2 Glu side chains (pY+1 and pY+2 residues as defined in Table 3.9).   However, 
these variations were not viewed as significant as the differences were found to be 
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qualitatively no greater than the differences observed between similar complex structures 
in the asymmetric units of the crystals.  Also, the side chains were exposed to solvent, 
which may have made a contribution to the slight differences in orientation. Again, no 
compelling evidence was found to account for the differences in enthalpy between 3.44 
and 3.45. 
A computational study was undertaken with collaborators in order to investigate 
the effects of surface contact areas on the enthalpic binding terms of 3.44 and 3.45; 
however, this study also revealed no significant qualitative differences between the two 
complexes.
274,275,333
  To summarize, while we were gratified to discover that introducing 
conformation constraints into a ligand lessened the entropic penalties on binding, we 
were not able to significantly improve the binding affinity of our constrained ligand due 
to enthalpy-entropy compensation.  Nor were we able to find any physical evidence to 
explain the differences in the binding enthalpies between 3.44 and 3.45.  It seemed likely 
that the enthalpic penalty of 3.44 arose from the combination of differences in H-bonding 
interactions that were not detectable by x-ray crystallography. 
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Figure 3.6: Three bound structures of native peptide 3.43 were overlaid with two bound 
conformations of 3.44. 
 
a 
Reprinted with permission from Davidson, J. P.; Lubman, O.; Rose, T.; Waksman, G.; Martin, S. F. 
"Calorimetric and Structural Studies of 1,2,3-Trisubstituted Cyclopropanes as Conformationally 
Constrained Peptide Inhibitors of Src SH2 Domain Binding" J. Am. Chem. Soc. 2002, 124, 205-215.  
Copyright (2002) American Chemical Society. 
 
3.3.7 GROWTH RECEPTOR BINDING PROTEIN 2 (GRB2) SH2 DOMAIN 
The growth receptor binding protein 2 (Grb2) SH2 domain is known to recognize 
and selectively bind to phosphotyrosine (pY) peptides of the general structure 3.46 (Table 
3.10).
332
 We wanted to investigate the effects of a cyclopropyl restraint on known 
inhibitor 3.46, where X = valine so we first synthesized the flexible control molecule 3.47 
and the restrained peptide 3.53.  When 3.47 and 3.53 were titrated against Grb2 SH2, we 
were gratified to find that that we observed an increase in binding affinity associated with 
constrained mimic 3.53, but we were very surprised to find that the enhanced affinity 
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appeared to be enthalpically, not entropically, driven.
274,332
  The entropy of binding was 
actually found to be unfavorable, which went against existing paradigms regarding ligand 
preorganization being linked to entropic benefits.  Naturally we were intrigued to learn 
more. 
  A number of different residues are tolerated at the pY + 1 (illustrated as Xaa in 
Table 3.10) position of 3.46 in potent binders of the Grb2 SH2 domain.
275,331,332
  We 
designed and synthesized the constricted cyclopropyl peptides 3.54-3.58, displaying both 
hydrophobic and hydrophilic character at the Xaa residue, in order to further evaluate 
their thermodynamics of binding with the Grb2 SH2 domain.  We were particularly 
interested to see if ligand preorganization was always accompanied by unfavorable 
entropies of binding.  Peptides 3.54-3.58 were synthesized via the addition of a 
methylene group and transposition of the amide functionality of the pY residue of 3.46, 
compounds 3.48-3.52 were also synthesized to act as suitable flexible controls (fpYXN) 
for the constrained compounds 3.54-3.58 (cpYXN).    
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Table 3.10 
 
Ligand Ka (M
-1
) ΔG°  
(kcal mol 
-1
) 
ΔH°  
(kcal mol 
-1
) 
ΔS°  
(cal mol 
-1 
K
-1
) 
- TΔS°  
(kcal mol 
-1
) 
3.47 (fYVN) (4.5 ± 0.12) x 105 -7.7 ± 0.02 -5.4 ± 0.14 7.9 ± 0.22 -2.4 ± 0.07 
3.53 (cYVN) (2.8 ± 0.10) x 106 -8.8 ± 0.02  -7.9 ± 0.29 3.0 ± 0.30 -0.9 ± 0.09 
3.48 (fYIN) (4.0 ± 0.15) x 105 -7.7 ± 0.02 -5.5 ± 0.20 7.4 ± 0.30 -2.2 ± 0.09 
3.54 (cYIN) (2.1 ± 0.08) x 106 -8.6 ± 0.02 -8.3 ± 0.30 1.3 ± 0.30 -0.4 ± 0.09 
3.49 (fYLN) (1.7 ± 0.06) x 105 -7.1 ± 0.02 -4.6 ± 0.17 8.6 ± 0.30 -2.6 ± 0.09 
3.55 (cYLN) (7.1 ± 0.27) x 105 -8.0 ± 0.02  -6.0 ± 0.22  6.6 ± 0.30 -2.0 ± 0.09 
3.50 (fYQN) (5.6 ± 0.15) x 105 -7.8 ± 0.02 -8.7 ± 0.23 -2.8 ± 0.22 0.8 ± 0.07 
3.56 (cYQN) (1.2 ± 0.06) x 106 -8.3 ± 0.01 -9.8 ± 0.20 -5.2 ± 0.18 1.5 ± 0.05 
3.51 (fYEN) (3.0 ± 0.08) x 105 -7.5 ± 0.02 -8.8 ± 0.23 -4.3 ± 0.22 1.3 ± 0.07 
3.57 (cYEN) (3.6 ± 0.10) x 105 -7.6 ± 0.02 -10.3 ± 0.27 -9.0 ± 0.22 2.7 ± 0.07 
3.52 (fYKN) (9.8 ± 0.23) x 104 -6.8 ± 0.02 -7.7 ± 0.20 -3.0 ± 0.21 0.9 ± 0.07 
3.58 (cYKN) (5.5 ± 0.15) x 105 -7.8 ± 0.02 -9.2 ± 0.24 -4.6 ± 0.22 1.4 ± 0.07 
 
Binding thermodynamics of peptides 3.47-3.58 for Grb2 SH2 were determined by 
ITC, and it was found that the constrained ligands 3.53-3.58 typically bound to the 
domain with higher affinities than their flexible controls 3.47-3.52, regardless of the 
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amino acid present at the pY + 1 position (Table 3.10, column 2 and 3, Ka  and 
ΔG°).275,331,332  The respective ΔΔG°’s between the constrained and flexible controls 
ranged from 0.1 to 1.1 kcal mol
-1
, the latter which represented a significant increase in 
affinity
 
.  We were gratified to see that the first part of our original hypothesis, namely 
that ligand preorganization would increase binding affinity between ligands and protein 
receptors, was validated; however, we also wanted to know if the said increase in binding 
affinity was entropically driven.   
 When we calculated ΔS° from ΔG° (which was itself calculated from Ka via 
equation 3.3) and ΔH° (which was obtained directly from the ITC experiments along with 
Ka) using the Gibb’s free energy equation (eq. 3.4), we made a surprising discovery.  
Without exception, the binding entropies for the constrained (ie preorganized) ligands 
3.53-3.58 were found to be more unfavorable than their flexible controls 3.47-3.52 (Table 
3.10, column 4), while the binding enthalpies of the constrained ligands 3.53-3.58 were 
more favorable than their flexible controls 3.47-3.52 (column 4).  Also, the contributions 
of the binding enthalpies dominated the contributions of the binding entropies (columns 4 
vs. 6).
274,331,332
   
 After observing that ligand preorganization was enthalpically, not entropically 
driven, we sought more information in order to understand this surprising result.  We 
measured the heat capacity changes between the sets of flexible and constrained ligands, 
but we found no significant differences in the values. Thus, desolvation effects did not 
appear to be the driving force behind the favorable enthalpies that had dominated binding 
with the Grb2 SH2 system
274,332
.    
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We then studied X-ray crystal structures of the complexes of ligands 3.34 
(fpYVN), 3.35 (fpYIN), 3.37 (fpYQN), 3.40 (cpYVN), 3.41 (cpYIN), and 3.43 (cpYQN) 
with the Grb2 SH2 domain.  Through a detailed a systematic investigation of the X-ray 
crystallographic data of the three sets of flexible and constrained protein-ligand 
complexes it was found that there were few structural differences between the two types 
of complexes.  While both the flexible and constrained ligands were found to bind to 
Grb2 in similar orientations, there were a few significant differences.  Namely, the 
constrained ligands were shown to make more direct contacts (ie non-polar interactions 
that do not involve water molecules) with the Grb2 domain than their flexible 
counterparts.  From these observations and those of our ITC studies, it appears that there 
is a positive correlation between the number of direct contacts that a ligand makes with 
the Grb2 SH2 domain and the enthalpy of binding.  The more direct contacts a ligand was 
found to make Grb2, the more favorable the enthalpy, and therefore the Gibb’s free 
energy of binding.  This effect may help to explain why the preorganization of ligands 
was observed to be enthalpically driven.  
  We found no compelling evidence that any of the above processes was solely 
responsible for the enthalpic compensation that we observed during binding. In 
conclusion, what we learned from this investigation was that protein-ligand interactions 
are highly complex processes that can still defy understanding in the face of a wealth of 
thermodynamic and structural data; however this only further underscored the need for 
more information with which to characterize and interpret these systems.  Toward that 
end, we collaborated with Dr. Pengyu Ren to carry out computational studies of our Grb2 
SH2 protein-ligand complexes.
334
  The complexes of flexible/constrained ligand pairs 
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3.34 (fpYVN)/3.40 (cpYVN) and 3.35 (fpYIN)/3.41 (cpYIN) and the Grb2 SH2 domain 
were examined using molecular dynamics simulations with a polarizable force field.
334
  
We were pleased to find that our calculated values for the binding free energies, 
enthalpies, and entropies of the complexes matched those that we obtained 
experimentally from ITC.  Additionally, the computational studies indicated the 
introduction of the cyclopropyl conformational constraint onto ligands 3.40 and 3.41 
prevented them from adopting a stabilized macrocyclic structure in solution that 
entropically benefitted ligands 3.34 and 3.35 upon binding with the domain.  Analysis of 
these conformational ensembles suggested that the differences in the unbound structures 
of the flexible and constrained ligands did account for the unfavorable binding entropies 
of the constrained ligands.  The most significant finding from our computational studies 
was that the introduction of a conformational constraint into a ligand does not 
automatically correlate with a lower entropy in solution.  Though flexible ligands 3.34 
and 3.35 existed as stabilized macrocycles in solution, which does not correlate with their 
bound structures with the Grb2 SH2 domain, they exhibited a lower entropy in solution 
because of a series of subtle and complex inter- and intramolecular interactions.  Our 
results highlight the need for detailed structural information on the unbound ligands in 
solution in addition to structural information about the bound ligand-protein complex.
334
   
 We also investigated another series of ligands of type 3.46 in which the Xaa 
residue was comprised of -cycloaliphatic amino acids, containing three to seven-
membered rings (Table 3.11).
335
  In addition to furthering our studies on the effects of 
ligand preorganization on the thermodynamics of binding, the study of ligands 3.59-3.63 
also enabled us to investigate the effects of non-polar surface area on binding 
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thermodynamics. When the ring size of the ligand constraint was increased, so was the 
non-polar surface on the ligand.  When ligands 3.59-3.63 were titrated against Grb2 SH2 
using ITC, we saw binding affinities increase with ring size from three to six-membered 
rings, with six and seven-membered rings being equipotent.  Amazingly, we also saw that 
the increased binding affinity was accompanied by favorable binding enthalpies, which 
dominated less favorable binding entropies.  Thus, we had obtained evidence of an 
enthalpically driven hydrophobic effect.  When the x-ray crystal structures of ligands 
3.59-3.63 in the domain were examined, the only significant differences to account for 
the favorable enthalpy appeared to be in the number of vdW contacts between the domain 
and the Xaa residues.  Once again the results of our studies have continued to question 
the validity of long existing ligand design paradigms.  
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Table 3.11 
 
Ligand 
Ka 
( x 10
5
 M
-1
) 
ΔG°obs  
(kcal mol
-1
) 
ΔH°obs  
(kcal mol
-1
) 
-TΔS°obs  
(cal mol
-1
) 
3.59 1.6 ± 0.1 -7.1 ± 0.1 -3.3 ± 0.3 -3.8 ± 0.1 
3.60 4.3 ± 0.4 -7.7 ± 0.1 -5.4 ± 0.3 -2.3 ± 0.2 
3.61 16.1 ± 0.6 -8.5 ± 0.1 -6.3 ± 0.4 -2.2 ± 0.2 
3.62 69.6 ± 12 -9.3 ± 0.1 -8.5 ± 0.4 -0.8 ± 0.4 
3.63 37.0 ± 3.3 8.9 ± 0.1 -6.8 ± 0.3 -2.1 ± 0.2 
 
3.3.8 SRC SH2 DOMAIN REVISITED 
 Contemporaneous to our work on the Grb SH2 system, we were also undertaking 
collaborative NMR and molecular dynamics (MD) experiments on the Src SH2 
system.
336
  Recall that while the Grb SH2 system showed enthalpically driven binding 
affinity increases due to ligand preorganization,
332,335
 the Src SH2 system had showed 
entropically driven binding affinity increases due to ligand preorganization.
333
  Also 
recall that enthalpy-entropy compensation caused the entropic benefit gained through 
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ligand preorganization in the Src system to be offset by competing unfavorable enthalpic 
interactions, though we could not find a definitive reason as to why this enthalpic 
compensation was occurring.
333
 We were also perplexed by the fact that this trend was 
not observed in the Grb2 SH2 system (cf. Section 3.3.7).
332,335
  All our studies with Grb2 
found that enthalpy was the driving factor in enhanced binding affinities accompanied by 
ligand preorganization and that enthalpy-entropy compensation was not a complicating 
factor during binding.  It appeared as though molecular recognition phenomena in 
aqueous systems was even more complex than we had first thought and that making 
generalized predictions will require comprehensive studies over a series of different 
protein-ligand systems. Through additional NMR and MD experiments, we had hoped to 
better explain the enthalpy-entropy compensation phenomenon within our Src system and 
perhaps gain insight into why it had not affected our Grb2 system.
336
   
It is well known that the thermal motions of proteins, and thus their corresponding 
conformational fluctuations, play an important role in protein-ligand interactions.
273,275,336
  
Quantifying these motions however, proves a more difficult task.  While X-ray 
crystallography can provide accurate three dimensional representations of bound protein-
ligand complexes, it is a static technique and therefore cannot measure dynamic 
differences within the complexes.  In the past, NMR relaxation and molecular dynamics 
simulations have been used as valuable tools with which to investigate the internal 
dynamics of protein-ligand interactions.
273,275,336
  When the dynamic results are combined 
with the structural data obtained from X-ray crystallographic studies, an even more 
complete and useful picture of protein-ligand interactions emerges. 
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In a joint collaboration with Dr. Carol Post, we further expanded our 
investigations of protein-ligand interactions between ligands 3.43-3.45 (cf. Table 3.9 and 
Figure 3.7) and Src using both NMR relaxation studies and molecular dynamics 
simulations.
336
  We found that relative chemical shift differences (CSD’s) within 1H-15N 
HSQC spectra of the apo-protein and protein-ligand complexes correlated with small 
differences in the bound state geometries of 3.43-3.45 which were previously invisible to 
us from X-ray crystallography.
336
  The CSD’s reflected differences in proton shielding 
and deshielding within the system, and these appear to correlate linearly with the 
enthalpies of binding  Namely, the ligand that was shifted the most upfield in the 
spectrum corresponded to the flexible mimic 3.44, which possessed the most favorable 
enthalpy of binding of the series 3.43-3.45.
274,336
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Figure 3.7:  Previous ligands for the Src SH2 protein domain. 
 
The stronger hydrogen-bonding interactions suggested by CSD’s were found to be 
consistent with the observed enthalpic penalty that we observed in our previous Src 
binding studies regarding ligand 3.45.  These results suggest that introducing a 
conformational constraint at the pY site of the native peptide can lead to unfavorable 
enthalpic interactions due to a disturbance of the distance and orientation dependent 
hydrogen bonds.  The pY site is known as a binding “hot spot” because the residue 
contains interactions that contribute to the majority of the free energy of binding.
336
  
Furthermore, MD simulations and 
15
N NMR relaxation measurements suggested that the 
dynamic motion of the protein was not significantly different between 3.44 and 3.45, and 
thus do not significantly contribute to differences in binding entropy or enthalpy.  
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However, such computational studies are not necessarily sensitive enough to detect subtle 
differences, and it will be essential to probe variations in protein dynamics in the 
complexes by NMR experiments. 
3.4 SUMMARY OF PREVIOUS MARTIN GROUP WORK 
In summary, we investigated a variety of protein-ligand interactions and have 
found that the binding process is incredibly complex and difficult to predict.  Our early 
studies on renin protease inhibitors, matrix metalloprotease inhibitors, enkephalins, ras 
farnesyltransferase inhibitors, and HIV-1 protease inhibitors (cf. sections 3.3.1-3.3.5)
275
 
showed that the binding affinities of constrained ligands were equipotent or only slightly 
more favorable than those of their flexible counterparts.  However, we had not carried out 
ITC experiments, so we could not correlate any of our results with the enthalpies or 
entropies of binding, though we did obtain the first X-ray crystal structure of an HIV-1 
protease-ligand bound complex.
320
   
Through our work with the Src SH2 domain (cf. Section 3.3.6), we provided the 
first evidence that ligand preorganization was accompanied by a more favorable binding 
entropy.  We also found that the binding affinity of the Src SH2-ligand complexes was 
not enhanced to the degree that we had expected as the entropic benefits were 
accompanied by significant enthalpic penalties.
333
  Restricting independent rotors, ie 
bonds, in flexible ligands should be accompanied by an entropic advantage ranging from 
0.7-1.6 kcal mol
-1
,
308,337-339
 and while we did find that the constrained ligands showed a 
1.5-2.7 kcal mol
-1 
entropic advantage over the flexible ligands, the entropic advantage 
was offset by an enthalpic penalty of 1.4-1.9 kcal mol
-1
.
333
  Thus, the overall binding 
affinity of the constrained vs. flexible ligands remained unchanged.  However, this result 
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was by no means universal across all protein-ligand systems.  When we examined the 
Grb2 SH2 domain (cf. Section 3.3.7), we found that ligand preorganization did lead to an 
increase in binding affinity, though much to our surprise we also found that increased 
binding affinity was attributed to an enthalpic, not an entropic benefit.
332
  Additionally, 
unlike the Src SH2 system the enthalpic benefit was not offset by an accompanying 
entropic penalty.  We were incredibly intrigued by how complex bimolecular associations 
in aqueous media really are.   
Though we had made some significant contributions toward understanding 
molecular recognition phenomena in biological systems, we seemed to create more 
questions than we had answered.  While enthalpy-entropy compensation played an 
important role in our Src SH2 binding studies, it did not affect our Grb SH2 system to 
nearly as large an extent, which further underscored the need for continued investigations 
into this complex and interesting phenomenon.  While we had succeeded in providing 
evidence that ligand preorganization lead to increased binding affinity due to enthalpic 
benefits in our Grb SH2 work, we had also found that ligand preorganization produced 
favorable binding entropies without a resulting increase in binding affinity.  These results 
were completely unexpected and challenged a long-standing paradigm of protein-ligand 
thermodynamics.  Further study is required.   
In his original Src SH2 publications, Waksman had reported that the crystal 
structure of pYEEI and Src showed two well-defined binding pockets that “resemble a 
two-pronged plug engaging a two-holed socket”.327,328  The first pocket contained the 
phosphotyrosine residue, which is known to be a key residue in all SH2 domains, while 
the second pocket, also called the hydrophobic pocket, showed that the isoleucine residue 
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of the ligand was also responsible for key binding interactions within the domain.  
Waksman surmised that the hydrophobic pocket was critical to determining peptide 
specificity, meaning the isoleucine residue served to orient and anchor the peptide to the 
Src SH2 domain.
327,328
  During our collaboration with Dr. Post, our CSD data also 
indicated to us that the the pY + 3 sidechain (Ile) of the native peptide 3.43 played an 
important role in binding between the Src SH2 protein pocket pYEEI.
336
  Based on this 
information, we formulated a hypothesis that we may be able to introduce a cyclopropyl 
conformation constraint in the pY + 3 residue, which resided outside of the hot spot 
region.  Hopefully, we will be able to gain the same entropic benefit from ligand 
preorganization that we saw before without incurring an offsetting enthalpic penalty.  We 
had already found that even the smallest, almost invisible, of changes in orientation 
between the hot spot of the peptide and the binding pocket can cause drastic changes in 
the binding enthalpy, but we didn’t know anything about how a conformational constraint 
would behave in a non hotspot region.  Perhaps this technology would emerge as a useful 
tool towards rational ligand design.  Our current work towards designing, synthesizing, 
and analyzing the thermodynamics of constrained and flexible pY + 3 mimics for pYEEI 
will be discussed in detail. 
3.5 DESIGN AND SYNTHESIS OF SRC-SH2 PY +3 CONSTRAINED AND FLEXIBLE LIGANDS 
Based on Waksman’s original crystal data and the CSD data obtained through 
collaboration with Dr. Post, we formulated a hypothesis that we may be able to introduce 
a cyclopropyl conformation constraint in the pY + 3 residue, which resided outside of the 
hot spot region.
327,328,336
  Hopefully we will be able to gain the same entropic benefit from 
ligand preorganization that we saw before without incurring an offsetting enthalpic 
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penalty.  We had already found that even the smallest, almost invisible, of changes in 
orientation between the hot spot of the peptide and the binding pocket can cause 
favorable and unfavorable binding enthalpies, but we didn’t know anything about how a 
conformational constraint would behave in a non hotspot region.  Presumably any weak 
vdW forces that we might disrupt at the pY+3 ligand would prove less crucial to the 
overall binding affinity than the disruption of the distance and orientation dependent 
hydrogen bonds created between the pY residue and the binding pocket.   
Toward that end, two sets of ligands 3.64 and 3.65, as well as 3.66 and 3.67 were 
designed to investigate the effects of adding a conformational constraint at a non hot-spot 
residue (Figure 3.8).  Molecular modeling experiments between constrained mimic 3.44 
and the Src binding pocket (cf. Figure 3.6)
333,336
 suggested that the trans-cyclopropane 
ring of 3.65 would position the ethyl group in the orientation required to make optimal 
vdW contacts within the Src SH2 domain (Figure 3.8).  We also designed cyclopropane 
ring 3.67 in order to assess the thermodynamic effects associated with restricting the side 
chain of a ligand as compared to restricting the backbone and sidechain as we were 
planning to do with ligand 3.65.  We designed ligands 3.64 and 3.66 to act as flexible 
controls for the constrained 3.65 and 3.67, respectively. Preparation of 3.64 and 3.65 
would require the addition of an extra carbon atom into the pY+3 residue, as well as 
replacement of the isoleucine sidechain with a propyl chain.  Ligands 3.66 and 3.67 
would also require replacement of the isoleucine sidechain with a propyl group, and ethyl 
cyclopropane, respectively. Their synthesis will be described shortly. 
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Figure 3.8:  pY+3 Peptide mimics for Src SH2. 
 
3.5.1 SYNTHESIS OF FLEXIBLE CONTROL LIGAND 3.64 
The forward synthesis of 3.64 had been partially accomplished previously by Dr. 
Jianhua Tian, a former post doc within the Martin lab (Scheme 3.1).
340
  Valeric acid 
(3.68) was coupled to Evan’s auxiliary 3.69 in 78% yield, followed by the alkylation of 
chiral imide 3.70 with benzyl-2-bromoacetate (3.71) in 70% yield.  The benzyl ester of 
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3.72 was then reductively cleaved in quantitative yield, and the resulting acid 3.73 was 
subjected to one-pot Curtius rearrangement conditions
341,342
 to provide a modest 32% 
yield of the desired carbamate 3.74, which was contaminated with a significant amount of 
urea.
340
  The chiral auxiliary was then cleaved with lithium benzyloxide to provide -
amino ester 3.75 in 62% yield, which was ready for use in standard peptide coupling 
conditions. 
Scheme 3.1 
 
 
When Jianhua’s results were reproduced, we found an opportunity to improve the 
Curtius rearrangement of acid 3.73 to amide 3.74, which had proceeded in only 32% 
yield. While trying to optimize this key reaction, we noticed that the reaction between 
DPPA and acid 3.73 would not proceed to completion, even after stirring at room 
temperature for two days.  Nevertheless, we carried out the heating required for 
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rearrangement of acyl azide 3.75 to isocyanate 3.76, in the presence of the leftover 
(diphenylphosphoryl azide) DPPA.  DPPA has been touted as a useful reagent to 
transform carboxylic acids to acyl azides because it serves to activate the acid as well as 
supplies the requisite azide functionality under mild conditions.
343
  When acid 3.73 was 
subjected to the rearrangement conditions, two products were isolated from the reaction 
mixture.  The desired carbamate 3.74 was the minor product, and the major product was a 
compound that we could not identify via 
1
H NMR analysis.  When an IR of the unknown 
compound was obtained, a distinctive stretch appeared in the 2100 cm
-1
 region, which is 
indicative of acyl azide compounds.   Acyl azides are expected intermediates in Curtius 
rearrangements (3.75, Scheme 3.2), so the unknown product was re-subjected to re-
arrangement conditions (heating under reflux in the presence of t-BuOH).  However, no 
carbamate 3.74 was ever obtained.  The only compound recovered from the reaction 
mixture was starting material, which we had originally presumed to be acyl azide 3.75, 
but now appeared to be something else.   
Scheme 3.2 
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A literature search then showed us that carbamoyl azides, such as 3.77, could be 
formed in Curtius rearrangements when DPPA was present in the reaction mixture 
(Scheme 3.2).
344
  After re-examining the 
1
H NMR and IR data of our unknown 
compound and comparing these with those of similar known compounds, we surmised 
that our  unknown compound, was in fact, carbamoyl azide 3.77 (Scheme 3.2).  This was 
soon supported with LRMS and 
13
C NMR data that helped us to explain the resistance of 
the unknown compound to convert to the desired carbamate 3.74 when re-subjected to re-
arrangement conditions.  We surmised that when DPPA was heated under rearrangement 
conditions it could undergo dissociation into hydrazoic acid, which could then compete 
with t-BuOH as nucleophile in the addition to isocyanate 3.76.   
 Since DPPA did not seem to convert acid 3.73 to acyl azide 3.75 in good yields 
without heat, the decision was made to switch to a two-step procedure in which a mixed 
anhydride was made, and then subsequently displaced with sodium azide (Scheme 
3.3).
333
  When followed by a mild aqueous work-up, this would ensure that all of the 
azide would be removed from the mixture prior to the start of the isocyanate formation.  
After some optimization, the two-step route provided the desired carbamate 3.74  in 76% 
yield, which was a large improvement over the previous yield of 32% (Scheme 3.3).
345
  
The chiral auxiliary was then cleaved to provide the -amino ester 3.75 in 70% yield.   
Scheme 3.3 
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 Carbamate 3.75 was treated with HCl in dioxanes to provide HCl salt 3.76 in 
quantitative yield, and then 3.76 underwent a peptide coupling with protected glutamic 
acid NHBoc-E(OBn)-OH using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI), 
hydroxybenzotriazole (HOBt), and 4-methylmorpholine (NMM) to provide the 
pseudopeptide 3.77 in 60% yield (Scheme 3.4).  After another deprotection/peptide 
coupling sequence, tripeptide 3.79 was obtained in 63% yield over two steps.  
Scheme 3.4 
 The amine of tripeptide 3.79 was unmasked and immediately subjected to reaction 
with protected phosphotyrosine NHZ-pY(OBn)2-OH to provide tetrapeptide 3.80 in 32% 
yield over two steps (Scheme 3.5).  Acid-catalyzed hydrogenation of 3.80 with 
Pearlman’s catalyst (Pd(OH)2/C) and hydrogen gas followed by treatment with acetic 
anhydride (Ac2O) provided our desired flexible peptide mimic 3.64 in 19% yield over the 
final two steps. 
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Scheme 3.5 
 
3.5.2 SYNTHESIS OF CONSTRAINED LIGAND 3.65 
The flexible peptide mimic 3.64 was synthesized in order to act as a control 
molecule for ITC studies involving the constrained ligand 3.65 (cf. Figure 3.8).  In order 
to obtain the trans- cyclopropyl peptide mimic 3.65, we planned to follow a synthetic 
strategy similar to  a route we used to obtain our matrix metalloprotease inhibitors (cf. 
compounds 3.23-3.26, Section 3.3.2).
324
  The route began with the formation of-keto 
ester 3.84 from the reaction of alcohol 3.82 with dioxinone 3.83 in 99% yield (Scheme 
3.6).
346,347
  -Keto ester 3.84 was then subjected to diazo transfer conditions using 2-
azido-1,3-dimethylimidazolinium hexafluorophosphate (ADMP) (3.85),
348
 followed by a 
lithium hydroxide-mediated hydrolysis to provide the diazo compound 3.86 in 93% yield 
over two steps.
319,349
  An asymmetric rhodium catalyzed cyclopropanation was next 
carried out on 3.86 to provide cyclopropane 3.87 in modest yield (76%) and e.r. 
(85:15).
314,315,317-319,323,349,350
  An undergraduate student in our lab, Joseph Lee, carried out 
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the racemic cyclopropanation of 3.86 with Cu(TBS)2 in 6% overall yield, which enabled 
the determination of the enantiomeric ratio by  HPLC.
319,349,351
  Lactone 3.87 was opened 
with an aluminum-amine salt
322
 to provide the Weinreb amide 3.88 in 74% yield, and the 
alcohol was oxidized to aldehyde 3.89 with PCC in 69% yield.  
Scheme 3.6 
 
 We then attempted to epimerize cis-aldehyde 3.89 to trans-aldehyde 3.90 by 
heating a solution of 3.89 in MeOH with triethylamine over reflux for three days, 
following previous precedent from our work with MMP inhibitors (Schemes 3.7 and 
3.8).
324
  However, we were disappointed to find that we could not achieve favorable 
conversion of 3.89 to 3.90.  The reaction proceeded in 50% yield and only slightly 
favored the desired trans-cyclopropane epimer.   
Scheme 3.7 
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 When we compared our system to those of our MMP inhibitors, we noticed a 
significant difference in the orientation of the cyclopropyl substituents.
324
  In the MMP 
system, isopropyl substituent of 3.91 was positioned on the same face of the 
cyclopropane ring as the Weinreb amide and aldehyde functionalities (Scheme 3.8).  
Upon exposure to epimerization conditions, the aldehyde moiety of 3.91 adopted an 
orientation on the opposite side of the isopropyl substituent.  Presumably alleviation of 
the steric congestion of 3.91 provided the driving force for the quantitative conversion of 
3.91 to trans-cyclopropane 3.92.  This driving force was not present in our Src SH2 
system as the ethyl cyclopropane substituent of 3.89 was already on the opposite side of 
both the Weinreb amide and aldehyde moieties (cf. Scheme 3.7).  Epimerization of the 
ethyl substituent of 3.89 would provide steric hindrance as opposed to alleviating it and 
we speculated that the poor epimerization results of 3.89 to 3.90 were due to this 
phenomenon.   
Scheme 3.8 
 
 We had run into a similar aldehyde epimerization problem before while working 
with our HIV-1 protease system (cf. Section 3.3.5).
320
  Using the same method as we used 
to synthesize 3.89, we had obtained the very similar cis-cyclopropane 3.97 from 
diazoester 3.93 (Scheme 3.9).  Cyclopropane 3.97 differed from 3.89 through a different 
amide protecting group and a methyl, as opposed to ethyl, substituent on the 
cyclopropane ring.  When we attempted to epimerize the aldehyde functionality of 3.97 
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we had observed the poor conversion 3.98, presumably due to the same steric issues as 
our Src SH2 system.   
Scheme 3.9 
 We were eventually able to overcome the problem by redesigning the route in 
order to avoid the troublesome aldehyde epimerization step.  Starting from the opposite 
diastereomer of 3.93, diazoester 3.98 underwent rhodium catalyzed cyclopropanation to 
provide lactone 3.99 (Scheme 3.10).  The lactone was opened using the same aluminum-
amine complex to provide the alcohol 3.100.  However, instead of oxidation of the 
alcohol and epimerization of the resulting aldehyde, the amide of 3.100 was epimerized 
using sodium hexamethyldisilazane (NaHMDS) to provide trans-cyclopropane 3.101.  
Oxidation of 3.101 followed by treatment with acid provided cyclopropane 3.99, which 
contained the requisite stereochemistry and functionality for the successful elaboration to 
the final ligand 3.41.  
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Scheme 3.10 
 Future work towards the constrained peptide mimic 3.65 will focus on utilizing 
the method from our work with HIV-1 protease inhibitors (Scheme 3.11).  Starting from 
diazoester 3.103, we will follow the route described in Scheme 3.9 to obtain the desired 
trans-cyclopropane ring 3.90.  Once we are able to obtain cyclopropane 3.90, we 
envision exposing it to the same Curtius rearrangement conditions we developed from the 
synthesis of flexible control 3.64 (cf. Scheme 3.3) to provide the alloc-protected 3.105.  
Hydrolysis of the Weinreb amide and protection of the resulting ester with benzyl alcohol 
would provide amide 3.106.  A mild palladium (0) catalyzed coupling between alloc-
amide 3.106 and pentafluorophenyl ester 3.107 would provide the pseudo di-peptide 
3.108, which could be further elaborated to the desired constrained ligand 3.65 using the 
same standard peptide coupling conditions we had used to obtain 3.65 
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Scheme 3.11 
3.5.3 SYNTHESIS OF FLEXIBLE CONTROL LIGAND 3.66 
 Synthesis of the flexible ligand 3.66 was fairly straightforward and was comprised 
of a series of standard peptide coupling steps (Scheme 3.12).  The commercially available 
HCl salt of norvaline was coupled with protected glutamic acid NHBoc-E(OBn)-OH 
using EDCI, HOBt, and NMM to provide the pseudopeptide 3.77 in 60% yield (Scheme 
3.12).  A standard deprotection/peptide coupling/deprotection sequence then provided 
3.113 in 50% yield over three steps.  The amine salt of tripeptide 3.113 was unmasked 
and immediately subjected to reaction with protected phosphotyrosine NHZ-pY(OBn)2-
OH to provide tetrapeptide 3.114 in 34% yield over two steps.  Acid catalyzed 
hydrogenation with Pearlman’s catalyst (Pd(OH)2/C) and hydrogen gas followed by 
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treatment with acetic anhydride (Ac2O) provided our desired flexible peptide mimic 3.66 
in 26% yield over the final two steps. 
Scheme 3.12 
 
3.5.4 SYNTHESIS OF CONSTRAINED LIGAND 3.67 
 The flexible peptide mimic 3.66 was synthesized in order to act as a control 
molecule for ITC studies involving the constrained ligand 3.67 (cf. Figure 3.8).  
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Fortunately a route was reported by Najera and coworkers towards our desired 
cyclopropyl restraint 3.124 (Schemes 3.13 and 3.14).
352,353
  Boc-valine 3.115 was coupled 
with the hydrochloride salt of dimethylamine to provide amide 3.116, which was 
immediately treated with phenyl magnesium bromide (PhMgBr) and acid to provide 
phenyl ketone 3.117 in 69% yield over two steps.  Hydrochloride salt 3.117 was coupled 
with mixed anhydride 3.118 in the presence of triethylamine to provide 3.119 in 95% 
yield.  Upon treatment with aqueous HCl in EtOAc and saturated potassium carbonate, 
pyrazinone 3.120 was formed in 86% yield.  Protection of the amide, followed by 
Knoevenagel condensation with propionaldehyde provided unsaturated pyrazinone 3.122 
in 72% yield over two steps.   
Scheme 3.13 
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 Pyrazinone 3.122 then underwent a diastereoselective Corey-Chaykovsky 
cyclopropanation to provide 3.123 in 79% yield, which was then heated under reflux in 
the presence of 3 M aqueous hydrochloric acid to provide cyclopropane 3.124 in 24% 
yield (Scheme 3.14).   
Scheme 3.14 
 
 
 We have successfully reproduced Najera’s procedure to obtain cyclopropane 
3.124, and attempts are ongoing to elaborate 3.124 to the desired constrained mimic 3.67.  
We envisioned benzyl protection of 3.124 using Dean-Stark conditions would provide 
3.125, which could then be elaborated to 3.67 using the standard peptide coupling 
conditions used to synthesize 3.64 and 3.66.   
Scheme 3.15 
 
3.6  SUMMARY AND FUTURE DIRECTIONS 
 In conclusion, we designed routes toward four pY+3 peptide mimics for the Src 
SH2 domain (Figure 3.8).  We successfully synthesized both flexible mimics 3.64 and 
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3.66, which included the optimization of a troublesome Curtius rearrangement.  We also 
made significant progress towards the constrained mimics 3.65 and 3.67.  Approximately 
halfway through the synthesis of 3.65, we discovered a troubling epimerization reaction.  
However, we believe that redesigning our route using other existing Martin group 
methodology will enable us to overcome the problem and complete the synthesis of 3.65.  
We also obtained a significant quantity (ca. 200 mg) of cyclopropane 3.124, that when 
subjected to a Dean-Stark benzyl ester protection, will be a short sequence of peptide 
couplings away from the desired ligand 3.67. 
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Figure 3.8:  pY+3 Peptide mimics for Src SH2. 
 
 
 
Once we have obtained all of our desired ligands, namely 3.64-3.67, we can test 
the hypothesis we developed based on our collaboration with Dr. Carol Post.  CSD data 
showed us a potentially important interaction between the Src SH2 protein pocket and the 
pY + 3 sidechain (Ile) of the native peptide 3.43,
336
 and based on this information, we 
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formulated a hypothesis that we may be able to introduce a cyclopropyl conformation 
constraint in the pY + 3 residue, which resided outside of the hot spot region.  Hopefully 
we will be able to gain the same entropic benefit from ligand preorganization that we saw 
before without incurring an offsetting enthalpic penalty.  We had already found that even 
the smallest, almost invisible, of changes in orientation between the hot spot of the 
peptide and the binding pocket can cause drastic changes in the enthalpy of the binding 
event, but we didn’t know anything about how a conformational constraint would behave 
in a non hotspot region.  Perhaps this technology would emerge as a useful tool towards 
rational ligand design.  We look forward to obtaining preliminary ITC thermodynamic 
data.   
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Chapter 4: Experimental Procedures 
4.1 GENERAL METHODS   
Methanol (MeOH), acetonitrile (CH3CN), and N,N-dimethylformamide (DMF) 
were dried by filtration through two columns of activated molecular sieves.  
Tetrahydrofuran (THF) was passed through two columns of activated neutral alumina 
prior to use and toluene was passed through a column of activated neutral alumina as well 
as further deoxygenated by being passed through a column of activated Q5.  
Diisopropylamine, triethylamine (Et3N), ethanol (EtOH), pyridine (Pyr), dichloromethane 
(DCM), chlorotrimethylsilane (TMSCl), methylchloroformate, and 
hexamethylphosphoramide (HMPA) were distilled from CaH2 prior to use.  TMSOTf was 
distilled over CaH2 and phenyl isocyanate was distilled over P2O5 before use. Samarium 
powder (40 mesh, 99% trace metals basis) was purchased from Acros and crushed with a 
mortar and pestle under nitrogen prior to use. All hydrogenations were performed as 
follows: the round-bottom flask containing the reaction mixture was evacuated under 
high vacuum and backfilled with N2 (x 3) to remove any oxygen present.  The round-
bottom flask was evacuated under high vacuum a fourth time, and then placed under 1 
atm of H2 (2 “double bagged” 9 inch latex helium grade balloons) at room temperature.  
All other reagents were purchased and used as received.  Glassware used in the reactions 
was dried overnight in an oven at 120 C or flame-dried under a high pressure vacuum.  
All reactions were performed under an atmosphere of argon or nitrogen.   All reaction 
temperatures reported are those of the oil bath surrounding the reaction vessel.  Reverse 
phase HPLC was conducted using a binary solvent system, where solvent system A was 
0.1% aqueous TFA and solvent system B was 0.1% TFA in acetonitrile, with a C18 
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column (10 mm particle size, 300 Å pore size), 22 mm diameter x 250 mm (flow rate of 5 
mL/min).  Concentration in vacuo or concentration under reduced pressure was 
performed using a rotary evaporator with a bath temperature at 25-30 ºC.  Lyophilization 
to provide the final ligands was performed using a three phase procedure:  first the HPLC 
mixture was lyophilized, then the ligand was dissolved in H2O and lyophilized, and 
finally the ligand was dissolved in a mixture of MeCN/H2O (2:1) and lyophilized to 
provide the final product. 
 Melting points were determined using a Thomas-Hoover Uni-melt capillary 
melting point apparatus and are uncorrected.  Infrared (IR) spectra were obtained with a 
Perkin-Elmer FTIR 1600 series spectrometer, on sodium chloride plates as solutions in 
the solvent indicated.   Band positions are given in reciprocal centimeters (cm
-1
).  Proton 
nuclear magnetic resonance (
1
H NMR) spectra were obtained on a 400 MHz spectrometer 
as solution in CDCl3.  Chemical shifts are reported in parts per million (ppm) downfield 
from tetramethylsilane (TMS) and for CDCl3 are referenced to an internal TMS standard 
(δ 0.00).  Coupling constants (J) are reported in Hz and the splitting abbreviations used 
are: s, singlet; d, doublet; t, triplet; q, quartet; dt, doublet of triplets; ddd, doublet of 
doublets of doublets; dtd, doublet of triplets of doublets; dq, doublet of quartets; m, 
multiplet; comp, overlapping multiplets of magnetically non-equivalent protons; br, 
broad.  Carbon nuclear magnetic resonance (
13
C NMR) spectra were obtained using the 
above-mentioned instrument operating at 100 MHz and chemical shifts are reported in 
ppm relative to the center line of the multiplet for deuterium solvent peaks (δ 77.0 for 
CDCl3). Thin layer chromatography (TLC) was performed on glass-backed pre-coated 
silica gel plates (0.25 mm thick with 60 F254) and were visualized using one or both of the 
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following manners: UV light (254 nm) and staining with either p-anisaldehyde (PAA), 
phosphomolybdic acid (PMA) or potassium permanganate (KMnO4). Flash 
chromatography was performed using glass columns and “medium pressure” silica gel 
(Sorbent Technologies, 45-70 ).  Some of the previous work and characterization was 
first done by Dr. Jianhua Tian, and subsequently repeated by the author.  This is indicated 
by compound names starting with JT. 
4.2 EXPERIMENTALS 
Representative procedure for the reaction of heterocyclic carbinols/acetates with -
nucleophiles 
 
Methyl 2,2-dimethyl-3-(1-methyl-1H-indol-2-yl) butanoate (1.541). (ab02094).  
Freshly distilled TMSOTf (516 mg, 0.42 mL, 2.30 mmol) was added dropwise to a 
solution of (1-methoxy-2-methylprop-1-enyloxy)trimethylsilane (1.540)
114  
(601 mg, 0.70 
mL, 3.45 mmol) and 1-(1-methyl-1H-indol-2-yl)ethyl acetate (1.538) (500 mg, 2.30 
mmol) in MeCN (3 mL) at -40 °C under argon.  The solution was stirred at -40 °C for 1 
h, whereupon saturated NaHCO3 (20 mL) was added.  The layers were separated, and the 
aqueous layer was extracted with Et2O (2 x 15 mL).  The combined organic layers were 
washed with brine (20 mL), dried (Na2SO4), and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with Et2O/pentane (1:4) to give 
525 mg (88 %) of ester 1.541 as a white solid (mp = 95 - 97 °C). 
1
H NMR (400 MHz, 
CDCl3) δ 7.56 (d, J = 7.2 Hz, 1 H), 7.29 (d, J = 7.2 Hz, 1 H), 7.17 (t, J = 7.2 Hz, 1 H), 
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7.08 (t, J = 7.2 Hz, 1 H), 6.34 (s, 1 H), 3.75 (s, 3 H), 3.68 (s, 3 H), 3.52 (q, J = 7.2 Hz, 1 
H), 1.28 (d, J = 7.2 Hz, 3 H), 1.25 (s, 3 H), 1.1 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 
178.4, 142.5, 137.1, 127.9, 121.1, 120.2, 119.7, 109.4, 100.3, 52.2, 47.2, 37.3, 30.3, 24.6, 
20.2, 18.0; IR (DCM) 1730, 1466, 1300, 1250, 1231, 1188, 1136, 776, 734 cm
-1
; mass 
spectrum (CI) m/z 260.1653 [C16H22NO2 (M+1) requires 260.1651], 260 (base), 158.   
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 7.2 Hz, 1 H, 
C10-H), 7.29 (d, J = 7.2 Hz, 1 H, C13-H), 7.17 (t, J = 7.2 Hz, 1 H, C12-H), 7.08 (t, J = 
7.2 Hz, 1 H, C11-H), 6.34 (s, 1 H, C8-H), 3.75 (s, 3 H, C15-H), 3.68 (s, 3 H, C5-H), 3.52 
(q, J = 7.2 Hz, 1 H, C3-H), 1.28 (d, J = 7.2 Hz, 3 H, C6-H), 1.25 (s, 3 H, C4-H), 1.1 (s, 3 
H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 178.4 (C 1), 142.5 (C 7), 137.1 (C 14), 127.9 
(C 9), 121.1 (C 10 or C 12), 120.2 (C 10 or C 12), 119.7 (C 11), 109.4 (C 13), 100.3 (C 
8), 52.2 (C 5), 47.2 (C 15), 37.3 (C 2), 30.3 (C 3), 24.6 (C 4 or C 6), 20.2 (C 4 or C 6), 
18.0 (C 4 or C 6).  
 
Methyl 2,2,3-trimethyl-3-(1-methyl-1H-indol-2-yl)butanoate (1.574).  
(ab02055).  The residue was purified by flash chromatography eluting with Et2O: 
pentane (1:4) to give 93% of ester 1.574 as a white solid (mp = 79 - 81 °C). 
1
H NMR 
(400 MHz, CDCl3) δ 7.54 (d, J = 7.8 Hz, 1 H), 7.25 (d, J = 7.8 Hz, 1 H),  7.18 (t, J = 7.8 
Hz, 1 H), 7.08 (t, J = 7.8 Hz, 1 H), 6.43 (s, 1 H), 3.84 (s, 3 H) 3.59 (s, 3 H), 1.58 (s, 6 H), 
1.21 (s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 177.2, 144.6, 138.2, 126.8, 121.1, 119.9, 
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119.4, 109.1, 103.6, 51.6, 49.7, 42.3, 33.5, 26.7, 22.5; IR (DCM) 1720, 1468, 1270, 1130 
cm
-1
; mass spectrum (CI) m/z 274.1807 [C17H24NO2 (M+1) requires 274.1807], 274 
(base), 172.    
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 7.8 Hz, 1 H, 
C10-H), 7.25 (d, J = 7.8 Hz, 1 H, C13-H),  7.18 (t, J = 7.8 Hz, 1 H, C12-H), 7.08 (t, J = 
7.8 Hz, 1 H, C11-H), 6.43 (s, 1 H, C8-H), 3.84 (s, 3 H, C15-H) 3.59 (s, 3 H C5-H), 1.58 
(s, 6 H, C6-H), 1.21 (s, 6 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 177.2 (C 1), 144.6 (C 
7), 138.2 (C 14), 126.8 (C 9), 121.1 (C 12), 119.9 (C 10), 119.4 (C 11), 109.1 (C 13), 
103.6 (C 8), 51.6 (C 2), 49.7 (C 5), 42.3 (C 15), 33.5 (C 3), 26.7 (C 6), 22.5 (C 4). 
 
 
5-(2-(1-Methyl-1H-indol-2-yl)propan-2-yl)furan-2(5H)-one (1.576).  
(ab02086).  The residue was purified by flash chromatography eluting with Et2O to give 
88% of ester 1.576 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 7.6 Hz, 1 
H), 7.31 (d, J = 7.6 Hz, 1 H),  7.25-7.21 (comp, 2 H), 7.11 (t, J = 7.6 Hz, 1 H), 6.38 (s, 1 
H), 6.10 (dd, J = 5.8, 2.2Hz, 1 H), 5.40 (t, J = 1.8 Hz, 1H),  3.94 (s, 3 H), 1.66 (s, 3 H), 
1.43 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 172.9, 154.5, 142.8, 138.9, 126.9, 122.7, 
121.9, 120.4, 119.9, 109.1, 101.0, 87.9, 39.7, 33.0, 25.6, 22.5; IR (DCM) 1755, 1469, 
1316, 1162, 1094, 735 cm
-1
; mass spectrum (ESI) m/z 256.13321 [C16H18NO2 (M+1) 
requires 256.1332], 256 (base), 173, 172, 158.  
  
 
273 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 7.6 Hz, 1 H, 
C10-H), 7.31 (d, J = 7.6 Hz, 1 H, C13-H),  7.25-7.21 (comp, 2 H, C12-H and C 3-H), 
7.11 (t, J = 7.6 Hz, 1 H, C11-H), 6.38 (s, 1 H, C8-H), 6.10 (dd, J = 5.8, 2.2 Hz, 1 H, C2-
H), 5.40 (t, J = 1.8 Hz, 1H, C4-H),  3.94 (s, 3 H, C15-H), 1.66 (s, 3 H, C6-H), 1.43 (s, 3 
H, C6-H); 
13
C NMR (100 MHz, CDCl3) δ 172.9 (C 1), 154.5 (C 3), 142.8 (C 7), 138.9 (C 
14), 126.9 (C 9), 122.7 (C 2), 121.9 (C 12), 120.4 (C 10), 119.9 (C 11), 109.1 (C 13), 
101.0 (C 8), 87.9 (C 4), 39.7 (C 15), 33.0 (C 5), 25.6 (C 6), 22.5 (C 6).   
 
 
Methyl 3-(1H-indol-2-yl)-2,2,3-trimethylbutanoate (1.575).  (ab02090).  The 
residue was purified by flash chromatography eluting with Et2O: pentane (1:2) to give 
77% of ester 1.575 as a brown solid (mp = 99 - 102 °C). 
1
H NMR (400 MHz, CDCl3) δ 
8.49 ( br, 1 H), 7.55 (d, J = 8.0 Hz, 1 H),  7.33 (d, J = 8.0 Hz, 1 H), 7.13 (t, J = 8.0 Hz, 1 
H), 7.06 (t, J = 8.0 Hz, 1 H), 6.33 (s, 1 H), 3.61 (s, 3 H), 1.46 (s, 6 H), 1.18 (s, 6 H); 
13
C 
NMR (100 MHz, CDCl3) δ178.6, 144.7, 135.9, 128.1, 121.5, 120.2, 119.7, 110.8, 101.0, 
52.0, 49.1, 40.6, 24.7, 22.5; IR (DCM) 1707, 1459, 1275, 1132 cm
-1
; mass spectrum (CI) 
m/z 260.1654 [C16H22NO2 (M+1) requires 260.1651], 260 (base), 158.  
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 8.49 ( br, 1 H, N-H), 7.55 (d, 
J = 8.0 Hz, 1 H, C10-H),  7.33 (d, J = 8.0 Hz, 1 H, C13-H), 7.13 (t, J = 8.0 Hz, 1 H, C12-
H), 7.06 (t, J = 8.0 Hz, 1 H, C11-H), 6.33 (s, 1 H, C8-H), 3.61 (s, 3 H, C5-H), 1.46 (s, 6 
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H, C6-H), 1.18 (s, 6 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ178.6 (C 1), 144.7 (C 7), 
135.9 (C 14), 128.1 (C 9), 121.5 (C 12), 120.2 (C 10), 119.7 (C 11), 110.8 (C 13), 101.0 
(C 8), 52.0 (C 2), 49.1 (C 5), 40.6 (C 3), 24.7 (C 6), 22.5 (C 4). 
 
 
Ethyl 3-(1-methyl-1H-indol-2-yl)butanoate (1.558).  (ab02073).  The residue 
was purified by flash chromatography eluting with Et2O: pentane (1:4) to give 68% of 
ester 1.558 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 7.6 Hz, 1 H), 
7.28 (d, J = 7.6 Hz, 1 H),  7.17 (t, J = 7.6 Hz, 1 H), 7.07 (t, J = 7.6 Hz, 1 H), 6.27 (s, 1 
H), 4.13 (q, J = 7.2 Hz, 2 H), 3.73 (s, 3 H),  3.51 (sextet, J = 6.7 Hz, 1 H), 2.79 (dd, J = 
16.0, 6.7 Hz, 1 H), 2.58 (dd, J = 16.0, 6.7 Hz, 1 H), 1.36 (d, J = 6.7 Hz, 3 H), 1.23 (t, J = 
7.2 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 172.1, 144.8, 137.3, 127.7, 120.9, 120.0, 
119.4, 108.9, 97.0, 60.5, 41.5, 29.5, 28.0, 20.9, 14.2; IR (DCM) 1733, 1468, 1184, 1036, 
749 cm
-1
; mass spectrum (ESI) m/z 246.14886 [C15H20NO2 (M+1)  requires 246.1487],  
246, 158 (base), 143.  
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 7.6 Hz, 1 H, 
C10-H), 7.28 (d, J = 7.6 Hz, 1 H, C13-H),  7.17 (t, J = 7.6 Hz, 1 H, C12-H), 7.07 (t, J = 
7.6 Hz, 1 H, C11-H), 6.27 (s, 1 H, C8-H), 4.13 (q, J = 7.2 Hz, 2 H, C4-H), 3.73 (s, 3 H, 
C15-H),  3.51 (sextet, J = 6.7 Hz, 1 H, C1-H), 2.79 (dd, J = 16.0, 6.7 Hz, 1 H, C2-H), 
2.58 (dd, J = 16.0, 6.7 Hz, 1 H, C2-H), 1.36 (d, J = 6.7 Hz, 3 H, C6-H), 1.23 (t, J = 7.2 
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Hz, 3 H, C5-H); 
13
C NMR (100 MHz, CDCl3) δ 172.1 (C 3), 144.8 (C 7), 137.3 (C 14), 
127.7 (C 9), 120.9 (C 12), 120.0 (C 10), 119.4 (C 11), 108.9 (C 13), 97.0 (C 8), 60.5 (C 
4), 41.5 (C 2), 29.5 (C 15), 28.0 (C 1), 20.9 (C 6), 14.2 (C-5). 
 
 
(E)-Methyl 3-methyl-5-(1-methyl-1H-indol-2-yl)hex-2-enoate (1.559).  
(ab02067).  The residue was purified by flash chromatography eluting with Et2O: 
pentane (1:4) to give 47% of ester 1.559 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 
7.54 (d, J = 7.8 Hz, 1 H), 7.28 (d, J = 7.8 Hz, 1 H),  7.17 (t, J = 7.8 Hz, 1 H), 7.07 (t, J = 
7.8 Hz, 1 H), 6.29 (s, 1 H), 5.75 (s, 1 H), 3.72 (s, 3 H), 3.69 (s, 3 H), 3.21 (sextet, J = 6.6 
Hz, 1 H), 2.65 (dd, J = 13.5, 6.6 Hz, 1 H), 2.35 (dd, J = 13.5, 6.6 Hz), 2.20 (s, 3 H), 1.30 
(d, J = 6.6 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ166.9, 157.3, 145.2, 137.3, 127.8, 
120.9, 120.0, 119.4, 117.4, 108.9, 97.3, 50.9, 48.2, 29.5, 29.1, 20.2, 18.8; IR (DCM) 
1717, 1647, 1467, 1227, 1152, 748 cm
-1
; mass spectrum (ESI) m/z 272.16451 
[C17H22NO2 (M+1) requires 272.1650], 272 (base).  
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 7.8 Hz, 1 H, 
C12-H), 7.28 (d, J = 7.8 Hz, 1 H, C15-H),  7.17 (t, J = 7.8 Hz, 1 H, C14-H), 7.07 (t, J = 
7.8 Hz, 1 H, C13-H), 6.29 (s, 1 H, C10-H), 5.75 (s, 1 H, C2-H), 3.72 (s, 3 H, C17-H), 
3.69 (s, 3 H, C5-H), 3.21 (sextet, J = 6.6 Hz, 1 H, C7-H), 2.65 (dd, J = 13.5, 6.6 Hz, 1 H, 
C6-H), 2.35 (dd, J = 13.5, 6.6 Hz, C6-H), 2.20 (s, 3 H, C4-H), 1.30 (d, J = 6.6 Hz, 3 H, 
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C8-H); 
13
C NMR (100 MHz, CDCl3) δ166.9 (C 1), 157.3 (C 3), 145.2 (C 9), 137.3 (C 
16), 127.8 (C 11), 120.9 (C 14), 120.0 (C 12), 119.4 (C 13), 117.4 (C 2), 108.9 (C 15), 
97.3 (C 10), 50.9 (C 5), 48.2 (C 6), 29.5 (C 17), 29.1 (C 7), 20.2 (C 8), 18.8 (C 4). 
 
 
Methyl 2,2-dimethyl-3-(1-methyl-1H-pyrrol-2-yl)butanoate (1.609). 
(ab02058).  The residue was purified by flash chromatography eluting with Et2O: 
pentane (1:9) to give 49% of ester 1.609 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 
6.51 (t, J = 3.2  Hz, 1 H), 6.08 (t, J = 3.2 Hz, 1 H), 5.95 (d, J = 3.2 Hz, 1 H), 3.67 (s, 3 
H), 3.60 (s, 3 H), 3.30 (q, J = 7.2 Hz, 1 H), 1.18 (s, 3 H), 1.16 (d, J = 7.2 Hz, 3 H), 1.04 
(s, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 178.4, 134.3, 121.1, 106.6, 51.8, 47.2, 37.0, 
34.2, 24.4, 19.8, 17.8; IR (DCM) 1729, 1259, 1145, 1123, 706 cm
-1
; mass spectrum (CI) 
m/z 210.1496 [C12H20NO2 (M+1) requires 210.1494], 210 (base), 108.   
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ6.51 (t, J = 3.2  Hz, 1 H, 
C10-H), 6.08 (t, J = 3.2 Hz, 1 H, C9-H), 5.95 (d, J = 3.2 Hz, 1 H, C8-H), 3.67 (s, 3 H, 
C11-H), 3.60 (s, 3 H, C5-H), 3.30 (q, J = 7.2 Hz, 1 H, C1-H), 1.18 (s, 3 H, C4-H), 1.16 
(d, J = 7.2 Hz, 3 H, C6-H), 1.04 (s, 3 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 178.4 (C 
3), 134.3 (C 7), 121.1 (C 10), 106.6 (C 8 and C 9), 51.8 (C 5), 47.2 (C 2), 37.0 (C 1), 34.2 
(C 11), 24.4 (C 4), 19.8 (C 4), 17.8 (C 6). 
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Methyl 2,2,3-trimethyl-3-(1-methyl-1H-pyrrol-2-yl)butanoate (1.608). 
(ab02065).  The residue was purified by flash chromatography eluting with Et2O: 
pentane (1:4) to give 88% of ester 1.608 as a white solid (mp = 52 - 55 °C). 
1
H NMR 
(400 MHz, CDCl3) δ 6.43-6.42 (comp, 1 H), 6.04-6.01 (comp, 2 H), 3.71 (s, 3 H), 3.61 (s, 
3 H), 1.46 (s, 6 H), 1.15 (s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 177.5, 136.4, 124.3, 
110.4, 105.6, 51.5, 50.1, 41.7, 38.4, 26.3, 22.4; IR (DCM) 1719, 1298, 1268, 1134, 1093 
cm
-1
; mass spectrum (CI) m/z 224.16451 [C13H22NO2 (M+1) requires 224.1649], 224 
(base).    
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 6.43 (comp, 1 H, C10-H), 
6.03 (comp, 2 H, C8-H and C9-H), 3.71 (s, 3 H, C11-H), 3.61 (s, 3 H, C5-H), 1.46 (s, 6 
H, C6-H), 1.15 (s, 6 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 177.5 (C 1), 136.4 (C 7), 
124.3 (C 10), 110.4 (C 9), 105.6 (C 8), 51.5 (C 2), 50.1 (C 5), 41.7 (C 11), 38.4 (C 3), 
26.3 (C 6), 22.4 (C 4). 
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Methyl 2,2-dimethyl-3-(1-(phenylsulfonyl)-1H-pyrrol-2-yl)butanoate (1.610). 
(ab02075). The residue was purified by flash chromatography eluting with Et2O: pentane 
(1:2) to give 42% of ester 1.610 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.75 (d, 
J = 7.6  Hz, 2 H), 7.59 (t, J = 7.6 Hz, 1 H), 7.50 (t,  J = 7.6 Hz, 2 H), 7.33 (dd, J = 3.6, 1.6 
Hz, 1 H), 6.25 (t, J = 3.6 Hz, 1 H), 6.08 (dd, J = 3.6, 1.6 Hz, 1 H), 3.86 (q, 7.0 Hz, 1 H), 
3.66 (s, 3 H), 1.11  (s, 3 H), 1.05 (s, 3 H), 0.83 (d, J = 7.0 Hz, 3 H); 
13
C NMR (100 MHz, 
CDCl3) δ 172.5, 134.3, 132.2, 128.4, 124.0, 121.3, 117.4, 107.9, 106.5, 46.5, 41.5, 31.6, 
19.8, 14.8, 12.6; IR (DCM) 1727, 1365, 1267, 1177, 1151, 729 cm
-1
; mass spectrum (CI) 
m/z 336.1270 [C17H22NO4S (M+1) requires 336.1270], 336, 304, 234, 173 (base), 157, 
113.    
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 7.6  Hz, 2 H, 
C11-H), 7.59 (t, J = 7.6 Hz, 1 H, C13-H), 7.50 (t,  J = 7.6 Hz, 2 H, C12-H), 7.33 (dd, J = 
3.6, 1.6 Hz, 1 H, C10-H), 6.25 (t, J = 3.6 Hz, 1 H, C9-H), 6.08 (dd, J = 3.6, 1.6 Hz, 1 H, 
C8-H), 3.86 (q, 7.0 Hz, 1 H, C1-H), 3.66 (s, 3 H, C5-H), 1.11 (s, 3 H, C4-H), 1.05 (s, 3 
H, C4-H), 0.83 (d, J = 7.0 Hz, 3 H, C6-H); 
13
C NMR (100 MHz, CDCl3) δ 172.5 (C 3), 
134.3 (C 14), 132.2 (C 13), 128.4 (C 7), 124.0 (C 11), 121.3 (C 12), 117.4 (C 10), 107.9 
(C 9), 106.5 (C 8), 46.5 (C 5), 41.5 (C 2), 31.6 (C 1), 19.8 (C 4), 14.8 (C 4), 12.6 (C 6). 
 
 
Methyl 3-(furan-2-yl)-2,2-dimethylpropanoate (1.589).  (ab02068).  The 
residue was purified by flash chromatography eluting with Et2O: pentane (1:9) to give 
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36% of ester 1.589 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 3.2 Hz, 1 
H), 6.27 (d, J = 3.2 Hz, 1 H), 6.01 (d,  J = 3.2 Hz, 1 H), 3.68 (s, 3 H), 2.88 (s, 2 H), 1.20 
(s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 177.7, 152.7, 141.3, 110.1, 107.4, 51.9, 43.0, 
38.4, 24.9; IR (DCM) 1735, 1259, 1193, 1147 cm
-1
; mass spectrum (CI) m/z 183.1016 
[C10H15O3 (M+1) requires 183.1021], 183 (base), 149, 123, 113.    
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 3.2 Hz, 1 H, C9-
H), 6.27 (d, J = 3.2 Hz, 1 H, C8-H), 6.01 (d,  J = 3.2 Hz, 1 H, C7-H), 3.68 (s, 3 H, C5-H), 
2.88 (s, 2 H, C3-H), 1.20 (s, 6 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 177.7 (C 1), 
152.7 (C 6), 141.3 (C 9), 110.1 (C 8), 107.4 (C 7), 51.9 (C 5), 43.0 (C 2), 38.4 (C 3), 24.9 
(C 4).   
 
Methyl 3-(furan-2-yl)-2,2-dimethylbutanoate (1.596).  (ab02056).  The residue 
was purified by flash chromatography eluting with Et2O: pentane (1:9) to give 62% of 
ester 1.596 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 1.8 Hz, 1 H), 
6.28 (d, J = 1.8 Hz, 1 H),  6.03 (d, J = 1.8 Hz, 1 H), 3.68 (s, 3 H), 3.30 (q, J = 7.4 Hz, 1 
H), 1.20 (d, J = 7.4 Hz, 3 H), 1.14 (s, 3 H), 1.09 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 
173.2, 152.1, 136.2, 105.1, 101.6, 47.0, 41.4, 35.5, 18.6, 16.3, 9.4; IR (DCM) 1731, 1263, 
1133, 736 cm
-1
; mass spectrum (ESI) m/z 197.11722 [C11H17O3 (M+1) requires 
197.1173], 197, 165, 137 (base).   
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 1.8 Hz, 1 H, 
C10-H), 6.28 (d, J = 1.8 Hz, 1 H, C9-H),  6.03 (d, J = 1.8 Hz, 1 H, C8-H), 3.68 (s, 3 H, 
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C5-H), 3.30 (q, J = 7.4 Hz, 1 H, C3-H), 1.20 (d, J = 7.4 Hz, 3 H, C6-H), 1.14 (s, 3 H, C4-
H), 1.09 (s, 3 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 173.2 (C 1), 152.1 (C 7), 136.2 
(C 10), 105.1 (C 9), 101.6 (C 8), 47.0 (C 5), 41.4 (C 2), 35.5 (C 3), 18.6 (C 6), 16.3 (C 4), 
9.4 (C 4). 
 
Methyl 3-(furan-2-yl)-2,2,3-trimethylbutanoate (1.597). (ab02076).  The 
residue was purified by flash chromatography eluting with Et2O: pentane (1:9) to give 
45% of ester 1.597 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 1.8 Hz, 1 
H), 6.28 (d, J = 1.8 Hz, 1 H),  6.03 (d, J = 1.8 Hz, 1 H), 3.58 (s, 3 H), 1.34 (s, 6 H), 1.14 
(s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 177.0, 160.5, 140.7, 109.7, 105.5, 51.4, 48.8, 
40.9, 23.2, 22.0; IR (DCM) 1727, 1280, 1135, 733 cm
-1
; mass spectrum (ESI) m/z 
211.13287 [C12H19O3 (M+1) requires 211.1330], 211 base).   
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 1.8 Hz, 1 H, 
C10-H), 6.28 (d, J = 1.8 Hz, 1 H, C9-H),  6.03 (d, J = 1.8 Hz, 1 H, C8-H), 3.58 (s, 3 H, 
C5-H), 1.34 (s, 6 H, C6-H), 1.14 (s, 6 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 177.0 (C 
1), 160.5 (C 7), 140.7 (C 10), 109.7 (C 9), 105.5 (C 8), 51.4 (C 5), 48.8 (C 2), 40.9 (C 3), 
23.2 (C 6), 22.0 (C 4). 
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Methyl 2,2-dimethyl-3-(thiophen-2-yl)butanoate (1.617).  (ab02062).  The 
residue was purified by flash chromatography eluting with Et2O: pentane (1:9) to give 
79% of ester 1.617 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.15 (d, J = 4.2 Hz, 1 
H), 6.93 (d, J = 4.2 Hz, 1 H),  6.82 (d, J = 4.2 Hz, 1 H), 3.67 (s, 3 H), 3.52 (q, J = 7.0 Hz, 
1 H), 1.29 (d, J = 7.0 Hz, 3 H), 1.19 (s, 3 H), 1.11 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) 
δ 177.9, 145.9, 126.2, 125.4, 123.3, 51.8, 46.7, 42.1, 23.3, 21.2, 17.7; IR (DCM) 1732, 
1260, 1133, 696 cm
-1
; mass spectrum (ESI) m/z 213.09438 [C11H17O2S (M+1) requires 
213.0942], 213 (base). 
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.15 (d, J = 4.2 Hz, 1 H,  
C10-H), 6.93 (d, J = 4.2 Hz, 1 H, C9-H),  6.82 (d, J = 4.2 Hz, 1 H, C8-H), 3.67 (s, 3 H, 
C5-H), 3.52 (q, J = 7.0 Hz, 1 H, C3-H), 1.29 (d, J = 7.0 Hz, 3 H, C6-H), 1.19 (s, 3 H, C4-
H), 1.11 (s, 3 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 177.9 (C 1), 145.9 (C 7), 126.2 
(C 8), 125.4 (C 9), 123.3 (C 10), 51.8 (C 5), 46.7 (C 2), 42.1 (C 3), 23.3 (C 6), 21.2 (C 4), 
17.7 (C 4). 
 
Methyl 2,2,3-trimethyl-3-(thiophen-2-yl)butanoate (1.618).  (ab02050). The 
residue was purified by flash chromatography eluting with Et2O: pentane (1:9) to give 
84% of ester 1.618 as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.14 (d, J = 4.2 Hz, 1 
H), 6.93 (d, J = 4.2 Hz, 1 H),  6.84 (d, J = 4.2 Hz, 1 H), 3.57 (s, 3 H), 1.46 (s, 6 H), 1.71 
(s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 177.0, 151.5, 126.0, 124.7, 123.1, 51.4, 49.2, 
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42.2, 26.6, 22.2; IR (DCM) 2977, 1726, 1466, 1270, 1129, 696 cm
-1
; mass spectrum 
(ESI) m/z 227.11003 [C12H19O2S (M+1) requires 227.1104], 227 (base), 125.  
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.14 (d, J = 4.2 Hz, 1 H, 
C10-H), 6.93 (d, J = 4.2 Hz, 1 H, C9-H),  6.84 (d, J = 4.2 Hz, 1 H, C8-H), 3.57 (s, 3 H, 
C5-H), 1.46 (s, 6 H, C6-H), 1.71 (s, 6 H, C4-H); 
13
C NMR (100 MHz, CDCl3) δ 177.0 (C 
1), 151.5 (C 7), 126.0 (C 8), 124.7 (C 9), 123.1 (C 10), 51.4 (C 2), 49.2 (C 5), 42.2 (C 3), 
26.6 (C 6), 22.2 (C 4). 
 
 
2.170 
 2,3-Dimethoxy-5-(2-(triethylsilyloxy)ethyl)cyclohexa-2,5-diene-1,4-dione 
(2.170). (ab02250).  n-BuLi (1.20 mL, 2.70 mmol, 2.30 M in hexanes) was added to a 
solution of 2.169
216
 (500 mg, 2.70 mmol) in anhydrous THF (20 mL) at -78 °C.  The 
reaction was stirred for 30 min, and a solution of dimethoxysquarate
241
 (2.155) (384 mg, 
2.70 mmol) in THF (8 mL) was then added.  The mixture was stirred for 1 h, and the cold 
bath was replaced with a 0 °C bath. The reaction was stirred for an additional 30 min, 
whereupon aqueous saturated NH4Cl (ca 30 mL) was added.  The layers were separated, 
and the aqueous layer was extracted with Et2O (2 x 10 mL).  The organic layers were 
combined, washed with brine (ca. 50 mL), dried (Na2SO4), and concentrated under 
reduced pressure.  The crude squarate thus obtained was dissolved in anhydrous toluene 
(28 mL), and the solution was sparged with argon for 30 min. The solution was then 
  
 
283 
heated under reflux for 2 h.  The solution was cooled to room temperature and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with hexanes/EtOAc (4:1) to yield quinone 2.170 in 690 mg (78% over 2 steps) as 
a brown oil.  
 1
H NMR (500 MHz, CDCl3) δ 6.43 (t, J = 1.3 Hz, 1 H), 3.94 (s, 3 H), 3.92 
(s, 3 H), 3.69 (t, J = 6.1 Hz, 2 H), 2.56 (td, J = 6.1, 1.3 Hz, 2 H), 0.85 (t, J = 8.0 Hz, 9 H), 
0.50 (q, J = 8.0 Hz, 6 H); 
13
C NMR (125 MHz, CDCl3) δ 184.1, 184.0, 144.9, 144.6, 
144.4, 132.2, 61.1, 61.0, 60.5, 32.2, 6.6, 4.3; IR (DCM) 2954, 2877, 1779, 1657, 1603, 
1458, 1280, 1100, 745 cm
-1
 LRMS (CI), m/z calculated for C16H26O5 Si
+ 
(M+1), 327; 
found, 327; mass spectrum, 195, 197, 297, 327 (base).   
NMR Assignments: 
 1
H NMR (500 MHz, CDCl3) δ 6.43 (t, J = 1.3 Hz, 1 H, C6-
H), 3.94 (s, 3 H, C7 or C8-H), 3.92 (s, 3 H, C7 or C8-H), 3.69 (t, J = 6.1 Hz, 2 H, C10-
H), 2.56 (td, J = 6.1, 1.3 Hz, 2 H, C9-H), 0.85 (t, J = 8.0 Hz, 9 H, C12-H), 0.50 (q, J = 
8.0 Hz, 6 H, C11-H); 
13
C NMR (125 MHz, CDCl3) δ 184.1 (C1 or C4), 184.0 (C1 or C4), 
144.9 (C2 or C3), 144.6 (C2 or C3), 144.4 (C5), 132.2 (C6), 61.1 (C7 or C8), 61.0 (C7 or 
C8), 60.5 (C10), 32.2 (C9), 6.6 (C12), 4.3 (C11). 
 
 
2.171 
 2,3-Dimethoxy-5-(2-(triethylsilyloxy)ethyl)benzene-1,4-diol (2.171).  
(ab02269). To a solution of 2.170 (50 mg, 0.15 mmol) in anhydrous MeCN (3 mL) was 
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added Pd/C (5 mg, 10% by wt).  The flask was evacuated with a high vacuum pump (< 1 
torr) through a N2 line until bubbles appeared in the solution, at which point the flask was 
backfilled with N2. This was repeated once and then the flask was evacuated for a third 
time and placed under H2 (9” helium grade latex balloon).  The reaction was stirred at 
room temperature for 1 h, whereupon the solids were removed by vacuum filtration 
through a fritted funnel containing a thin layer of Celite. The filter pad was washed with 
Et2O (4 x 5 mL), and the combined washings were concentrated under reduced pressure. 
The residue was purified by flash chromatography eluting with hexanes/EtOAc (1:2) to 
yield 33 mg (67%) of hydroquinone 2.171 as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 
7.18 (s, 1 H), 6.42 (s, 1 H), 5.30 (s, 1 H), 3.92 (s, 3 H), 3.91 (s, 3 H), 3.83 (t, 2 H), 2.80 (t, 
2 H), 0.90 (t, 9 H), 0.60 (q, 6 H); LRMS (CI), m/z calculated for C16H28O5Si 
+ 
(M+1), 
329; found, 329; mass spectrum, 183, 197 (base), 215, 227, 299, 327, 329.  
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.18 (s, 1 H, C1-OH, C4-
OH, or C6-H), 6.42 (s, 1 H, C1-OH, C4-OH, or C6-H), 5.30 (s, 1 H, C1-OH, C4-OH, or 
C6-H), 3.92 (s, 3 H, C7 or C8-H), 3.91 (s, 3 H, C7 or C8-H), 3.83 (t, 2 H, C10-H), 2.80 
(t, 2 H, C9-H), 0.90 (t, 9 H, C12-H), 0.60 (q, 6 H, C11-H). 
 
2.168 
 5-(2-Hydroxyethyl)-2,3-dimethoxycyclohexa-2,5-diene-1,4-dione (2.168).  
(ab02239):  Pyridine (10 mg, 0.01 mL, 0.15 mmol) and HF·Pyridine (44 mg, 0.04 mL, 
0.33 mmol, 70% HF in 30% pyridine) were added sequentially to a solution of TES-
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protected quinone 2.171 (100 mg, 0.30 mmol) in anhydrous MeCN (3 mL) at 0 °C.  The 
reaction was stirred for 5 min, and H2O (ca 1 mL) and Et2O (ca 1 mL) were added.  The 
layers were separated, and the aqueous layer was extracted with Et2O (2 x 5 mL).  The 
organic layers were combined, washed with 1 M HCl (ca 10 mL), H2O (ca 10 mL), and 
brine (ca 10 mL), dried (Na2SO4), and concentrated under reduced pressure to yield 62 
mg (97%) of quinone 2.168 as an orange oil which was not purified further.  
1
H NMR 
(400 MHz, CDCl3) δ 6.51 (s, 1 H), 4.01 (s, 3 H), 3.99 (s, 3 H), 3.81 (t, J = 6.0 Hz, 2 H), 
2.67 (td, J = 6.0, 0.80 Hz); 
13
C NMR (100 MHz, CDCl3) δ 184.4, 184.1, 145.0, 144.8, 
144.4, 132.2, 61.3, 61.2, 60.8, 32.3; IR (DCM) 3404, 1631, 1467, 1368, 1198, 1113, 
1073; LRMS (CI), m/z calculated for C10H12O5
 + 
(M+1), 213; found, 214; mass spectrum, 
183, 196, 197, 213, 214 (base), 215.   
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 6.51 (s, 1 H, C6-H), 4.01 (s, 
3 H, C7 or C8-H), 3.99 (s, 3 H, C7 or C8-H), 3.81 (t, J = 6.0 Hz, 2 H, C10-H), 2.67 (td, J 
= 6.0, 0.80 Hz, C9-H); 
13
C NMR (100 MHz, CDCl3) δ 184.4 (C1 or C4), 184.1 (C1 or 
C4), 145.0 (C3 or C2), 144.8 (C3 or C2), 144.4 (C5), 132.2 (C6), 61.3 (C7 or C8), 61.2 
(C7 or C8), 60.8 (C10), 32.3 (C9).  
 
 
 
 
2.173 
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 2-(4,5-Dimethoxy-3,6-dioxocyclohexa-1,4-dienyl)ethyl methanesulfonate 
(2.173).  (ab02256).  Mesyl chloride (74 mg, 0.05 mL, 0.71 mmol) was added to a 
solution of 2.168 (100 mg, 0.47 mmol) and Et3N (73 mg, 0.10 mL, 0.71 mmol) in 
anhydrous DCM (5 mL).  The reaction was stirred for 14.5 h, whereupon aqueous 
saturated NH4Cl (ca 5 mL) was added.  The layers were separated, and the aqueous layer 
was extracted with DCM (2 x 3 mL).  The organic layers were combined, washed with 1 
M HCl (2 x 10 mL), H2O (ca 10 mL), and brine (ca 10 mL), dried (Na2SO4), and 
concentrated under reduced pressure to yield 112 mg (82%) of 2.173 as a red oil which 
was used without further purification.  
1
H NMR (400 MHz, CDCl3) δ 6.50 (s, 1 H), 4.40 
(t, 2 H), 4.05 (s, 3 H), 4.00 (s, 3 H), 3.00 (s, 3 H), 2.85 (t, 2 H); IR (DCM) 2851, 2256, 
1659, 1604, 913, 744; HRMS (CI), m/z calculated for C11H15O7S 
+ 
(M+1), 291.0583; 
found, 291.0538; mass spectrum, 290, 291 (base), 292. 
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 6.50 (s, 1 H, C6-H), 4.40 (t, 
2 H, C10-H), 4.05 (s, 3 H, C7 or C8-H), 4.00 (s, 3 H, C7 or C8-H), 3.00 (s, 3 H, C11-H), 
2.85 (t, 2 H, C9-H). 
 
 
2.176 
 2,3-Dimethoxy-5-(2-(4-methoxybenzyloxy)ethyl)cyclohexa-2,5-diene-1,4-
dione (2.176).  (ab02291). n-BuLi (0.16 mL, 0.39 mmol, 2.20 M in hexanes) was added 
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to a solution of 2.175
219
 (75 mg, 0.39 mmol) in anhydrous THF (2 mL) at -78 °C.  The 
reaction was stirred for 1 h, and a solution of dimethoxysquarate
241
 (2.155) (50 mg, 0.39 
mmol) in THF (1.5 mL) was then added.  The mixture was stirred for 1 h, whereupon 
aqueous saturated NH4Cl (ca 5 mL) was added.  The layers were separated, and the 
aqueous layer was extracted with Et2O (2 x 5 mL).  The organic layers were combined, 
washed with brine (ca 10 mL), dried (Na2SO4), and concentrated under reduced pressure.  
The crude squarate thus obtained was dissolved in anhydrous toluene (3.5 mL), and the 
solution was sparged with argon for 10 min. The solution was then heated under reflux 
for 50 min.  The solution was cooled to room temperature and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
pentanes/EtOAc (4:1) to yield quinone 2.176 in 48 mg (41% over 2 steps) as an orange 
oil.  
1
H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.8 Hz, 2 H), 6.86 (d, J = 8.8 Hz, 2 H), 
6.48 (t, J = 1.2 Hz), 4.42 (s, 2 H), 4.01 (s, 3 H), 3.97 (s, 3 H), 3.80 (s, 3 H), 3.61 (t, J = 
8.0 Hz, 2 H), 2.69 (td, J = 8.0, 1.2 Hz, 2 H); IR (DCM) 1652, 1603, 1513, 1455, 1247, 
1092; HRMS (CI), m/z calculated for C18H20O6 
+ 
(M+1), 332.1260; found, 332.1258; 
mass spectrum, 332 (base), 334. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.8 Hz, 2 H, C13 
or C14-H), 6.86 (d, J = 8.8 Hz, 2 H, C13 or C14-H), 6.48 (t, J = 1.2 Hz, C6-H), 4.42 (s, 2 
H, C11-H), 4.01 (s, 3 H, C7 or C8-H), 3.97 (s, 3 H, C7 or C8-H), 3.80 (s, 3 H, C16-H), 
3.61 (t, J = 8.0 Hz, 2 H, C10-H), 2.69 (td, J = 8.0, 1.2 Hz, 2 H, C9-H). 
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2.179 
 2,3-Dimethoxy-5-(2-(methoxymethoxy)ethyl)cyclohexa-2,5-diene-1,4-dione 
(2.179).  (ab03034).  n-BuLi (0.30 mL, 0.70 mmol, 2.10 M in hexanes) was added to a 
solution of 2.178
222
 (80 mg, 0.70 mmol) in anhydrous THF (4 mL) at -78 °C.  The 
reaction was stirred for 2 h, and a solution of dimethoxysquarate
241
 (2.155) (100 mg, 0.70 
mmol) in THF (3 mL) was added.  The mixture was stirred for 3 h, whereupon aqueous 
saturated NH4Cl (ca. 10 mL) was added.  The layers were separated, and the aqueous 
layer was extracted with Et2O (2 x 5 mL).  The organic layers were combined, washed 
with brine (ca. 20 mL), dried (Na2SO4), and concentrated under reduced pressure.  The 
crude squarate thus obtained was dissolved in anhydrous toluene (7 mL), and the solution 
was sparged with Argon for 10 min. The solution was then heated under reflux for 1.5 h.  
The solution was cooled to room temperature and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with hexanes/EtOAc (1:1) to 
yield quinone 2.179 in 160 mg (89% over 2 steps) as a red oil.  
1
H NMR (500 MHz, 
CDCl3) δ 6.45 (t, J = 1.5 Hz, 1 H), 4.53 (s, 2 H), 3.95 (s, 3 H), 3.93 (s, 3 H), 3.65 (t, J = 
6.1 Hz, 2 H), 3.27 (s, 3 H), 2.64 (td, J = 6.1, 1.5 Hz, 2 H); 
13
C NMR (125 MHz, CDCl3) δ 
184.2, 184.0, 145.0, 144.7, 144.4, 131.9, 96.4, 64.9, 61.3, 61.2, 55.4, 29.2; IR (DCM) 
1656, 1604, 1456, 1280, 1217, 1149, 1109, 1031; HRMS (CI), m/z calculated for 
C12H16O6 
+ 
(M+1), 257.1025; found, 257.1026; mass spectrum, 239 (base), 257, 258. 
  NMR Assignments: 
1
H NMR (500 MHz, CDCl3) δ 6.45 (t, J = 1.5 Hz, 1 H, C6-
H), 4.53 (s, 2 H, C11-H), 3.95 (s, 3 H, C7 or C8-H), 3.93 (s, 3 H, C7 or C8-H), 3.65 (t, J 
= 6.1 Hz, 2 H, C10-H), 3.27 (s, 3 H, C12-H), 2.64 (td, J = 6.1, 1.5 Hz, 2 H,  C9-H); 
13
C 
NMR (125 MHz, CDCl3) δ 184.2 (C1 or C4), 184.0 (C1 or C4), 145.0 (C2 or C3), 144.7 
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(C2 or C3), 144.4 (C5), 131.9 (C6), 96.4 (C11), 64.9 (C10), 61.3 (C7 or C8), 61.2 (C7 or 
C8), 55.4 (C12), 29.2 (C9). 
 
 
2.180 
 2,3-Dimethoxy-5-(2-(methoxymethoxy)ethyl)benzene-1,4-diol (2.180).  
(ab03042).  To a solution of 2.179 (377 mg, 1.50 mmol) in anhydrous MeCN (15 mL) 
was added Pd/C (38 mg, 10% by wt).  The flask was evacuated with a high vacuum pump 
(< 1 torr) through a N2 line until bubbles appeared in the solution, at which point the flask 
was backfilled with N2. This was repeated once and then the flask was evacuated for a 
third time and placed under H2 (9” helium grade latex balloon).    The reaction was stirred 
at room temperature for 1 h, whereupon the solids were removed by vacuum filtration 
through a fritted funnel containing a thin layer of Celite. The filterpad was washed with 
Et2O (4 x 10 mL), and the combined washings were concentrated under reduced pressure 
to yield 372 mg (96%) of hydroquinone 2.180 as a yellow oil.  
1
H NMR (600 MHz, 
CDCl3) δ 6.49 (s, 1 H), 6.11 (s, 1 H), 5.18 (s, 1 H), 4.62 (s, 2 H), 3.89 (s, 3 H), 3.89 (s, 3 
H), 3.75 (t, J = 6.4 Hz, 2 H), 3.30 (s, 3 H), 2.83 (t, J = 6.4 Hz, 2 H); 
13
C NMR (150 MHz, 
CDCl3) δ 141.9, 141.2, 140.2, 138.2, 121.1, 110.8, 96.3, 68.0, 60.9, 60.7, 55.3, 31.0;  IR 
(DCM) 3396, 1468, 1112, 1077, 1029; HRMS (CI), m/z calculated for C12H18O6 
+ 
(M+1), 
258.1103; found, 258.1098; mass spectrum, 227 (base), 258. 
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NMR Assignments:  
1
H NMR (600 MHz, CDCl3) δ 6.49 (s, 1 H, C6-H), 6.11 (s, 
1 H, C4-OH), 5.18 (s, 1 H, C1-OH), 4.62 (s, 2 H, C11-H), 3.89 (s, 3 H, C7 or C8-H), 3.89 
(s, 3 H, C7 or C8-H), 3.75 (t, J = 6.4 Hz, 2 H, C10-H), 3.30 (s, 3 H, C12-H), 2.83 (t, J = 
6.4 Hz, 2 H, C9-H); 
13
C NMR (150 MHz, CDCl3) δ 141.9 (C1 or C4), 141.2 (C1 or C4), 
140.2 (C2 or C3), 138.2 (C2 or C3), 121.1 (C5), 110.8 (C6), 96.3 (C11), 68.0 (C10), 60.9 
(C7 or C8), 60.7 (C7 or C8), 55.3 (C12), 31.0 (C9). 
 
 
2.182 
 2,3-Dimethoxy-6-(2-(methoxymethoxy)ethyl)-4-(triethylsilyloxy)phenol 
(2.182).  (ab03060).  A solution of TESOTf (105 mg, 0.090 mL, 0.73 mmol) in DCM 
(0.07M) was added to a solution of  2.180 (94 mg, 0.36 mmol) and 2,6-lutidine (0.090 
mL, 0.73 mmol) in anhydrous DCM (26 mL, 0.014M) at -78 °C via syringe pump (10 
mL syringe, 15 mm diameter, 10 mL/h) over 1 h.  The reaction was stirred for 30 min, 
and then the -78 °C cold bath was replaced with a 0 °C cold bath.  The reaction was 
stirred for 1 h, the cold bath was removed, and the reaction was warmed to room 
temperature and stirred for 22 h, whereupon aqueous saturated NH4Cl (ca 50 mL) was 
added.  The layers were separated, and the aqueous layer was extracted with DCM (2 x 
20 mL).  The organic layers were combined, washed with brine (ca 50 mL), dried 
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(MgSO4), and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with hexanes/EtOAc (4:1) to provide 75 mg (56%) of TES-
protected hydroquinone 2.182 as a yellow oil.  
1
H NMR (600 MHz, CDCl3) δ 6.39 (s, 1 
H), 5.90 (s, 1 H), 4.60 (s, 2 H), 3.89 (s, 3 H), 3.81 (s, 3 H), 3.72 (t, J = 6.7 Hz, 2 H), 3.29 
(s, 3 H), 2.81 (t, J = 6.7 Hz, 2 H), 0.97 (t, J = 8.0 Hz, 9 H), 0.71 (q, J = 8.0 Hz, 6 H); 
13
C 
NMR (150 MHz, CDCl3) δ 142.6, 141.9, 141.7, 140.7, 119.7, 116.7, 96.3, 67.8, 61.1, 
60.5, 55.2, 30.7, 6.6, 5.0; IR (DCM) 3402, 1495, 1463, 1366, 1111, 1081, 1020, 959; 
HRMS (CI), m/z calculated for C18H32O6Si 
+ 
(M+1), 372.1968; found, 372.1968; mass 
spectrum, 372 (base), 373, 374. 
NMR Assignments:  
1
H NMR (600 MHz, CDCl3) δ 6.39 (s, 1 H, C6-H), 5.90 (s, 
1 H, C4-OH), 4.60 (s, 2 H, C11-H), 3.89 (s, 3 H, C7-H), 3.81 (s, 3 H, C8-H), 3.72 (t, J = 
6.7 Hz, 2 H, C10-H), 3.29 (s, 3 H, C12-H), 2.81 (t, J = 6.7 Hz, 2 H, C9-H), 0.97 (t, J = 
8.0 Hz, 9 H, C14-H), 0.71 (q, J = 8.0 Hz, 6 H, C13-H); 
13
C NMR (150 MHz, CDCl3) δ 
142.6 (C4), 141.9 (C3), 141.7 (C2), 140.7 (C1), 119.7 (C5), 116.7 (C6), 96.3 (C11), 67.8 
(C10), 61.1 (C7), 60.5 (C8), 55.2 (C12), 30.7 (C9), 6.6 (C14), 5.0 (C13). 
 
 
2.185 
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 2,3-Dimethoxy-6-(2-(methoxymethoxy)ethyl)-4-(triethylsilyloxy)phenyl 
trifluoromethanesulfonate (2.185).  (ab03063).  Triethylamine (0.04 mL, 29.0 mg, 0.28 
mmol) was added to a solution of 2,3-dimethoxy-6-(2-(methoxymethoxy)ethyl)-4-
(triethylsilyloxy)phenol (2.182) (52.0 mg, 0.14 mmol) in DCM (2.0 mL) at -78 °C.  The 
reaction was stirred for 10 min, whereupon Tf2O (0.03 mL, 50.3 mg, 0.17 mmol) was 
added.  After 30 min NH4Cl(sat) (ca 2 mL) was added, and the mixture was allowed to 
warm to room temperature.  The layers were separated, and the aqueous layer was 
extracted with DCM (1 x 3 mL).  The organic layers were combined, washed with 1 M 
HCl (ca 5 mL) and brine (ca 5 mL), dried (MgSO4), and concentrated to yield 54 mg 
(76%) of triflate 2.185 as a colorless oil that was used in further reactions without 
purification.  
1
H NMR (400 MHz, CDCl3) δ 6.57 (s, 1 H), 4.60 (s, 2 H), 3.95 (s, 3 H), 
3.83 (s, 3 H), 3.70 (t, J = 6.8 Hz, 2 H), 3.30 (s, 3 H), 2.87 (t, J = 6.8 Hz, 2 H), 0.10 (t, J = 
7.8 Hz, 9 H), 0.77 (q, J = 7.8 Hz, 6 H);  
13
C NMR (100 MHz, CDCl3) δ 149.0, 146.0, 
143.3, 135.2, 126.8, 118.7 (q, J = 320.1 Hz), 116.2, 96.4, 66.7, 61.3, 60.7, 55.2, 30.0, 6.6, 
5.0; IR (DCM) 1576, 1416, 1210, 1141, 1111, 1020, 951; HRMS (CI), m/z calculated for 
C19H31O8SSiF3 
+
 (M+1), 504.1461; found, 504.1458; mass spectrum 504 (base), 505, 506.   
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 6.57 (s, 1 H, C5-H), 4.60 (s, 
2 H, C9-H), 3.95 (s, 3 H, C13 or C14-H), 3.83 (s, 3 H, C13 or C14-H), 3.70 (t, J = 6.8 
Hz, 2 H, C7-H), 3.30 (s, 3 H, C10-H), 2.87 (t, J = 6.8 Hz, 2 H, C8-H), 0.10 (t, J = 7.8 Hz, 
9 H, C12-H), 0.77 (q, J = 7.8 Hz, 6 H, C11-H  );  
13
C NMR (100 MHz, CDCl3) δ 149.0 
(C1), 146.0 (C2 or C3), 143.3 (C2 or C3), 135.2 (C4), 126.8 (C6), 118.7 (q, J = 320.1 Hz, 
C15), 116.2 (C5), 96.4 (C9), 66.7 (C8), 61.3 (C13 or C14), 60.7 (C13 or C14), 55.2 
(C10), 30.0 (C7), 6.6 (C11), 5.0 (C12).  
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2.162 
 tert-Butyl 2-(4,5-dimethoxy-3,6-dioxocyclohexa-1,4-dienyl)ethylcarbamate 
(2.162).  (ab03154).  n-BuLi (5.0 mL, 1.05 mmol, 2.10 M) was added to a solution of 
tert-butylbut-3-ynylcarbamate (2.160) (90 mg, 0.53 mmol) in THF (1 mL) at 0 °C, and 
the pale yellow solution darkened to a bright yellow.  The reaction was stirred for 1.5 h 
before the temperature was cooled to -78 °C, and a solution of dimethoxysquarate (2.155) 
(50.0 mg, 0.35 mmol) in THF (3 mL) was added dropwise.  After 1 h, NH4Cl(sat) (ca. 5 
mL) was added, and the mixture was allowed to warm to room temperature.  The layers 
were separated, and the aqueous layer was extracted with Et2O (2 x5 mL).  The organic 
layers were combined, dried (MgSO4), and concentrated to yield a yellow oil.  This oil 
was immediately dissolved in toluene (4 mL), and the resulting solution was sparged with 
argon for 5 min.  The solution was then heated under reflux for 2 h, cooled to room 
temperature and concentrated.  The residue was purified by flash chromatography eluting 
with EtOAc/hexanes (1:2) to yield 20 mg (18% over 2 steps) of quinone 2.162 as a red 
oil.  
1
H NMR (400 MHz, CDCl3) δ 6.48 (s, 1 H), 5.92 (br, 1 H), 4.19 (t, 2 H), 4.05 (s, 3 
H), 4.01 (s, 3H), 3.79 (t, 2 H), 1.55 (s, 9 H); LRMS (CI), m/z calculated for C15H21NO6
- 
(M), 311.14; found, 311; mass spectrum, 310, 311 (base), 312. 
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NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 6.48 (s, 1 H, C8-H), 5.92 (br, 
1 H, NH), 4.19 (t, 2 H, C1-H), 4.05 (s, 3 H, C11 or C12-H), 4.01 (s, 3H, C11 or C12-H), 
3.79 (t, 2 H, C2-H), 1.55 (s, 9 H, C10-H). 
 
 
2.201 
 2-Bromo-3-hydroxy-4,5-dimethoxybenzaldehyde (2.201).  (ab03257).  
Bromine (0.65 mL, 2.03 g, 12.60 mmol) was added to a solution of 2.196 (2.29 g, 12.60 
mmol) in HOAc (14 mL).  The reaction was stirred for 17 h, whereupon it was added to a 
mixture of H2O and ice.  The brown precipitate was collected via vacuum filtration and 
washed with H2O, to yield 2.59 g (79%) of crude 2.201 as a brown solid.  An analytical 
sample was prepared by recrystallization from hexanes to give 2.201 as a tan solid; mp = 
144-145 °C.  
1
H NMR (500 MHz, CDCl3) δ 10.29 (s, 1 H), 7.17 (s, 1 H), 6.27 (br, 1 H), 
4.03 (s, 3 H), 3.92 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 191.1, 151.5, 146.9, 140.9, 
128.5, 106.7, 104.5, 61.3, 56.2; IR (DCM) 3375, 1680, 1588, 1575, 1427, 1344, 1331, 
1147; HRMS (ESI), m/z calculated for C9H9BrO4Na
+
 (M+1), 282.95764; found 
282.9575; mass spectrum, 282 (base), 284.   
NMR Assignments: 
1
H NMR (500 MHz, CDCl3) δ 10.29 (s, 1 H, C7-H), 7.17 (s, 
1 H, C6-H), 6.27 (br, 1 H, OH), 4.03 (s, 3 H, C8 or C9-H), 3.92 (s, 3 H, C8 or C9-H); 
13
C 
NMR (100 MHz, CDCl3) δ 191.1 (C7), 151.5 (C4 or C5), 146.9 (C4 or C5), 140.9 (C3), 
128.5 (C1), 106.7 (C2), 104.5 (C6), 61.3 (C8 or C9), 56.2 (C8 or C9).  
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2.202 
 3-(Benzyloxy)-2-bromo-4,5-dimethoxybenzaldehyde (2.202).  (ab03215).  A 
mixture of NaH (1.32 g, 33.0 mmol, 60%) and crude phenol 2.201 (7.82 g, 30.0 mmol) in 
deoxygenated (freeze/pump/thaw x 3) DMF (60 mL) was stirred for 1.5 h at 0 °C, and 
then BnBr (3.60 mL, 5.18 g, 30.0 mmol) was added.  The reaction was allowed to warm 
to room temperature and stirred for 4 h, whereupon the solution was added to a mixture 
of H2O and ice.  The pale yellow precipitate was collected via vacuum filtration and 
washed with H2O, to yield 9.58 g (91%) of crude 2.202 as a pale yellow solid.  An 
analytical sample was prepared by recrystallization from petroleum ether to give 2.202 as 
a pale yellow solid; mp = 108-109 °C.  
1
H NMR (400 MHz, CDCl3) δ 10.31 (s, 1 H), 
7.57 (d, J = 7.6 Hz, 2 H), 7.41-7.33 (comp, 4 H), 5.07 (s, 2 H), 3.97 (s, 3 H), 3.93 (s, 3 
H); 
13
C NMR (100 MHz, CDCl3) 191.2, 153.1, 149.7, 149.0, 136.4, 128.6, 128.5, 128.4, 
116.0, 107.6, 75.6, 61.4, 56.3; IR (DCM) 1688, 1372, 1329, 1110; HRMS (CI) m/z 
calculated for C16H16O4Br
+
 (M+1), 351.0232; found, 351.0234; mass spectrum, 351 
(base), 353, 354. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 10.31 (s, 1 H, C7-H), 7.57 (d, 
J = 7.6 Hz, 2 H, C11-H), 7.41-7.33 (comp, 4 H, C6, C12, and C13-H), 5.07 (s, 2 H, C10-
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H), 3.97 (s, 3 H, C8 or C9-H), 3.93 (s, 3 H, C8 or C9-H); 
13
C NMR (100 MHz, CDCl3) δ 
191.2 (C7), 153.1 (C3), 149.7 (C4 or C5), 149.0 (C4 or C5), 136.4 (Ar), 128.6 (C11 or 
C12), 128.5 (C11 or C12), 128.4 (Ar), 116.0 (Ar), 107.6 (Ar), 75.6 (C10), 61.4 (C8 or 
C9), 56.3 (C8 or C9). 
 
2.203 
 3-(Benzyloxy)-2-bromo-4,5-dimethoxy-1-(2-nitrovinyl)benzene (2.203).  
(ab03287).  A solution of aldehyde 2.202 (1.46 g, 4.20 mmol), NH4OAc (1.90 g, 25.20 
mmol), and MeNO2 (1.36 mL, 1.53 g) in HOAc (20 mL) was heated in an oil bath at 100 
°C.  The reaction was stirred for 3.5 h, and the solution was cooled to room temperature 
and added to a mixture of H2O and ice.  The bright yellow precipitate was collected via 
vacuum filtration and washed with H2O, to yield 1.43 g (86%) of 2.203 as a bright yellow 
oily solid.  
1
H NMR (400 MHz, CDCl3) δ 8.42 (d, J = 13.6, 1 H), 7.55-7.36 (comp, 6 H), 
6.90 (s, 1 H), 5.06 (s, 2 H), 3.95 (s, 3 H), 3.92 (s, 3 H); 
13
CNMR (150 MHz, CDCl3) δ 
153.1, 150.6, 146.7, 138.2, 138.0, 136.4, 128.6, 128.6, 128.5, 128.5, 128.5, 125.5, 115.0, 
106.8, 75.5, 61.4, 56.4;  IR (DCM) 3103, 1625, 1508, 1483, 1328, 1110; HRMS (CI) m/z 
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calculated for C17H16BrNO5
+
 (M+1), 393.0212; found, 393.0209; mass spectrum, 392, 
393 (base), 394, 395 (base) 396. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 8.42 (d, J = 13.6, 1 H, C8), 
7.55-7.36 (comp, 6 H, C7, C13, C14, C15-H), 6.90 (s, 1 H, C6-H), 5.06 (s, 2 H, C11-H), 
3.95 (s, 3 H, C9 or C10-H), 3.92 (s, 3 H, C9 or C10-H). 
13
CNMR (150 MHz, CDCl3) δ 
153.1 (C3), 150.6 (C5), 146.7 (C4), 138.2 (C7, C8, or C12), 138.0 (C7, C8, or C12), 
136.4 (C7, C8, or C12), 128.6 (CAr), 128.6 (CAr), 128.5 (CAr), 128.5 (CAr), 128.5 
(CAr), 125.5 (CAr), 115.0 (CAr), 106.8 (CAr), 75.5 (C11), 61.4 (C9 or C10), 56.4 (C9 or 
C10). 
 
2.204 
 2-(3-(Benzyloxy)-2-bromo-4,5-dimethoxyphenyl)ethanamine (2.204).  
(ab03261).  TMSCl (3.20 mL, 2.74 g, 25.60 mmol) was added to a solution of LiBH4 
(280.0 mg, 12.80 mmol) in THF (10 mL).  The solution was purged with N2 for 10 min, 
whereupon a solution of 2.203 (1.28 g, 3.20 mmol) in THF (10 mL) was added dropwise.  
The mixture was heated under under reflux for 23 h and then cooled room temperature.  
MeOH (ca 5 mL) was added slowly dropwise, and the mixture was concentrated under 
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reduced pressure.  Et2O (ca 5 mL) and 6 M NaOH (ca 5 mL) were added to the residue, 
and the layers were separated.  The aqueous layer was extracted with Et2O (2 x 5 mL), 
and the combined organic layers were dried (MgSO4) and concentrated to yield 1.03 g 
(100% conversion, 88% mass balance) of amine 2.204 as a brown oil.  *NMR data shown 
is for a mixture of amine and what is presumed to be the N-OH compound 2.205.  
1
H 
NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.8 Hz, 2 H), 7.39 (t, J = 7.2 Hz, 2 H), 7.34, (t, J 
= 6.6 Hz, 1 H), 6.68 (s, 1 H), 5.05 (s, 2 H), 3.87 (s, 6 H), 3.20 (t, J = 7.2 Hz, 1 H), 3.01 (t, 
J = 7.2 Hz, 1 H), 2.98 (br, 1 H), 2.90 (br, 1 H); 
13
C NMR (150 MHz, CDCl3) δ 152.6, 
150.0, 142.0, 137.1, 134.8, 134.5, 128.5, 128.42, 128.40, 128.2, 111.3, 109.8, 75.3, 61.2, 
56.2, 53.4, 34.2; IR (DCM) 3436, 3198, 2385, 1556, 1483, 1110; HRMS (ESI) m/z 
calculated for C17H21NO3Br
+
 (M+1), 366.05; found, 366.0694; mass spectrum, 366 
(base), 367, 368, 369. 
NMR Assignments: *NMR data shown is for a mixture of amine and what is 
presumed to be the N-OH compound.  
1
H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.8 Hz, 
2 H, C13-H), 7.39 (t, J = 7.2 Hz, 2 H, C14-H), 7.34, (t, J = 6.6 Hz, 1 H, C15-H), 6.68 (s, 
1 H, C6-H), 5.05 (s, 2 H, C11-H), 3.87 (s, 6 H, C9 and C10-H), 3.20 (t, J = 7.2 Hz, 1 H, 
C8-H), 3.01 (t, J = 7.2 Hz, 1 H, C8-H), 2.98 (br, 1 H, C7-H), 2.90 (br, 1 H, C7-H); 
13
C 
NMR (150 MHz, CDCl3) δ 152.6 (CAr), 150.0 (CAr), 142.0 (CAr), 137.1 (CAr), 134.8 
(CAr), 134.5 (CAr), 128.5 (CAr), 128.42 (CAr), 128.40 (CAr),  128.2 (CAr), 111.3 
(CAr), 109.8 (CAr), 75.3 (C11), 61.2 (C9 or C10), 56.2 (C9 or C10), 53.4 (C7 or C8), 
34.2 (C7 or C8). 
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2.207 
 2-Benzyl 1-ethyl 6-(benzyloxy)-5-bromo-7,8-dimethoxy-3,4-
tetrahydroisoquinoline-1,2(1H)-dicarboxylate (2.207).  (ab03267).  Ethyl glyoxylate 
(0.67 mL, 0.345 g, 3.4 mmol, 50%) was added to a solution of crude amine 2.204 (1.24 g, 
3.40 mmol) and 4 Å molecular sieves in DCM (10 mL).  The reaction was stirred for 1 h 
and then cooled to 0 °C.  CbzCl (0.49 mL, 0.600 g, 3.40 mmol) and TMSOTf (0.12 mL, 
0.147 g, 0.68 mmol) were added, and the reaction was stirred for 2 h at room 
temperature.  NaHCO3(sat)  (ca. 10 mL) was added, and the layers were separated.  The 
aqueous layer was extracted with DCM (3 x 5 mL), and the combined organic layers 
were dried (MgSO4) and concentrated to yield a yellow oil.  The residue was purified by 
flash chromatography eluting with EtOAc/hexanes (1:4) to yield 0.570 g (30% over 2 
steps from the amine) of 2.207 as a colorless oil.  
1
H NMR (500 MHz, DMSO-d6, 130°C) 
δ 7.53 (d, J =7.0 Hz, 2 H), 7.40-7.29 (comp, 8 H), 5.94 (s, 1 H), 5.18 (dd, J = 12.5, 15.0 
Hz, 2 H), 5.08 (dd, J = 12.0, 14.0 Hz, 2 H), 4.13 (m, 2 H), 3.90 (s, 3 H), 3.85 (comp, 4 
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H), 3.51 (dtd, J = 5.5, 6.5, 8.0 Hz, 1 H), 2.84 (comp, 2 H), 1.16 (t, J = 7.0 Hz, 3 H); 
13
C 
NMR (125 MHz, DMSO-d6, 130°C) δ 168.8, 154.0, 149.4, 148.9, 144.3, 136.2, 136.1, 
129.8, 127.6, 127.5, 127.4, 127.3, 127.2, 127.1, 126.7, 125.8, 121.9, 112.2, 74.2, 66.3, 
60.5, 60.1, 59.8, 52.5, 40.0-39.0, 27.4, 13.0; LCMS (ESI) m/z calculated for 
C29H30BrNO7
+
 (M+1), 584; found, 584; mass spectrum, 584 (base), 586.   
NMR Assignments:  
1
H NMR (500 MHz, DMSO-d6, 130°C) δ 7.53 (d, J =7.0 
Hz, 2 H, CAr-H), 7.40-7.29 (comp, 8 H, CAr-H), 5.94 (s, 1 H, C25-H), 5.18 (dd, J = 
12.5, 15.0 Hz, 2 H, C11 or C18-H), 5.08 (dd, J = 11.0, 14.0 Hz, 2 H, C11 or C18-H), 4.13 
(m, 2 H, C8-H), 3.90 (s, 3 H, C24 or C24-H), 3.85 (comp, 4 H, C23 or C24-H and C16 or 
C17-H), 3.51 (dtd, J = 5.5, 6.5, 8.0 Hz, 1 H, C16 or C17-H), 2.84 (comp, 2 H, C16 or 
C17-H), 1.16 (t, J = 7.0 Hz, 3 H, C9-H); 
13
C NMR (125 MHz, DMSO-d6, 130°C) δ 168.8 
(C7), 154.0 (C10), 149.4 (CAr), 148.9 (CAr), 144.3 (CAr), 136.2 (CAr), 136.1 (CAr), 
129.8, (CAr), 127.6 (2 CAr), 127.5 (CAr), 127.4 (CAr), 127.3 (CAr), 127.2 (CAr), 127.1 
(CAr), 126.7 (2 CAr), 125.8 (CAr), 121.9 (CAr), 112.2 (CAr), 74.2 (C11 or C18), 66.3 
(C11 or C18), 60.5 (C8), 60.1 (C23 or C24), 59.8 (C23 or C24), 52.5 (C25), 40.0-39.0 
(C16 or C17), 27.4 (C16 or C17), 13.0 (C9). 
  
 
301 
 
2.209 
 2-Benzyl 1-ethyl 6-(benzyloxy)-7,8-dimethoxy-3,4-tetrahydroisoquinoline-
1,2(1H)-dicarboxylate (2.209).  (ab03302).  A solution of 2.207 (60.0 mg, 0.10 mmol), 
Pd(OAc)2 (5.0 mg, 0.020 mmol), PPh3 (5.0 mg, 0.020 mmol), and K2CO3 (28.0 mg, 0.20 
mmol) in EtOH (5 mL) was sparged with N2 for 10 min.  The reaction was heated under 
reflux for 1 h, cooled to room temperature and then concentrated under reduced pressure.  
Et2O (ca 5 mL) and NaHCO3(sat)  (ca 5 mL) were added to the residue, and the layers were 
separated.  The aqueous layer was extracted with Et2O (3 x 2 mL), and the combined 
organic layers dried (MgSO4) and concentrated to yield a yellow oil.  The residue was 
purified by flash chromatography eluting with EtOAc/hexanes (1:4) to yield 50.0 mg 
(98%) of 2.209 as a pale yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.5-7.2 (comp, 10 H), 
6.5 (d, 1 H), 6.0 (d, 1 H), 5.3-5.1 (comp, 4 H), 4.3-4.1 (comp, 2 H), 4.0 (d, 3 H), 3.8 (s, 3 
H), 3.8-3.4 (comp, 2 H), 3.0-2.6 (comp, 2 H), 1.2 (dt, 3 H); LCMS (APCI) m/z calculated 
for C29H31NO7
+
 (M+1), 506; found, 506; mass spectrum, 506 (base), 507.   
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NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.5-7.2 (comp, 10 H, CAr-
H), 6.5 (d, 1 H, C2-H), 6.0 (d, 1 H, C25-H --rotamers), 5.3-5.1 (comp, 4 H, C18 and C11-
H), 4.3-4.1 (comp, 2 H, C8), 4.0 (d, 3 H, C23 or C24-H), 3.8 (s, 3 H, C23 or C24-H), 3.8-
3.4 (comp, 2 H, C16-H), 3.0-2.6 (comp, 2 H, C17-H), 1.2 (dt, 3 H, C10-H).   
 
 
2.236 
 2-(3-(Benzyloxy)-2-bromo-4,5-dimethoxyphenyl)ethanamine hydrochloride 
salt (2.236).  (ab04067).  Chlorotrimethylsilane (29.0 mL, 24.8 g, 228.9 mmol) was 
added to a solution of lithium borohydride (2.5 g, 114.0 mmol) in THF (100 mL) at room 
temperature.  The reaction was purged with N2 for 10 min to remove silane, whereupon 
3-(benzyloxy)-2-bromo-4,5-dimethoxy-1-(2-nitrovinyl)benzene (2.203) (11.25 g, 28.5 
mmol) was added to the mixture.  The reaction was heated under reflux for 14 h before 
being cooled to room temperature.  MeOH (ca. 100 mL) was added, and the mixture was 
concentrated under reduced pressure.  NaOH (6 M, ca. 100 mL) and Et2O (ca. 100 mL) 
were added to the residue, and the layers were separated.  The aqueous layer was 
extracted with Et2O (2 x 100 mL), and the organic layers were combined, dried (MgSO4), 
and concentrated to yield a brown oil.  Anhydrous HCl (6 M in EtOH, ca. 100 mL) was 
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added and after 2 h, the mixture was concentrated.  The crude salt was recrystallized from 
Et2O/isopropanol (95:5) to yield 7.5 g (65%) of 2.236 as a brown solid; mp 140-142 °C.  
1
H NMR (600 MHz, CD3OD) δ 7.52 (d, J = 7.3 Hz, 2 H), 7.36 (t, J = 7.3 Hz, 2 H), 7.32 
(t, J =  7.3 Hz, 1 H), 6.88 (s, 1 H), 5.03 (s, 2 H), 3.88 (s, 3 H), 3.83 (s, 3 H), 3.16-3.15 (m, 
2 H), 3.11-3.09 (m, 2 H); 
13
C NMR (150 MHz, CD3OD) δ 154.7, 151.3, 144.1, 138.4, 
132.9, 129.5 (2C), 129.4 (2C), 129.2, 111.8, 111.5, 76.4, 61.5, 56.8, 40.4, 35.2; IR 
(DCM) 3398, 2939, 1568, 1485, 1370, 1116; HRMS (CI) m/z calculated for 
C17H21NO3Br
79+
 (M+1), 366.07; found, 366.0708; mass spectrum, 366 (base). 
NMR Assignments: 
1
H NMR (600 MHz, CD3OD) δ 7.52 (d, J = 7.3 Hz, 2 H, 
C13-H), 7.36 (t, J = 7.3 Hz, 2 H, C14-H), 7.32 (t, J =  7.3 Hz, 1 H, C15-H), 6.88 (s, 1 H, 
C6-H), 5.03 (s, 2 H, C11-H), 3.88 (s, 3 H, C9 or C10-H), 3.83 (s, 3 H, C9 or C10-H), 
3.16-3.15 (m, 2 H, C8-H), 3.11-3.09 (m, 2 H, C7-H); 
13
C NMR (150 MHz, CD3OD) δ 
154.7 (C3), 151.3 (C5), 144.1 (C4), 138.4 (C-Ar), 132.9 (C-Ar), 129.5 (2C, C-Ar), 129.4 
(2C, C-Ar), 129.2 (C-Ar), 111.8 (C-Ar), 111.5 (C-Ar), 76.4 (C11), 61.5 (C9 or C10), 56.8 
(C9 or C10), 40.4 (C8), 35.2 (C7). 
 
 
2.237 
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 Ethyl 6-(benzyloxy)-5-bromo-7,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline-
1-carboxylate (2.237).  (ab04083).  A solution of amine hydrochloride salt 2.236 (1.42 
g, 3.5 mmol), triethylamine (0.98 mL, 0.71 g, 7.00 mmol), ethyl glyoxylate (0.69 mL, 
50% toluene solution, 0.071 g, 3.5 mmol) and 4 Ǻ molecular sieves (ca. 20) in toluene 
(50 mL) was stirred at room temperature for 3 h.  The mixture was then vacuum filtered 
through a fritted funnel containing a layer of celite, washing with toluene.  The combined 
filtrate and washings were concentrated to provide 1.65 g of the intermediate imine.  A 
solution of toluene/TFA (1% by volume) (60 mL) was added to the imine, and the 
reaction was heated at 80 °C (oil bath temperature).  The reaction was stirred for 1.5 h 
and then cooled to room temperature.  The mixture was concentrated, and 1 M NaOH (ca. 
50 mL) and Et2O (ca. 50 mL) were added.  The layers were separated, and the aqueous 
layer was extracted with Et2O (4 x 20 mL).  The organic layers were combined, dried 
(MgSO4), and concentrated to provide 1.48 g (94%) of 2.237 as a yellow oil.  The 
product was carried on without further purification. 
1
H NMR (600 MHz, CDCl3) δ 7.57 
(d, J = 7.4 Hz, 2 H), 7.40 (t, J = 7.4 Hz, 2 H), 7.34 (t, J =  7.4 Hz, 1 H), 7.26 (s, 1 H), 
5.05 (d, J = 15.6 Hz, 1 H), 5.03 (d, J = 15.6 Hz, 1 H), 4.23 (qd, J = 2.1, 7.2 Hz, 2 H), 3.88 
(s, 3 H), 3.87 (s, 3 H), 3.15-3.11 (m, 1 H), 3.04-2.99 (m, 1 H), 2.78-2.73 (m, 1 H), 2.71-
2.65 (m, 1 H), 1.30 (t, J = 7.2 Hz, 3 H); 
13
C NMR (150 MHz, CDCl3) δ 172.8, 150.2, 
149.5, 144.7, 137.1, 131.0, 128.5 (2C), 128.4 (2C), 128.2, 124.1, 114.6, 75.2, 61.2, 61.0, 
60.4, 55.7, 40.5, 30.0, 14.3; IR (DCM) 1733, 1463, 1410, 1342, 1184, 1092, 1020; 
HRMS (CI) m/z calculated for C21H25NO5Br
79+
 (M+1), 450.0916; found, 450.0916; mass 
spectrum, 450 (base). 
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NMR Assignments: 
1
H NMR (600 MHz, CDCl3) δ 7.57 (d, J = 7.4 Hz, 2 H, 
C13-H), 7.40 (t, J = 7.4 Hz, 2 H, C14-H), 7.34 (t, J =  7.4 Hz, 1 H, C15-H), 7.26 (s, 1 H, 
C16-H), 5.05 (d, J = 15.6 Hz, 1 H, C11-H), 5.03 (d, J = 15.6 Hz, 1 H, C11-H), 4.23 (qd, J 
= 2.1, 7.2 Hz, 2 H, C18-H), 3.88 (s, 3 H, C9 or C10-H), 3.87 (s, 3 H, C9 or C10-H), 3.15-
3.11 (m, 1 H, C8-H), 3.04-2.99 (m, 1 H, C8-H), 2.78-2.73 (m, 1 H, C7-H), 2.71-2.65 (m, 
1 H, C7-H), 1.30 (t, J = 7.2 Hz, 3 H, C19-H); 
13
C NMR (150 MHz, CDCl3) 172.8 (C17), 
150.2 (C3), 149.5 (C5), 144.7 (C4), 137.1 (C-Ar), 131.0 (C-Ar), 128.5 (2C, C13), 128.4 
(2C, C14), 128.2 (C-Ar), 124.1 (C-Ar), 114.6 (C-Ar), 75.2 (C11), 61.2 (C9 or C10), 61.0 
(C9 or C10), 60.4 (C16 or C18), 55.7 (C16 or C18), 40.5 (C8), 30.0 (C7), 14.3 (C19). 
 
Preparation of Samarium Diiodide (SmI2, 0.1 M solution in THF) (ab04270).  
Samarium powder (2.0 g, 13.3 mmol, Acros), which had been crushed with a mortar and 
pestle under nitrogen prior to use, was added to a 250 mL flame-dried RB flask outfitted 
with a stir bar, followed by 100 mL of THF.  The slurry was deoxygenated via 
freeze/pump/thaw (x 3), and iodine (2.54 g, 10.0 mmol) was added.  The mixture was 
purged with argon, and the flask was outfitted with a reflux condenser.  The reaction was 
heated under reflux for 20 h and then cooled to room temperature.  The 0.1 M solution 
can be stored under argon and at room temperature for approximately one week.   
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2.241 
 Ethyl 2-(4-(benzyloxy)-3-bromo-5,6-dimethoxy-2-(2-
(methoxycarbonylamino)ethyl)phe-nyl)acetate.  (2.241).  (ab04110).  SmI2 (24.0 mL, 
0.2 M in THF, 4.80 mmol) was added to a deoxygenated (f/p/t x 3) solution of 2.237 (216 
mg, 0.48 mmol), HMPA (0.84 mL, 0.87 g, 4.80 mmol), and MeOH (0.19 mL, 0.15 g, 
4.80 mmol) in THF (3 mL) at room temperature.  The reaction was stirred for 18 h, 
whereupon NaHCO3(sat) (ca. 5 mL) was added.  The solids were removed by vacuum 
filtration through a fritted funnel containing a layer of celite, washing with H2O and Et2O.  
The layers of the filtrate were separated, and the aqueous layer was extracted with Et2O 
(3 x 10 mL). The organic layers were combined and concentrated.  The residue was then 
washed with H2O (3 x 20 mL) to remove excess HMPA.  Et2O (ca. 10 mL) was added to 
the residue, and the solution was washed with brine (1 x 10 mL), dried (MgSO4) and 
concentrated to yield 165 mg of a brown oil.  DCM (3 mL) and triethylamine (0.18 mL, 
0.14 g, 1.3 mmol) were added to the oil, and the mixture was cooled to 0 °C.  
Methylchloroformate (0.04 mL, 0.05 g, 0.48 mmol) was added dropwise, and the reaction 
was stirred for 2 h.  NaHCO3(sat) (ca. 5 mL) was added, and the mixture was warmed to 
room temperature.  The layers were separated, and the aqueous layer was extracted with 
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DCM (3 x 5 mL).  The organic layers were combined, dried (MgSO4), and concentrated 
to yield a yellow oil.  The crude mixture was purified by flash chromatography eluting 
with EtOAc/hexanes (1:1) to provide 66 mg (27% over 2 steps) of 2.241 as a clear oil.  
1
H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.1 Hz, 2 H), 7.40 (t, J = 7.1 Hz, 2 H), 7.34 (t, 
J = 7.1 Hz, 1 H), 5.04 (s, 2 H), 4.95 (br, 1 H), 4.19 (q, J = 7.1 Hz, 2 H), 3.89 (s, 3 H), 
3.88 (s, 3 H), 3.78, (s, 2 H), 3.67 (s, 3 H), 3.32 (q, J = 7.0 Hz, 2 H), 3.03 (t, J = 7.0 Hz, 2 
H), 1.29 (t, J = 7.1 Hz, 3 H); 
13
C NMR (125 MHz, CDCl3) δ 172.1, 157.3, 152.2, 149.6, 
145.9, 137.2, 133.2, 128.7 (2C), 128.6 (3C), 128.4, 115.9, 75.4, 61.2 (2C), 61.0, 52.3, 
40.4, 33.9, 33.4, 14.4; IR (DCM) 3367, 1731, 1526, 1463, 1407, 1327, 1242, 1189, 1107, 
1025; HRMS (ESI) m/z calculated for C23H29NO7Br
79+
 (M+1), 510.11219; found, 
510.1125; mass spectrum, 510, 532 (M +1+Na) (base). 
 NMR Assignments: 
1
H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.1 Hz, 2 H, 
C13-H), 7.40 (t, J = 7.1 Hz, 2 H, C14-H), 7.34 (t, J = 7.1 Hz, 1 H, C15-H), 5.04 (s, 2 H, 
C11-H), 4.95 (br, 1 H, NH), 4.19 (q, J = 7.1 Hz, 2 H, C18-H), 3.89 (s, 3 H, C9 or C10-
H), 3.88 (s, 3 H, C9 or C10-H), 3.78, (s, 2 H, C16-H), 3.67 (s, 3 H, C21-H), 3.32 (q, J = 
7.0 Hz, 2 H, C8-H), 3.03 (t, J = 7.0 Hz, 2 H, C7-H), 1.29 (t, J = 7.1 Hz, 3 H, C19-H); 
13
C 
NMR (125 MHz, CDCl3) δ 172.1 (C17), 157.3 (C20), 152.2 (C3), 149.6 (C5), 145.9 
(C4), 137.2 (CAr), 133.2 (CAr), 128.7 (2C, CAr), 128.6 (3C, CAr), 128.4 (CAr), 115.9 
(CAr), 75.4 (C11), 61.2 (2C, C9, C10, or C18), 61.0 (C9, C10, or C18), 52.3 (C21), 40.4 
(C8 or C16), 33.9 (C8 or C16), 33.4 (C7), 14.4 (C19). 
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2.242 
 Ethyl 2-(4-hydroxy-2,3-dimethoxy-6-(2-
(methoxycarbonylamino)ethyl)phenyl)acetate (2.242).  (ab04113).  A solution of 
benzyl ether 2.241 (67 mg, 0.13 mmol) and Pd/C (10 % by wt, 14 mg) in MeOH (5 mL) 
was evacuated with a vacuum pump and backfilled with H2 (balloon) (3x).  The reaction 
was stirred at room temperature for 24 h.  The solids were removed by vacuum filtration 
through a fritted funnel containing a layer of celite, washing with MeOH.  The filtrate 
was concentrated, and H2O (ca. 10 mL) and DCM (ca. 10 mL) were added.  The layers 
were separated, and the aqueous layer was extracted with DCM (2 x 5 mL).  The organic 
layers were combined, dried (Na2SO4), and concentrated.  The residue was purified by 
flash chromatography eluting with EtOAc/hexanes (1:1) to provide 28 mg (64%) of 2.242 
as a clear oil.  
1
H NMR (500 MHz, CDCl3) δ 6.57 (s, 1 H), 5.79 (s, 1 H), 4.93 (br, 1 H), 
4.17 (q, J = 7.1 Hz, 2 H), 3.88 (s, 3 H), 3.83 (s, 3 H), 3.66 (br, 3 H), 3.63 (s, 2 H), 3.36 (q, 
J = 6.6 Hz, 2 H), 2.72 (t, J = 6.6 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3 H); 
13
C NMR (125 MHz, 
CDCl3) δ 172.6, 157.3, 151.6, 148.8, 138.5, 134.1, 119.2, 111.6, 61.1, 60.7, 60.4, 52.3, 
41.8, 33.3, 32.0, 14.4; IR (DCM) 3366, 2849, 2362, 1706, 1493, 1461, 1261, 1194, 1025; 
HRMS (CI) m/z calculated for C16H24NO7
+
 (M+1), 342.1553; found, 342.1550; mass 
spectrum, 342 (base). 
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NMR Assignments: 
1
H NMR (500 MHz, CDCl3) δ 6.57 (s, 1 H, C2-H), 5.79 (s, 
1 H, OH), 4.93 (br, 1 H, NH), 4.17 (q, J = 7.1 Hz, 2 H, C13-H), 3.88 (s, 3 H, C9 or C10-
H), 3.83 (s, 3 H, C9 or C10-H), 3.66 (br, 3 H, C16-H), 3.63 (s, 2 H, C11-H), 3.36 (q, J = 
6.6 Hz, 2 H, C8-H), 2.72 (t, J = 6.6 Hz, C7-H), 1.26 (t, J = 7.1 Hz, 3 H, C14-H); 
13
C 
NMR (125 MHz, CDCl3) δ 172.6 (C12), 157.3 (C15), 151.6 (C5), 148.8 (CAr), 138.5 
(CAr), 134.1 (CAr), 119.2 (CAr), 111.6 (CAr), 61.1 (C9, C10 or C13), 60.7 (C9, C10, or 
C13), 60.4 (C9, C10, or C13), 52.3 (C16), 41.8 (C8), 33.3 (C7 or C11), 32.0 (C7 or C11), 
14.4 (C14). 
 
 
2.244 
Ethyl 2-(3-acetoxy-2,3-dimethoxy-6-(2-(methoxycarbonylamino)ethyl)-4-
oxocyclohexa-1,5-dienyl)acetate (2.244).  (ab04101).  Iodobenzene diacetate (39 mg, 
0.12 mmol) was added to a solution of phenol 2.242 (40 mg, 0.12 mmol) in 
hexafluoroisopropanol (5 mL) at 0 °C.  The reaction was stirred for 1.5 h, and the solvent 
was evaporated under reduced pressure.  NaHCO3(sat) (ca. 5 mL) and DCM (ca. 5 mL) 
were added to the residue, and the layers were separated.  The aqueous layer was 
extracted with DCM (3 x 5 mL), and the organic layers were combined, dried (MgSO4), 
and concentrated to give 17 mg (35%) of 2.244 as a yellow oil.  
1
H NMR (600 MHz, 
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CDCl3) δ 5.81 (s, 1 H), 4.94 (br, 1 H), 4.16 (q, J = 7.1 Hz, 2 H), 3.89 (s, 3 H), 3.67 (br, 3 
H), 3.47 (d, J = 16.8 Hz, 1 H), 3.42 (s, 3 H), 3.36 (m, 2 H), 3.26 (d, J = 16.8 Hz, 1 H), 
2.56 (t, J = 6.8 Hz, 2 H), 2.14 (s, 3 H), 1.26 (t, J = 7.1 Hz, 3 H); 
13
C NMR (150 MHz, 
CDCl3) δ 189.7, 171.0, 168.8, 156.9, 156.0, 155.7, 119.4, 114.8, 93.7, 61.1, 59.6, 52.2, 
50.9, 39.2, 34.4, 31.1, 20.4, 14.2; IR (DCM) 3382, 1730, 1527, 1463, 1275, 1260, 1084, 
1026; LRMS (APCI/ESI) m/z calculated for C18H25NO9
+
 (M+1), 400.39; found, 340.2 
(M+1-OAc); mass spectrum, 340 (base). 
NMR Assignments: 
1
H NMR (600 MHz, CDCl3) δ 5.81 (s, 1 H, C2-H), 4.94 (br, 
1 H, NH), 4.16 (q, J = 7.1 Hz, 2 H, C13-H), 3.89 (s, 3 H, C9-H), 3.67 (br, 3 H, C16-H), 
3.47 (d, J = 16.8 Hz, 1 H, C11-H), 3.42 (s, 3 H, C10-H), 3.36 (m, 2 H, C8-H), 3.26 (d, J 
= 16.8 Hz, 1 H, C11-H), 2.56 (t, J = 6.8 Hz, 2 H, C7-H), 2.14 (s, 3 H, C18-H), 1.26 (t, J = 
7.1 Hz, 3 H, C14-H); 
13
C NMR (150 MHz, CDCl3) δ 189.7 (C3), 171.0 (C12 or C17), 
168.8 (C12 or C17), 156.9 (C15), 156.0 (C5 or C7), 155.7 (C5 or C7), 119.4 (C4, C6, or 
C2), 114.8 (C4, C5, or C2), 93.7 (C4, C5, or C2), 61.1 (C13), 59.6 (C9), 52.2 (C10 or 
C16), 50.9 (C10 or C16), 39.2 (C7, C8, or C11), 34.4 (C7, C8, or C11), 31.1 (C7, C8, or 
C11), 20.4 (C18), 14.2 (C14). 
 
2.252 
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 Ethyl 6-(benzyloxy)-7,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline-1-
carboxylate (2.252). (ab04257).  A deoxygenated (freeze/pump/thaw x 3) mixture of 
2.237 (627 mg, 1.32 mmol), Pd(OAc)2 (58 mg, 0.260 mmol), PPh3 (68 mg, 0.260 mmol), 
K2CO3 (365 mg, 2.64 mmol), and NH4HCO2 (416 mg, 6.60 mmol) in EtOH (7 mL) was 
heated under reflux for 2.5 h, whereupon it as allowed to cool to room temperature.  The 
mixture was then vacuum filtered through a fritted funnel containing a layer of Celite, 
washing with EtOH (ca. 10 mL).  The combined filtrate and washings were collected and 
concentrated under reduced pressure.  Et2O (ca. 20 mL) and H2O (ca. 20 mL) were added 
to the residue, and the layers were separated.  The aqueous layer was extracted with Et2O 
(2 x 30 mL), and the organic layers were combined, washed (ca. 100 mL brine), dried 
(MgSO4), and concentrated under reduced pressure.  The crude mixture was purified by 
flash chromatography eluting with MeOH/CH2Cl2 (5:95) to provide 250 mg (51%) of 
2.252 as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.46-7.30 (comp, 5 H), 6.48 (s, 1 
H), 5.09 (s, 2 H), 4.68 (s, 1 H), 4.23 (q, J = 6.8 Hz, 2 H), 3.87 (s, 3 H), 3.85 (s, 3 H), 
3.06-3.04 (comp, 2 H), 2.78-2.63 (comp, 2 H), 2.07 (br, 1 H), 1.30 (t, J = 6.8 Hz, 3 H).  
LCMS (ESI/APCI) m/z calculated for C21H25NO5
+
 (M+1), 372; found, 372. 
NMR Assignments:  
1
H NMR (400 MHz, CDCl3) δ 7.46-7.30 (comp, 5 H, H-
Ar), 6.48 (s, 1 H, C3-H), 5.09 (s, 2 H, C11-H), 4.68 (s, 1 H, C19-H), 4.23 (q, J = 6.8 Hz, 
2 H, C17-H), 3.87 (s, 3 H, C9 or C10-H), 3.85 (s, 3 H, C9 or C10-H), 3.06-3.04 (comp, 2 
H, C8-H), 2.78-2.63 (comp, 2 H, C7-H), 2.07 (br, 1 H, N-H) 1.30 (t, J = 6.8 Hz, 3 H, 
C18-H). 
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2.238 
 Ethyl 2-(6-(2-aminoethyl)-4-(benzyloxy)-2,3-dimethoxyphenyl)acetate 
(2.238).  (ab04158).  SmI2 (0.2 M in THF, 13.5 mL, 2.7 mmol) was added to a 
deoxygenated (freeze/pump/thaw x 3) solution of 2.252 (147 mg, 0.4 mmol), HMPA 
(0.47 mL, 484 mg, 2.7 mmol), and MeOH (0.10 mL, 79 mg, 2.7 mmol) in THF (1 mL) at 
room temperature.  The reaction was then stirred for 16 h, whereupon Celite, NaHCO3 
(sat.) (ca. 2 mL), and Et2O (ca. 2 mL) were added.  The mixture was vacuum filtered 
through a fritted funnel containing a layer of Celite, washing with H2O (ca. 5 mL) and 
Et2O (ca. 5 mL).  The combined filtrate and washings were collected and the layers were 
separated.  The aqueous layer was extracted with Et2O (3 x 20 mL), and the organic 
layers were combined, dried (MgSO4) and concentrated under reduced pressure.  The 
crude product was washed with H2O (in order to remove any remaining HMPA), diluted 
with Et2O (ca. 5 mL), dried (MgSO4), and concentrated under reduced pressure.  The 
crude mixture was purified by flash chromatography eluting with MeOH/CH2Cl2 (1:10) 
to provide 37 mg (25%) of 2.238 as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.5 (d, 2 
H), 7.4 (t, 3 H), 6.7 (s, 1 H), 5.2 (s, 2 H), 4.2 (q, 2 H), 3.8 (s, 3 H), 3.8 (s, 3 H), 3.7 (s, 2 
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H), 3.3 (t, 2 H), 3.1 (t, 2 H), 1.3 (t, 3 H).  LCMS (ESI/APCI) m/z calculated for 
C21H27NO5
+
 (M+1), 374; found, 374. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.5 (d, 2 H, C13-H), 7.4 (t, 3 
H, C14 and C15-H), 6.7 (s, 1 H, C3-H), 5.2 (s, 2 H, C11-H), 4.2 (q, 2 H, C17-H), 3.8 (s, 3 
H, C9 or C10-H), 3.8 (s, 3 H, C9 or C10-H), 3.7 (s, 2 H, C19-H), 3.3 (t, 2 H, C8-H), 3.1 
(t, 2 H, C7-H), 1.3 (t, 3 H, C18-H). 
 
 
2.269 
2-(3-(Benzyloxy)-2-bromo-4,5-dimethoxyphenyl)acetonitrile (2.269).  
(ab05059).  NaBH4 (117.0 mg, 3.1 mmol) was added portionwise to a solution of 
aldehyde 2.202 (1.0 g, 2.8 mmol) in MeOH (50 mL) at 0 ºC.  The reaction was stirred for 
1 h, warmed to room temperature, and concentrated under reduced pressure.  H2O (ca. 20 
mL) and Et2O (ca. 20 mL) were added to the residue, and the layers were separated.  The 
aqueous layer was extracted with Et2O (2 x 20 mL), and then the organic layers were 
combined, washed (1 x brine), dried (MgSO4), and concentrated under reduced pressure 
to yield 989 mg of the intermediate alcohol as a white solid.  The crude alcohol was 
dissolved in DCM (30 mL) and the solution was cooled to 0 ºC.  Et3N (0.04 mL, 0.28 
mmol) was added, followed by SOCl2 (0.3 mL, 4.2 mmol).  The ice bath was removed 
and the reaction was stirred at room temperature for 3 h.  NaHCO3 (sat.) (ca. 30 mL) was 
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added and the layers were separated.  The aqueous layer was extracted with DCM (2 x 30 
mL) and the organic layers were combined, dried (MgSO4) and concentrated under 
reduced pressure.  DMF (30 mL) was added to the residue, followed by NaCN (686 mg, 
14.0 mmol). The reaction was stirred at room temperature for 1 h before NaHCO3 (sat.) (ca. 
30 mL) and Et2O (ca. 30 mL) were added.  The layers were separated and the aqueous 
layer was extracted with Et2O (2 x 30 mL).  The organic layers were combined, washed 
(3 x H2O then 1 x brine), dried (MgSO4), and concentrated under reduced pressure to 
yield a tan oily solid.  The crude mixture was purified by flash chromatography eluting 
with EtOAc/hexanes (1:4) to provide 520 mg (51%) of nitrile 2.269 over 3 steps. 
1
H 
NMR (400 MHz, CDCl3) δ 7.6 (d, 2 H), 7.5-7.3 (m, 3 H), 6.9 (s, 1 H), 5.1 (s, 2 H), 3.95 
(s, 3 H), 3.90 (s, 3 H). 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.6 (d, 2 H, Ar-H), 7.5-7.3 
(m, 3 H, Ar-H), 6.9 (s, 1 H, C11-H), 5.1 (s, 2 H, C9-H), 3.95 (s, 3 H, C14 or C15-H), 
3.90 (s, 3 H, C14 or C15-H). 
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2.277 
Benzyl 3-(benzyloxy)-2-bromo-4,5-dimethoxyphenethylcarbamate (2.277).  
(ab05109).  CbzCl (0.12 mL, 0.87 mmol), was added to a solution of amine salt 2.236 
(233 mg, 0.58 mmol) and Et3N (0.16 mL, 1.16 mmol) in DCM (20 mL) at 0 ºC.  The 
reaction was stirred for 2.75 h, whereupon NaHCO3 (sat.) (ca. 30 mL) was added.  The 
layers were separated, and the aqueous layer was extracted with DCM (2 x 20 mL).  The 
organic layers were combined, dried (MgSO4) and concentrated under reduced pressure 
to yield a light yellow oil.  The crude mixture was purified by column chromatography 
eluting with EtOAc/hexanes (1:4) to provide 166 mg (57%) of carbamate 2.277 as a 
yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.6 (d, 2 H), 7.4-7.2 (comp, 8 H), 6.6 (s, 1 H), 
5.2 (s, 2 H), 5.0 (s, 2 H), 4.8 (br, 1 H), 3.9 (s, 3 H), 3.8 (s, 3 H), 3.4-3.5 (m, 2 H), 3.0-2.9 
(m, 2 H); LCMS (ESI/APCI) m/z calculated for C25H26BrNO5
+79
 (M+1), 500; found, 500; 
mass spectrum, 502 (M
+81
+1). 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.6 (d, 2 H), 7.4-7.2 (comp, 8 
H, Ar-H), 6.6 (s, 1 H, C10-H), 5.2 (s, 2 H, C5 or C15-H), 5.0 (s, 2 H, C5 or C15-H), 4.8 
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(br, 1 H, N-H), 3.9 (s, 3 H, C19 or C20-H), 3.8 (s, 3 H, C19 or C20-H), 3.4-3.5 (m, 2 H, 
C8-H), 3.0-2.9 (m, 2 H, C7-H). 
 
 
2.278 
Benzyl 3-(benzyloxy)-2-bromo-6-iodo-4,5-dimethoxyphenethylcarbamate 
(2.278).  (ab05118). A round bottom flask containing a stirbar and AgOTf (33 mg, 0.15 
mmol) was flame dried under vacuum.  The flask was then cooled to 0 ºC and a solution 
of carbamate 2.277 (73 mg, 0.15 mmol, azeotroped 3x with benzene) in DCM (4 mL), 
and neat iodine (38 mg, 0.15 mmol) were added.  The reaction was stirred for 1 h before 
being warmed to room temperature and vacuum filtered through a coarse fritted funnel 
containing a layer of celite. The residue and celite were washed with DCM (ca. 10 mL) 
and then the filtrate and washings were collected and concentrated under reduced 
pressure to yield a white solid.  The crude mixture was purified by column 
chromatography eluting with EtOAc/hexanes (1:4) to provide 52 mg (55%) of aryl iodide 
2.278 as well as 10 mg (14%) of RSM 2.277.  
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, 2 
  
 
317 
H), 7.41-7.33 (m, 8 H), 5.11 (s, 2 H), 5.04 (2, 2 H), 4.90 (br, 1 H), 3.89 (s, 3 H), 3.88 (s, 3 
H), 3.48-3.40 (m, 2 H), 3.37-3.33 (m, 2 H); LCMS (ESI/APCI) m/z calculated for 
C25H25BrINO5
+79
(M+1), 626; found, 636. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, 2 H, Ar-H 7.41-7.33 
(m, 8 H, Ar-H), 5.11 (s, 2 H, C7 or C15-H), 5.04 (2, 2 H, C7 or C15-H), 4.90 (br, 1 H, N-
H), 3.89 (s, 3 H, C19 or C20-H), 3.88 (s, 3 H, C19 or C20-H), 3.48-3.40 (m, 2 H, C8-H), 
3.37-3.33 (m, 2 H, C7-H). 
 
 
2.280 
Benzyl 2-allyl-5-(benzyloxy)-6-bromo-3,4-dimethoxyphenethylcarbamate 
(2.280). (ab05125).  A slurry of aryl iodide 2.278 (29 mg, 0.046 mmol), 
allyltributylstannane (13 uL, 0.041 mmol), and Pd(PPh3)Cl2 (6.0 mg) in DMF (0.5 mL) 
was deoxygenated via freeze/pump/thaw 3x.  The reaction was then stirred under reflux 
for 1.5 h.  The mixture was cooled to room temperature and vacuum filtered through a 
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fritted funnel containing a layer of celite.  The residue and celite were washed with Et2O 
(ca. 10 mL), and the filtrate and washings were transferred to a separatory funnel where 
they were washed with (3 x ca. 10 mL H2O).  The organic layer was dried (MgSO4) and 
concentrated under reduced pressure.  The crude mixture was purified by column 
chromatography eluting with EtOAc/hexanes (1:9) to yield the desired product 2.280 
contaminated with a tin byproduct.  
1
H NMR (400 MHz, CDCl3) δ 7.6 (d, 2 H), 7.5-7.3 
(comp, 8 H), 6.0-5.9 (m, 1 H), 5.2-4.8 (comp, 6 H), 3.9 (s, 3 H), 3.8 (s, 3 H), 3.5-3.4 (m, 
2 H), 3.4-3.3 (m, 2 H), 3.0 (t, 2 H); LRMS (ESI/APCI) m/z calculated for 
C28H30BrNO5
+79
 (M+1), 540; found, 540; mass spectrum, 542 (M
+81
+1). 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.6 (d, 2 H, Ar-H), 7.5-7.3 
(comp, 8 H, Ar-H), 6.0-5.9 (m, 1 H, C22-H), 5.2-4.8 (comp, 6 H, C7, C15, C23-H), 3.9 
(s, 3 H, C19-H), 3.8 (s, 3 H, C20-H), 3.5-3.4 (m, 2 H, 21-H), 3.4-3.3 (m, 2 H, C7 or C8-
H), 3.0 (t, 2 H, C7 or C8-H). 
 
 
3.70 
 
(S)-4-Benzyl-3-pentanoyloxazolidin-2-one (3.70). (JT-03-180).  Pivaloyl 
chloride (816 mg, 834 L, 6.77 mmol) was added to a solution of valeric acid (576 mg, 
903 L, 5.64 mmol) and Et3N (1.14 g, 1.57 mL, 11.3 mmol) in THF (10 mL) at -15 ºC. 
After stirring at this temperature for 2 h, LiCl (287 mg, 6.77 mmol) was added. A 
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solution of auxiliary 3.69 (1.29 g, 6.77 mmol) in THF (15 mL) was then added dropwise, 
the cooling bath was removed, and the reaction mixture was stirred at room temperature 
for 3.5 h. EtOAc (50 mL) was added to the reaction mixture, and the mixture was washed 
with saturated NaHCO3 (3 x 15 mL). The organic layer was separated, and the aqueous 
layer was extracted with EtOAc (15 mL). The combined organic layers were dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with hexane/EtOAc (5/1) to give 1.15 g (78%) of 3.70 as 
colorless oil; 
1
H NMR (400 MHz, CDCl3) δ 7.34-7.32 (comp, 2 H), 7.30-7.27 (m, 1 H), 
7.23-7.21 (comp, 2 H), 4.71-4.65 (m, 1 H), 4.23-4.15 (comp, 2 H), 3.30 (dd, J = 3.2, 13.6 
Hz, 1 H), 3.03-2.89 (comp, 2 H), 2.77 (dd, J = 9.6, 13.6 Hz, 1 H), 1.73-1.63 (comp, 2 H), 
1.42 (hex, J = 7.2 Hz, 2 H), 0.96 (t, J = 7.2, 3 H); 
13
C NMR (100 MHz, CDCl3) 173.7, 
153.7, 135.6, 129.7, 129.2, 127.6, 66.4, 55.4, 38.1, 35.5, 26.6, 22.5, 14.1; IR (DCM) 
3385, 1778, 1697, 1385, 1352, 1197; HRMS (CI) m/z calcd for C15H20NO3
+
 (M + 1), 
262.1443; found, 262.1438. 
NMR Assignment. 
 1
H NMR (400 MHz, CDCl3) δ 7.34-7.32 (comp, 2 H, C11-
H), 7.30-7.27 (m, 1 H, C12-H), 7.23-7.21 (comp, 2 H, C10-H), 4.71-4.65 (m, 1 H, C7-H), 
4.23-4.15 (comp, 2 H, C13-H), 3.30 (dd, J = 3.2, 13.6 Hz, 1 H, C8-H), 3.03-2.89 (comp, 
2 H, C4-H), 2.77 (dd, J = 9.6, 13.6 Hz, 1 H, C8-H), 1.73-1.63 (comp, 2 H, C3-H), 1.42 
(hex, J = 7.2 Hz, 2 H, C2-H), 0.96 (t, J = 7.2, 3 H, C1-H); 
13
C NMR (100 MHz, CDCl3) 
173.7 (C5), 153.7 (C6), 135.6 (C9), 129.7 (C11), 129.2 (C10), 127.6 (C12), 66.4 (C13), 
55.4 (C7), 38.1 (C8), 35.5 (C4), 26.6 (C3), 22.5 (C2), 14.1 (C1). 
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3.72 
Benzyl 3-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)hexanoate (3.72). (JT-03-
192). NaHMDS (1.78 M, 191 L, 0.34 mmol) was added to a solution of 3.70 (68.3 mg, 
0.26 mmol) in THF (3 mL) at -78 °C. The solution was stirred for 1 h, and a solution of 
benzyl 2-bromoacetate (3.71) (83 mg, 0.36 mmol) in THF (1.5 mL) was added. The 
resulting solution was stirred at -78 °C for 2 h and quenched with saturated NH4Cl (2 
mL). The mixture was extracted with EtOAc (3 X 10 mL), and the combined organic 
layers were dried (Na2SO4) and concentrated under reduced pressure. The crude product 
was purified by flash chromatography, eluting with hexane/EtOAc (9/1 to 7/1) to give 
523 mg (70%) of 3.72 as colorless oil; 
1
H NMR (400 MHz, CDCl3) δ 7.35-7.21 (comp, 
10 H), 5.11 (s, 2 H), 4.65-4.61 (m, 1 H), 4.30-4.26 (m, 1 H), 4.18-4.09 (m, 2 H), 3.24 (dd, 
J = 2.8, 13.6 Hz, 1 H), 2.98 (dd, J = 11.2, 17.2 Hz, 1 H), 2.62 (dd, J = 4.4, 17.2 Hz, 1 H), 
2.48 (dd, J = 10.4, 13.6 Hz, 1 H), 1.71-1.62 (m, 1 H), 1.52-1.32 (comp, 3 H), 0.92 (t, J = 
7.2 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 176.0, 172.2, 153.3, 136.0, 136.0, 129.7, 
129.1, 128.8, 128.6, 128.5, 127.4, 66.8, 66.1, 55.8, 39.2, 37.5, 36.1, 34.5, 20.3, 14.2; IR 
(DCM) 3450, 1781, 1734, 1697, 1387, 1350, 1174; HRMS (CI) m/z calcd for 
C24H28NO5
+
 (M + 1), 410.1967; found, 410.1942. 
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NMR Assignment.
 1
H NMR (400 MHz, CDCl3) δ 7.35-7.21 (comp, 10 H, C11-H 
& C12-H & C13-H & C17-H & C18-H & C19-H), 5.11 (s, 2 H, C9-H), 4.65-4.61 (m, 1 
H, C14-H), 4.30-4.26 (m, 1 H, C4-H), 4.18-4.09 (m, 2 H, C20-H), 3.24 (dd, J = 2.8, 13.6 
Hz, 1 H, C15-H), 2.98 (dd, J = 11.2, 17.2 Hz, 1 H, C7-H), 2.62 (dd, J = 4.4, 17.2 Hz, 1 H, 
C7-H), 2.48 (dd, J = 10.4, 13.6 Hz, 1 H, C15-H), 1.71-1.62 (m, 1 H, C3-H), 1.52-1.32 
(comp, 3 H, C3-H & C2-H), 0.92 (t, J = 7.2 Hz, 3 H, C1-H); 
13
C NMR (100 MHz, 
CDCl3) δ 176.0 (C8), 172.2 (C5), 153.3 (C6), 136.0 (C10 & C16), 129.7 (C18), 129.1 
(C17), 128.8 (C12), 128.6 (C11), 128.5 (C13), 127.4 (C19), 66.8 (C9), 66.1 (C20), 55.8 
(C14), 39.2 (C4), 37.5 (C15), 36.1 (C7), 34.5 (C3), 20.3 (C2), 14.2 (C1). 
 
 
3.73 
(R)-3-((S)-4-Benzyl-2-oxooxazolidine-3-carbonyl)hexanoic acid (3.73). (JT-
03-194).  A mixture of 3.72 (523 mg, 1.28 mmol) and Pd/C (109 mg, 0.102 mmol) in 
EtOH (10 mL) was stirred under 1 atm of H2 at room temperature for 2 h. The mixture 
was filtered through a celite plug, which was washed with EtOH (8 mL). The combined 
filtrate and washings were concentrated under reduced pressure to give 406 mg (99%) of 
3.73 as colorless oil.  The product was sufficiently pure by 
1
H NMR to carry on without 
further purification; 
1
H NMR (400 MHz, CDCl3) δ 7.36-7.24 (comp, 5 H), 4.69-4.65 (m, 
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1 H), 4.23-4.16 (comp, 3 H), 3.28 (dd, J = 3.2, 13.6 Hz, 1 H), 2.95 (dd, J = 10.8, 17.6 Hz, 
1 H), 2.75 (dd, J = 10.0, 13.6 Hz, 1 H), 2.59 (dd, J = 4.0, 17.6 Hz, 1 H), 1.68-1.61 (m, 1 
H), 1.51-1.32 (comp, 3 H), 0.92 (t, J = 7.6 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 
177.0, 175.9, 153.3, 135.7, 129.8, 129.2, 127.5, 66.2, 55.8, 39.1, 37.6, 35.4, 34.3, 20.3, 
14.2; IR (DCM) 3422, 2361, 1780, 1699, 1390, 1213, 1195; HRMS (CI) m/z calcd for 
C17H22NO5
+
 (M + 1), 320.1498; found, 320.1496. 
NMR Assignment.
 1
H NMR (400 MHz, CDCl3) δ 7.36-7.24 (comp, 5 H, C12-H 
& C13-H & C14-H), 4.69-4.65 (m, 1 H, C9-H), 4.23-4.16 (comp, 3 H, C4-H & C15-H), 
3.28 (dd, J = 3.2, 13.6 Hz, 1 H, C10-H), 2.95 (dd, J = 10.8, 17.6 Hz, 1 H, C7-H), 2.75 
(dd, J = 10.0, 13.6 Hz, 1 H, C10-H), 2.59 (dd, J = 4.0, 17.6 Hz, 1 H, C7-H), 1.68-1.61 
(m, 1 H, C3-H), 1.51-1.32 (comp, 3 H, C2-H & C3-H), 0.92 (t, J = 7.6 Hz, 3 H, C1-H); 
13
C NMR (100 MHz, CDCl3) δ 177.0 (C8), 175.9 (C5), 153.3 (C6), 135.7 (C11), 129.8 
(C13), 129.2 (C12), 127.5 (C14), 66.2 (C15), 55.8 (C9), 39.1 (C10), 37.6 (C4), 35.4 (C7), 
34.3 (C3), 20.3 (C2), 14.2 (C1). 
 
 
3.74 
tert-Butyl (R)-2-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)pentylcarbamate 
3.74.  (ab05249).  Ethyl chloroformate (250 mg, 0.22 mL, 2.3 mmol) was added to a 
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solution of acid 3.73 (670 mg, 2.1 mmol) and Et3N (254 mg, 0.35 mL, 2.5 mmol) in 
acetone (15 mL) at 0 ºC.  The reaction was stirred for 2 h, and a solution of NaN3 (345 
mg, 5.3 mmol) in H2O (15 mL) was added.  The reaction was stirred for 2 h and then 
concentrated in a cold rotovap (0 ºC) bath to remove the acetone.  Benzene (ca. 15 mL) 
was added to the mixture, and the layers were separated.  The aqueous layer was 
extracted with benzene (2 x 10 mL), and the organic layers were combined, dried 
(MgSO4), and concentrated in vacuo.  Toluene (ca. 80 mL) was added to the residue, and 
the solution was stored in the freezer overnight.  The solution was then heated under 
reflux, and the toluene was removed by distillation until only about 5 mL remained.  t-
BuOH (5 mL) was added to the solution, and the mixture was heated at 80 ºC for 17 h 
before being cooled to room temperature and concentrated under reduced pressure.  The 
crude product was purified by flash chromatography eluting with hexane/EtOAc (4/1) to 
give 471 mg (57%) of 3.74 as colorless oil; 
1
H NMR (500 MHz, DMSO, 130 °C) δ 7.31 
(t, J = 7.6 Hz, 2 H), 7.24 (t, J = 6.9 Hz, 3 H), 6.08 (br, 1 H), 4.70 (hep, J  = 3.4 Hz, 1 H), 
4.33 (t, J = 8.5 Hz, 1 H), 4.14 (dd, J = 3.4, 8.5 Hz, 1 H), 3.90 (q, J  = 6.4 Hz, 1 H), 3.32-
3.23 (comp, 2 H), 3.17 (dd, J = 3.4, 13.9 Hz, 1 H), 2.89 (dd, J = 8.5, 13.9 Hz, 1 H), 1.62 
(hex, J = 7.3 Hz, 1 H), 1.50-1.40 (comp, 10 H), 1.37-1.28 (comp, 2 H), 0.88 (t, J = 7.3 
Hz, 3 H);  
13
C NMR (125 MHz, DMSO, 130 °C) δ 173.9, 154.8, 152.3, 135.4, 128.6, 
128.6, 127.7, 127.7, 126.0, 77.2, 65.5, 54.1, 42.4, 41.4, 36.7, 31.0, 27.6, 27.6, 27.6, 18.7, 
12.9; IR (DCM) 3405, 2264, 1779, 1697, 1505, 1390, 1259, 1211, 1171; HRMS (CI) m/z 
calcd for C21H31N2O5
+
 (M + 1), 391.2233; found, 391.2237. 
NMR Assignment. 
1
H NMR (500 MHz, DMSO, 130 °C) δ 7.31 (t, J = 7.6 Hz, 2 
H, C14-H), 7.24 (t, J = 6.9 Hz, 3 H, C15 and C16-H), 6.08 (br, 1 H, N-H), 4.70 (hep, J  = 
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3.4 Hz, 1 H, C11-H), 4.33 (t, J = 8.5 Hz, 1 H, C17-H), 4.14 (dd, J = 3.4, 8.5 Hz, 1 H, 
C17-H), 3.90 (q, J  = 6.4 Hz, 1 H, C4-H), 3.32-3.23 (comp, 2 H, C7-H), 3.17 (dd, J = 3.4, 
13.9 Hz, 1 H, C12-H), 2.89 (dd, J = 8.5, 13.9 Hz, 1 H, C12-H), 1.62 (hex, J = 7.3 Hz, 1H, 
C3-H), 1.50-1.40 (comp, 10 H, C3-H and C10-H), 1.37-1.28 (comp, 2 H, C2-H), 0.88 (t, 
J = 7.3 Hz, 3 H, C1-H);  
13
C NMR (125 MHz, DMSO, 130 °C) δ 173.9 (C5), 154.8 (C6 
or C8), 152.3 (C6 or C8), 135.4 (C13), 128.6 (C14), 128.6 (C14), 127.7 (C15), 127.7 
(C15), 126.0 (C16), 77.2 (C9), 65.5 (C17), 54.1 (C11), 42.4 (C7, C4 or C12), 41.4 (C7, 
C4 or C12), 36.7 (C7, C4, or C12), 31.0 (C3), 27.6 (C10), 27.6 (C10), 27.6 (C10), 18.7 
(C2), 12.9 (C1).  
 
 
3.75 
(R)-Benzyl 2-((tert-butoxycarbonylamino)methyl)pentanoate 3.75.  
(ab05207).  n-BuLi (0.51 mL, 2.1 M in hexanes, 1.08 mmol) was added to solution of 
BnOH (157 mg, 0.15 mL, 1.44 mmol) in THF (5 mL) at -15 to -20 ºC.  The reaction was 
stirred for 2 h, whereupon a solution of amide 3.74 (280 mg, 0.72 mmol) in THF (14 mL) 
was added dropwise.  After stirring the mixture for 4 h, H2O (5 mL) was added, and the 
reaction was warmed to room temperature.  The layers were separated, and the aqueous 
layer was extracted with Et2O (2 x 10 mL).  The organic layers were combined, dried 
(MgSO4), and concentrated in vacuo.  The crude product was purified by flash 
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chromatography eluting with hexane/EtOAc (4/1) to give 161 mg (70%) of 3.75 as 
colorless oil; 
1
H NMR (400 MHz, CDCl3) δ 7.38-7.27 (comp, 5 H), 5.14 (s, 2 H), 4.88 
(br, 1 H), 3.39-3.21 (comp, 2 H), 2.68-2.61 (m, 1 H), 1.66-1.19 (comp, 13 H), 0.89 (t, J = 
7.2 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 175.3, 155.8, 135.9, 128.6, 128.6, 128.2, 
128.2, 128.1, 79.3, 66.3, 45.5, 41.6, 31.9, 28.3, 28.3, 28.3, 20.3, 13.9; IR (DCM) 3383, 
2506, 1715, 1504, 1455, 1366, 1252, 1170; HRMS (CI) m/z calcd for C18H28NO4
+
 (M + 
1), 322.2018; found, 322.2010. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ 7.38-7.27 (comp, 5 H, C12, 
C13, and C14-H), 5.14 (s, 2 H, C6-H), 4.88 (br, 1 H, N-H), 3.39-3.21 (comp, 2 H, C7-H), 
2.68-2.61 (m, 1 H, C4-H), 1.66-1.19 (comp, 13 H, C3, C2, C10-H), 0.89 (t, J = 7.2 Hz, 3 
H, C1-H); 
13
C NMR (100 MHz, CDCl3) δ 175.3 (C5), 155.8 (C8), 135.9 (C11), 128.6 
(C12), 128.6 (C12), 128.2 (C13), 128.2 (C13), 128.1 (C14), 79.3 (C9), 66.3 (C6), 45.5 
(C7 or C4), 41.6 (C7 or C4), 31.9 (C3), 28.3 (C10), 28.3 (C10), 28.3 (C10), 20.3 (C2), 
13.9 (C1). 
 
 
3.76 
(R)-Benzyl 2-(aminomethyl)pentanoate hydrochloride salt 3.76.  (ab05208).  
A solution of HCl in dioxane (5 mL, ca. 4 M) was added to a round-bottom flask 
containing amide 3.75 (161 mg. 0.50 mmol) at room temperature.  The reaction was 
stirred for 21 h, and the solvents were removed in vacuo.  The crude product was washed 
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with cold hexanes to yield 128 mg (quant.) of 3.76  as a viscous oil; 
1
H NMR (400 MHz, 
CD3OD) δ 7.40-7.32 (comp, 5 H), 5.20 (dd, J = 12.0, 35.6 Hz, 2 H), 3.22 (dd, J = 9.0, 
13.0 Hz, 1 H), 3.06 (dd, J = 4.4, 13.0 Hz, 1 H), 2.86-2.79 (m, 1 H), 1.70-1.54 (comp, 2 
H), 1.37-1.25 (comp, 2 H), 0.90 (t, J = 7.4 Hz, 3 H); 
13
C NMR (100 MHz, CD3OD) δ 
173.0, 135.7, 128.2, 128.2, 128.2, 128.2, 128.1, 66.7, 42.6, 39.9, 31.7, 19.4, 12.7; IR 
(DCM) 3435, 2528, 2079, 1642, 1455; HRMS (ESI) m/z calcd for C13H20NO2
+
 (M+1), 
222.14886; found, 222.14862. 
NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.40-7.32 (comp, 5 H, C9, 
C10, and C11 H)), 5.20 (dd, J = 12.0, 35.6 Hz, 2 H, C6-H), 3.22 (dd, J = 9.0, 13.0 Hz, 1 
H, C7-H), 3.06 (dd, J = 4.4, 13.0 Hz, 1 H, C7-H), 2.86-2.79 (m, 1 H, C4-H), 1.70-1.54 
(comp, 2 H, C3-H), 1.37-1.25 (comp, 2 H, C2-H), 0.90 (t, J = 7.4 Hz, 3 H, C1-H); 
13
C 
NMR (100 MHz, CD3OD) δ 173.0 (C5), 135.7 (C8), 128.2 (C9), 128.2 (C9), 128.2 
(C10), 128.2 (C10), 128.1 (C11), 66.7 (C6), 42.6 (C7), 39.9 (C4), 31.7 (C3), 19.4 (C2), 
12.7 (C1). 
 
3.77 
(S)-Benzyl 5-((R)-2-(benzyloxycarbonyl)pentylamino)-4-(tert-
butoxycarbonylamino)-5-oxopentanoate 3.77.  (ab05211).  NMM (166 mg, 0.18 mL, 
1.62 mmol) was added to a solution of the HCl salt 3.76 (140 mg, 0.54 mmol), protected 
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glutamic acid NHBoc-E(OBn)-OH (183 mg, 0.54 mmol), EDCI·HCl (114 mg, 0.59 
mmol), and HOBt (146 mg, 1.08 mmol) in DMF (10 mL) at room temperature, and the 
reaction was stirred for 16 h.  NaHCO3(sat.) (40 mL) and Et2O (20 mL) were then added.  
The layers were separated, and the aqueous layer was extracted with Et2O (2 x 20 mL).  
The organic layers were combined, washed with H2O (4 x 80 mL) and NaCl(sat) (1 x 100 
mL), dried (MgSO4), and concentrated in vacuo.  The crude product was purified by flash 
chromatography eluting with hexane/EtOAc (1/2) to give 175 mg (60%) of 3.77 as 
colorless oil; 
1
H NMR (400 MHz, CD3OD) δ 7.35-7.28 (comp, 10 H), 5.15-5.03 (comp, 4 
H), 4.02 (dd, J = 5.6, 8.8 Hz, 1 H), 3.41 (dd, J = 5.8, 13.4 Hz, 1 H), 3.33-3.27 (comp, 1 
H), 2.73-2.66 (m, 1 H), 2.41 (t, J = 7.6 Hz, 2 H), 2.04-1.96 (m, 1 H), 1.87-1.77 (m, 1 H), 
1.60-1.42 (comp, 11 H), 1.32-1.23 (m, 2 H), 0.86 (t, J = 7.2 Hz, 3 H); 
13
C NMR (100 
MHz, CD3OD) δ 174.5, 173.2, 172.8, 156.3, 136.1, 136.1, 128.1, 128.1, 128.1, 128.1, 
128.1, 128.1, 128.1, 128.1, 128.0, 127.8, 79.3, 66.0, 66.0, 53.8, 44.9, 40.6, 31.65, 29.9, 
27.3, 27.3, 27.3, 27.2, 19.8, 12.8; IR (DCM) 3435, 2090, 1646, 1168; HRMS (ESI) m/z 
calcd for C30H40N2NaO7
+
 (M+22), 563.27277; found, 563.27328. 
NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.35-7.28 (comp, 10 H, 
CAr-H), 5.15-5.03 (comp, 4 H, C8 and C20-H), 4.02 (dd, J = 5.6, 8.8 Hz, 1 H, C4-H), 
3.41 (dd, J = 5.8, 13.4 Hz, 1 H, C14-H), 3.33-3.27 (comp, 1 H, C14-H), 2.73-2.66 (m, 1 
H, C15-H), 2.41 (t, J = 7.6 Hz, 2 H, C6-H), 2.04-1.96 (m, 1 H, C5-H), 1.87-1.77 (m, 1 H, 
C5-H), 1.60-1.42 (comp, 11 H, C1 and C16), 1.32-1.23 (m, 2 H, C17-H), 0.86 (t, J = 7.2 
Hz, 3H, C18-H); 
13
C NMR (100 MHz, CD3OD) δ 174.5 (C7 or C19), 173.2 (C7 or C19), 
172.8 (C13), 156.3 (C3), 136.1 (C9), 136.1 (C21), 128.1 (CAr), 128.1 (CAr), 128.1 
(CAr), 128.1 (CAr), 128.1 (CAr), 128.1 (CAr), 128.1 (CAr), 128.1 (CAr), 128.0 (C24 or 
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C12), 127.8 (C24 or C12), 79.3 (C2), 66.0 (C20 or C8), 66.0 (C20 or C8), 53.8 (C4), 44.9 
(C15), 40.6 (C14), 31.7 (C6), 29.9 (C5), 27.3 (C1), 27.3 (C1), 27.3 (C1), 27.2 (C16), 19.8 
(C17), 12.8 (C18). 
 
 
3.78 
(S)-Benzyl 4-amino-5-((R)-2-(benzyloxycarbonyl)pentylamino)-5-
oxopentanoate hydrochloride salt 3.78.  (ab05213).  A solution of HCl in dioxane (5 
mL, ca. 4 M) was added to a round-bottom flask containing amide 3.77 (175 mg. 0.32 
mmol) at room temperature.  The reaction was stirred for 16 h, and the solvents were then 
removed in vacuo.  The crude product was washed with cold hexanes to yield 151 mg 
(100%) of 3.78  as a viscous oil; 
1
H NMR (400 MHz, CD3OD) δ 7.36-7.26 (comp, 10 H), 
5.14-5.02 (comp, 4 H), 3.92 (t, J = 6.4 Hz, 1 H), 3.54 (dd, J = 5.2, 13.6 Hz, 1 H), 3.31-
3.24 (m, 1 H), 2.76-2.69 (m, 1 H), 2.56-2.46 (m, 2 H), 2.14-2.08 (m, 2 H), 1.63-1.59 (m, 
1 H), 1.51-1.42 (m, 1 H), 1.31-1.21 (m, 2 H), 0.86 (t, J = 7.2 Hz, 3 H); 
13
C NMR (100 
MHz, CD3OD) δ 174.3, 172.0, 168.4, 136.0, 135.9, 128.2, 128.2, 128.2, 128.2, 128.2, 
128.2, 128.2, 128.2, 128.0, 128.0, 66.3, 66.1, 52.1, 44.8, 40.9, 31.7, 28.8, 26.2, 19.8, 
12.8; IR (DCM) 3415, 2360, 2341, 1732, 1683, 1276, 1261; HRMS (ESI) m/z calcd for 
C25H32N2NaO5
+
 (M+22), 463.22034; found, 463.22062. 
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NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.36-7.26 (comp, 10 H, 
CAr-H), 5.14-5.02 (comp, 4 H, C8 and C20-H), 3.92 (t, J = 6.4 Hz, 1 H, C4-H), 3.54 (dd, 
J = 5.2, 13.6 Hz, 1 H, C14-H), 3.31-3.24 (m, 1 H, C14-H), 2.76-2.69 (m, 1 H, C15-H), 
2.56-2.46 (m, 2 H, C6-H), 2.14-2.08 (m, 2 H, C5-H), 1.63-1.59 (m, 1 H, C16-H ), 1.51-
1.42 (m, 1 H, C16-H), 1.31-1.21 (m, 2 H, C17-H), 0.86 (t, J = 7.2 Hz, 3 H, C18-H); 
13
C 
NMR (100 MHz, CD3OD) δ 174.3 (C7 or C19), 172.0 (C7 or C19), 168.4 (C13), 136.0 
(C21 or C9), 135.9 (C21 or C9), 128.2 (CAr), 128.2 (CAr), 128.2 (CAr), 128.2 (CAr), 
128.2 (CAr), 128.2 (CAr), 128.2 (CAr), 128.2 (CAr), 128.0 (C1 or C12), 128.0 (C1 or 
C12), 66.3 (C8 or C20), 66.1 (C8 or C20), 52.1 (C4), 44.8 (C15), 40.9 (C14), 31.7 (C6), 
28.8 (C5), 26.2 (C16), 19.8 (C17), 12.8 (C18). 
 
 
3.79 
(6S, 9S, 13R)-Benzyl 6,9-bis(3-(benzyloxy)-3-oxopropyl)-2,2-dimethyl-4,7,10-
trioxo-3-oxa-5,8,11-triazahexadecane-13-carboxylate 3.79.  (ab05215).  NMM (55 
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mg, 0.06 mL, 0.50 mmol) was added to a solution of the HCl salt 3.78 (80 mg, 0.17 
mmol), protected glutamic acid NHBoc-E(OBn)-OH (57 mg, 0.17 mmol), EDCI·HCl (35 
mg, 0.19 mmol), and HOBt (45 mg, 0.34 mmol) in DMF (5 mL) at room temperature, 
and the reaction was stirred for 16 h.  NaHCO3(sat.) (20 mL) and Et2O (10 mL) were then 
added.  The layers were separated, and the aqueous layer was extracted with Et2O (2 x 20 
mL).  The organic layers were combined, washed with H2O (4 x 40 mL) and NaCl(sat.) (1 
x 50 mL), dried (MgSO4), and concentrated in vacuo.  The crude product was purified by 
flash chromatography eluting with hexane/EtOAc (1/2) to give 81 mg (63%) of 3.79 as 
colorless oil; 
1
H NMR (400 MHz, CD3OD) δ 7.35-7.27 (comp, 15 H), 5.13-5.05 (comp, 6 
H), 4.32 (dd, J = 5.1, 8.9 Hz, 1 H), 4.04 (dd, J = 5.9, 8.3 Hz, 1 H), 3.40 (dd, J = 5.5, 13.5 
Hz, 1 H), 3.31-3.26 (m, 1 H), 2.72-2.67 (m, 1 H), 2.47-2.41 (comp, 4 H), 2.08-2.04 (m, 1 
H), 1.92-1.85 (m, 1 H), 1.59-1.53 (m, 1 H), 1.48-1.40 (comp, 11 H), 1.31-1.22 (comp, 3 
H), 0.86 (t, J = 7.4 Hz, 3 H); 
13
C NMR (100 MHz, CD3OD) δ 175.9, 174.5, 174.5, 174.3, 
173.5, 158.0, 137.60, 137.50, 137.59, 129.6, 129.6, 129.6, 129.6, 129.6, 129.6, 129.6, 
129.6, 129.6, 129.4, 129.4, 129.3, 129.3, 129.2, 129.2, 80.9, 67.5, 67.5, 55.5, 53.8, 46.4, 
42.2, 33.1, 31.4, 31.2, 28.8, 28.8, 28.8, 28.4, 28.1, 21.3, 14.2; IR (DCM) 3630, 3319, 
3282, 1734, 1645, 1521, 1456, 1391, 1366, 1251, 1168; HRMS (ESI) m/z calcd for 
C42H53N3NaO10
+
 (M+22), 783.36557; found, 783.36556. 
NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.35-7.27 (comp, 15 H, 
CAr-H), 5.13-5.05 (comp, 6 H, C8, C20, C30-H), 4.32 (dd, J = 5.1, 8.9 Hz, 1 H, C2 or 
C4-H), 4.04 (dd, J = 5.9, 8.3 Hz, 1 H, C2 or C4-H), 3.40 (dd, J = 5.5, 13.5 Hz, 1 H, C14-
H), 3.31-3.26 (m, 1 H, C14-H), 2.72-2.67 (m, 1 H, C15-H), 2.47-2.41 (comp, 4 H, C28 
and C6-H), 2.08-2.04 (m, 1 H, C5 or C27-H), 1.92-1.85 (m, 1 H, C5 or C27-H), 1.59-
  
 
331 
1.53 (m, 1 H, C5 or C27-H), 1.48-1.40 (comp, 11 H, C5 or C27-H, C26-H, C16-H), 1.31-
1.22 (comp, 3 H, C16, C17-H), 0.86 (t, J = 7.4 Hz, 3 H, C18-H); 
13
C NMR (100 MHz, 
CD3OD) δ 175.9 (C7, C19, or C29), 174.5 (C7, C19, or C29), 174.5 (C7, C19 or C29), 
174.3 (C13 or C3), 173.5 (C13 or C3), 158.0 (C1), 137.60 (C9, C21, or C31), 137.50 (C9, 
C21, or C31), 137.59 (C9, C21, or C31), 129.6 (CAr), 129.6 (CAr), 129.6 (CAr), 129.6 
(CAr), 129.6 (CAr), 129.6 (CAr), 129.6 (CAr), 129.6 (CAr), 129.6 (CAr), 129.4 (CAr), 
129.4 (CAr), 129.3 (CAr), 129.3 (C12, C24, or C34), 129.2 (C12, C24, or C34), 129.2 
(C12, C24, or C34), 80.9 (C25), 67.5 (C8, C20 or C30), 67.5 (C8, C20, or C30), 67.5 
(C3, C20, or C30), 55.5 (C2), 53.8 (C4), 46.4 (C15), 42.2 (C14), 33.1 (C6 or C28), 31.4 
(C6 or C28), 31.2 (C16), 28.8 (C26), 28.8 (C26), 28.8 (C26), 28.4 (C27 or C5), 28.1 (C27 
or C5), 21.3 (C17), 14.2 (C18). 
 
 
3.80 
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(5S, 8S, 11S, 15R)-Benzyl 8,11-bis(3-(benzyloxy)-3-oxopropyl)-5-(4-
(bis(benzyloxy)phosphoryloxy)benzyl)-3,6,9,12-tetraoxo-1-phenyl-15-propyl-2-oxa-
4,7,10,13-tetraazahexadecan-16-oate 3.80.  (ab06111). A solution of HCl in dioxanes 
(4 mL, 4 M) was added to a round-bottom flask containing amide 3.79 (110 mg, 0.14 
mmol).  The reaction was stirred for 20 h, and the solvents were removed in vacuo.  The 
residue was washed with cold Et2O to yield 100 mg of its HCl salt as a clear oil.  The 
crude salt was dissolved in DMF (2 mL), and protected phosphotyrosine NHZ-
pY(OBn)2-OH (81 mg, 0.14 mmol), EDCI·HCl (29 mg, 0.15 mmol), HOBt (38 mg, 0.28 
mmol), and NMM (46 mg, 0.05 mL, 0.42 mmol) were added.  The reaction was stirred at 
room temperature for 18 h, whereupon NaHCO3(sat.) (10 mL) and Et2O (5 mL) were 
added.  The layers were separated, and the aqueous layer was extracted with Et2O (2 x 10 
mL).  The organic layers were combined, washed with H2O (4 x 20 mL) and NaCl (1 x 
20 mL), dried (MgSO4), and concentrated in vacuo.  The crude product was purified by a 
flash chromatography eluting with EtOAc to give 54 mg (32%) of 3.80 as colorless oil; 
1
H NMR (500 MHz, CD3OD) δ 7.32-7.21 (comp, 30 H), 7.15 (d, J = 8.5 Hz, 2 H), 7.00 
(d, J = 8.5 Hz, 2 H), 5.11-4.95 (comp, 12 H), 4.35-4.29 (comp, 3 H), 3.34-3.33 (m, 1 H), 
3.06 (dd, J = 14.1, 5.2 Hz, 1 H), 2.84 (dd, J = 14.1, 9.1 Hz, 1 H), 2.71-2.67 (m, 1 H), 2.40 
(t,  J = 7.6 Hz, 4 H), 2.13-2.05 (comp, 2 H), 1.96-1.88 (comp, 2 H), 1.57-1.50 (m, 1 H), 
1.47-1.40 (m, 1 H), 1.31-1.20 (comp, 2 H), 0.83 (t, J = 7.3 Hz, 3 H); 
13
C NMR (125 
MHz, CD3OD) δ 175.8, 174.4, 174.3 174.2, 174.1, 173.4, 173.3, 158.5, 150.6, 150.6, 
138.0, 137.5, 137.5, 137.5, 136.8, 136.8, 135.8, 131.8, 131.8, 129.8, 129.8, 129.7, 129.7, 
129.7, 129.7, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.4, 129.4, 129.3, 
129.3, 129.3, 129.3, 129.2, 129.2, 129.2, 129.2, 129.2, 129.2, 129.2, 129.0, 128.8, 121.1, 
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121.0, 71.5, 71.5, 67.8, 67.5, 67.4, 67.4, 57.8, 54.4, 54.0, 46.3, 42.1, 37.9, 33.1, 31.3, 
31.3, 28.2, 27.7, 21.2, 14.2; IR (DCM) 3422, 2359, 2342, 1685, 1652, 1636; HRMS 
(ESI) m/z calcd for C68H74N4NaO15P
+
 (M+22), 1239.47023; found, 1239.46894. 
NMR Assignments: 
1
H NMR (500 MHz, CD3OD) δ 7.32-7.21 (comp, 30 H, 
CAr-H), 7.15 (d, J = 8.5 Hz, 2 H, C40 or C41-H), 7.00 (d, J = 8.5 Hz, 2 H, C40 or C41-
H), 5.11-4.95 (comp, 12 H, C43, C37, C30, C8, and C20), 4.35-4.29 (comp, 3 H, C35, 
C2, and C4-H), 3.34-3.33 (m, 2 H, C14-H), 3.06 (dd, J = 14.1, 5.2 Hz, 1 H, C38-H), 2.84 
(dd, J = 14.1, 9.1 Hz, 1 H, C38-H), 2.71-2.67 (m, 1 H, C15-H), 2.40 (t,  J = 7.6 Hz, 4 H, 
C6 and C28-H), 2.13-2.05 (comp, 2 H, C5 or C27-H), 1.96-1.88 (comp, 2 H, C5 or C27-
H), 1.57-1.50 (m, 1 H, C16-H), 1.47-1.40 (m, 1 H, C16-H), 1.31-1.20 (comp, 2 H, C17-
H), 0.83 (t, J = 7.3 Hz, 3 H, C18-H); 
13
C NMR (125 MHz, CD3OD) δ 175.8 (C36, C1, 
C29, C3, C7, C13, or C19), 174.4 8 (C36, C1, C29, C3, C7, C13, or C19), 174.3 8 (C36, 
C1, C29, C3, C7, C13, or C19), 174.2 8 (C36, C1, C29, C3, C7, C13, or C19), 174.1 8 
(C36, C1, C29, C3, C7, C13, or C19), 173.4 8 (C36, C1, C29, C3, C7, C13, or C19), 
173.3 8 (C36, C1, C29, C3, C7, C13, or C19), 158.5 (C48, C44, C42, C39, C31, C9, or 
C21), 150.6 (C48, C44, C42, C39, C31, C9, or C21), 150.6 (C48, C44, C42, C39, C31, 
C9, or C21), 138.0 (C48, C44, C42, C39, C31, C9, or C21), 137.5(C48, C44, C42, C39, 
C31, C9, or C21), 137.5 (C48, C44, C42, C39, C31, C9, or C21), 137.5 (C48, C44, C42, 
C39, C31, C9, or C21), 136.8 (C48, C44, C42, C39, C31, C9, or C21), 136.8 (C48, C44, 
C42, C39, C31, C9, or C21), 135.8 (CAr), 131.8 (C40 or C41), 131.8 (C40 or C41), 
129.8 (CAr), 129.8 (CAr), 129.7 (CAr), 129.7 (CAr), 129.7 (CAr), 129.7 (CAr), 129.5 
(CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 
129.5 (CAr), 129.4 (CAr), 129.4 (CAr), 129.3 (CAr), 129.3 (CAr), 129.3 (CAr), 129.3 
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(CAr), 129.2 (CAr), 129.2 (CAr), 129.2 (CAr), 129.2 (CAr), 129.2 (CAr), 129.2 (CAr), 
129.2 (CAr), 129.0 (CAr), 128.8 (CAr), 121.1 (C40 or C 41), 121.0 (C40 or C41), 71.5 
(C37, C30, C43, C8, or C20), 71.5 (C37, C30, C43, C8, or C20), 67.8 (C37, C30, C43, 
C8, or C20), 67.5 (C37, C30, C43, C8, or C20), 67.4 (C37, C30, C43, C8, or C20), 67.4 
(C37, C30, C43, C8, or C20), 57.8 (C35, C2, or C4), 54.4 (C35, C2, or C4), 54.0 (C35, 
C2, or C4), 46.3(C15), 42.1 (C14), 37.9 (C38), 33.1 (C16), 31.3 (C6 or C28), 31.3 (C6 or 
C28), 28.2 (C5 or C27-H), 27.7 (C5 or C27-H), 21.2 (C17), 14.2 (C18). 
 
 
3.64 
(4S, 7S, 10S, 14R)-7,10-Bis(2-carboxyethyl)-2,5,8,11-tetraoxo-4-(4-
(phosphonooxy)benzyl)-14-propyl-3,6,9,12-tetraazapentadecan-15-oic acid 3.64.  
(ab06121).  A slurry of tetrapeptide 3.80 (42 mg, 0.04 mmol), Pearlman’s catalyst (5 
mg), and HCl (6 drops, 6 M) in MeCN (5 mL) and H2O (5 mL) was stirred under 1 atm 
of H2 at room temperature for 2.5 h.  The mixture was heated and vacuum filtered hot 
through a fritted funnel containing a layer of celite, washing with MeCN/H2O.  The 
combined filtrate and washings were concentrated under reduced pressure.  The residue 
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was dissolved in dioxane/H2O (4/1, 1 mL) and Ac2O (184 mg, 0.17 mL, 1.75 mmol) was 
added.  The reaction was stirred for 19 h at room temperature and then concentrated in 
vacuo.  The residue was purified via reverse phase HPLC (11.6 min) and lyophilized to 
yield 5 mg (19%) of ligand 3.64 as a white solid; 
1
H NMR (500 MHz, D2O) δ 7.13 (d, J = 
8.5 Hz, 2 H), 7.04 (d, J = 7.8 Hz, 2 H), 4.45 (t, J = 7.4 Hz, 1 H), 4.24-4.15 (comp, 2 H), 
3.36-3.32 (m, 1 H), 3.29-3.25 (m, 1 H), 2.99-2.90 (comp, 2 H), 2.63-2.58 (m, 1 H), 2.40-
2.28 (comp, 4 H), 2.02-1.79 (comp, 7 H), 1.49-1.39 (comp, 2 H), 1.27-1.22 (comp, 2 H), 
0.81 (t, J = 7.3 Hz, 3 H); 
13
C NMR (125 MHz, D2O) δ 179.4, 177.5, 177.3, 174.6, 173.7, 
173.5, 172.9, 151.4, 132.2, 130.7, 120.9, 55.7, 53.8, 53.1, 45.2, 41.1, 36.6, 31.7, 30.3, 
30.1, 26.5, 26.3, 22.0, 20.0, 13.5;  HRMS (ESI) m/z calcd for C27H38N4O14P
-
 (M-1), 
673.21276; found, 673.21413. 
NMR Assignments: 
1
H NMR (500 MHz, D2O) δ 7.13 (d, J = 8.5 Hz, 2 H, C23 or 
C24-H), 7.04 (d, J = 7.8 Hz, 2 H, C23 or C24-H), 4.45 (t, J = 7.4 Hz, 1 H, C18-H), 4.24-
4.15 (comp, 2 H, C2 and C4-H), 3.36-3.32 (m, 1 H, C9-H), 3.29-3.25 (m, 1 H, C9-H), 
2.99-2.90 (comp, 2 H, C21-H), 2.63-2.58 (m, 1 H, C10-H), 2.40-2.28 (comp, 4 H, C6 and 
C16-H), 2.02-1.79 (comp, 7 H, C5, C15, and C20-H), 1.49-1.39 (comp, 2 H, C11-H), 
1.27-1.22 (comp, 2 H, C12-H), 0.81 (t, J = 7.3 Hz, 3 H, C13-H).   
13
C NMR (125 MHz, 
D2O) δ 179.4 (C1, C19, C17, C3, C7, C8, or C14), 177.5 (C1, C19, C17, C3, C7, C8, or 
C14), 177.3 (C1, C19, C17, C3, C7, C8, or C14), 174.6 (C1, C19, C17, C3, C7, C8, or 
C14), 173.7 (C1, C19, C17, C3, C7, C8, or C14), 173.5 (C1, C19, C17, C3, C7, C8, or 
C14), 172.9 (C1, C19, C17, C3, C7, C8, or C14), 151.4 (C25), 132.2 (C22), 130.7 (C23 
or C24), 120.9 (C23 or C24), 55.7 (C18), 53.8 (C2 or C4), 53.1 (C2 or C4), 45.2 (C10), 
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41.1 (C9), 36.6 (C21), 31.7 (C11), 30.3 (C6 or C16), 30.1 (C6 or C16), 26.5 (C5, C15, or 
C20), 26.3 (C5, C15 or C20), 22.0 (C5, C15 or C20), 20.0 (C12), 13.5 (C13). 
 
 
3.84 
(E)-Pent-2-enyl 3-oxobutanoate 3.84. (ab05168). A solution of (E)-pent-2-en-1-
ol (3.82) (1.2 mL, 1.0 g, 11.6 mmol) and 2,2,6-trimethyl-4H-l,3-dioxin-4-one (3.83)
346,347
 
(2.0 mL, 2.14 g, 12.8 mmol) in 6 mL of xylene was immersed in a pre-heated oil bath 
(150 °C).  The evolution of acetone became apparent within several minutes.  Heating 
was continued for a total of 1 h. The reaction was cooled to room temperature, and the 
reaction was concentrated in vacuo. The product was purified via column 
chromatography (EtOAc/ hexane 1:4) to yield 1.95 g (99%) of -ketoester 3.84 as a clear 
oil.  
1
H NMR (400 MHz, CDCl3) δ  -ketoester (> 90%) 5.89-5.81 (m, 1 H), 5.61-5.52 
(m, 1 H), 4.59 (d, J = 5.6 Hz, 2 H), 3.47 (s, 2 H), 2.28 (s, 3 H), 2.08 (p, J = 7.6 Hz, 2 H), 
1.01 (t, J = 7.6 Hz, 3 H); enol tautomer (<10%) 5.89-5.81 (m, 1 H), 5.61-5.52 (m, 1 H), 
5.00 (s, 1 H), 4.14 (t, J = 6.8 Hz, 2 H), 1.96 (s, 3 H), 1.67-1.63 (m, 2 H), 0.91 (t, J = 6.8 
Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 200.6, 166.9, 138.8, 122.1, 66.2, 50.1, 30.1, 
25.2, 13.0; IR (DCM) 3447, 2361, 2339, 1734, 1717, 1699, 1684, 1671, 1652, 1636, 
1559, 1541, 1457; HRMS (CI) m/z calcd for C9H15O3
+
 (M + 1), 171.1021; found, 
171.1020. 
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NMR Assignments:
  1
H NMR (400 MHz, CDCl3) δ 5.89-5.81 (m, 1 H, C3 or C4-
H), 5.61-5.52 (m, 1 H, C3 or C4-H), 4.59 (d, J = 5.6 Hz, 2 H, C5-H), 3.47 (s, 2 H, C7-H), 
2.28 (s, 3 H, C9-H), 2.08 (p, J = 7.6 Hz, 2 H, C2-H), 1.01 (t, J = 7.6 Hz, 3 H, C1-H); 
13
C 
NMR (100 MHz, CDCl3) δ 200.6 (C8), 166.9 (C6), 138.8 (C3 or C4), 122.1 (C3 or C4), 
66.2 (C5), 50.1 (C7), 30.1 (C9), 25.2 (C2), 13.0 (C1). 
 
 
3.86 
(E)-Pent-2-enyl 2-diazoacetate 3.86. (ab05204).  A solution of 3.84 (100 mg, 
0.59 mmol) and Et3N (0.16 mL, 116 mg, 1.18 mmol) in THF (5 mL) was added to a 
solution of 2-azido-1,3-dimethylimidazolinium hexafluorophosphate (ADMP)
348
 3.85 
(200 mg, 0.71 mmol) in MeCN (1 mL) at 0 °C.  Stirring was continued for 2 h, 
whereupon a solution of LiOH·H2O (82 mg, 1.95 mmol) in H2O (5 mL) was added in one 
portion.  The reaction was warmed to room temperature and stirred for 1 h.  Et2O/EtOAc 
(2/1) was added (ca. 10 mL), and the layers were separated.  The aqueous layer was 
extracted with Et2O/EtOAc (2/1) (2 x 10 mL), and then the organic layers were 
combined, dried (MgSO4), and concentrated in vacuo.  The residue was purified via 
column chromatography (EtOAc/hexanes 1/9) to yield 84 mg (93%) of diazoester XX as 
a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ  5.85-5.79 (m, 1 H), 5.59-5.52 (m, 1 H), 4.75 
(br, 1 H), 4.60 (d, J = 6.8 Hz, 2 H), 2.08 (p, J = 7.6 Hz, 2 H), 1.00 (t, J = 7.6 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 138.2, 122.7, 122.7, 65.6, 46.2, 25.2, 13.1; IR (DCM) 
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3430, 2111, 1682, 1392, 1355, 1240, 1181, 969; HRMS (CI) m/z calcd for C7H11N2O2
+
 
(M + 1), 155.0821; found, 155.0822. 
NMR Assignments:
  1
H NMR (400 MHz, CDCl3) δ 5.85-5.79 (m, 1 H, C3 or C4-
H), 5.59-5.52 (m, 1 H, C3 or C4-H), 4.75 (br, 1 H, C7-H), 4.60 (d, J = 6.8 Hz, 2 H, C5-
H), 2.08 (p, J = 7.6 Hz, 2 H, C2-H), 1.00 (t, J = 7.6 Hz, 3 H, C1-H); 
13
C NMR (100 MHz, 
CDCl3) δ 138.2 (C6), 122.7 (C3 or C4), 122.7 (C3 or C4), 65.6 (C5), 46.2 (C7), 25.2 
(C2), 13.1 (C1).   
 
3.87 
(1R, 5S, 6S)-6-Ethyl-3-oxabicyclo[3.1.0]hexan-2-one 3.87. (ab06039).  A 
solution of diazoester 3.86 (500 mg, 3.24 mmol) in CH2Cl2 (35 mL) was added to a 
solution of Rh2(5S-MEPY)4(MeCN)2(i-PrOH)
314-318,323
 (29 mg, 0.032 mmol) in CH2Cl2 
(10 mL) via a syringe pump (syringe diameter: 30 mm (60 mL)) over 24 h (1.5 mL/h) at 
50 °C (oil bath).  The reaction was cooled to room temperature and concentrated in 
vacuo.  The residue was purified via column chromatography (EtOAc/hexanes 1/4) to 
yield 310 mg (76%) of cyclopropane 3.87 as a pale yellow oil.  
1
H NMR (400 MHz, 
CDCl3) δ  4.31 (dd, J = 5.0, 9.0 Hz, 1 H), 4.22 (d, J = 9.0 Hz, 1 H), 2.03 (q, J = 5.0 Hz, 1 
H), 1.86 (dd, J = 2.5, 5.0 Hz, 1 H), 1.43-1.37 (comp, 2 H), 1.21-1.17 (m, 1 H), 1.03 (t, J = 
7.5 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 176.1, 69.5, 28.0, 24.4, 23.8, 23.7, 12.9; IR 
(DCM) 3500, 2361, 1767, 1644, 1460, 1372, 1276, 1172; HRMS (CI) m/z calcd for 
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C7H11O2
+
 (M + 1), 127.0759; found, 127.0760; HPLC (210 nm): Whelk-O1 (6% CH3CN 
/ 20% i-PrOH / hexanes, 1.2 mL/min) 16.5 min (minor), 17.6 min (major); 93:7 er. 
NMR Assignments: 
1
H NMR (400 MHz, CDCl3) δ  4.31 (dd, J = 5.0, 9.0 Hz, 1 
H, C5-H), 4.22 (d, J = 9.0 Hz, 1 H, C5-H), 2.03 (q, J = 5.0 Hz, 1 H, C4), 1.86 (dd, J = 
2.5, 5.0 Hz, 1 H, C7-H), 1.43-1.37 (comp, 2 H, C2-H), 1.21-1.17 (m, 1 H, C3-H), 1.03 (t, 
J = 7.5 Hz, 3 H, C1-H); 
13
C NMR (100 MHz, CDCl3) δ 176.1 (C6), 69.5 (C5), 28.0 (C7), 
24.4 (C2) , 23.8 (C3 or C4), 23.7 (C3 or C4), 12.9 (C1).   
 
 
3.88 
(1R, 2S, 3S)-2-Ethyl-3-(hydroxymethyl)-N-methoxy-N-
methylcyclopropanecarboxamide 3.88. (ab06051).  AlMe3 (9.0 mL, 2.0 M in toluene, 
18 mmol) was added dropwise to a slurry of N,O-dimethylhydroxylamine (1.46 g, 15 
mmol) in DCM (5 mL) at 0 ºC.  The reaction was stirred for 1.5 h, and then a solution of 
lactone 3.87 (310 mg, 2.5 mmol) in DCM (10 mL) was added.  The reaction was warmed 
to room temperature and stirred for 3 h before being re-cooled to 0 ºC.  1 M HCl was 
added slowly until the evolution of bubbles had ceased and the reaction warmed to room 
temperature, and the layers were then separated.  The aqueous layer was extracted with 
DCM (2 x 10 mL), and the organic layers were combined, washed (1 x brine), dried 
(MgSO4), and concentrated under reduced pressure.  The residue was purified by flash 
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chromatography eluting with hexane/EtOAc (1/1) to give 344 mg (74%) of 3.88 as a pale 
yellow oil; 
1
H NMR (600 MHz, CDCl3) δ 3.95 (dd, J = 12.0, 4.2 Hz, 1 H), 3.78-3.73 
(comp, 4 H), 3.22 (s, 3 H), 2.93 (br, 1 H), 2.02-1.99 (m, 1 H), 1.58 (p, J = 6.6 Hz, 1 H), 
1.45-1.38 (comp, 3 H), 0.99 (t, J = 7.5 Hz, 3 H); 
13
C NMR (150 MHz, CDCl3) δ 173.8, 
61.6, 60.2, 32.6, 30.8, 26.7, 26.2, 22.5, 13.1; IR (DCM) 3430, 2361, 2341, 1635, 1458; 
HRMS (ESI) m/z calcd for C9H17NNaO3
+
 (M + 22), 210.11006; found, 210.10998. 
NMR Assignments: 
1
H NMR (600 MHz, CDCl3) δ 3.95 (dd, J = 12.0, 4.2 Hz, 1 
H, C5-H), 3.78-3.73 (comp, 4 H, C8-H and C5-H), 3.22 (s, 3 H, C9-H), 2.93 (br, 1 H, 
OH), 2.02-1.99 (m, 1 H, C3 or C4-H), 1.58 (p, J = 6.6 Hz, 1 H, C3 or C4-H), 1.45-1.38 
(comp, 3 H, C2 and C7-H), 0.99 (t, J = 7.5 Hz, 3 H, C1-H); 
13
C NMR (150 MHz, CDCl3) 
δ 173.8 (C6), 61.6 (C8), 60.2 (C5), 32.6 (C9), 30.8 (C3, C4, or C2), 26.7 (C3 or C4), 26.2 
(C3, C4 or C2), 22.5 (C7), 13.1 (C1). 
 
 
3.89 
(1R, 2S, 3S)-2-Ethyl-3-formyl-N-methoxy-N-
methylcyclopropanecarboxamide 3.89.  (ab06140).  A slurry of alcohol 3.88 (137 mg, 
1.3 mmol), PCC (560 mg, 2.6 mmol) and celite in DCM (20 mL) was stirred at room 
temperature for 3 h. The reaction was concentrated under reduced pressure, and Et2O (ca. 
20 mL) was added to the residue.  The residue was vacuum filtered through a fritted 
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funnel containing a layer of celite, followed by washing with Et2O (ca. 20 mL).  The 
combined filtrate and washings were collected and concentrated.  The residue was 
purified by flash chromatography eluting with hexane/EtOAc (1/1) to give 165 mg (69%) 
of 3.89 as a pale yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 9.32 (d, J = 6.7 Hz, 1 H), 3.74 
(s, 3 H), 3.22 (s, 3 H), 2.60-2.57 (m, 1 H), 2.34 (p, J = 6.5 Hz, 1 H), 1.92-1.88 (m, 1 H), 
1.59-1.45 (comp, 2 H), 1.03 (t, J = 7.4 Hz, 3 H); 
13
C NMR (125 MHz, CDCl3) δ 200.3, 
169.9, 61.8, 37.7, 32.5, 28.6, 27.6, 25.0, 12.9; IR (DCM) 3446, 2360, 1699, 1648; HRMS 
(ESI) m/z calcd for C9H15NNaO3
+
 (M + 22), 208.09441; found, 208.09436. 
NMR Assignments: 
1
H NMR (500 MHz, CDCl3) δ 9.32 (d, J = 6.7 Hz, 1 H, C5-
H), 3.74 (s, 3 H, C8-H), 3.22 (s, 3 H, C9-H), 2.60-2.57 (m, 1 H, C7-H), 2.34 (p, J = 6.5 
Hz, 1 H, C3-H), 1.92-1.88 (m, 1 H, C4-H), 1.59-1.45 (comp, 2 H, C2-H), 1.03 (t, J = 7.4 
Hz, 3 H, C1-H); 
13
C NMR (125 MHz, CDCl3) δ 200.3 (C5), 169.9 (C6), 61.8 (C8), 37.7 
(C9), 32.5 (C7), 28.6 (C3 or C4), 27.6 (C3 or C4), 25.0 (C2), 12.9 (C1). 
 
 
3.90 
(1R, 2S, 3R)-2-Ethyl-3-formyl-N-methoxy-N-
methylcyclopropanecarboxamide 3.90. (ab06108).  A solution of aldehyde 3.90 (34 
mg, 0.18 mmol) and Et3N (276 mg, 0.38 mL, 2.7 mmol) in MeOH (1 mL) was heated 
under reflux for 3 d, whereupon it was cooled to room temperature and concentrated in 
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vacuo.  The residue was purified by flash chromatography eluting with hexane/EtOAc 
(1/1) to give 16 mg (50%) of a 63:37 inseparable mixture of product 3.90 to RSM 3.89.  
Indicative aldehyde peaks:  
1
H NMR (400 MHz, CDCl3) δ product 3.90 9.70 (d, J < 6.7 
Hz, 0.63 H) : RSM 3.89 9.32 (d, J = 6.7 Hz, 0.37 H). 
 
 
3.110 
(S)-Benzyl 5-((S)-1-(benzyloxy)-1-oxopentan-2-ylamino)-4-(tert-
butoxycarbonylamino)-5-oxopentanoate 3.110. (ab05199).  NMM (368 mg, 0.4 mL, 
3.6 mmol) was added to a solution of the HCl salt 3.109 (247 mg, 1.2 mmol), protected 
glutamic acid NHBoc-E(OBn)-OH (405 mg, 1.2 mmol), EDCI·HCl (249 mg, 1.3 mmol), 
and HOBt (324 mg, 2.4 mmol) in DMF (30 mL) at room temperature, and the reaction 
was stirred for 16 h.  NaHCO3(sat.) (120 mL) and Et2O (60 mL) were added.  The layers 
were separated, and the aqueous layer was extracted with Et2O (2 x 60 mL).  The organic 
layers were combined, washed with H2O (4 x 240 mL) and NaCl(sat) (1 x 300 mL), dried 
(MgSO4), and concentrated in vacuo.  The crude product was purified by flash 
chromatography eluting with hexane/EtOAc (1/2) to give 380 mg (60%) of 3.110 as a 
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colorless oil; 
1
H NMR (400 MHz, CD3OD) δ 7.33-7.27 (comp, 10 H), 5.15-5.07 (comp, 4 
H), 4.43 (dd, J = 9.0, 5.0 Hz, 1 H), 4.14 (dd, J = 8.0, 6.0 Hz, 1 H), 2.44 (t, J = 7.6 Hz, 2 
H), 2.09-2.00 (m, 1 H), 1.92-1.74 (comp, 2 H), 1.71-1.62 (m, 1 H), 1.41-1.25 (m, 11 H), 
0.88 (t, J = 7.4 Hz, 3 H); 
13
C NMR (100 MHz, CD3OD) δ 173.1, 172.9, 171.9, 156.3, 
136.2, 135.8, 128.2, 128.2, 128.2, 128.2, 128.0, 128.0, 128.0, 127.8, 127.8, 127.8, 79.3, 
66.5, 66.0, 53.5, 52.3, 33.0, 29.9, 27.4, 27.4, 27.4, 27.2, 18.5, 12.6; IR (DCM) 3442, 
2486, 1739, 1660, 1456, 1415, 1171; HRMS (ESI) m/z calcd for C29H38N2NaO7
+
 (M + 
22), 549.25712; found, 549.25764. 
NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.33-7.27 (comp, 10 H, 
CAr-H), 5.15-5.07 (comp, 4 H, C2 and C17-H), 4.43 (dd, J = 9.0, 5.0 Hz, 1 H, C7 or 
C10-H), 4.14 (dd, J = 8.0, 6.0 Hz, 1 H, C7 or C10-H), 2.44 (t, J = 7.6 Hz, 2 H, C15-H), 
2.09-2.00 (m, 1 H, C8 or C14-H), 1.92-1.74 (comp, 2 H, C8 or C14-H), 1.71-1.62 (m, 1 
H, C8 or C14-H), 1.41-1.25 (m, 11 H, C22 and C13-H), 0.88 (t, J = 7.4 Hz, 3 H, C23-H); 
13
C NMR (100 MHz, CD3OD) δ 173.1 (C1, C9, or C16), 172.9 (C1, C9, or C16), 171.9 
(C1, C9, or C16), 156.3 (C11), 136.2 (C3 or C18), 135.8 (C3 or C18), 128.2 (CAr), 128.2 
(CAr), 128.2 (CAr), 128.2 (CAr), 128.0 (CAr), 128.0 (CAr), 128.0 (CAr), 127.8 (CAr), 
127.8 (CAr), 127.8 (CAr), 79.3 (C12), 66.5 (C2 or C17), 66.0 (C2 or C17), 53.5 (C7 or 
C10), 52.3 (C7 or C10), 33.0 (C15), 29.9 (C8), 27.4 (C13), 27.4 (C13), 27.4 (C13), 27.2 
(C14), 18.5 (C22), 12.6 (C23). 
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3.111 
(S)-Benzyl 4-amino-5-((S)-1-(benzyloxy)-1-oxopentan-2-ylamino)-5-
oxopentanoate hydrochloride salt 3.111.  (ab05205).  A solution of HCl in dioxane (10 
mL, ca. 4 M) was added to a round-bottom flask containing amide 3.110 (342 mg. 0.65 
mmol) at room temperature.  The reaction was stirred for 16 h, and the solvents were then 
removed in vacuo.  The crude product was washed with cold hexanes to give 300 mg of 
3.111 (100%) as a viscous colorless oil; 
1
H NMR (400 MHz, CD3OD) δ 7.34-7.28 (comp, 
10 H), 5.16-5.07 (comp, 4 H), 4.47 (dd, J = 9.2, 5.2 Hz, 1 H), 4.06 (t, J = 6.2 Hz, 1 H), 
2.63-2.58 (comp, 2 H), 2.22-2.14 (comp, 2 H), 1.83-1.69 (comp, 2 H), 1.43-1.36 (comp, 2 
H), 0.90 (t, J = 7.4 Hz, 3 H);  
13
C NMR (100 MHz, CD3OD) δ 172.3, 171.6, 168.5, 136.0, 
135.7, 128.3, 128.3, 128.3, 128.3, 128.1, 128.1, 128.1, 127.9, 127.9, 127.9, 66.7, 66.3, 
52.6, 52.0, 32.8, 28.8, 26.3, 18.6, 12.5; IR (DCM) 1739, 1680, 1498, 1456, 1190, 1003; 
HRMS (ESI) m/z calcd for C24H30N2NaO5
+
 (M + 22), 449.20469; found, 449.20469. 
NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.34-7.28 (comp, 10 H, 
CAr-H), 5.16-5.07 (comp, 4 H, C2 and C17-H), 4.47 (dd, J = 9.2, 5.2 Hz, 1 H, C7-H), 
4.06 (t, J = 6.2 Hz, 1 H, C10-H), 2.63-2.58 (comp, 2 H, C15-H), 2.22-2.14 (comp, 2 H, 
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C14 or C8-H), 1.83-1.69 (comp, 2 H, C14 or C8-H), 1.43-1.36 (comp, 2 H, C22-H), 0.90 
(t, J = 7.4 Hz, 3 H, C23-H);  
13
C NMR (100 MHz, CD3OD) δ 172.3 (C1, C9, or C16), 
171.6 (C1, C9, or C16), 168.5 (C1, C9, or C16), 136.0 (C3 or C18), 135.7 (C3 or C18), 
128.3 (CAr), 128.3 (CAr), 128.3 (CAr), 128.3 (CAr), 128.1 (CAr), 128.1 (CAr), 128.1 
(CAr), 127.9 (CAr), 127.9 (CAr), 127.9 (CAr), 66.7 (C2 or C17), 66.3 (C2 or C17), 52.6 
(C7 or C10), 52.0 (C7 or C10), 32.8 (C15), 28.8 (C8 or C14), 26.3 (C8 or C14), 18.6 
(C22), 12.5 (C23). 
 
 
3.112 
(6S, 9S, 12S)-Benzyl 6,9-bis(3-(benzyloxy)-3-oxopropyl)-2,2-dimethyl-4,7,10-trioxo-
3-oxa-5,8,11-triazapentadecane-12-carboxylate 3.112.  (ab05206).  NMM (221 mg, 
0.24 mL, 2.2 mmol) was added to a solution of the HCl salt 3.111 (300 mg, 0.73 mmol), 
protected glutamic acid NHBoc-E(OBn)-OH (246 mg, 0.73 mmol), EDCI·HCl (153 mg, 
0.8 mmol), and HOBt (197 mg, 1.5 mmol) in DMF (8 mL) at room temperature, and the 
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reaction was stirred for 16 h.  NaHCO3(sat.) (40 mL) and Et2O (20 mL) were then added.  
The layers were separated, and the aqueous layer was extracted with Et2O (2 x 20 mL).  
The organic layers were combined, washed with H2O (4 x 80  mL) and NaCl(sat) (1 x 100 
mL), dried (MgSO4), and concentrated in vacuo.  The crude product was purified by flash 
chromatography eluting with hexane/EtOAc (1/2)  to give 259 mg (54%) of 3.112 as a 
viscous colorless oil; 
1
H NMR (400 MHz, CD3OD) δ 7.33-7.28 (comp, 15 H), 5.15-5.07 
(comp, 6 H), 4.46-4.38 (comp, 2 H), 4.09-4.06 (m, 1 H), 2.45 (q, J= 7.6 Hz, 4 H), 2.15-
2.01 (comp, 2 H), 1.97-1.83 (comp, 2 H), 1.81-1.72 (m, 1 H), 1.70-1.60 (m, 1 H), 1.39-
1.28 (comp, 11 H), 0.86 (t, J = 7.4 Hz, 3 H); 
13
C NMR (100 MHz, CD3OD) δ 172.9, 
172.9, 172.0, 171.9, 171.9, 156.4, 136.1, 136.1, 135.8, 128.2, 128.2, 128.2, 128.2, 128.0, 
128.0, 128.0, 127.9, 127.9, 127.9, 127.8, 127.8, 127.8, 127.8, 127.8, 79.3, 66.5, 66.0, 
66.0, 53.8, 52.3, 52.1, 32.9, 30.0, 29.7, 27.3, 27.3, 27.3, 27.1, 26.8, 18.6, 12.1; IR (DCM) 
2358, 2343, 1737, 1639, 1458, 1390, 1167; HRMS (ESI) m/z calcd for C41H51N3NaO10
+
 
(M + 22), 768.34667; found, 768.34612. 
NMR Assignments: 
1
H NMR (400 MHz, CD3OD) δ 7.33-7.28 (comp, 15 H, 
CAr-H), 5.15-5.07 (comp, 6 H, C2, C17, and C28-H), 4.46-4.38 (comp, 2 H, C10 and 
C33-H), 4.09-4.06 (m, 1 H, C7-H), 2.45 (q, J= 7.6 Hz, 4 H, C15 and C26-H), 2.15-2.01 
(comp, 2 H, C14 or C25-H), 1.97-1.83 (comp, 2 H, C14 or C25-H), 1.81-1.72 (m, 1 H, 
C8-H), 1.70-1.60 (m, 1 H, C8-H), 1.39-1.28 (comp, 11 H, C36 and C22-H), 0.86 (t, J = 
7.4 Hz, 3 H, C23-H); 
13
C NMR (100 MHz, CD3OD) δ 172.9 (C16), 172.9 (C27), 172.0 
(C1), 171.9 (C9), 171.9 (C24), 156.4 (C34), 136.1 (C29), 136.1 (C18), 135.8 (C3), 128.2 
(CAr), 128.2 (CAr), 128.2 (CAr), 128.2 (CAr), 128.0 (CAr), 128.0 (CAr), 128.0 (CAr), 
127.9 (CAr), 127.9 (CAr), 127.9 (CAr), 127.8 (CAr), 127.8 (CAr), 127.8 (CAr), 127.8 
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(CAr), 127.8 (CAr), 79.3 (C35), 66.5 (C2), 66.0 (C17), 66.0 (C28), 53.8 (C7), 52.3 (C10 
or C33), 52.1 (C10 or C33), 32.9 (C8), 30.0 (C15 or C26), 29.7 (C15 or C26), 27.3 (C36), 
27.3 (C36), 27.3 (C36), 27.1 (C14), 26.8 (C25), 18.6 (C22), 12.1 (C23). 
 
 
3.113 
(S)-Benzyl 4-amino-5-((S)-5-(benzyloxy)-1-((S)-1-(benzyloxy)-1-oxopentan-2-
ylamino)-1,5-dioxopentan-2-ylamino)-5-oxopentanoate hydrochloride salt 3.113.  
(ab05210).  A solution of HCl in dioxane (5 mL, ca. 4 M) was added to a round-bottom 
flask containing amide 3.112 (259 mg. 0.35 mmol) at room temperature.  The reaction 
was stirred for 16 h, and the solvents were removed in vacuo.  The crude product was 
washed with cold hexanes to give to give 223 (93%) mg of 3.113  as a viscous colorless 
oil; 
1
H NMR (400 MHz, CD3OD) δ 7.35-7.27 (comp, 15 H), 5.15-5.07 (comp, 6 H), 4.46 
(dd, J = 7.8, 6.4 Hz, 1 H), 4.39 (dd, J = 11, 5.2 Hz, 1 H), 3.99 (t, J = 6.4 Hz, 1 H), 2.57 (t, 
J = 7.6 Hz, 2 H), 2.49 (t, J = 7.6 Hz, 2 H), 2.19-2.06 (comp, 3 H), 2.02-1.92 (m, 1 H), 
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1.81-1.73 (m, 1 H), 1.72-1.60 (m, 1 H), 1.41-1.24 (comp, 2 H), 0.85 (t, J = 7.6 Hz, 3 H); 
13
C NMR (100 MHz, CD3OD) δ 172.7, 172.2, 171.7, 171.8, 168.1, 136.1, 135.9, 135.7, 
128.2, 128.2, 128.2, 128.2, 128.2, 128.0, 128.0, 128.0, 128.0, 128.0, 127.9, 127.9, 127.9, 
127.9, 127.9, 66.5, 66.3, 66.1, 52.5, 52.4, 52.0, 32.9, 29.7, 28.7, 26.9, 26.2, 18.6, 12.5; IR 
(DCM) 3401, 1648, 1559, 1542, 1508, 1458; HRMS (ESI) m/z calcd for C36H43N3NaO8
+
 
(M + 22), 668.29424; found, 668.29448. 
NMR Assignments:  
1
H NMR (400 MHz, CD3OD) δ 7.35-7.27 (comp, 15 H, 
CAr-H), 5.15-5.07 (comp, 6 H, C2, C17, and C28-H), 4.46 (dd, J = 7.8, 6.4 Hz, 1 H, C10 
or C33-H), 4.39 (dd, J = 11, 5.2 Hz, 1 H, C10 or C33-H), 3.99 (t, J = 6.4 Hz, 1 H, C7-H), 
2.57 (t, J = 7.6 Hz, 2 H, C15 or C26-H), 2.49 (t, J = 7.6 Hz, 2 H, C15 or C26-H), 2.19-
2.06 (comp, 3 H, C8 and C14 or C25-H), 2.02-1.92 (m, 1 H, C14 or C25-H), 1.81-1.73 
(m, 1 H, C14 or C25-H), 1.72-1.60 (m, 1 H, C14 or C25-H), 1.41-1.24 (comp, 2 H, C22-
H), 0.85 (t, J = 7.6 Hz, 3 H, C23-H); 
13
C NMR (100 MHz, CD3OD) δ 172.7 (C1, C9, 
C16, C24, or C27), 172.2 (C1, C9, C16, C24, or C27), 171.7 (C1, C9, C16, C24, or C27), 
171.8 (C1, C9, C16, C24, or C27), 168.1 (C1, C9, C16, C24, or C27), 136.1 (C3, C18, or 
C29), 135.9 (C3, C18, or C29), 135.7 (C3, C18, or C29), 128.2 (CAr), 128.2 (CAr), 
128.2 (CAr), 128.2 (CAr), 128.2 (CAr), 128.0 (CAr), 128.0 (CAr), 128.0 (CAr), 128.0 
(CAr), 128.0 (CAr), 127.9 (CAr), 127.9 (CAr), 127.9 (CAr), 127.9 (CAr), 127.9 (CAr), 
66.5 (C2, C17, or C28), 66.3 (C2, C17, or C28), 66.1 (C2, C17, or C28), 52.5 (C7, C10, 
or C33), 52.4 (C7, C10, or C33), 52.0 (C7, C10, or C33), 32.9 (C8), 29.7 (C15 or C26), 
28.7 (C15 or C26), 26.9 (C14 or C25), 26.2 (C14 or C25), 18.6 (C22), 12.5 (C23). 
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3.114 
(5S, 8S, 11S, 14S)-Benzyl 8,11-bis(3-(benzyloxy)-3-oxopropyl)-5-(4-
(bis(benzyloxy)phosphoryloxy)benzyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13-
tetraazaheptadecane-14-carboxylate 3.114. (ab05287).  Amine salt 3.113 (227 mg, 
0.33 mmol) was dissolved in DMF (12 mL), and protected phosphotyrosine NHZ-
pY(OBn)2-OH (190 mg, 0.33 mmol), EDCI·HCl (69 mg, 0.36 mmol), HOBt (90 mg, 
0.66 mmol), and NMM (101 mg, 0.11 mL, 0.99 mmol) were added.  The reaction was 
stirred at room temperature for 18 h, whereupon NaHCO3(sat.) (20 mL) and Et2O (10 mL) 
were added.  The layers were separated, and the aqueous layer was extracted with Et2O (2 
x 20 mL).  The organic layers were combined, washed with H2O (4 x 40 mL) and NaCl 
(1 x 40 mL), dried (MgSO4), and concentrated in vacuo.  The crude product was purified 
by a flash chromatography eluting with EtOAc to give 136 mg (34%) of 3.114 as a 
viscous colorless oil; 
1
H NMR (500 MHz, CD3OD) δ 7.33-7.22 (comp, 30 H), 7.16 (d, J 
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= 8.5 Hz, 2 H), 7.00 (d, J = 8.5 Hz, 2 H), 5.15-4.96 (comp, 12 H), 4.41-4.38 (m, 2 H), 
4.36-4.32 (m, 2 H), 3.07 (dd, J = 14.0, 5.0 Hz, 1 H), 2.83 (dd, J = 14.0, 9.2 Hz, 1 H), 
2.46-2.39 (comp, 4 H), 2.12-2.08 (m, 1 H), 1.98-1.93 (m, 1 H), 1.78-1.72 (m, 1 H), 1.69-
1.63 (m, 1 H), 1.38-1.28 (m, 4 H), 0.85 (t, J = 5.5 Hz, 3 H); 
13
C NMR (125 MHz, 
CD3OD) δ 174.2, 174.2, 174.0, 173.5, 173.4, 173.3, 173.2, 138.1, 137.5, 137.5, 137.2, 
137.2, 136.9, 131.8, 131.8, 129.9, 129.9, 129.9, 129.7, 129.7, 129.7, 129.7, 129.7, 129.7, 
129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.5, 129.4, 129.4, 
129.4, 129.4, 129.3, 129.3, 129.3, 129.2, 129.2, 129.2, 128.8, 128.8, 121.1, 121.1, 71.5, 
71.5, 67.9, 67.9, 67.4, 67.4, 57.7, 53.8, 53.8, 53.8, 37.9, 34.4, 31.3, 31.3, 28.2, 20.0, 20.0, 
13.9; IR (DCM) 3437, 2088, 1735, 1636, 1539, 1507, 1455, 1386, 1215, 1168, 1016; 
HRMS (ESI) m/z calcd for C67H71N4NaO15P
+
 (M + 22), 1225.45458; found, 1225.45406. 
NMR Assignments: 
1
H NMR (500 MHz, CD3OD) δ 7.33-7.22 (comp, 30 H, 
CAr-H), 7.16 (d, J = 8.5 Hz, 2 H, C38 or C39-H), 7.00 (d, J = 8.5 Hz, 2 H, C38 or C39-
H), 5.15-4.96 (comp, 12 H, C2, C17, C28, C41, and C47-H), 4.41-4.38 (m, 2 H, C7, C10, 
C33 or C35-H), 4.36-4.32 (m, 2 H, C7, C10, C33 or C35-H), 3.07 (dd, J = 14.0, 5.0 Hz, 1 
H, C36-H), 2.83 (dd, J = 14.0, 9.2 Hz, 1 H, C36-H), 2.46-2.39 (comp, 4 H, C15 and C26-
H), 2.12-2.08 (m, 1 H, C14 or C25-H), 1.98-1.93 (m, 1 H, C14 or C25-H), 1.78-1.72 (m, 
1 H, C14 or C25-H), 1.69-1.63 (m, 1 H, C14 or C25-H), 1.38-1.28 (m, 4 H, C8 and C22-
H), 0.85 (t, J = 5.5 Hz, 3 H, C23-H); 
13
C NMR (125 MHz, CD3OD) δ 174.2 (C1, C9, 
C16, C24, C27, C34, or C46), 174.2 (C1, C9, C16, C24, C27, C34, or C46), 174.0 (C1, 
C9, C16, C24, C27, C34, or C46), 173.5 (C1, C9, C16, C24, C27, C34, or C46), 173.4 
(C1, C9, C16, C24, C27, C34, or C46), 173.3 (C1, C9, C16, C24, C27, C34, or C46), 
173.2 (C1, C9, C16, C24, C27, C34, or C46), 138.1 (C3, C18, C29, C42, or C48), 137.5 
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(C3, C18, C29, C42, or C48), 137.5 (C3, C18, C29, C42, or C48), 137.2 (C3, C18, C29, 
C42, or C48), 137.2 (C3, C18, C29, C42, or C48), 136.9 (C3, C18, C29, C42, or C48), 
131.8 (C37), 131.8 (C37), 129.9 (CAr), 129.9 (CAr), 129.9 (CAr), 129.7 (CAr), 129.7 
(CAr), 129.7 (CAr), 129.7 (CAr), 129.7 (CAr), 129.7 (CAr), 129.5 (CAr), 129.5 (CAr), 
129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 (CAr), 129.5 
(CAr), 129.5 (CAr), 129.5 (CAr), 129.4 (CAr), 129.4 (CAr), 129.4 (CAr), 129.4 (CAr), 
129.3 (CAr), 129.3 (CAr), 129.3 (CAr), 129.2 (CAr), 129.2 (CAr), 129.2 (CAr), 128.8 
(CAr), 128.8 (CAr), 121.1 (C40), 121.1 (C40), 71.5 (C2, C17, C28, C41, or C47), 71.5 
(C2, C17, C28, C41, or C47), 67.9 (C2, C17, C28, C41, or C47), 67.9 (C2, C17, C28, 
C41, or C47), 67.4 (C2, C17, C28, C41, or C47), 67.4 (C2, C17, C28, C41, or C47), 57.7 
(C7, C10, C33 or C35), 53.8 (C7, C10, C33 or C35), 53.8 (C7, C10, C33 or C35), 53.8 
(C7, C10, C33 or C35), 37.9 (C36), 34.4 (C14 or C25), 31.3 (C15 or C26), 31.3 (C15 or 
C26), 28.2 (C14 or C25), 20.0 (C8 or C22), 20.0 (C8 or C22), 13.9 (C23). 
 
 
3.66 
(4S, 7S, 10S, 13S)-7,10-Bis(2-carboxyethyl)-2,5,8,11-tetraoxo-4-(4-
(phosphonooxy)benzyl)-3,6,9,12-tetraazahexadecane-13-carboxylic acid 3.66.  
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(ab06100).  A slurry of tetrapeptide 3.114 (45 mg, 0.04 mmol), Pearlman’s catalyst (5 
mg), and HCl (6 drops, 6 M) in MeCN (0.5 mL) and H2O (0.5 mL) was stirred under 1 
atm of H2 at room temperature for 3.75 h.  The mixture was heated, and filtered through a 
fritted funnel containing a layer of celite, which was then washed with MeCN/H2O (ca. 5 
mL).  The combined filtrate and washings were concentrated under reduced pressure.  
The residue was dissolved in dioxane/H2O (4/1, 1 mL) and Ac2O (130 mg, 0.12 mL, 1.32 
mmol) was added.  The reaction was stirred for 19 h at room temperature before being 
concentrated in vacuo.  The residue was purified via reverse phase HPLC (11.28 min) 
and lyophilized to yield 7 mg (26%) of ligand 3.66 as a white solid; 
1
H NMR (600 MHz, 
D2O) δ 7.10 (d, J = 8.5 Hz, 2 H), 7.01 (d, J = 7.6 Hz, 2 H), 4.42 (t, J = 7.5 Hz, 1 H), 4.25-
4.22 (comp, 2 H), 4.19 (dd, J = 9.0, 5.6 Hz, 1 H), 2.96-2.87 (comp, 2 H), 2.41 (t, J = 7.6 
Hz, 2 H), 2.26 (t, J = 7.4 Hz, 2 H), 2.04-1.86 (comp, 7 H), 1.81-1.69 (m, 1 H), 1.66-1.60 
(m, 1 H), 1.32-1.21 (comp, 2 H), 0.79 (t, J = 7.3 Hz, 3 H); 
13
C NMR (125 MHz, D2O) δ 
177.0, 176.9, 175.8, 174.2, 173.2, 173.0, 172.4, 150.5 131.8, 130.2, 130.2, 120.5, 120.5, 
55.2, 52.8, 52.6, 52.6, 36.2, 32.4, 29.8, 29.7, 26.0, 26.0, 21.6, 18.4, 12.7; HRMS (ESI) 
m/z calcd for C26H36N4O14P
-
 (M - 1), 659.19711; found, 659.19717. 
NMR Assignments:  
1
H NMR (600 MHz, D2O) δ 7.10 (d, J = 8.5 Hz, 2 H, C23 
or C24-H), 7.01 (d, J = 7.6 Hz, 2 H, C23 or C24-H), 4.42 (t, J = 7.5 Hz, 1 H, C17-H), 
4.25-4.22 (comp, 2 H, C7 and C15-H), 4.19 (dd, J = 9.0, 5.6 Hz, 1 H, C2-H), 2.96-2.87 
(comp, 2 H, C20-H), 2.41 (t, J = 7.6 Hz, 2 H, C9 or C13-H), 2.26 (t, J = 7.4 Hz, 2 H, C9 
or C13-H), 2.04-1.86 (comp, 7 H, C8, C12, and C19-H), 1.81-1.69 (m, 1 H, C3-H), 1.66-
1.60 (m, 1 H, C3-H), 1.32-1.21 (comp, 2 H, C4-H), 0.79 (t, J = 7.3 Hz, 3 H, C5-H); 
13
C 
NMR (125 MHz, D2O) δ 177.0 (C1, C6, C10, C11, C14, C16, or C18), 176.9 (C1, C6, 
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C10, C11, C14, C16, or C18), 175.8 (C1, C6, C10, C11, C14, C16, or C18), 174.2 (C1, 
C6, C10, C11, C14, C16, or C18), 173.2 (C1, C6, C10, C11, C14, C16, or C18), 173.0 
(C1, C6, C10, C11, C14, C16, or C18), 172.4 (C1, C6, C10, C11, C14, C16, or C18), 
150.5 (C24), 131.8 (C21, C22, or C23), 130.2 (C21, C22, or C23), 130.2 (C21, C22, or 
C23), 120.5 (C21, C22, or C23), 120.5 (C21, C22, or C23), 55.2 (C2, C7, C15, or C17), 
52.8 (C2, C7, C15, or C17), 52.6 (C2, C7, C15, or C17), 52.6 (C2, C7, C15, or C17), 
36.2 (C20), 32.4 (C3), 29.8 (C9 or C13), 29.7 (C9 or C13), 26.0 (C8 or C12), 26.0 (C8 or 
C12), 21.6 (C19), 18.4 (C4), 12.7 (C5). 
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